data_2ltc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ltc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.471 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.441 -1.0 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.408 ' HG1' ' HA ' ' A' ' 532' ' ' ASN . 67.1 p -91.94 -172.12 3.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.712 0.291 . . . . 0.0 110.366 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.921 HG22 ' HB3' ' A' ' 531' ' ' LEU . 4.4 m -49.42 -29.89 4.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.897 170.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.491 ' HG2' ' CB ' ' A' ' 531' ' ' LEU . 85.3 mmm -67.64 -50.43 57.97 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.352 -0.217 . . . . 0.0 110.93 172.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . 0.471 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 1.0 OUTLIER -72.09 -29.77 64.45 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.136 -174.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 1.016 HG12 HG23 ' A' ' 625' ' ' VAL . 8.7 p -58.06 -35.02 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.504 0.669 . . . . 0.0 110.693 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.953 HD23 HG11 ' A' ' 508' ' ' VAL . 7.2 mt -81.65 -33.99 31.03 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.593 177.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -66.03 -25.02 66.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.856 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -102.24 1.88 50.66 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.76 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -111.5 141.83 44.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.522 0.661 . . . . 0.0 111.358 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . 0.441 ' HA ' ' OG ' ' A' ' 516' ' ' SER . 17.2 m120 -75.32 -23.99 57.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.035 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -87.07 -15.37 38.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.075 0.464 . . . . 0.0 110.418 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.871 ' HZ ' HG23 ' A' ' 627' ' ' VAL . 25.5 m-85 -109.51 8.1 25.04 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.898 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' SER . . . . . 0.441 ' OG ' ' HA ' ' A' ' 513' ' ' ASN . 67.8 m -57.24 -45.92 83.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -174.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.3 ttp -76.04 -24.02 55.16 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.218 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.524 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 46.8 tp -60.45 -45.22 94.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.984 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 515' ' ' PHE . 5.8 t -53.45 -46.61 59.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.553 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.2 72.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.685 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -71.81 -48.37 46.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.008 0.432 . . . . 0.0 109.931 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.746 HG12 HD21 ' A' ' 569' ' ' LEU . 43.3 mt -56.61 -39.0 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.612 0.72 . . . . 0.0 109.985 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -59.22 -53.25 60.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.909 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.0 m -59.23 -27.33 65.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.859 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -79.12 -28.25 42.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 65.02 32.58 84.67 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.675 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . 0.66 HD21 HD23 ' A' ' 569' ' ' LEU . 3.6 pp -102.65 24.58 10.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.356 0.578 . . . . 0.0 110.486 177.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 56.7 m -46.47 -53.12 11.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.295 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.41 -28.23 58.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -174.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 53.5 m -59.98 -52.47 65.25 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.715 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.921 ' HB3' HG22 ' A' ' 505' ' ' VAL . 27.2 mt -96.21 -8.43 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -175.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . 0.408 ' HA ' ' HG1' ' A' ' 504' ' ' THR . 4.1 t30 -92.88 -9.47 40.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.68 0.752 . . . . 0.0 110.409 -177.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -94.15 157.7 15.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.318 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -77.39 149.76 35.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.02 0.438 . . . . 0.0 110.785 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 164.66 -146.7 11.61 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.673 ' HB ' HG13 ' A' ' 577' ' ' ILE . 16.9 m -129.41 127.39 64.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -149.81 151.29 33.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 0.0 110.931 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 96.9 m -124.4 101.45 7.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.548 HG22 HG12 ' A' ' 573' ' ' ILE . 87.3 t -98.77 111.48 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.832 -174.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 56.3 m-85 -83.47 106.61 15.36 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -98.6 117.0 65.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.451 -166.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.599 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 72.3 Cg_endo -78.49 135.22 13.03 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.819 2.346 . . . . 0.0 112.121 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.3 p -78.45 -176.0 4.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.243 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . 0.5 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 12.0 m120 -73.68 -34.52 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.323 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 548' ' ' ARG . 1.5 pm0 -70.17 -18.99 63.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.099 0.476 . . . . 0.0 110.342 175.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.12 64.37 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.212 0.53 . . . . 0.0 110.789 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' A' ' 544' ' ' ASN . 19.2 m-85 -66.49 -12.78 59.17 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.195 172.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . 0.507 ' HA ' ' HE ' ' A' ' 548' ' ' ARG . 3.3 mmp_? -92.57 -13.63 29.44 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.323 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -92.36 4.61 53.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.917 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 66.5 mt -113.05 142.71 27.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 0.0 111.588 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 31.3 Cg_exo -59.08 128.07 26.45 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.358 2.039 . . . . 0.0 111.179 174.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.08 -29.07 53.63 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.955 2.437 . . . . 0.0 113.389 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -59.13 -53.82 54.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.524 0.202 . . . . 0.0 111.47 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.493 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 32.3 mm-40 -63.89 -37.33 86.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.313 0.577 . . . . 0.0 110.633 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -40.22 63.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.817 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 70.8 m -59.38 -22.96 62.15 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.65 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 554' ' ' GLU . 73.5 mtp180 -73.34 -45.14 56.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.298 173.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.641 ' HB3' ' HA ' ' A' ' 565' ' ' LEU . 13.1 mt -67.71 -53.42 27.67 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.559 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -15.58 63.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.802 0.334 . . . . 0.0 111.623 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -88.4 -29.44 19.37 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.44 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . 0.642 ' OD2' ' HG3' ' A' ' 563' ' ' LYS . 24.5 t70 -131.05 124.69 31.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.793 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -62.43 -47.06 85.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -171.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.642 ' HG3' ' OD2' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -72.31 -24.82 61.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.973 -177.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.544 ' HG3' HD21 ' A' ' 558' ' ' LEU . 5.2 tp10 -68.52 -42.71 78.11 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.641 ' HA ' ' HB3' ' A' ' 558' ' ' LEU . 3.4 tt -65.75 -50.97 62.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . 0.427 ' HB3' ' HE2' ' A' ' 570' ' ' LYS . . . -54.87 -32.16 60.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.693 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -52.77 -53.64 45.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.455 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 59.2 mt -82.57 -39.79 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.746 HD21 HG12 ' A' ' 522' ' ' ILE . 22.4 tp -55.75 -36.48 67.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.612 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 68.6 mttm -68.24 -22.64 64.76 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.805 0.336 . . . . 0.0 111.872 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.645 ' O ' HD22 ' A' ' 597' ' ' LEU . 32.5 t80 -80.15 -17.28 52.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.892 0.377 . . . . 0.0 110.842 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . 0.649 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 4.0 m80 -77.87 -8.89 58.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.263 0.554 . . . . 0.0 110.872 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 539' ' ' VAL . 36.2 mt -110.8 116.67 53.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.929 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -78.71 161.77 48.32 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.23 175.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.481 ' OD1' ' HB2' ' A' ' 590' ' ' LYS . 5.2 p-10 -81.57 -10.13 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -172.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -156.69 178.02 10.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 176.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.673 HG13 ' HB ' ' A' ' 536' ' ' VAL . 36.7 mt -89.87 114.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.113 0.482 . . . . 0.0 112.208 -168.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 5.6 tt -112.96 96.16 5.79 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.5 m -80.61 169.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.795 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 617' ' ' ASP . 35.5 p -47.46 -43.28 24.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.376 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -70.42 -6.87 59.4 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.988 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.76 -7.63 47.43 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.226 -0.511 . . . . 0.0 111.927 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.75 HG21 ' HB2' ' A' ' 601' ' ' LEU . 58.2 mt -76.76 104.97 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.982 0.42 . . . . 0.0 110.16 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -103.64 -152.11 22.81 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.003 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -50.91 -56.75 10.83 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.011 0.434 . . . . 0.0 110.534 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.402 HD22 ' HG3' ' A' ' 598' ' ' GLU . 6.3 tt -160.32 109.27 1.71 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.212 173.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 97.6 t -116.5 124.89 73.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.923 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -98.01 126.88 43.63 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.855 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 21.9 tp -115.94 142.46 46.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.492 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.481 ' HB2' ' OD1' ' A' ' 575' ' ' ASP . 37.2 mtmm -71.84 163.13 28.38 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.782 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.9 p -128.44 -176.83 3.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.005 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 63.1 mt -82.11 -41.86 19.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.38 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.52 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 31.9 tt0 -59.25 -29.83 67.84 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.579 0.704 . . . . 0.0 110.255 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.79 -11.06 7.46 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.642 169.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . 0.55 ' OD2' ' HG2' ' A' ' 596' ' ' LYS . 3.7 t70 -94.02 -156.38 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.493 0.646 . . . . 0.0 109.985 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.55 ' HG2' ' OD2' ' A' ' 595' ' ' ASP . 19.9 pttm -117.94 142.02 47.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.863 0.363 . . . . 0.0 111.215 -172.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.645 HD22 ' O ' ' A' ' 571' ' ' TYR . 67.1 mt -92.13 116.83 29.28 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 34.5 tt0 -91.26 85.83 5.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.348 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . 0.53 HG11 HG22 ' A' ' 583' ' ' ILE . 35.0 t -93.21 128.87 44.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.796 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 2.7 p -140.25 148.91 42.17 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.586 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.75 ' HB2' HG21 ' A' ' 583' ' ' ILE . 59.3 tp -119.25 112.8 19.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -131.13 110.42 11.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.967 0.413 . . . . 0.0 110.837 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 59.55 53.0 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.423 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 69.81 -5.56 1.21 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.875 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.59 120.73 46.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.88 0.372 . . . . 0.0 110.438 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.454 HG22 ' HG3' ' A' ' 616' ' ' PRO . 43.1 t -85.77 140.81 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.856 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 607' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 40.6 m -132.16 142.56 49.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.603 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.6 p -134.69 123.81 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 120.882 0.373 . . . . 0.0 110.046 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.695 ' ND2' HD11 ' A' ' 632' ' ' LEU . 31.5 m-20 61.15 32.1 19.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.559 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 53.2 mttp 76.56 -0.12 3.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.806 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.481 ' HB3' ' OD1' ' A' ' 630' ' ' ASN . 5.3 mm-40 -99.61 130.13 27.4 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.427 ' HD2' HD22 ' A' ' 630' ' ' ASN . 16.5 Cg_exo -68.81 134.46 30.11 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.988 2.458 . . . . 0.0 113.049 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 49.0 t -86.37 143.17 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.703 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.11 12.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.655 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 616' ' ' PRO . 32.0 tt0 -152.87 104.65 2.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.162 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . 0.479 ' HA ' ' HD1' ' A' ' 626' ' ' HIS . 75.0 Cg_endo -74.39 157.41 45.36 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.569 2.179 . . . . 0.0 113.114 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 580' ' ' SER . 1.3 t70 76.7 59.81 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.734 166.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 22.3 mt -108.81 97.12 5.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 165.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 57.4 mtp -79.93 142.64 34.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.621 0.724 . . . . 0.0 112.846 -167.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.72 -175.43 2.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.251 171.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 12.6 t -82.42 -17.16 46.35 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.316 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.668 HD22 HG21 ' A' ' 505' ' ' VAL . 32.1 p-10 -119.22 14.52 13.03 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 162.76 -160.29 32.69 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.139 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.73 148.96 32.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.746 0.308 . . . . 0.0 110.179 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . 1.016 HG23 HG12 ' A' ' 508' ' ' VAL . 87.5 t -118.28 145.21 24.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.481 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . 0.535 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 74.4 m-70 -132.08 126.43 33.76 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.871 HG23 ' HZ ' ' A' ' 515' ' ' PHE . 82.6 t -79.15 119.08 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.2 145.76 21.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.917 0.389 . . . . 0.0 110.241 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 22.9 p -97.73 9.77 41.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . 0.481 ' OD1' ' HB3' ' A' ' 611' ' ' GLU . 2.6 p30 -140.25 147.89 40.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.666 176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.404 HG11 ' N ' ' A' ' 632' ' ' LEU . 43.9 t -82.23 160.62 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.695 HD11 ' ND2' ' A' ' 609' ' ' ASN . 42.4 mt . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -167.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.688 0 CA-C-O 121.744 0.635 . . . . 0.0 113.398 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 508' ' ' VAL . 72.4 p -86.01 -171.2 3.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.299 -0.951 . . . . 0.0 110.14 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.689 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 36.4 t -43.9 -45.0 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 123.537 0.523 . . . . 0.0 111.185 173.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.499 ' HB2' ' HB2' ' A' ' 531' ' ' LEU . 10.2 tpt -63.78 -42.3 97.78 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.953 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . 0.507 ' HA ' ' HB2' ' A' ' 510' ' ' LYS . 25.3 t70 -67.78 -37.77 82.49 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.818 0.342 . . . . 0.0 110.631 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.518 HG21 ' HB2' ' A' ' 620' ' ' ALA . 82.8 t -50.61 -40.7 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.796 174.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 5.9 mt -82.37 -35.17 28.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.405 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 507' ' ' ASP . 17.3 mmmt -60.41 -40.71 91.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.823 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -90.87 -12.74 60.13 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.815 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -102.86 141.29 35.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.296 0.57 . . . . 0.0 111.092 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -75.94 -25.86 56.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.573 -174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -83.09 -15.98 48.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.1 0.476 . . . . 0.0 110.246 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.826 ' HZ ' HG21 ' A' ' 627' ' ' VAL . 24.6 m-85 -109.34 17.78 21.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.379 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 12.0 p -57.54 -61.38 2.54 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' MET . . . . . 0.444 ' HE3' ' CG ' ' A' ' 547' ' ' PHE . 2.4 ttp -70.57 -20.79 62.76 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.009 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.539 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 49.5 tp -57.42 -45.25 84.81 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.654 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.434 ' O ' ' HB2' ' A' ' 523' ' ' GLN . 9.1 t -51.39 -47.82 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.905 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.28 -39.32 89.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.905 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.46 -42.09 96.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.028 0.442 . . . . 0.0 110.404 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.676 HG12 HD13 ' A' ' 569' ' ' LEU . 49.8 mt -69.74 -29.1 39.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.557 0.694 . . . . 0.0 109.992 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.0 OUTLIER -65.48 -53.54 41.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.877 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.3 m -65.75 -16.19 63.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.986 0.422 . . . . 0.0 110.904 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -80.5 -17.34 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.267 173.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 74.93 17.94 80.19 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.381 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . 0.741 HD12 HD11 ' A' ' 569' ' ' LEU . 82.1 mt -97.31 17.15 18.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.556 -0.379 . . . . 0.0 111.556 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 46.6 m -55.99 -48.75 75.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . 0.654 ' HA ' ' HB2' ' A' ' 532' ' ' ASN . 31.8 tt0 -62.73 -25.04 67.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.621 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 40.6 m -61.23 -50.48 72.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.608 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.66 ' HG ' ' CG1' ' A' ' 505' ' ' VAL . 0.3 OUTLIER -84.82 -21.65 29.79 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.429 176.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . 0.654 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 0.9 OUTLIER -70.03 -22.2 63.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.671 0.272 . . . . 0.0 110.837 175.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -84.97 126.25 33.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . 0.466 ' OE2' ' HA ' ' A' ' 622' ' ' ASN . 13.9 tp10 -70.79 145.99 50.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.663 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 166.42 -132.1 2.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.827 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.557 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.5 m -137.36 127.47 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.656 0.265 . . . . 0.0 110.555 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -149.81 154.63 38.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.967 0.413 . . . . 0.0 110.626 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.7 m -129.02 105.01 7.91 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.779 HG21 HG12 ' A' ' 573' ' ' ILE . 93.5 t -107.26 113.89 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.065 -174.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 60.5 m-85 -83.1 111.25 18.72 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 171.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -104.65 119.71 52.73 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.964 -165.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 541' ' ' ALA . 5.7 Cg_exo -77.89 141.6 19.22 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.335 2.69 . . . . 0.0 112.018 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 81.2 p -83.38 -179.15 7.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.111 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -58.45 -40.47 82.69 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.21 0.529 . . . . 0.0 110.281 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 545' ' ' GLU . 1.5 mp0 -62.78 -23.4 67.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.163 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -78.08 -31.35 50.12 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.275 0.559 . . . . 0.0 111.878 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . 0.496 ' CD1' ' HZ2' ' A' ' 555' ' ' TRP . 41.7 m-85 -67.06 -12.56 60.26 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.238 175.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -91.52 -8.79 46.56 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.73 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -91.16 -8.51 48.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.391 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.55 HD11 ' HE1' ' A' ' 555' ' ' TRP . 40.8 mt -100.3 142.42 24.58 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.411 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.92 142.24 92.4 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.709 2.273 . . . . 0.0 111.665 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.14 -40.38 77.18 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.22 2.613 . . . . 0.0 113.123 -175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -59.61 -51.21 70.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.521 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.518 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 6.9 mp0 -60.43 -41.33 93.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.459 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' TRP . . . . . 0.55 ' HE1' HD11 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -69.17 -45.4 70.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.912 -177.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 35.2 p -58.58 -21.93 54.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.263 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -75.98 -49.86 16.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.87 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.606 ' HB3' ' HA ' ' A' ' 565' ' ' LEU . 12.9 mt -61.18 -63.68 1.21 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.728 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . 0.857 HD12 HD12 ' A' ' 565' ' ' LEU . 3.5 mm? -58.53 -12.02 3.57 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.297 0.639 . . . . 0.0 112.542 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -74.68 -35.46 51.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.876 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . 0.517 ' OD2' ' HG3' ' A' ' 563' ' ' LYS . 16.9 t70 -144.67 153.03 41.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.218 0.509 . . . . 0.0 111.127 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -62.49 -47.28 84.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.048 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.517 ' HG3' ' OD2' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -71.31 -17.75 62.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.941 -177.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.444 ' N ' ' HD3' ' A' ' 563' ' ' LYS . 5.6 mm-40 -81.12 -42.41 20.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.676 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.857 HD12 HD12 ' A' ' 559' ' ' LEU . 0.6 OUTLIER -69.89 -48.27 59.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.329 0.585 . . . . 0.0 109.655 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . 0.476 ' HB3' ' HE3' ' A' ' 570' ' ' LYS . . . -62.56 -27.54 69.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.834 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -52.49 -53.9 39.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.852 0.358 . . . . 0.0 110.686 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 66.1 mt -83.43 -39.06 14.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.366 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.741 HD11 HD12 ' A' ' 527' ' ' LEU . 0.8 OUTLIER -54.99 -32.74 61.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.124 -178.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 97.2 mttt -74.91 -13.75 60.57 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.563 ' O ' HD22 ' A' ' 597' ' ' LEU . 44.7 t80 -86.71 -19.11 29.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.048 0.452 . . . . 0.0 110.885 -177.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 15.3 m80 -77.78 -12.62 59.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.137 0.494 . . . . 0.0 110.566 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.779 HG12 HG21 ' A' ' 539' ' ' VAL . 68.3 mt -105.51 120.5 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.292 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.95 155.86 24.92 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.17 -4.86 57.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.29 168.54 23.76 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.506 0.193 . . . . 0.0 110.509 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.557 HG13 ' HB ' ' A' ' 536' ' ' VAL . 33.1 mt -89.0 117.5 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.602 -170.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 53.3 tp -117.66 97.9 6.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 24.4 m -79.24 170.64 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.096 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.605 ' HA ' HD12 ' A' ' 583' ' ' ILE . 17.9 m -55.96 -30.18 61.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.768 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.5 -13.43 65.46 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.135 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.86 -26.82 7.77 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.74 HG23 ' HB2' ' A' ' 601' ' ' LEU . 74.9 mt -60.9 103.89 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.069 0.461 . . . . 0.0 110.035 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -115.49 -137.03 6.13 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.12 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -59.67 -60.52 3.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 0.0 110.509 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 7.9 tt -157.9 112.75 2.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 67.2 t -121.65 133.53 67.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.128 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . 0.828 ' HD3' ' H ' ' A' ' 588' ' ' ARG . 0.0 OUTLIER -99.33 126.82 45.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.849 -179.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.47 125.51 49.09 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -75.02 143.24 43.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.221 0.534 . . . . 0.0 110.603 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.598 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 84.8 p -107.9 -178.62 3.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.735 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.554 ' CD1' HG22 ' A' ' 573' ' ' ILE . 7.0 mp -73.99 -36.14 64.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.38 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -65.97 -30.56 71.15 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 121.559 0.695 . . . . 0.0 110.138 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 126.24 -21.9 6.03 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.08 -0.964 . . . . 0.0 114.006 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 596' ' ' LYS . 5.5 t70 -81.85 -165.52 1.0 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.042 0.921 . . . . 0.0 110.585 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.468 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 0.2 OUTLIER -123.45 135.51 54.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 0.0 111.442 -170.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.563 HD22 ' O ' ' A' ' 571' ' ' TYR . 84.2 mt -84.74 122.09 28.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.482 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 37.3 mt-10 -92.05 90.27 7.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.44 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . 0.481 HG11 HG21 ' A' ' 583' ' ' ILE . 40.4 t -93.32 133.42 34.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.01 -176.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 32.2 t -143.92 136.82 27.35 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.74 ' HB2' HG23 ' A' ' 583' ' ' ILE . 63.7 tp -113.22 112.98 24.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -133.49 112.52 11.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 604' ' ' ASN . 15.3 t-20 60.03 47.14 10.04 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.13 0.491 . . . . 0.0 109.785 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' A' ' 603' ' ' ASN . 10.2 t30 74.11 -14.95 0.64 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.723 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 55.9 t -84.18 115.81 26.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 122.175 -0.328 . . . . 0.0 110.665 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.546 HG22 HD11 ' A' ' 601' ' ' LEU . 43.8 t -84.51 136.09 23.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.599 176.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 607' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 44.9 m -126.0 147.98 49.4 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 176.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.49 HG11 ' CD1' ' A' ' 540' ' ' PHE . 7.0 p -141.12 119.57 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 1.036 HD21 HD13 ' A' ' 632' ' ' LEU . 29.5 m-20 62.12 31.43 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 24.4 tptp 86.92 -24.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.215 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 14.4 mm-40 -83.24 132.02 51.53 Favored Pre-proline 0 C--N 1.317 -0.834 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.646 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 13.8 Cg_exo -71.28 135.25 26.48 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.117 2.544 . . . . 0.0 112.856 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.572 HG11 ' HB3' ' A' ' 626' ' ' HIS . 24.7 t -88.74 136.25 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.206 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -88.8 -48.52 7.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.667 -177.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -132.72 89.7 34.6 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.01 159.28 53.79 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.662 2.241 . . . . 0.0 113.431 171.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.482 ' HB2' ' HG ' ' A' ' 580' ' ' SER . 0.3 OUTLIER 75.76 39.02 0.34 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.438 165.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 41.5 mt -87.38 85.76 2.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 166.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 55.7 mtp -80.71 129.57 34.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.645 0.736 . . . . 0.0 112.715 -170.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 508' ' ' VAL . . . -99.65 -171.42 2.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.148 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.401 ' OG1' HG23 ' A' ' 504' ' ' THR . 62.4 p -73.67 -38.46 64.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.498 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.466 ' HA ' ' OE2' ' A' ' 534' ' ' GLU . 30.0 p-10 -99.19 6.06 46.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.47 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 164.27 -152.64 22.53 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.189 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 8.8 p -134.77 144.48 34.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.809 0.338 . . . . 0.0 110.697 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.89 140.55 37.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.709 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . 0.572 ' HB3' HG11 ' A' ' 613' ' ' VAL . 52.3 m-70 -126.9 126.44 43.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.389 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.826 HG21 ' HZ ' ' A' ' 515' ' ' PHE . 69.3 t -76.95 118.74 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.15 149.03 19.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.114 171.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 36.8 p -99.19 15.52 25.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.643 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -138.66 156.03 47.78 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.409 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.425 HG13 ' H ' ' A' ' 632' ' ' LEU . 36.1 t -98.37 160.73 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 174.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 1.036 HD13 HD21 ' A' ' 609' ' ' ASN . 16.2 mt . . . . . 0 C--N 1.319 -0.755 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.633 -167.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.444 -0.779 0 CA-C-O 121.747 0.637 . . . . 0.0 112.931 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.495 ' HG1' ' HA ' ' A' ' 532' ' ' ASN . 51.9 p -91.0 -170.33 2.64 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.862 -0.669 . . . . 0.0 109.687 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.78 HG13 HG22 ' A' ' 539' ' ' VAL . 99.4 t -47.18 -43.42 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 0.0 110.627 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.538 ' HE1' HG23 ' A' ' 528' ' ' THR . 36.0 tpp -62.7 -41.07 98.95 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.883 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . 0.822 ' HA ' ' HD3' ' A' ' 510' ' ' LYS . 7.7 t70 -68.17 -32.13 72.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.643 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 504' ' ' THR . 99.6 t -51.3 -60.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.432 173.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.606 HD13 ' O ' ' A' ' 505' ' ' VAL . 5.1 mp -57.36 -37.64 72.92 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.055 0.942 . . . . 0.0 112.18 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.822 ' HD3' ' HA ' ' A' ' 507' ' ' ASP . 40.1 mtpt -54.53 -39.82 68.03 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -94.18 -17.05 41.56 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.143 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -85.37 132.78 34.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.084 0.469 . . . . 0.0 111.092 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -76.49 -25.51 54.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.727 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -80.94 -21.77 40.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.791 0.329 . . . . 0.0 110.351 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.559 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 20.7 m-85 -109.6 13.44 23.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.417 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 74.6 m -57.69 -49.82 75.23 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.5 ttp -74.93 -20.77 59.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.51 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.681 HD12 ' HZ ' ' A' ' 547' ' ' PHE . 59.7 tp -59.48 -44.03 93.14 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.735 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 509' ' ' LEU . 9.4 t -51.66 -51.91 24.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.377 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.61 97.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.971 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.5 83.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.382 0.61 . . . . 0.0 110.406 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.77 HG12 HD22 ' A' ' 569' ' ' LEU . 97.5 mt -62.86 -37.68 79.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.619 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -63.32 -49.15 75.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.746 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 8.5 t -60.57 -32.82 71.89 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.059 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 565' ' ' LEU . . . -71.08 -22.26 62.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.031 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 75.98 19.33 78.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.257 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . 0.72 HD21 HD21 ' A' ' 569' ' ' LEU . 3.6 pp -106.79 22.25 16.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.478 0.639 . . . . 0.0 110.646 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.538 HG23 ' HE1' ' A' ' 506' ' ' MET . 42.0 m -54.6 -43.22 71.97 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.864 175.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 533' ' ' ARG . 7.9 pt-20 -57.22 -33.15 67.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.422 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.0 m -63.47 -52.57 60.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 110.401 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.444 HD23 HD11 ' A' ' 573' ' ' ILE . 59.8 mt -74.09 -22.75 59.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.542 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . 0.495 ' HA ' ' HG1' ' A' ' 504' ' ' THR . 1.0 OUTLIER -91.85 9.54 32.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 176.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 529' ' ' GLU . 71.4 ttt180 -101.87 143.32 31.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.831 0.348 . . . . 0.0 110.313 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.66 146.69 54.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.544 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 150.83 -139.96 7.59 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.629 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.462 ' HB ' HG13 ' A' ' 577' ' ' ILE . 8.3 m -135.84 127.47 44.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -149.33 146.82 27.72 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 97.5 m -119.11 102.45 8.74 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 170.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.78 HG22 HG13 ' A' ' 505' ' ' VAL . 93.3 t -99.32 113.47 34.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 -173.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.512 ' HB2' HD12 ' A' ' 632' ' ' LEU . 52.5 m-85 -86.14 103.87 15.19 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 171.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -96.88 115.24 65.64 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.373 -167.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.608 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 70.1 Cg_endo -81.32 135.04 9.3 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.461 2.107 . . . . 0.0 111.821 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.738 ' HG1' ' HG2' ' A' ' 545' ' ' GLU . 47.8 p -70.03 173.69 6.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.441 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . 0.535 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -67.82 -33.04 74.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.944 0.402 . . . . 0.0 110.902 -178.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.738 ' HG2' ' HG1' ' A' ' 543' ' ' THR . 1.7 pm0 -70.17 -19.75 63.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.858 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -76.34 -33.24 58.98 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.004 0.431 . . . . 0.0 111.3 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . 0.681 ' HZ ' HD12 ' A' ' 518' ' ' LEU . 14.8 m-85 -64.79 -14.85 60.54 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . 0.421 ' HD2' ' HA ' ' A' ' 548' ' ' ARG . 12.9 tpt180 -92.95 -14.75 27.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.84 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -80.67 -19.39 45.35 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.278 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.471 HD13 ' HB ' ' A' ' 631' ' ' VAL . 78.9 mt -97.95 137.2 20.89 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.888 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 34.8 Cg_exo -61.64 136.82 65.02 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.583 2.189 . . . . 0.0 112.051 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.64 -37.5 53.45 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.965 2.443 . . . . 0.0 112.437 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -54.31 -34.17 60.39 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.096 0.474 . . . . 0.0 111.245 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.93 -44.39 12.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.731 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' TRP . . . . . 0.475 ' CE3' HD13 ' A' ' 559' ' ' LEU . 0.0 OUTLIER -81.46 -37.94 27.2 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 29.3 t -54.66 -34.91 62.92 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -66.57 -42.88 86.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.506 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.685 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 46.3 mt -59.06 -54.36 47.98 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.858 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . 0.803 ' HG ' HD21 ' A' ' 565' ' ' LEU . 1.0 OUTLIER -70.7 -3.13 16.97 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -76.96 -29.57 56.97 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.681 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . 0.632 ' OD1' ' HG3' ' A' ' 563' ' ' LYS . 11.1 t70 -142.73 150.95 40.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.556 -176.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.05 81.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.632 ' HG3' ' OD1' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -80.52 -18.45 48.47 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.735 -178.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.506 ' HG2' ' HB3' ' A' ' 561' ' ' ASP . 15.5 mm-40 -72.38 -42.89 64.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.803 HD21 ' HG ' ' A' ' 559' ' ' LEU . 16.8 mt -61.93 -57.16 12.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.09 174.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -54.66 -27.27 38.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.991 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -53.41 -61.78 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.168 0.293 . . . . 0.0 111.491 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 68.7 mt -84.85 -37.65 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.873 0.368 . . . . 0.0 110.207 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.77 HD22 HG12 ' A' ' 522' ' ' ILE . 29.3 tp -55.0 -37.43 66.58 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.822 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 7.8 mtpm? -78.87 -12.91 60.05 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.629 ' HB2' ' CB ' ' A' ' 593' ' ' GLN . 62.0 t80 -84.4 -11.99 55.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.414 0.626 . . . . 0.0 109.666 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . 0.699 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 1.2 m80 -79.49 -16.7 55.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.871 171.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.611 ' HB ' ' HG ' ' A' ' 592' ' ' LEU . 10.7 mm -98.31 115.53 38.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.598 -176.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -80.45 153.83 35.73 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.043 172.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.79 -11.82 59.92 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -171.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.6 177.68 10.1 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.462 HG13 ' HB ' ' A' ' 536' ' ' VAL . 41.7 mt -87.28 120.07 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.572 -172.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 589' ' ' LEU . 4.2 tt -121.36 99.32 6.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.0 167.91 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.918 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.665 ' HB2' ' HB2' ' A' ' 617' ' ' ASP . 36.6 t -56.98 -34.89 68.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.464 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.36 -9.57 61.33 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.345 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -106.03 -9.43 32.19 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.596 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 580' ' ' SER . 76.0 mt -61.97 -44.39 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . 59.14 -99.0 0.12 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.753 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -121.03 -53.18 2.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.937 0.399 . . . . 0.0 110.197 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 599' ' ' VAL . 5.3 tt -162.35 107.75 1.21 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 75.1 t -126.73 129.3 71.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . 0.612 ' HD3' ' HD2' ' A' ' 596' ' ' LYS . 4.0 ptp85 -97.09 128.16 43.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.727 0.775 . . . . 0.0 111.753 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.553 ' HB2' HD11 ' A' ' 578' ' ' LEU . 21.4 tp -120.4 131.92 55.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.843 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.61 ' HA ' ' HA ' ' A' ' 596' ' ' LYS . 81.1 tttt -76.51 151.97 36.22 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.169 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.587 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 85.7 p -110.9 -173.69 2.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.51 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.654 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 59.6 mt -80.43 -36.12 34.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.132 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.629 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.3 tt0 -58.46 -30.78 67.21 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.365 0.602 . . . . 0.0 110.502 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.7 6.14 6.16 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.079 -1.058 . . . . 0.0 114.89 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . 0.432 ' CG ' ' H ' ' A' ' 596' ' ' LYS . 7.4 t70 -123.52 -170.54 2.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 118.033 0.917 . . . . 0.0 109.793 174.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.612 ' HD2' ' HD3' ' A' ' 588' ' ' ARG . 23.4 pttm -103.82 142.04 35.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.124 0.487 . . . . 0.0 111.175 -172.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 571' ' ' TYR . 41.8 mt -89.95 117.03 28.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.629 175.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -82.35 94.24 7.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . 0.501 HG13 HG23 ' A' ' 583' ' ' ILE . 45.6 t -100.56 124.25 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.782 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.632 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 32.9 t -122.77 161.52 23.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.67 -176.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.498 HD13 HG23 ' A' ' 606' ' ' VAL . 60.0 tp -142.53 113.22 7.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . 0.586 ' O ' HG13 ' A' ' 605' ' ' VAL . 87.8 tttt -135.13 99.79 4.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.806 0.336 . . . . 0.0 110.443 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.56 67.0 1.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.655 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 69.31 10.38 7.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 171.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 602' ' ' LYS . 11.6 p -122.15 126.84 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.175 0.512 . . . . 0.0 110.962 171.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 40.0 t -93.83 138.15 21.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.537 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 607' ' ' SER . . . . . 0.632 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 19.3 m -124.26 104.47 8.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 540' ' ' PHE . 6.9 p -110.4 117.1 54.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.867 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.643 HD21 ' HB3' ' A' ' 632' ' ' LEU . 9.0 m-20 60.72 33.55 20.16 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.812 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . 0.408 ' HZ1' ' HB2' ' A' ' 610' ' ' LYS . 19.5 mtmm 83.18 -13.1 0.82 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.013 1.325 . . . . 0.0 111.861 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.501 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 19.9 mm-40 -91.7 132.47 33.06 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.96 0.409 . . . . 0.0 110.604 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 2.7 Cg_exo -75.5 125.95 9.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.909 2.406 . . . . 0.0 112.38 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 22.9 t -83.7 133.1 29.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -75.76 -60.28 2.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.972 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -138.89 101.18 7.88 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.606 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . 0.487 ' CB ' ' HD1' ' A' ' 626' ' ' HIS . 80.5 Cg_endo -73.1 168.74 23.96 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.877 2.385 . . . . 0.0 114.137 176.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.665 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 1.4 t70 76.11 42.79 0.18 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.158 165.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 36.7 mt -94.62 92.65 3.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 167.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.486 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 59.5 mtp -80.09 136.16 36.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.243 0.544 . . . . 0.0 112.268 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -99.49 -172.76 2.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.501 172.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 13.2 p -76.76 -26.73 54.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.965 0.412 . . . . 0.0 111.316 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.485 ' OD1' HG21 ' A' ' 505' ' ' VAL . 27.0 p-10 -116.8 15.7 15.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.894 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . 0.425 ' HA2' HG12 ' A' ' 577' ' ' ILE . . . 164.3 -157.53 29.88 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.921 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 13.0 p -133.43 144.73 35.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.826 0.346 . . . . 0.0 110.652 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 79.6 t -114.72 142.27 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.226 0.536 . . . . 0.0 110.48 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . 0.487 ' HD1' ' CB ' ' A' ' 616' ' ' PRO . 68.0 m-70 -126.59 121.9 33.53 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.262 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.559 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 85.4 t -76.16 117.98 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 111.501 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . 0.474 HG13 ' HA ' ' A' ' 542' ' ' PRO . 1.5 pt -119.02 142.53 33.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.291 173.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 39.9 p -96.29 7.41 46.53 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.708 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . 0.427 ' O ' HD11 ' A' ' 628' ' ' ILE . 6.0 m-20 -128.79 144.05 51.07 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.249 176.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.592 HG13 ' HE2' ' A' ' 572' ' ' HIS . 47.0 t -83.43 157.31 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.699 ' HB2' ' CE1' ' A' ' 572' ' ' HIS . 86.9 mt . . . . . 0 C--N 1.32 -0.689 0 CA-C-O 121.323 0.582 . . . . 0.0 111.397 -166.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.546 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.681 0 N-CA-C 112.105 -0.398 . . . . 0.0 112.105 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 58.3 p -94.46 -170.31 2.23 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.576 ' O ' HD13 ' A' ' 509' ' ' LEU . 73.0 t -46.06 -42.83 4.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.603 170.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.407 ' HE2' HG13 ' A' ' 519' ' ' VAL . 7.7 tpt -59.73 -40.61 88.63 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.659 0.266 . . . . 0.0 111.066 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . 0.546 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 2.2 t70 -68.81 -34.55 75.72 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.207 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 505' ' ' VAL . 99.1 t -51.79 -56.89 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.001 0.429 . . . . 0.0 110.85 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 509' ' ' LEU . 5.4 mp -57.31 -42.33 81.62 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.461 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 510' ' ' LYS . 1.5 tmmt? -67.32 -25.76 66.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -99.49 13.01 61.51 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.872 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -122.63 139.13 54.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.922 0.391 . . . . 0.0 110.895 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -75.46 -16.47 60.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.489 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -91.29 -24.83 19.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.824 0.345 . . . . 0.0 110.901 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.899 ' HZ ' HG21 ' A' ' 627' ' ' VAL . 17.2 m-85 -107.01 8.36 30.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.656 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 13.3 p -54.05 -54.22 42.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' MET . . . . . 0.443 ' HE3' ' HB3' ' A' ' 517' ' ' MET . 3.7 tmm? -67.87 -29.89 69.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.214 0.53 . . . . 0.0 109.866 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 41.8 tp -57.42 -45.83 84.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.404 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 515' ' ' PHE . 10.0 t -52.75 -52.02 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.394 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.54 77.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.181 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -72.67 -49.57 30.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.51 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.494 HG12 HD12 ' A' ' 569' ' ' LEU . 77.1 mt -57.94 -35.1 50.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.502 0.668 . . . . 0.0 109.681 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.0 OUTLIER -56.63 -57.5 12.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.21 173.279 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.2 m -57.4 -26.55 61.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.793 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -77.95 -15.85 58.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.369 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 79.51 8.29 87.86 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.341 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 566' ' ' ALA . 71.2 mt -83.26 9.19 11.3 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.795 0.331 . . . . 0.0 111.06 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 46.4 m -52.99 -43.66 66.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -51.54 -45.89 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.388 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 16.2 m -63.91 -41.87 97.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.337 . . . . 0.0 111.735 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 80.5 mt -91.24 -14.1 31.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.841 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . 0.431 ' N ' HD21 ' A' ' 532' ' ' ASN . 0.9 OUTLIER -87.56 -7.4 57.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.023 0.439 . . . . 0.0 110.341 172.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -92.79 147.47 22.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.468 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.11 151.94 43.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.71 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 153.0 -161.18 29.48 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.892 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.675 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.7 m -120.76 127.71 75.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.808 0.337 . . . . 0.0 110.23 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -141.84 155.53 45.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.083 0.468 . . . . 0.0 111.046 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.1 m -124.42 100.83 6.86 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 167.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.594 HG23 HG12 ' A' ' 573' ' ' ILE . 59.7 t -104.54 113.78 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -173.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.594 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 60.3 m-85 -86.26 113.84 22.59 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -103.58 116.57 61.73 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.97 139.42 29.99 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.251 2.634 . . . . 0.0 112.007 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 628' ' ' ILE . 67.6 p -83.05 -176.42 6.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.138 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.22 -30.95 69.73 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.112 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -64.53 -29.81 70.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -67.79 -35.28 78.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.378 0.609 . . . . 0.0 111.339 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . 0.487 ' O ' HD21 ' A' ' 550' ' ' LEU . 6.2 m-85 -73.25 -13.28 61.11 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.131 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -94.57 -38.53 10.83 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.148 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -90.96 7.24 41.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.393 0.616 . . . . 0.0 111.508 -172.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.757 HD11 ' CD1' ' A' ' 555' ' ' TRP . 0.5 OUTLIER -74.97 163.52 67.65 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.235 -178.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.603 ' HB2' ' OE1' ' A' ' 554' ' ' GLU . 3.3 Cg_exo -81.09 126.36 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.307 2.005 . . . . 0.0 109.916 166.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.7 -43.24 60.97 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.518 2.812 . . . . 0.0 114.263 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' A' ' 553' ' ' ARG . 24.9 mmt180 -71.93 -23.44 61.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 111.486 -172.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.618 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 0.9 OUTLIER -60.88 -53.48 56.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.45 0.643 . . . . 0.0 110.492 175.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' TRP . . . . . 0.757 ' CD1' HD11 ' A' ' 550' ' ' LEU . 4.7 m95 -80.3 -30.34 38.25 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.784 -172.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.425 ' OG ' ' HA ' ' A' ' 553' ' ' ARG . 25.3 p -58.68 -25.45 62.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.337 0.589 . . . . 0.0 109.577 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . 0.753 ' HG3' ' HG2' ' A' ' 564' ' ' GLU . 26.5 tpt180 -84.72 -46.98 10.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.743 173.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 554' ' ' GLU . 74.9 mt -63.19 -60.18 3.76 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . 0.419 HD21 HD12 ' A' ' 565' ' ' LEU . 0.1 OUTLIER -64.57 -12.35 44.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.891 0.376 . . . . 0.0 110.984 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -70.82 -35.84 65.98 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.848 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -145.78 147.3 31.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.319 0.56 . . . . 0.0 110.891 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -67.96 -47.29 69.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.367 -170.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.521 ' H ' ' HD2' ' A' ' 563' ' ' LYS . 0.0 OUTLIER -69.7 -22.85 63.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.061 -177.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.753 ' HG2' ' HG3' ' A' ' 557' ' ' ARG . 7.4 tp10 -77.75 -42.41 34.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.691 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -60.96 -49.43 77.5 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.495 0.664 . . . . 0.0 109.359 175.325 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . 0.492 ' HA ' HD11 ' A' ' 527' ' ' LEU . . . -55.83 -32.81 63.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.537 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . 0.401 ' O ' ' HG2' ' A' ' 570' ' ' LYS . 25.6 t-20 -57.63 -46.97 83.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.458 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.581 HD13 HD11 ' A' ' 558' ' ' LEU . 24.4 mt -83.98 -41.62 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.991 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.494 HD12 HG12 ' A' ' 522' ' ' ILE . 36.0 mt -57.87 -27.34 63.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 592' ' ' LEU . 22.3 ptmt -76.79 -12.66 60.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.014 0.435 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.593 ' O ' HD23 ' A' ' 597' ' ' LEU . 41.1 t80 -83.53 -18.72 37.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.228 0.537 . . . . 0.0 109.79 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . 0.724 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 20.8 m80 -76.16 -10.12 59.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.178 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.594 HG12 HG23 ' A' ' 539' ' ' VAL . 80.1 mt -115.78 119.63 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.056 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -83.83 161.96 38.75 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.902 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -90.15 3.19 54.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -160.68 170.45 20.76 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.436 172.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.675 HG13 ' HB ' ' A' ' 536' ' ' VAL . 64.3 mt -87.9 126.2 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.207 -168.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 589' ' ' LEU . 2.4 tt -121.51 93.51 4.03 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 20.7 m -77.65 166.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 111.81 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.609 ' HA ' HD11 ' A' ' 583' ' ' ILE . 20.9 t -62.24 -28.19 69.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.306 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.66 68.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.082 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.23 -22.54 11.58 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.035 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.85 HG23 ' HB2' ' A' ' 601' ' ' LEU . 74.0 mt -59.99 109.8 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.103 0.478 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -114.22 -154.24 11.02 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.576 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -50.92 -48.56 60.64 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.981 0.39 . . . . 0.0 110.79 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 4.1 tt -164.36 116.62 1.32 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.67 123.96 46.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . 0.463 ' HD3' ' H ' ' A' ' 588' ' ' ARG . 0.1 OUTLIER -97.23 129.66 44.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.544 0.687 . . . . 0.0 110.873 -174.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.756 ' HB2' HD13 ' A' ' 578' ' ' LEU . 1.5 tm? -110.94 120.04 41.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.242 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -67.24 146.93 53.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.111 0.481 . . . . 0.0 111.286 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.678 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.1 p -106.69 -174.78 2.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.835 -176.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 570' ' ' LYS . 72.9 mt -82.03 -41.44 20.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.06 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.51 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.7 tt0 -59.05 -29.76 67.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.126 0.489 . . . . 0.0 111.024 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 126.74 -14.16 6.76 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.573 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -89.9 -164.38 1.15 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.754 0.777 . . . . 0.0 109.601 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -120.79 137.16 54.67 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.904 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 571' ' ' TYR . 90.6 mt -84.57 116.16 23.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.719 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 90.2 mt-10 -85.28 89.69 7.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.293 -175.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . 0.497 HG11 HG21 ' A' ' 583' ' ' ILE . 47.8 t -91.04 122.23 42.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.74 0.305 . . . . 0.0 111.272 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 35.9 t -128.53 154.53 46.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.85 ' HB2' HG23 ' A' ' 583' ' ' ILE . 41.0 tp -126.07 129.07 48.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . 0.475 ' HE2' ' HB2' ' A' ' 602' ' ' LYS . 19.1 ttmm -146.78 102.63 3.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.734 0.302 . . . . 0.0 110.199 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 605' ' ' VAL . 18.7 t-20 58.72 56.88 3.95 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.389 -176.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 68.28 -14.89 0.23 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.983 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' A' ' 603' ' ' ASN . 58.7 t -82.42 110.42 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.582 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 55.9 t -79.38 136.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.837 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 607' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 36.8 m -124.23 109.42 13.38 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.948 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 11.4 p -112.95 129.14 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.424 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.665 ' ND2' HD11 ' A' ' 632' ' ' LEU . 44.0 m-20 57.86 29.43 17.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm 74.04 22.48 2.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.453 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 0.2 OUTLIER -125.95 149.08 65.05 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 5.9 Cg_exo -78.81 126.27 7.17 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.085 2.524 . . . . 0.0 112.666 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.582 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 61.2 t -77.76 136.0 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.524 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -84.74 -42.17 15.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.957 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.58 95.11 3.78 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.665 0.269 . . . . 0.0 110.731 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.99 167.15 27.68 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.437 2.091 . . . . 0.0 113.873 172.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.554 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 3.3 t70 75.15 28.95 0.98 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.721 165.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.51 86.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 63.1 mtp -78.38 148.08 33.83 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.362 0.601 . . . . 0.0 112.285 -171.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -124.17 -171.14 2.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.646 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.6 p -80.68 -19.71 44.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.748 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.484 ' OD1' HG22 ' A' ' 505' ' ' VAL . 24.4 p-10 -117.47 15.98 14.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.838 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.15 -148.34 19.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.886 -1.149 . . . . 0.0 113.085 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.7 p -132.14 147.6 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.575 0.226 . . . . 0.0 110.541 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 78.6 t -118.79 142.29 34.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.078 0.465 . . . . 0.0 110.768 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . 0.594 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 52.2 m-70 -130.42 126.82 37.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.413 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.899 HG21 ' HZ ' ' A' ' 515' ' ' PHE . 96.2 t -74.47 118.29 19.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.91 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 543' ' ' THR . 1.2 pt -110.49 171.86 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.014 0.435 . . . . 0.0 110.714 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 21.6 p -117.42 -5.89 11.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.711 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -131.39 168.2 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.306 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 76.8 t -84.03 148.21 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.724 ' HB2' ' CE1' ' A' ' 572' ' ' HIS . 82.6 mt . . . . . 0 C--N 1.32 -0.697 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.291 -170.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.513 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.441 -0.968 0 CA-C-O 121.282 0.379 . . . . 0.0 112.454 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.481 HG22 ' OE2' ' A' ' 534' ' ' GLU . 82.0 p -86.17 -168.94 2.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.647 -0.777 . . . . 0.0 110.988 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 4.7 p -56.94 -27.21 26.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.614 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.547 ' HE2' HG22 ' A' ' 522' ' ' ILE . 39.5 tpp -71.05 -44.5 65.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.842 174.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . 0.65 ' HA ' ' HB3' ' A' ' 510' ' ' LYS . 5.9 t70 -68.68 -27.31 65.86 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.031 0.443 . . . . 0.0 110.198 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 504' ' ' THR . 91.4 t -50.02 -41.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.674 171.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.481 ' N ' HD21 ' A' ' 509' ' ' LEU . 0.6 OUTLIER -82.03 -36.36 27.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.887 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.65 ' HB3' ' HA ' ' A' ' 507' ' ' ASP . 28.7 tttm -62.5 -31.45 72.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.802 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -93.78 6.57 73.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.007 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -114.66 137.64 51.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.816 0.341 . . . . 0.0 111.007 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -75.8 -24.08 55.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.589 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -77.56 -28.89 51.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.367 0.603 . . . . 0.0 109.7 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.796 ' HZ ' HG23 ' A' ' 627' ' ' VAL . 26.9 m-85 -105.28 14.78 28.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.877 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 34.8 p -56.45 -53.16 60.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.865 -176.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' MET . . . . . 0.423 ' HE2' ' HB3' ' A' ' 517' ' ' MET . 2.3 tmm? -68.42 -30.53 69.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.07 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.606 HD12 ' HZ ' ' A' ' 547' ' ' PHE . 54.7 tp -55.4 -47.5 75.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.76 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.63 HG23 ' HA ' ' A' ' 510' ' ' LYS . 4.0 t -52.27 -47.2 45.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.716 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.82 74.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.041 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.6 -50.2 39.66 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.283 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.552 HG12 HD12 ' A' ' 569' ' ' LEU . 42.9 mt -60.59 -31.38 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.529 0.681 . . . . 0.0 109.658 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.5 OUTLIER -59.63 -59.33 5.61 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.203 173.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.0 m -58.08 -26.83 63.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.897 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 565' ' ' LEU . . . -75.09 -17.29 60.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.184 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 70.96 50.32 24.0 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.612 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 566' ' ' ALA . 76.9 mt -128.41 15.47 6.6 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.486 ' HA ' ' HE1' ' A' ' 506' ' ' MET . 88.1 m -61.82 -51.57 67.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . 0.658 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 0.0 OUTLIER -60.24 -29.08 68.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.486 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 36.7 m -62.42 -47.95 81.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.962 0.41 . . . . 0.0 110.491 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.545 HD11 ' HE3' ' A' ' 506' ' ' MET . 67.2 mt -91.09 -5.03 55.74 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.693 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 0.9 OUTLIER -83.95 -5.89 59.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.042 172.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 80.5 mtp180 -85.65 135.41 33.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.792 0.33 . . . . 0.0 110.661 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . 0.481 ' OE2' HG22 ' A' ' 504' ' ' THR . 13.3 mm-40 -78.76 137.04 37.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.951 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 164.47 -117.29 0.75 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.053 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 1.049 HG23 HG13 ' A' ' 577' ' ' ILE . 0.7 OUTLIER -145.99 125.56 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.58 0.229 . . . . 0.0 110.709 -178.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -155.03 137.22 14.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.68 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' THR . . . . . 0.563 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 98.1 m -107.35 102.32 11.62 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.704 HG23 HG12 ' A' ' 573' ' ' ILE . 61.3 t -99.84 114.89 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.095 0.474 . . . . 0.0 111.211 -175.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 48.6 m-85 -85.77 108.39 18.06 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -100.56 119.39 58.85 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.057 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.553 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 85.5 Cg_endo -82.76 140.14 10.22 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.53 2.153 . . . . 0.0 112.437 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 75.4 p -78.7 -175.93 4.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.532 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -68.94 -35.23 76.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.378 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 545' ' ' GLU . 1.7 mp0 -61.62 -29.96 70.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.064 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -70.07 -34.48 73.25 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.392 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . 0.606 ' HZ ' HD12 ' A' ' 518' ' ' LEU . 21.9 m-85 -70.87 -15.9 62.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.605 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -91.46 -10.91 39.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.063 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -88.09 -2.06 58.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.362 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.691 HD11 ' HE1' ' A' ' 555' ' ' TRP . 66.5 mt -109.68 144.07 29.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.189 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.74 126.5 18.34 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.506 2.137 . . . . 0.0 111.126 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.27 -24.61 60.54 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.891 2.394 . . . . 0.0 113.499 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -68.27 -40.84 81.73 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.788 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -37.84 79.68 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.677 0.751 . . . . 0.0 109.574 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' TRP . . . . . 0.691 ' HE1' HD11 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -70.35 -38.24 74.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.832 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.4 t -55.16 -28.25 51.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.574 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . 0.889 ' HG2' ' HG2' ' A' ' 564' ' ' GLU . 14.6 ttp85 -75.72 -32.11 59.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.817 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.464 ' HB3' ' HG ' ' A' ' 565' ' ' LEU . 9.1 mt -78.4 -53.74 6.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.056 0.455 . . . . 0.0 110.333 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -70.64 -14.31 62.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.261 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -90.6 -49.01 3.3 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -105.15 114.32 28.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.103 0.477 . . . . 0.0 110.063 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.19 -33.09 73.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.214 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -62.31 -37.36 85.28 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.889 ' HG2' ' HG2' ' A' ' 557' ' ' ARG . 7.8 tp10 -69.48 -44.79 70.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.945 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 558' ' ' LEU . 0.5 OUTLIER -62.28 -42.02 98.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . 0.48 ' HA ' HD13 ' A' ' 527' ' ' LEU . . . -57.94 -38.13 75.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.363 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 564' ' ' GLU . 92.7 m-20 -57.06 -56.83 16.64 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.9 0.381 . . . . 0.0 111.077 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 50.3 mt -67.53 -50.21 63.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.486 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.552 HD12 HG12 ' A' ' 522' ' ' ILE . 83.2 mt -59.73 -23.22 63.01 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 34.7 mttp -70.89 -18.09 62.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.781 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.621 ' O ' HD21 ' A' ' 597' ' ' LEU . 35.3 t80 -92.74 -1.83 56.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.398 0.618 . . . . 0.0 110.167 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . 0.595 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 5.7 m80 -89.58 -15.13 33.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.208 174.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.704 HG12 HG23 ' A' ' 539' ' ' VAL . 76.3 mt -111.02 121.0 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.873 -175.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.635 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -88.23 153.85 24.77 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.295 176.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.9 -21.32 64.24 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . 0.616 ' HA ' ' CG2' ' A' ' 536' ' ' VAL . 15.7 pt-20 -145.4 153.3 41.06 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 122.224 -0.298 . . . . 0.0 110.676 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 1.049 HG13 HG23 ' A' ' 536' ' ' VAL . 75.2 mt -70.24 114.62 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.814 -176.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' A' ' 589' ' ' LEU . 1.6 tt -111.4 98.96 7.85 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 28.5 m -76.59 163.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.534 -176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.663 ' HA ' HD11 ' A' ' 583' ' ' ILE . 28.4 m -56.75 -31.13 64.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.378 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.19 -15.54 67.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.861 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.1 -10.97 40.92 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.219 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.663 HD11 ' HA ' ' A' ' 580' ' ' SER . 71.0 mt -78.18 -3.86 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 122.876 0.47 . . . . 0.0 111.262 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -50.7 129.12 29.86 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.804 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 71.49 -85.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.796 0.838 . . . . 0.0 110.868 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.468 HD21 ' HG3' ' A' ' 598' ' ' GLU . 4.7 tt -167.55 117.56 0.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 89.6 t -132.94 130.72 58.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.941 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . 0.516 ' HB3' ' OE1' ' A' ' 598' ' ' GLU . 0.7 OUTLIER -96.96 128.77 44.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.577 0.703 . . . . 0.0 111.28 -178.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.705 ' HB2' HD13 ' A' ' 578' ' ' LEU . 31.1 tp -116.84 126.73 53.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.369 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -65.9 134.35 52.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.777 0.323 . . . . 0.0 110.373 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.635 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 86.7 p -99.24 -171.63 2.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.554 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 570' ' ' LYS . 79.3 mt -81.64 -39.05 25.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -62.54 -30.36 71.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.559 0.695 . . . . 0.0 110.263 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.44 -17.46 6.96 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.503 170.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . 0.486 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.3 t70 -84.12 -176.77 6.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.461 0.631 . . . . 0.0 109.705 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.21 139.56 39.69 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.871 0.367 . . . . 0.0 110.693 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.621 HD21 ' O ' ' A' ' 571' ' ' TYR . 94.9 mt -81.97 115.52 21.17 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.516 ' OE1' ' HB3' ' A' ' 588' ' ' ARG . 2.3 tp10 -94.07 87.28 5.26 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 608' ' ' VAL . 2.0 t -99.12 128.16 51.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.007 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.611 ' O ' ' HA ' ' A' ' 606' ' ' VAL . 33.1 t -131.29 108.5 9.71 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.365 -174.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 606' ' ' VAL . 56.8 tp -108.16 116.09 31.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.825 0.345 . . . . 0.0 110.442 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -151.37 133.63 15.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.678 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 58.58 40.56 23.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.598 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . 0.458 HD21 ' HA ' ' A' ' 604' ' ' ASN . 7.1 m120 66.15 11.87 8.14 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.597 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.84 107.47 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.022 0.439 . . . . 0.0 110.223 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.863 HG12 ' HB ' ' A' ' 613' ' ' VAL . 1.4 p -98.14 137.84 24.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.668 176.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 50.3 m -132.19 120.57 22.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 599' ' ' VAL . 7.6 p -110.27 123.65 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.067 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.709 ' ND2' HD13 ' A' ' 632' ' ' LEU . 24.0 m-20 61.38 33.88 18.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.468 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 48.5 mtpt 83.31 -14.19 0.73 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.32 1.012 . . . . 0.0 112.03 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 34.0 mm-40 -96.72 122.59 56.57 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.811 0.339 . . . . 0.0 110.547 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 23.7 Cg_exo -63.83 133.71 40.26 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.851 2.367 . . . . 0.0 112.499 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.863 ' HB ' HG12 ' A' ' 606' ' ' VAL . 44.4 t -88.8 137.46 21.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -87.09 -60.61 1.93 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.397 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -128.23 92.44 41.49 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.618 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.28 167.72 26.59 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.606 2.204 . . . . 0.0 113.219 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 74.88 38.28 0.46 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.463 0.705 . . . . 0.0 112.827 166.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 34.0 mt -98.11 89.9 2.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 171.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 53.0 mtp -82.44 160.46 22.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.542 0.686 . . . . 0.0 112.499 -169.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . 0.422 ' HB1' HG22 ' A' ' 508' ' ' VAL . . . -130.95 -171.17 2.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.446 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 26.0 p -72.93 -37.11 67.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.181 0.515 . . . . 0.0 110.811 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.463 ' HB3' ' OE2' ' A' ' 534' ' ' GLU . 33.4 p-10 -109.95 13.41 23.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.172 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 165.3 -138.1 5.05 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.193 -1.479 . . . . 0.0 113.927 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 10.1 p -160.13 148.74 6.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.727 -171.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.49 139.99 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.296 0.57 . . . . 0.0 110.968 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 60.9 m-70 -127.52 117.85 22.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.796 HG23 ' HZ ' ' A' ' 515' ' ' PHE . 58.1 t -72.34 119.0 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -173.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -114.31 150.0 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.074 0.464 . . . . 0.0 110.733 173.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 18.1 p -96.82 6.84 47.9 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.924 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -138.67 155.21 48.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.953 0.406 . . . . 0.0 111.489 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 60.4 t -86.99 157.21 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.709 HD13 ' ND2' ' A' ' 609' ' ' ASN . 38.2 mt . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 120.724 0.297 . . . . 0.0 110.899 -167.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.619 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 508' ' ' VAL . 68.7 p -124.91 -170.48 2.17 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 54.8 t -42.54 -42.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.638 0.586 . . . . 0.0 110.727 168.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.476 ' HE3' HG13 ' A' ' 519' ' ' VAL . 0.0 OUTLIER -60.39 -48.9 79.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.261 -178.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -71.54 -28.32 63.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.816 0.341 . . . . 0.0 110.456 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 504' ' ' THR . 71.5 t -53.98 -42.7 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.588 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 4.8 mt -82.18 -33.18 29.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.162 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.526 ' HA ' HG21 ' A' ' 519' ' ' VAL . 1.9 tmmm? -59.9 -40.02 87.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.991 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -89.13 -2.81 76.96 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.785 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.35 144.98 30.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.645 0.723 . . . . 0.0 110.811 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -75.25 -35.0 61.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.578 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -78.43 -13.37 59.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.881 0.372 . . . . 0.0 110.445 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.631 ' HZ ' HG21 ' A' ' 627' ' ' VAL . 24.1 m-85 -113.41 9.63 18.19 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.003 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 64.5 m -58.54 -44.53 89.65 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -173.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.0 ptm -83.24 -20.15 35.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.701 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.56 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 46.9 tp -57.95 -41.67 83.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.38 0.609 . . . . 0.0 109.462 172.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.526 HG21 ' HA ' ' A' ' 510' ' ' LYS . 18.6 t -52.04 -52.97 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.666 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -60.32 -32.84 71.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.6 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.11 -49.87 46.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.951 0.405 . . . . 0.0 110.508 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.457 HG22 ' HB2' ' A' ' 527' ' ' LEU . 58.6 mt -59.42 -34.2 53.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.486 0.66 . . . . 0.0 109.953 175.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -66.56 -49.51 66.16 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.924 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.3 m -57.12 -34.27 68.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.378 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.88 ' HB3' HD21 ' A' ' 565' ' ' LEU . . . -78.18 -17.97 56.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.142 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 74.58 18.62 79.99 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.005 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . 0.457 ' HB2' HG22 ' A' ' 522' ' ' ILE . 93.3 mt -84.6 5.83 26.31 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.547 -0.384 . . . . 0.0 111.466 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 19.0 m -56.76 -44.13 81.48 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.097 0.475 . . . . 0.0 109.954 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -53.99 -35.23 61.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.029 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 8.3 m -69.49 -36.76 76.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 111.447 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 97.2 mt -96.3 -27.41 14.99 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -173.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -84.58 23.27 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -118.46 152.42 35.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.815 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -69.77 115.68 9.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -178.13 -163.78 30.23 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.659 ' HB ' HG13 ' A' ' 577' ' ' ILE . 20.8 m -119.52 127.93 75.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . 0.503 ' O ' ' HA3' ' A' ' 623' ' ' GLY . 96.5 m-85 -148.54 140.6 23.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.795 0.331 . . . . 0.0 110.683 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 93.5 m -113.74 101.58 9.43 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 170.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.561 HG21 HG12 ' A' ' 505' ' ' VAL . 56.6 t -101.41 119.78 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.419 -174.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.605 ' CD2' HG11 ' A' ' 608' ' ' VAL . 51.5 m-85 -86.43 111.98 21.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -106.99 112.88 63.07 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.705 -167.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.804 ' HA ' HG13 ' A' ' 628' ' ' ILE . 3.3 Cg_exo -79.7 143.21 16.59 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.243 2.628 . . . . 0.0 112.709 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 68.9 p -85.73 -177.44 6.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.585 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -67.86 -25.57 65.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.767 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -71.13 -22.03 62.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.548 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -83.67 -34.62 24.95 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.059 0.457 . . . . 0.0 111.467 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . 0.493 ' HZ ' HD12 ' A' ' 518' ' ' LEU . 5.0 m-85 -68.55 -13.98 62.7 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -93.57 -17.11 23.7 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.615 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -82.8 -13.03 56.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.019 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.515 HD13 ' HE1' ' A' ' 555' ' ' TRP . 46.4 mt -101.63 133.64 20.68 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.8 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.8 135.28 67.09 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.384 2.056 . . . . 0.0 110.925 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.54 -33.56 23.91 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.199 2.599 . . . . 0.0 113.579 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 553' ' ' ARG . 11.4 ptt180 -60.24 -36.24 77.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.656 0.265 . . . . 0.0 111.388 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 557' ' ' ARG . 0.4 OUTLIER -72.72 -40.84 65.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.92 0.39 . . . . 0.0 110.777 -175.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' TRP . . . . . 0.515 ' HE1' HD13 ' A' ' 550' ' ' LEU . 1.1 m95 -80.69 -29.04 36.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.227 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 37.5 t -57.03 -29.65 63.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.332 168.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 554' ' ' GLU . 50.0 mtt180 -75.52 -40.04 57.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.206 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.505 ' HG ' ' HA ' ' A' ' 555' ' ' TRP . 5.3 mt -75.77 -54.66 6.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.882 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 559' ' ' LEU . 0.2 OUTLIER -64.36 -14.21 55.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.666 0.269 . . . . 0.0 111.583 178.19 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -98.65 -21.53 16.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.46 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . 0.458 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 25.9 t70 -135.75 118.77 16.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.081 0.467 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.78 68.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.792 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.458 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 5.1 tmtm? -59.63 -43.32 93.88 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.096 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 567' ' ' ASN . 8.2 tp10 -75.76 -34.81 60.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.554 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.88 HD21 ' HB3' ' A' ' 525' ' ' ALA . 5.6 tt -68.57 -45.27 72.5 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.11 0.481 . . . . 0.0 109.759 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -64.2 -30.36 71.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.518 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . 0.778 ' HA ' ' NE2' ' A' ' 593' ' ' GLN . 39.0 t30 -55.93 -45.03 78.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.439 0.638 . . . . 0.0 110.506 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 60.6 mt -85.85 -62.53 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.442 -178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.439 ' O ' HD22 ' A' ' 569' ' ' LEU . 3.2 tt -55.12 -35.76 65.0 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.509 ' HG2' ' HB2' ' A' ' 592' ' ' LEU . 19.7 ttpp -72.25 -12.34 61.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.647 ' O ' HD23 ' A' ' 597' ' ' LEU . 41.7 t80 -89.28 -18.71 26.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.589 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . 0.728 ' HE2' HG22 ' A' ' 631' ' ' VAL . 2.0 m-70 -73.3 -14.12 61.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.309 0.575 . . . . 0.0 109.91 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.537 HG12 HG22 ' A' ' 539' ' ' VAL . 61.2 mt -101.81 121.78 53.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.839 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -84.74 164.18 39.1 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.873 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.03 -33.35 75.6 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.171 0.588 . . . . 0.0 112.072 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . 0.402 ' HA ' HG21 ' A' ' 536' ' ' VAL . 13.6 pt-20 -146.37 -178.29 6.08 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.191 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.722 HG22 HG22 ' A' ' 624' ' ' VAL . 14.9 mt -82.28 110.56 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 123.395 0.434 . . . . 0.0 111.114 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -117.67 94.54 4.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 27.5 m -81.96 172.18 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.473 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.565 ' HA ' HD13 ' A' ' 583' ' ' ILE . 15.8 m -63.03 -20.4 65.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.472 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.01 -13.14 63.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.437 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -103.55 -20.07 11.4 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.565 HD13 ' HA ' ' A' ' 580' ' ' SER . 76.5 mt -74.85 90.12 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.202 0.525 . . . . 0.0 110.396 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -102.83 -123.98 5.37 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.876 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -66.5 -57.94 6.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.073 0.463 . . . . 0.0 110.23 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 55.0 tp -156.86 114.42 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.644 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 10.1 p -132.18 132.29 60.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 120.945 0.402 . . . . 0.0 110.126 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . 0.686 ' HG2' ' HA ' ' A' ' 598' ' ' GLU . 40.0 mtp180 -112.5 127.09 55.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.33 0.586 . . . . 0.0 110.899 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.61 126.83 55.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.912 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 3.7 tmmt? -62.95 140.77 58.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.65 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.8 p -103.6 -174.52 2.56 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.744 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.509 ' HB2' ' HG2' ' A' ' 570' ' ' LYS . 78.9 mt -81.56 -42.26 20.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.89 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.778 ' NE2' ' HA ' ' A' ' 567' ' ' ASN . 6.4 tp-100 -61.64 -29.26 69.95 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 127.18 11.7 3.37 Favored Glycine 0 C--N 1.321 -0.267 0 C-N-CA 120.028 -1.082 . . . . 0.0 114.521 166.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 596' ' ' LYS . 8.8 t70 -117.43 -156.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 172.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.422 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 16.0 ptpt -135.46 130.81 35.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.214 0.53 . . . . 0.0 111.922 -176.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 571' ' ' TYR . 92.7 mt -68.6 122.33 18.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.851 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.686 ' HA ' ' HG2' ' A' ' 588' ' ' ARG . 30.0 tt0 -86.35 94.46 9.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . 0.454 HG12 HG21 ' A' ' 583' ' ' ILE . 36.1 t -105.52 133.82 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.802 -175.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 606' ' ' VAL . 7.7 p -140.5 161.84 36.76 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.748 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.456 ' HB2' HG23 ' A' ' 583' ' ' ILE . 67.6 tp -127.46 113.26 15.94 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -136.84 126.21 24.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.443 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 54.59 44.05 29.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.344 0.593 . . . . 0.0 110.546 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 65.3 t30 70.44 -0.39 2.9 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.355 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.76 119.68 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.489 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.781 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 25.9 t -77.59 148.48 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 607' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 611' ' ' GLU . 49.1 m -140.21 112.32 7.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.065 0.46 . . . . 0.0 111.968 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.605 HG11 ' CD2' ' A' ' 540' ' ' PHE . 7.5 p -117.17 135.71 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.156 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 1.053 ' HB2' HD21 ' A' ' 632' ' ' LEU . 77.1 m-20 53.58 33.18 15.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.177 0.513 . . . . 0.0 110.397 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt 77.22 9.09 2.71 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.373 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 608' ' ' VAL . 0.3 OUTLIER -113.97 149.65 42.24 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.447 ' HD2' ' ND2' ' A' ' 630' ' ' ASN . 1.4 Cg_endo -85.98 124.84 2.61 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.986 2.457 . . . . 0.0 113.161 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.781 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 49.9 t -76.19 143.94 12.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.383 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' A' ' 629' ' ' THR . . . -89.98 -43.98 10.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.415 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -151.06 92.07 3.86 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 120.971 0.415 . . . . 0.0 111.787 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . 0.548 ' HG3' HG22 ' A' ' 606' ' ' VAL . 83.1 Cg_endo -76.28 169.45 21.97 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.914 2.409 . . . . 0.0 114.124 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 74.47 27.92 1.35 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.693 -1.139 . . . . 0.0 113.15 166.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 45.0 mt -87.33 91.84 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 170.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.753 ' HG2' HG13 ' A' ' 624' ' ' VAL . 51.7 mtp -80.18 128.97 34.14 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.585 0.707 . . . . 0.0 112.176 -170.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -100.73 166.92 10.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.341 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -15.13 53.98 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.505 ' OD1' HG22 ' A' ' 505' ' ' VAL . 25.2 p-10 -116.62 15.51 15.51 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 537' ' ' TYR . . . 147.03 -133.51 4.81 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 119.765 -1.207 . . . . 0.0 113.455 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . 0.753 HG13 ' HG2' ' A' ' 619' ' ' MET . 0.0 OUTLIER -129.32 152.7 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.109 0.481 . . . . 0.0 111.597 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . 0.473 HG21 HG11 ' A' ' 505' ' ' VAL . 43.7 t -122.65 131.14 73.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.586 170.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . 0.489 ' HB2' ' CD2' ' A' ' 540' ' ' PHE . 77.6 m-70 -120.14 110.56 16.77 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.18 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.631 HG21 ' HZ ' ' A' ' 515' ' ' PHE . 98.9 t -66.93 118.39 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.691 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . 0.804 HG13 ' HA ' ' A' ' 542' ' ' PRO . 5.1 pt -115.77 143.97 24.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.616 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 629' ' ' THR . . . . . 0.522 HG23 ' HB1' ' A' ' 614' ' ' ALA . 24.5 p -94.73 1.4 55.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.797 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . 0.447 ' ND2' ' HD2' ' A' ' 612' ' ' PRO . 6.5 m-80 -135.92 135.9 40.02 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.898 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.728 HG22 ' HE2' ' A' ' 572' ' ' HIS . 0.2 OUTLIER -90.3 147.18 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 172.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 1.053 HD21 ' HB2' ' A' ' 609' ' ' ASN . 1.5 mp . . . . . 0 N--CA 1.437 -1.079 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.12 -158.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.559 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.443 -0.86 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.422 ' HA ' HG23 ' A' ' 621' ' ' THR . 76.4 p -88.2 -171.67 3.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.838 175.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.571 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 93.5 t -45.16 -46.15 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 123.35 0.406 . . . . 0.0 111.33 174.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.798 ' HE3' HG21 ' A' ' 522' ' ' ILE . 0.0 OUTLIER -60.64 -38.11 83.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.886 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . 0.559 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 16.9 t70 -68.19 -38.52 82.09 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 505' ' ' VAL . 96.0 t -53.1 -40.42 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.421 176.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 8.1 mt -77.7 -20.38 53.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.099 -174.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -83.32 -26.24 30.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.162 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -89.38 -0.7 79.44 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.105 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -122.26 141.18 51.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.996 0.398 . . . . 0.0 111.441 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -75.5 -22.59 57.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.102 -177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -73.52 -20.24 60.71 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 110.374 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.715 ' HZ ' HG23 ' A' ' 627' ' ' VAL . 15.9 m-85 -114.74 19.2 16.14 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.788 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 32.9 t -59.05 -57.31 13.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.75 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -64.5 -30.09 71.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.933 0.397 . . . . 0.0 110.237 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.555 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 57.8 tp -53.85 -45.43 70.92 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.873 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 14.8 t -50.94 -51.32 21.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.856 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.42 82.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.143 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -65.53 -51.18 61.8 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.42 . . . . 0.0 109.871 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.798 HG21 ' HE3' ' A' ' 506' ' ' MET . 96.6 mt -56.76 -33.63 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.698 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -38.82 92.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.427 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 22.3 m -66.43 -22.22 66.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.035 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -89.51 -30.0 18.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.613 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.41 67.4 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 114.489 0.556 . . . . 0.0 114.489 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 2.0 pp -82.48 24.68 0.68 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.973 0.887 . . . . 0.0 112.531 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.524 ' HA ' ' HE2' ' A' ' 506' ' ' MET . 58.5 m -57.98 -42.06 84.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.414 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.44 -30.7 65.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.974 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 85.1 m -58.9 -48.61 80.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.802 0.334 . . . . 0.0 111.273 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.727 ' HB2' ' SD ' ' A' ' 506' ' ' MET . 82.9 mt -96.95 -1.22 46.15 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.214 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 528' ' ' THR . 2.1 t-20 -81.29 -19.01 43.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.964 0.412 . . . . 0.0 110.976 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . 0.448 ' HG2' ' H ' ' A' ' 534' ' ' GLU . 33.0 ttt180 -104.06 168.33 9.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.868 0.366 . . . . 0.0 111.238 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' A' ' 533' ' ' ARG . 10.7 tp10 -58.02 147.73 28.43 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.407 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 154.85 -178.3 31.64 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.688 ' HB ' HG13 ' A' ' 577' ' ' ILE . 14.9 m -116.85 126.45 74.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -149.7 142.81 24.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.067 0.461 . . . . 0.0 110.884 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 97.9 m -112.23 110.41 20.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.624 HG22 HG12 ' A' ' 573' ' ' ILE . 65.0 t -109.29 114.94 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 120.879 0.371 . . . . 0.0 111.031 -175.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.619 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 80.4 m-85 -86.33 109.79 19.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -101.7 118.74 58.98 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.528 -166.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.649 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 72.3 Cg_endo -77.51 140.06 18.76 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.63 2.22 . . . . 0.0 111.778 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 69.5 p -78.8 -177.81 5.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.146 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . 0.536 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -73.58 -26.67 60.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.148 0.499 . . . . 0.0 110.152 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 548' ' ' ARG . 1.7 mp0 -68.36 -23.84 64.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.145 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -74.97 -31.37 61.44 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.883 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . 0.536 ' CD2' ' HA ' ' A' ' 544' ' ' ASN . 22.9 m-85 -65.64 -14.53 61.38 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . 0.62 ' HA ' ' HE ' ' A' ' 548' ' ' ARG . 3.3 mmp_? -93.93 -1.44 54.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.487 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -98.67 -11.38 22.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.7 HD12 ' HE1' ' A' ' 555' ' ' TRP . 32.5 mt -98.92 136.81 20.5 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.322 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 4.7 Cg_exo -74.8 140.25 25.83 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.884 2.389 . . . . 0.0 111.379 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.57 -16.8 25.52 Favored 'Trans proline' 0 C--O 1.224 -0.187 0 C-N-CA 123.043 2.495 . . . . 0.0 112.397 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -53.33 -46.76 69.6 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.768 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.468 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 27.4 mm-40 -87.07 -40.5 14.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.239 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' TRP . . . . . 0.7 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.1 OUTLIER -62.26 -38.13 88.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.738 -173.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 24.4 t -52.24 -33.02 39.59 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.579 0.55 . . . . 0.0 111.195 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 -83.95 -37.0 22.85 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 120.531 0.205 . . . . 0.0 110.611 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.813 ' HB3' HD12 ' A' ' 565' ' ' LEU . 41.4 mt -64.78 -49.36 71.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.762 0.315 . . . . 0.0 111.336 -175.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.45 1.98 14.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.872 0.367 . . . . 0.0 111.316 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -108.47 -48.09 0.88 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.879 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . 0.577 ' CG ' ' HZ1' ' A' ' 563' ' ' LYS . 13.3 t70 -104.11 126.79 51.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.966 0.413 . . . . 0.0 109.906 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.64 66.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.268 -170.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.577 ' HZ1' ' CG ' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -79.68 -20.88 45.54 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.295 -177.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.13 -38.82 69.19 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.022 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.813 HD12 ' HB3' ' A' ' 558' ' ' LEU . 18.1 tp -71.41 -41.43 69.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 563' ' ' LYS . . . -59.54 -40.55 87.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.15 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -55.08 -44.53 74.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 632' ' ' LEU . 63.3 mt -72.29 -45.45 61.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.453 HD13 HG12 ' A' ' 522' ' ' ILE . 89.5 mt -64.65 -25.55 68.0 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 97.3 mttt -74.13 -13.72 60.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.69 0.281 . . . . 0.0 111.44 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.55 ' O ' HD22 ' A' ' 597' ' ' LEU . 57.6 t80 -91.51 -18.46 24.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.089 0.471 . . . . 0.0 110.03 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . 0.649 ' HD2' ' HD3' ' A' ' 542' ' ' PRO . 12.0 m80 -74.84 -13.08 60.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.74 HG22 HD22 ' A' ' 592' ' ' LEU . 55.5 mt -109.3 137.91 39.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.857 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -106.67 164.45 13.39 Favored Glycine 0 CA--C 1.516 0.156 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 172.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.61 -10.23 59.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.246 0.523 . . . . 0.0 112.407 -171.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -144.46 169.86 17.15 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 122.502 -0.123 . . . . 0.0 110.811 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.688 HG13 ' HB ' ' A' ' 536' ' ' VAL . 8.3 mt -88.03 122.99 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.635 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 56.0 tp -126.92 93.7 3.83 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.645 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.17 179.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.036 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 10.9 m -62.25 -23.42 66.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.902 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.58 -17.47 72.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.566 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.26 -34.14 4.91 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.92 HG21 ' HB2' ' A' ' 601' ' ' LEU . 77.7 mt -62.52 99.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 122.968 0.507 . . . . 0.0 110.031 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . -121.05 -73.16 0.32 Allowed Glycine 0 C--O 1.226 -0.367 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.87 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -98.82 -82.25 0.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.839 0.352 . . . . 0.0 110.332 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 5.2 tt -155.18 117.42 4.19 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.49 133.68 67.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.492 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -105.38 110.0 22.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.82 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.72 127.66 53.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -175.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -71.87 147.28 47.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.873 0.368 . . . . 0.0 110.091 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.467 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 85.8 p -108.98 -178.1 3.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.971 0.415 . . . . 0.0 110.443 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.74 HD22 HG22 ' A' ' 573' ' ' ILE . 1.6 mm? -73.62 -37.82 65.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.837 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -64.18 -31.46 72.67 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.459 0.647 . . . . 0.0 110.085 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.29 -17.82 6.98 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.889 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . 0.438 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 4.3 t70 -85.6 -165.84 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.975 0.888 . . . . 0.0 110.563 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.424 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 13.8 pttp -115.74 134.18 55.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.19 0.519 . . . . 0.0 111.746 -171.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.55 HD22 ' O ' ' A' ' 571' ' ' TYR . 87.1 mt -90.93 115.34 27.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 39.6 mt-10 -92.9 101.02 13.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.244 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 607' ' ' SER . 39.7 t -108.29 130.87 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 123.353 0.408 . . . . 0.0 111.345 -175.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 22.7 t -134.0 157.93 44.82 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.35 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.92 ' HB2' HG21 ' A' ' 583' ' ' ILE . 55.7 tp -128.92 118.78 23.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 172.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -152.28 129.9 11.52 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.17 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 58.86 33.29 22.96 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.417 0.448 . . . . 0.0 110.57 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 75.58 -2.55 2.77 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.384 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.61 113.94 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.104 0.478 . . . . 0.0 110.864 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 600' ' ' SER . 61.5 t -77.47 134.12 29.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.446 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 607' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 15.9 m -120.52 105.91 11.29 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.656 HG21 ' OD1' ' A' ' 609' ' ' ASN . 12.6 p -111.03 139.79 33.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.656 ' OD1' HG21 ' A' ' 608' ' ' VAL . 3.1 m120 58.36 25.61 13.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . 0.887 ' HB2' ' HZ2' ' A' ' 610' ' ' LYS . 3.7 ttmp? 69.58 22.59 6.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.946 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -130.96 147.5 66.54 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 121.079 0.466 . . . . 0.0 109.952 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -60.76 128.8 26.78 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.55 2.833 . . . . 0.0 113.85 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.631 HG21 HG13 ' A' ' 608' ' ' VAL . 47.8 t -81.47 143.19 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 172.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -79.25 -61.38 2.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.38 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -139.41 100.87 7.55 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . 0.404 ' CB ' ' HD1' ' A' ' 626' ' ' HIS . 74.1 Cg_endo -72.27 162.51 41.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.846 2.364 . . . . 0.0 114.15 174.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 74.89 45.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.533 164.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 34.9 mt -96.03 87.2 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 165.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 49.9 mtp -76.5 146.19 38.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.519 0.675 . . . . 0.0 112.575 -171.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.48 -171.51 1.85 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.549 -1.205 . . . . 0.0 107.928 172.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 504' ' ' THR . 12.6 t -82.69 -15.71 50.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.863 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.465 ' OD1' HG22 ' A' ' 505' ' ' VAL . 27.9 p-10 -118.72 19.3 13.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.944 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.57 -148.38 19.35 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.69 -1.243 . . . . 0.0 112.993 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 15.0 p -139.31 146.35 25.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.916 0.389 . . . . 0.0 111.093 -175.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 69.9 t -115.34 139.96 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.65 176.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . 0.619 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 67.0 m-70 -125.59 126.99 45.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.251 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.715 HG23 ' HZ ' ' A' ' 515' ' ' PHE . 91.6 t -77.19 119.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -174.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.2 153.0 16.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.038 0.447 . . . . 0.0 110.447 172.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 20.8 p -100.68 3.86 42.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -130.2 152.47 49.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.853 0.359 . . . . 0.0 110.137 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.45 ' HB ' HD11 ' A' ' 550' ' ' LEU . 43.6 t -87.82 151.77 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 172.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.571 ' HB2' ' CE1' ' A' ' 572' ' ' HIS . 36.8 mt . . . . . 0 C--N 1.318 -0.761 0 CA-C-O 120.906 0.384 . . . . 0.0 110.741 -168.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.403 ' HA3' ' HB2' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.448 -0.506 0 CA-C-O 121.303 0.391 . . . . 0.0 112.9 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.467 ' HA ' HG23 ' A' ' 621' ' ' THR . 68.6 p -92.74 -170.02 2.34 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.282 -0.459 . . . . 0.0 110.497 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.545 ' O ' HD11 ' A' ' 509' ' ' LEU . 94.6 t -43.87 -41.26 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.084 169.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 39.7 tpp -60.02 -46.06 90.76 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.148 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . 0.403 ' HB2' ' HA3' ' A' ' 503' ' ' GLY . 32.7 t70 -62.16 -42.32 99.15 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.949 0.404 . . . . 0.0 110.412 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.541 HG23 ' HB2' ' A' ' 620' ' ' ALA . 91.2 t -52.82 -46.98 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.266 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.545 HD11 ' O ' ' A' ' 505' ' ' VAL . 3.2 mp -75.67 -37.28 59.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.065 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.587 ' HA ' HG21 ' A' ' 519' ' ' VAL . 64.2 tttp -71.75 -29.9 65.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.957 0.408 . . . . 0.0 111.023 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -84.86 -10.25 79.29 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.726 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . 0.731 ' OD1' ' HG2' ' A' ' 514' ' ' ARG . 34.1 t0 -98.95 134.36 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.241 0.543 . . . . 0.0 110.782 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.41 -35.05 79.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.284 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . 0.731 ' HG2' ' OD1' ' A' ' 512' ' ' ASP . 23.7 ptt180 -83.08 -8.92 59.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.249 -173.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.864 ' HZ ' HG23 ' A' ' 627' ' ' VAL . 23.3 m-85 -116.27 13.0 15.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.943 0.401 . . . . 0.0 110.445 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 25.6 p -57.91 -49.57 76.29 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.272 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -69.4 -31.79 70.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.046 0.45 . . . . 0.0 110.113 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.572 HD12 ' HZ ' ' A' ' 547' ' ' PHE . 56.8 tp -54.57 -47.04 73.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.573 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 510' ' ' LYS . 6.5 t -50.57 -48.66 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.043 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 523' ' ' GLN . . . -63.64 -30.95 71.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.021 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.67 51.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.077 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.797 HG12 HD23 ' A' ' 569' ' ' LEU . 35.7 mt -57.1 -38.21 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.484 0.659 . . . . 0.0 109.612 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' A' ' 520' ' ' ALA . 18.5 tp60 -58.52 -58.91 6.47 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.281 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.0 m -58.81 -23.44 60.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.754 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -86.13 -13.69 46.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.179 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 75.14 12.46 83.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.758 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . 0.637 HD12 HD22 ' A' ' 569' ' ' LEU . 78.5 mt -86.27 13.66 7.7 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.541 -0.388 . . . . 0.0 111.516 -176.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 532' ' ' ASN . 36.7 m -55.57 -47.49 76.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . 0.66 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 12.7 pt-20 -69.2 -16.52 63.63 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.336 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 32.4 m -82.16 -44.67 16.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.623 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 531' ' ' LEU . 27.2 mt -82.47 -20.02 37.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.712 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 528' ' ' THR . 16.6 m-20 -91.01 22.89 3.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.003 0.43 . . . . 0.0 111.122 175.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . 0.66 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 11.7 mmt180 -103.15 163.86 11.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.551 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.09 153.76 17.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.183 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 137.9 -138.87 9.93 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.887 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.735 ' HB ' HG12 ' A' ' 577' ' ' ILE . 17.8 m -129.08 127.59 66.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -144.81 128.9 17.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.216 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 87.1 m -106.77 100.25 9.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 170.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.61 HG22 HG12 ' A' ' 573' ' ' ILE . 90.4 t -101.9 116.65 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.18 -173.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.561 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 54.2 m-85 -86.41 111.07 20.17 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 172.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -98.4 115.15 65.85 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.698 -168.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.592 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 73.3 Cg_endo -79.0 134.4 11.72 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.652 2.235 . . . . 0.0 111.181 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 71.4 p -75.95 -179.45 4.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.279 0.561 . . . . 0.0 111.595 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -74.0 -16.76 61.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.796 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 548' ' ' ARG . 39.0 tt0 -76.66 -25.85 54.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.792 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.409 ' HB1' ' N ' ' A' ' 631' ' ' VAL . . . -72.18 -42.36 65.96 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.568 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . 0.572 ' HZ ' HD12 ' A' ' 518' ' ' LEU . 9.1 m-85 -67.27 -13.91 62.42 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.647 0.737 . . . . 0.0 109.315 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . 0.407 ' HB3' ' O ' ' A' ' 545' ' ' GLU . 37.1 ttm180 -90.22 -10.53 44.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.325 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -97.47 -29.04 13.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.107 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.459 HD11 HG11 ' A' ' 631' ' ' VAL . 7.2 mp -78.67 140.58 59.3 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.018 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.408 ' HG2' ' CB ' ' A' ' 554' ' ' GLU . 23.1 Cg_endo -63.3 134.21 44.19 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.655 2.237 . . . . 0.0 112.052 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.66 -41.24 46.01 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.163 2.575 . . . . 0.0 112.534 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' A' ' 557' ' ' ARG . 40.0 ttm180 -57.32 -47.86 80.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.707 0.289 . . . . 0.0 110.751 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.408 ' CB ' ' HG2' ' A' ' 551' ' ' PRO . 41.3 tt0 -66.88 -46.25 75.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.098 0.475 . . . . 0.0 110.602 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' TRP . . . . . 0.438 ' CZ2' ' CD1' ' A' ' 547' ' ' PHE . 0.0 OUTLIER -72.44 -42.21 65.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.351 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 51.0 p -55.6 -26.15 42.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.564 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 553' ' ' ARG . 1.8 mmp_? -71.72 -35.57 70.24 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.608 HD21 HG13 ' A' ' 568' ' ' ILE . 16.0 mt -68.64 -50.29 52.43 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.25 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . 0.492 HD23 HD22 ' A' ' 565' ' ' LEU . 0.5 OUTLIER -70.25 0.98 5.36 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 178.013 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -78.03 -46.37 9.41 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.082 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . 0.418 ' OD2' ' HG2' ' A' ' 564' ' ' GLU . 32.1 t70 -125.24 142.65 51.37 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -72.46 -39.88 67.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.014 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.498 ' H ' ' HD2' ' A' ' 563' ' ' LYS . 0.0 OUTLIER -66.16 -35.78 81.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.65 -178.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.418 ' HG2' ' OD2' ' A' ' 561' ' ' ASP . 8.1 mm-40 -74.97 -39.99 60.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.728 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 558' ' ' LEU . 39.1 tp -65.32 -43.97 89.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.38 74.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.358 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -53.64 -51.6 62.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.173 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.608 HG13 HD21 ' A' ' 558' ' ' LEU . 24.2 mm -67.07 -52.77 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.797 HD23 HG12 ' A' ' 522' ' ' ILE . 26.7 tp -58.75 -24.56 61.86 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.97 -177.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 87.9 mttt -70.37 -18.08 63.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 0.0 111.627 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.508 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 37.5 t80 -89.77 10.08 24.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.992 0.901 . . . . 0.0 109.485 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . 0.592 ' HD2' ' HD3' ' A' ' 542' ' ' PRO . 13.4 m80 -103.78 -15.26 15.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.177 173.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 539' ' ' VAL . 64.5 mt -109.89 115.89 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.882 -175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.628 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -83.28 150.52 27.39 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.112 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -67.48 -21.7 65.5 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . 0.605 ' HG2' HD21 ' A' ' 589' ' ' LEU . 15.9 pt-20 -129.35 -178.32 4.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.596 -173.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.735 HG12 ' HB ' ' A' ' 536' ' ' VAL . 48.4 mm -96.16 110.38 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.504 174.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.546 HD23 HG11 ' A' ' 587' ' ' VAL . 57.5 tp -113.32 93.18 4.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . 0.467 HG11 HG22 ' A' ' 577' ' ' ILE . 21.3 m -79.15 168.53 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.689 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.6 ' HA ' HD11 ' A' ' 583' ' ' ILE . 3.5 m -53.16 -32.73 49.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.835 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.62 -17.88 71.42 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.175 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -95.76 -15.47 42.77 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.938 HG23 ' HB2' ' A' ' 601' ' ' LEU . 57.6 mt -75.54 119.59 23.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 601' ' ' LEU . . . -168.22 125.35 1.28 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 62.51 -82.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 O-C-N 124.168 0.569 . . . . 0.0 110.562 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 6.4 tt -163.27 117.24 1.61 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . 0.546 HG11 HD23 ' A' ' 578' ' ' LEU . 6.8 p -128.75 139.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -100.74 135.75 41.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.301 0.572 . . . . 0.0 111.585 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.605 HD21 ' HG2' ' A' ' 576' ' ' GLU . 1.0 OUTLIER -126.7 115.55 19.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.36 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -64.47 128.08 34.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 110.811 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.628 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 89.9 p -95.6 -173.53 2.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.537 -177.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 60.2 mt -76.69 -38.96 53.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.413 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.4 tt0 -61.21 -30.55 70.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.456 0.645 . . . . 0.0 110.501 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.95 -19.51 6.5 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.477 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . 0.508 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.7 t70 -84.6 -169.15 2.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.711 0.756 . . . . 0.0 109.951 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.457 ' HG2' ' OD1' ' A' ' 595' ' ' ASP . 14.2 pttm -110.11 136.33 49.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.923 -172.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.626 ' HA ' ' OD1' ' A' ' 609' ' ' ASN . 91.5 mt -84.22 114.97 22.2 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 170.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 45.8 mt-10 -86.52 84.91 7.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.393 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 607' ' ' SER . 46.2 t -86.46 118.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.688 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.862 ' HB2' ' HB2' ' A' ' 607' ' ' SER . 13.6 m -118.57 157.02 28.13 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.825 -176.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.938 ' HB2' HG23 ' A' ' 583' ' ' ILE . 58.4 tp -141.79 113.5 7.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -156.41 137.88 13.99 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 60.93 27.06 16.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 64.9 t30 63.84 11.68 6.14 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.436 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 60.0 t -95.13 118.45 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.573 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.55 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 48.9 t -82.17 147.9 5.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.848 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 607' ' ' SER . . . . . 0.862 ' HB2' ' HB2' ' A' ' 600' ' ' SER . 16.9 m -134.38 158.13 44.64 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.583 0.23 . . . . 0.0 110.868 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.6 p -153.27 121.23 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.648 175.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.769 HD21 HD11 ' A' ' 632' ' ' LEU . 19.6 m-20 61.46 37.61 16.51 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.986 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 80.1 -12.48 1.04 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.481 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 63.1 mm-40 -95.44 143.17 25.65 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.615 0.245 . . . . 0.0 110.79 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 3.1 Cg_exo -78.81 136.62 13.53 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.134 2.556 . . . . 0.0 112.791 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.55 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 40.4 t -89.22 134.38 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -89.29 -35.74 15.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.946 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . 0.461 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 29.5 tt0 -150.36 89.08 4.56 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.732 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.38 173.19 13.53 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.125 2.55 . . . . 0.0 113.47 171.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 t70 77.78 23.34 0.8 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.059 164.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 34.2 mt -94.36 90.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 122.05 -0.406 . . . . 0.0 110.135 174.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.545 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 60.6 mtp -85.91 149.49 25.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.472 0.654 . . . . 0.0 112.33 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . 0.541 ' HB2' HG23 ' A' ' 508' ' ' VAL . . . -113.22 -171.77 1.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.613 174.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 504' ' ' THR . 13.1 t -81.73 -17.46 47.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.414 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.429 ' OD1' HG23 ' A' ' 505' ' ' VAL . 28.7 p-10 -117.87 2.5 12.18 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . 0.421 ' HA2' HD12 ' A' ' 577' ' ' ILE . . . 173.14 -154.77 21.27 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.418 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 8.1 p -137.55 145.47 29.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 539' ' ' VAL . 75.6 t -117.4 140.87 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.978 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . 0.561 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 66.4 m-70 -126.74 118.86 25.56 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.039 175.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.864 HG23 ' HZ ' ' A' ' 515' ' ' PHE . 96.8 t -72.51 122.59 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.0 151.13 21.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.206 0.527 . . . . 0.0 110.592 172.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 11.9 p -94.04 3.22 55.63 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.153 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -136.6 146.27 45.87 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.123 0.487 . . . . 0.0 111.204 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.459 HG11 HD11 ' A' ' 550' ' ' LEU . 0.2 OUTLIER -92.68 158.25 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.769 HD11 HD21 ' A' ' 609' ' ' ASN . 16.6 mt . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 120.867 0.365 . . . . 0.0 111.647 -156.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.681 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.439 -1.113 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 508' ' ' VAL . 75.6 p -95.28 -173.96 3.07 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.678 ' O ' HD12 ' A' ' 509' ' ' LEU . 96.4 t -47.42 -41.06 7.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.396 170.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -41.89 97.86 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.697 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . 0.681 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 9.1 m-20 -68.65 -33.42 73.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.52 0.2 . . . . 0.0 111.159 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 504' ' ' THR . 96.0 t -51.66 -60.54 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.089 0.471 . . . . 0.0 110.958 174.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 505' ' ' VAL . 3.4 mp -59.27 -35.45 73.76 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.625 0.77 . . . . 0.0 111.269 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.592 ' HB3' ' HA ' ' A' ' 507' ' ' ASP . 43.5 tttt -63.75 -29.85 71.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.324 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -97.49 -23.3 14.41 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.237 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.75 132.22 35.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.934 0.397 . . . . 0.0 110.489 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.19 -18.98 58.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -78.92 -29.43 44.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.017 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.76 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 16.5 m-85 -101.71 18.76 19.59 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.008 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 21.0 p -57.94 -57.27 13.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' MET . . . . . 0.44 ' HE3' ' HB3' ' A' ' 517' ' ' MET . 7.8 ttp -74.13 -20.69 60.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.926 0.393 . . . . 0.0 110.158 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.508 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 50.5 tp -57.94 -41.96 83.92 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.909 176.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' A' ' 509' ' ' LEU . 15.2 t -53.45 -54.77 16.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.261 177.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.23 -31.52 72.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.087 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.13 -56.18 8.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.794 0.33 . . . . 0.0 110.37 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.462 ' HA ' HD11 ' A' ' 569' ' ' LEU . 61.6 mt -59.33 -32.24 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.231 0.539 . . . . 0.0 110.235 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.6 OUTLIER -55.59 -60.7 3.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.095 173.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.7 m -61.99 -19.11 62.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.351 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -85.44 -10.91 55.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 70.14 37.68 72.49 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.671 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.55 5.6 29.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.524 0.662 . . . . 0.0 111.044 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 27.2 m -53.46 -49.93 66.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.686 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . 0.632 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 28.3 mt-10 -66.03 -19.21 65.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.551 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 35.1 m -74.07 -34.32 63.99 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.083 0.468 . . . . 0.0 109.818 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.459 HD22 HD13 ' A' ' 573' ' ' ILE . 89.6 mt -93.07 -18.14 23.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.647 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . 0.52 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 0.9 OUTLIER -84.55 17.72 2.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 177.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 21.9 mmt180 -111.25 172.25 6.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.305 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.13 146.28 24.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 153.97 -147.13 16.04 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.896 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.58 ' HB ' HG13 ' A' ' 577' ' ' ILE . 11.2 m -131.7 128.29 60.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -148.15 132.21 17.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.968 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 95.7 m -104.68 105.23 15.23 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 172.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.759 HG23 HG12 ' A' ' 573' ' ' ILE . 62.6 t -104.78 112.57 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 120.888 0.375 . . . . 0.0 111.378 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.595 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 68.4 m-85 -85.95 108.98 18.45 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -104.66 122.41 43.65 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.069 -168.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.76 138.91 19.39 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.936 2.424 . . . . 0.0 112.491 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 67.4 p -82.78 -176.59 6.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.965 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . 0.463 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 10.8 m120 -62.07 -39.65 93.14 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.67 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -66.1 -21.49 66.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -76.88 -36.45 56.72 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.099 177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . 0.492 ' HZ ' ' HB2' ' A' ' 518' ' ' LEU . 9.5 m-85 -65.31 -13.02 57.49 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 170.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -94.91 -36.42 11.62 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.975 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -91.24 11.02 24.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.13 0.491 . . . . 0.0 111.724 -174.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.81 HD13 ' CD1' ' A' ' 555' ' ' TRP . 0.2 OUTLIER -76.8 167.32 37.73 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.643 -178.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.44 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 7.6 Cg_exo -73.91 125.93 10.27 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.21 1.94 . . . . 0.0 109.952 166.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.97 -54.52 5.31 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.909 2.406 . . . . 0.0 114.138 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -70.81 -18.77 62.72 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.638 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 5.9 tp10 -60.6 -54.87 40.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.609 0.718 . . . . 0.0 109.902 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' TRP . . . . . 0.81 ' CD1' HD13 ' A' ' 550' ' ' LEU . 6.7 m95 -77.79 -24.78 48.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.889 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 52.5 m -51.28 -35.04 35.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.43 0.633 . . . . 0.0 109.616 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -84.69 -50.9 7.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.154 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.674 HD22 ' HG3' ' A' ' 564' ' ' GLU . 40.6 mt -57.61 -55.31 36.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.983 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . 0.43 HD21 ' HA ' ' A' ' 559' ' ' LEU . 0.1 OUTLIER -70.44 -1.34 10.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -98.27 -31.47 6.5 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.651 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . 0.468 ' OD1' ' HG2' ' A' ' 563' ' ' LYS . 12.9 t70 -130.5 137.84 49.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.633 0.254 . . . . 0.0 110.42 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.7 63.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.63 ' HD3' ' H ' ' A' ' 563' ' ' LYS . 0.1 OUTLIER -73.82 -18.6 60.93 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.717 -178.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.674 ' HG3' HD22 ' A' ' 558' ' ' LEU . 3.7 tp10 -69.63 -46.45 66.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 558' ' ' LEU . 20.0 tp -68.04 -45.57 73.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.087 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . 0.475 ' HB2' ' HZ3' ' A' ' 570' ' ' LYS . . . -60.76 -23.57 65.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.403 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . 0.824 ' HA ' ' NE2' ' A' ' 593' ' ' GLN . 52.7 t30 -55.87 -50.84 69.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.578 0.704 . . . . 0.0 110.811 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.59 HD11 HD13 ' A' ' 558' ' ' LEU . 46.2 mt -84.53 -39.58 14.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.875 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 522' ' ' ILE . 75.0 mt -61.1 -28.25 68.96 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.475 ' HZ3' ' HB2' ' A' ' 566' ' ' ALA . 50.1 mttp -77.59 -10.15 59.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.907 177.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 50.5 t80 -100.3 -19.16 16.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.085 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -66.34 -24.94 66.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.381 0.61 . . . . 0.0 110.526 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.759 HG12 HG23 ' A' ' 539' ' ' VAL . 83.7 mt -105.43 141.16 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.486 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -102.81 165.92 16.54 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.29 -30.29 67.26 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . 0.484 ' O ' HD13 ' A' ' 589' ' ' LEU . 14.4 pt-20 -148.04 178.4 8.56 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 122.274 -0.266 . . . . 0.0 110.529 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.58 HG13 ' HB ' ' A' ' 536' ' ' VAL . 57.5 mt -81.16 122.23 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.143 0.497 . . . . 0.0 111.961 -171.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.502 HD22 HG11 ' A' ' 587' ' ' VAL . 55.0 tp -122.31 93.26 3.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.424 174.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 26.7 m -83.81 169.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.469 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.441 ' HA ' HD13 ' A' ' 583' ' ' ILE . 26.1 m -60.41 -15.65 28.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.887 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.76 -16.37 70.02 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 172.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.69 -28.11 6.81 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.809 HG21 ' HB2' ' A' ' 601' ' ' LEU . 53.4 mt -72.14 89.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.226 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -113.8 -58.59 0.39 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.327 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -113.46 -71.6 0.74 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 175.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 599' ' ' VAL . 6.2 tt -157.83 129.58 6.88 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . 0.502 HG11 HD22 ' A' ' 578' ' ' LEU . 6.8 p -143.86 139.64 25.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.22 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . 0.521 ' HB3' ' HG2' ' A' ' 598' ' ' GLU . 6.3 ptp180 -107.9 140.22 41.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.342 0.591 . . . . 0.0 111.491 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.484 HD13 ' O ' ' A' ' 576' ' ' GLU . 0.5 OUTLIER -124.45 121.63 35.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.298 -179.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.413 ' HD2' ' O ' ' A' ' 595' ' ' ASP . 24.2 tptm -63.62 140.94 58.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.69 0.281 . . . . 0.0 110.26 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.524 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 60.2 p -102.11 -177.83 3.52 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.721 ' H ' HD22 ' A' ' 592' ' ' LEU . 0.9 OUTLIER -76.68 -44.88 31.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 110.474 178.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.824 ' NE2' ' HA ' ' A' ' 567' ' ' ASN . 6.5 tp-100 -63.4 -30.8 71.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.491 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 124.62 16.02 3.15 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 119.731 -1.224 . . . . 0.0 114.438 168.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . 0.579 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 10.4 t70 -110.66 -164.87 0.95 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.878 0.839 . . . . 0.0 108.789 174.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.454 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 18.3 pttp -127.24 120.0 27.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.092 0.472 . . . . 0.0 111.35 -172.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 571' ' ' TYR . 98.3 mt -79.2 115.37 18.82 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.521 ' HG2' ' HB3' ' A' ' 588' ' ' ARG . 33.7 mt-10 -108.75 112.36 24.6 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.29 0.567 . . . . 0.0 110.782 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 586' ' ' LEU . 21.3 t -107.59 133.6 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.532 -171.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.741 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 37.9 t -126.02 160.81 29.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.809 ' HB2' HG21 ' A' ' 583' ' ' ILE . 48.8 tp -132.73 127.1 33.97 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . 0.476 ' HG2' ' OD1' ' A' ' 603' ' ' ASN . 60.6 tttp -156.42 129.1 7.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . 0.476 ' OD1' ' HG2' ' A' ' 602' ' ' LYS . 18.6 m120 61.15 28.03 17.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.03 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 56.9 t30 68.64 18.49 8.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.708 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.69 126.53 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.741 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.724 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 59.7 t -88.24 137.46 21.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.318 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 607' ' ' SER . . . . . 0.741 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 6.9 m -125.19 103.54 8.02 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.502 HG13 ' CD1' ' A' ' 540' ' ' PHE . 7.4 p -109.28 117.96 55.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.528 ' ND2' HD11 ' A' ' 632' ' ' LEU . 12.9 m-20 63.16 29.75 16.06 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 60.0 tttp 77.02 -2.39 2.67 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.311 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.509 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 70.0 mm-40 -92.42 129.57 40.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.397 . . . . 0.0 110.879 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 13.0 Cg_exo -70.51 126.58 12.96 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.295 2.663 . . . . 0.0 112.518 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.724 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 32.8 t -86.72 136.62 22.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.887 176.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -83.04 -57.0 3.47 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.128 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -133.66 100.74 13.37 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.451 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . 0.479 ' CB ' ' HD1' ' A' ' 626' ' ' HIS . 89.0 Cg_endo -75.29 164.26 33.15 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.824 2.349 . . . . 0.0 112.628 171.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 71.64 31.46 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 50.6 mt -85.66 90.21 2.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 168.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 66.6 mtp -79.7 148.39 31.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -169.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -118.45 -175.58 2.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.621 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.3 t -83.64 -9.45 58.88 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.528 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.491 ' OD1' HG23 ' A' ' 505' ' ' VAL . 28.7 p-10 -117.68 7.72 12.62 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.499 0.19 . . . . 0.0 111.481 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 159.25 -143.59 9.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.003 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.1 p -139.34 147.64 24.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.595 0.236 . . . . 0.0 110.589 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.5 141.76 34.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.322 0.582 . . . . 0.0 111.217 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . 0.595 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 46.7 m-70 -126.75 125.28 41.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.76 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 85.5 t -78.18 118.59 25.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.49 155.59 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 120.943 0.401 . . . . 0.0 110.716 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 19.9 p -102.65 4.06 37.84 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.444 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -137.4 163.3 31.38 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.982 0.42 . . . . 0.0 111.254 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.74 142.98 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.779 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.528 HD11 ' ND2' ' A' ' 609' ' ' ASN . 69.9 mt . . . . . 0 N--CA 1.432 -1.371 0 CA-C-O 120.635 0.255 . . . . 0.0 110.473 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.568 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 121.251 0.362 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 508' ' ' VAL . 79.0 p -85.98 -172.48 4.11 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.694 HG23 ' HB3' ' A' ' 531' ' ' LEU . 7.4 m -46.79 -37.97 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.222 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -45.13 90.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.274 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . 0.568 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 6.1 t70 -68.76 -33.35 73.75 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 504' ' ' THR . 94.3 t -52.65 -40.07 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.22 0.533 . . . . 0.0 110.538 174.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 5.6 mt -82.27 -34.51 28.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.405 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.587 ' HA ' HG21 ' A' ' 519' ' ' VAL . 58.1 tttp -66.51 -34.61 78.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.062 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -88.15 -5.4 76.6 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.645 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -106.75 142.04 37.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.29 0.545 . . . . 0.0 111.387 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -68.37 -32.8 73.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.786 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . 0.484 ' H ' ' HD2' ' A' ' 514' ' ' ARG . 3.1 mpt_? -83.02 -19.27 37.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -173.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.717 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 19.9 m-85 -107.75 5.55 26.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.172 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 68.5 m -59.98 -38.1 81.57 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.754 0.312 . . . . 0.0 111.579 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -82.56 -26.01 32.79 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 45.6 tp -58.02 -43.68 86.87 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.913 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 510' ' ' LYS . 7.2 t -50.69 -51.04 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.931 176.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -64.74 -32.8 74.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.926 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.89 -50.19 44.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.158 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.575 HG12 HD11 ' A' ' 569' ' ' LEU . 68.4 mt -57.94 -34.45 48.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.31 0.576 . . . . 0.0 109.789 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.55 -57.72 11.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.452 173.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.2 m -58.63 -26.56 63.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.995 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -74.63 -23.94 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.869 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 68.25 19.62 72.45 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.104 -0.57 . . . . 0.0 114.153 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . 0.595 HD22 ' HB3' ' A' ' 569' ' ' LEU . 3.8 pp -104.36 22.44 14.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.579 0.69 . . . . 0.0 111.135 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 88.8 m -53.81 -41.97 67.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.951 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . 0.599 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 1.0 OUTLIER -60.23 -16.38 33.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.226 -178.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 26.2 m -76.18 -51.0 13.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.906 0.384 . . . . 0.0 109.991 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.694 ' HB3' HG23 ' A' ' 505' ' ' VAL . 61.2 mt -81.39 -13.69 58.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.679 -177.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -72.89 -20.01 61.17 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.822 0.344 . . . . 0.0 111.416 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . 0.599 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 59.8 mtt180 -74.09 139.67 44.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.1 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -84.06 131.74 34.78 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 167.54 -120.64 0.92 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.425 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.8 m -137.99 126.81 32.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.716 0.294 . . . . 0.0 111.06 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -151.64 143.91 24.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.786 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.2 m -115.96 111.09 19.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.706 HG21 HG12 ' A' ' 573' ' ' ILE . 88.5 t -111.04 114.23 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.618 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 61.5 m-85 -84.87 108.99 17.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -100.11 121.13 54.84 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.969 -166.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.46 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 93.5 Cg_endo -83.51 138.93 8.76 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.789 2.326 . . . . 0.0 112.158 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 66.8 p -83.35 -178.02 6.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.244 0.545 . . . . 0.0 112.087 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . 0.427 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -62.57 -37.84 87.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.322 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -34.19 71.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.522 0.677 . . . . 0.0 110.238 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -70.54 -36.85 73.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.373 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . 0.434 ' HZ ' HD11 ' A' ' 518' ' ' LEU . 17.3 m-85 -66.44 -18.01 65.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.222 0.534 . . . . 0.0 109.655 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 548' ' ' ARG . 21.2 ttp85 -92.79 -16.26 25.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.047 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -80.51 -13.92 58.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.005 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.618 HD12 ' HB ' ' A' ' 631' ' ' VAL . 78.8 mt -95.34 143.36 25.98 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.017 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 24.6 Cg_exo -63.05 134.39 45.83 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.766 2.311 . . . . 0.0 111.755 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.45 -32.43 73.11 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.039 2.493 . . . . 0.0 112.234 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 44.2 mtm105 -57.87 -30.96 66.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.46 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -86.21 -52.18 5.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.255 0.55 . . . . 0.0 110.539 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' TRP . . . . . 0.463 ' HE1' HD13 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -68.84 -38.27 79.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -170.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.0 t -54.6 -24.97 23.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.195 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -82.92 -33.39 26.85 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.412 -0.18 . . . . 0.0 111.0 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.598 ' HB3' ' HG ' ' A' ' 565' ' ' LEU . 14.5 mt -65.26 -50.57 65.26 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 121.002 0.43 . . . . 0.0 110.292 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.34 -16.51 63.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.848 0.356 . . . . 0.0 111.424 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -85.95 -38.34 8.69 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.024 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -124.66 135.28 52.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 111.267 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -73.57 -31.34 63.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.11 -170.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.459 ' H ' ' HD2' ' A' ' 563' ' ' LYS . 9.6 mptt -71.2 -37.05 72.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.85 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.1 -34.52 73.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.676 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' A' ' 558' ' ' LEU . 0.4 OUTLIER -75.73 -47.27 26.74 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.892 0.377 . . . . 0.0 110.443 177.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -59.67 -33.99 72.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.426 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -56.3 -52.79 63.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.946 0.403 . . . . 0.0 111.033 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 632' ' ' LEU . 73.9 mt -71.46 -46.67 62.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.429 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.595 ' HB3' HD22 ' A' ' 527' ' ' LEU . 0.1 OUTLIER -51.96 -34.23 41.3 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.404 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 47.2 mttp -69.47 -26.05 64.38 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.583 ' O ' HD21 ' A' ' 597' ' ' LEU . 52.4 t80 -80.31 -17.04 53.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.959 0.409 . . . . 0.0 110.708 -176.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . 0.6 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 16.7 m80 -79.89 -6.18 56.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.257 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.706 HG12 HG21 ' A' ' 539' ' ' VAL . 69.1 mt -117.12 117.47 55.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.04 -175.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.1 167.49 34.48 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.64 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.553 ' OD2' ' HB2' ' A' ' 590' ' ' LYS . 8.0 m-20 -54.63 -42.22 70.97 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.06 -176.56 5.71 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.748 -168.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.509 HG12 ' HA2' ' A' ' 623' ' ' GLY . 58.6 mt -82.08 118.23 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.314 -173.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 4.6 tt -118.49 93.47 4.13 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.9 m -73.5 167.53 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.573 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.62 ' HA ' HD11 ' A' ' 583' ' ' ILE . 13.1 t -62.37 -24.15 67.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.2 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -71.04 -10.89 69.38 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.036 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -99.9 -17.51 25.3 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.737 HG21 ' HB2' ' A' ' 601' ' ' LEU . 77.4 mt -71.47 94.47 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.362 0.601 . . . . 0.0 110.394 176.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -109.15 -121.47 4.47 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.975 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -58.96 -62.79 1.62 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 110.528 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.427 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 7.9 tt -168.48 129.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.61 136.05 60.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.95 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -97.98 120.84 39.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.141 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.76 116.67 32.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.553 ' HB2' ' OD2' ' A' ' 575' ' ' ASP . 23.7 mmmt -63.88 139.23 58.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.723 0.296 . . . . 0.0 110.336 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.568 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 86.5 p -106.14 -173.92 2.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.346 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 76.3 mt -80.79 -39.69 26.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.829 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 571' ' ' TYR . 24.4 tt0 -61.84 -29.58 70.27 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.088 0.47 . . . . 0.0 110.833 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 127.03 -18.83 6.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.268 -0.968 . . . . 0.0 114.509 170.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 596' ' ' LYS . 8.8 t70 -88.52 -158.88 0.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.466 1.133 . . . . 0.0 109.893 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.475 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 10.8 pttm -124.75 135.98 53.46 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.862 0.363 . . . . 0.0 111.07 -169.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.583 HD21 ' O ' ' A' ' 571' ' ' TYR . 94.6 mt -83.85 115.34 22.21 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 172.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -91.32 84.84 5.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.69 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 608' ' ' VAL . 2.4 p -110.08 132.05 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.248 0.547 . . . . 0.0 111.69 -175.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.427 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 5.8 p -144.33 168.76 19.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.148 -176.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.737 ' HB2' HG21 ' A' ' 583' ' ' ILE . 1.8 tt -117.84 112.49 20.45 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -141.14 135.89 31.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.138 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 64.9 t30 61.41 36.29 17.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.279 0.561 . . . . 0.0 110.281 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 67.2 t30 73.24 -2.17 2.82 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.773 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 9.6 p -122.81 147.37 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.852 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.49 HG21 ' HG3' ' A' ' 616' ' ' PRO . 57.6 t -77.68 132.12 33.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.219 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 5.8 p -123.84 112.29 17.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.06 0.457 . . . . 0.0 111.21 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 599' ' ' VAL . 10.7 p -114.89 135.29 55.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.485 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.581 ' OD1' HG21 ' A' ' 608' ' ' VAL . 0.5 OUTLIER 57.75 26.36 12.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -177.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 62.8 mttm 76.09 1.4 3.44 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.205 1.002 . . . . 0.0 111.915 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 29.7 mm-40 -101.37 137.35 19.63 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.276 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 11.6 Cg_exo -72.45 126.58 11.7 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.021 2.48 . . . . 0.0 112.294 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.07 141.95 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.996 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -75.65 -60.3 2.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.857 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -141.68 113.48 6.54 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.615 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . 0.495 ' CB ' ' HD1' ' A' ' 626' ' ' HIS . 65.0 Cg_endo -81.51 169.88 15.03 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.833 2.355 . . . . 0.0 113.053 174.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 2.5 t70 72.95 28.28 1.99 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.479 165.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 52.3 mt -80.9 89.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.497 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 53.2 mtp -78.97 137.07 37.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.635 0.731 . . . . 0.0 112.74 -171.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -106.26 -177.74 3.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.017 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.444 HG23 ' HA ' ' A' ' 504' ' ' THR . 15.0 t -74.74 -16.54 60.73 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.332 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.615 HD22 HG22 ' A' ' 505' ' ' VAL . 30.7 p-10 -119.37 10.51 11.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . 0.509 ' HA2' HG12 ' A' ' 577' ' ' ILE . . . 161.79 -147.05 12.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.415 -1.374 . . . . 0.0 113.52 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.4 p -139.97 145.06 26.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.86 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 76.8 t -118.74 143.61 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.657 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . 0.618 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 34.9 m-70 -130.16 127.19 39.23 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.717 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 98.2 t -79.94 119.3 29.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.7 148.21 17.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.028 0.442 . . . . 0.0 110.581 172.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 33.0 p -95.74 10.5 36.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.65 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -136.03 155.63 49.94 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.618 ' HB ' HD12 ' A' ' 550' ' ' LEU . 52.0 t -96.83 157.29 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.6 ' HB2' ' CE1' ' A' ' 572' ' ' HIS . 46.4 mt . . . . . 0 C--N 1.315 -0.896 0 CA-C-O 120.856 0.36 . . . . 0.0 110.277 -170.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.691 0.282 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 103.32 13.24 29.09 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.527 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 27.2 ttt -78.92 96.38 5.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.107 0.48 . . . . 0.0 110.125 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.471 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . 174.99 -146.7 8.56 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.736 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.408 ' HG1' ' HA ' ' A' ' 532' ' ' ASN . 67.1 p -91.94 -172.12 3.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.712 0.291 . . . . 0.0 110.366 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.921 HG22 ' HB3' ' A' ' 531' ' ' LEU . 4.4 m -49.42 -29.89 4.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.897 170.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.491 ' HG2' ' CB ' ' A' ' 531' ' ' LEU . 85.3 mmm -67.64 -50.43 57.97 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.352 -0.217 . . . . 0.0 110.93 172.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . 0.471 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 1.0 OUTLIER -72.09 -29.77 64.45 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.136 -174.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 1.016 HG12 HG23 ' A' ' 625' ' ' VAL . 8.7 p -58.06 -35.02 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.504 0.669 . . . . 0.0 110.693 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.953 HD23 HG11 ' A' ' 508' ' ' VAL . 7.2 mt -81.65 -33.99 31.03 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.593 177.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -66.03 -25.02 66.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.856 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -102.24 1.88 50.66 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.76 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -111.5 141.83 44.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.522 0.661 . . . . 0.0 111.358 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . 0.441 ' HA ' ' OG ' ' A' ' 516' ' ' SER . 17.2 m120 -75.32 -23.99 57.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.035 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -87.07 -15.37 38.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.075 0.464 . . . . 0.0 110.418 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.871 ' HZ ' HG23 ' A' ' 627' ' ' VAL . 25.5 m-85 -109.51 8.1 25.04 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.898 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' SER . . . . . 0.441 ' OG ' ' HA ' ' A' ' 513' ' ' ASN . 67.8 m -57.24 -45.92 83.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -174.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.3 ttp -76.04 -24.02 55.16 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.218 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.524 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 46.8 tp -60.45 -45.22 94.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.984 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 515' ' ' PHE . 5.8 t -53.45 -46.61 59.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.553 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.2 72.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.685 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -71.81 -48.37 46.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.008 0.432 . . . . 0.0 109.931 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.746 HG12 HD21 ' A' ' 569' ' ' LEU . 43.3 mt -56.61 -39.0 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.612 0.72 . . . . 0.0 109.985 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -59.22 -53.25 60.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.909 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.0 m -59.23 -27.33 65.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.859 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -79.12 -28.25 42.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 65.02 32.58 84.67 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.675 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . 0.66 HD21 HD23 ' A' ' 569' ' ' LEU . 3.6 pp -102.65 24.58 10.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.356 0.578 . . . . 0.0 110.486 177.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 56.7 m -46.47 -53.12 11.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.295 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.41 -28.23 58.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -174.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 53.5 m -59.98 -52.47 65.25 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.715 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.921 ' HB3' HG22 ' A' ' 505' ' ' VAL . 27.2 mt -96.21 -8.43 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -175.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . 0.408 ' HA ' ' HG1' ' A' ' 504' ' ' THR . 4.1 t30 -92.88 -9.47 40.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.68 0.752 . . . . 0.0 110.409 -177.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -94.15 157.7 15.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.318 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -77.39 149.76 35.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.02 0.438 . . . . 0.0 110.785 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 164.66 -146.7 11.61 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.673 ' HB ' HG13 ' A' ' 577' ' ' ILE . 16.9 m -129.41 127.39 64.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -149.81 151.29 33.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 0.0 110.931 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 96.9 m -124.4 101.45 7.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.548 HG22 HG12 ' A' ' 573' ' ' ILE . 87.3 t -98.77 111.48 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.832 -174.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 56.3 m-85 -83.47 106.61 15.36 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -98.6 117.0 65.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.451 -166.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.599 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 72.3 Cg_endo -78.49 135.22 13.03 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.819 2.346 . . . . 0.0 112.121 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.3 p -78.45 -176.0 4.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.243 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . 0.5 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 12.0 m120 -73.68 -34.52 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.323 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 548' ' ' ARG . 1.5 pm0 -70.17 -18.99 63.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.099 0.476 . . . . 0.0 110.342 175.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.12 64.37 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.212 0.53 . . . . 0.0 110.789 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' A' ' 544' ' ' ASN . 19.2 m-85 -66.49 -12.78 59.17 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.195 172.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . 0.507 ' HA ' ' HE ' ' A' ' 548' ' ' ARG . 3.3 mmp_? -92.57 -13.63 29.44 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.323 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -92.36 4.61 53.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.917 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 66.5 mt -113.05 142.71 27.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 0.0 111.588 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 31.3 Cg_exo -59.08 128.07 26.45 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.358 2.039 . . . . 0.0 111.179 174.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.08 -29.07 53.63 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.955 2.437 . . . . 0.0 113.389 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -59.13 -53.82 54.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.524 0.202 . . . . 0.0 111.47 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.493 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 32.3 mm-40 -63.89 -37.33 86.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.313 0.577 . . . . 0.0 110.633 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -40.22 63.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.817 -177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 70.8 m -59.38 -22.96 62.15 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.65 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 554' ' ' GLU . 73.5 mtp180 -73.34 -45.14 56.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.298 173.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.641 ' HB3' ' HA ' ' A' ' 565' ' ' LEU . 13.1 mt -67.71 -53.42 27.67 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.559 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -15.58 63.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.802 0.334 . . . . 0.0 111.623 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -88.4 -29.44 19.37 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.44 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . 0.642 ' OD2' ' HG3' ' A' ' 563' ' ' LYS . 24.5 t70 -131.05 124.69 31.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.793 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -62.43 -47.06 85.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -171.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.642 ' HG3' ' OD2' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -72.31 -24.82 61.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.973 -177.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.544 ' HG3' HD21 ' A' ' 558' ' ' LEU . 5.2 tp10 -68.52 -42.71 78.11 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.641 ' HA ' ' HB3' ' A' ' 558' ' ' LEU . 3.4 tt -65.75 -50.97 62.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . 0.427 ' HB3' ' HE2' ' A' ' 570' ' ' LYS . . . -54.87 -32.16 60.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.693 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -52.77 -53.64 45.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.455 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 59.2 mt -82.57 -39.79 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.746 HD21 HG12 ' A' ' 522' ' ' ILE . 22.4 tp -55.75 -36.48 67.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.612 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 68.6 mttm -68.24 -22.64 64.76 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.805 0.336 . . . . 0.0 111.872 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.645 ' O ' HD22 ' A' ' 597' ' ' LEU . 32.5 t80 -80.15 -17.28 52.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.892 0.377 . . . . 0.0 110.842 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . 0.649 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 4.0 m80 -77.87 -8.89 58.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.263 0.554 . . . . 0.0 110.872 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.548 HG12 HG22 ' A' ' 539' ' ' VAL . 36.2 mt -110.8 116.67 53.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.929 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -78.71 161.77 48.32 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.23 175.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.481 ' OD1' ' HB2' ' A' ' 590' ' ' LYS . 5.2 p-10 -81.57 -10.13 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -172.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -156.69 178.02 10.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 176.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.673 HG13 ' HB ' ' A' ' 536' ' ' VAL . 36.7 mt -89.87 114.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.113 0.482 . . . . 0.0 112.208 -168.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 5.6 tt -112.96 96.16 5.79 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.5 m -80.61 169.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.795 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 617' ' ' ASP . 35.5 p -47.46 -43.28 24.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.376 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -70.42 -6.87 59.4 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.988 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.76 -7.63 47.43 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.226 -0.511 . . . . 0.0 111.927 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.75 HG21 ' HB2' ' A' ' 601' ' ' LEU . 58.2 mt -76.76 104.97 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.982 0.42 . . . . 0.0 110.16 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -103.64 -152.11 22.81 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.003 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -50.91 -56.75 10.83 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.011 0.434 . . . . 0.0 110.534 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.402 HD22 ' HG3' ' A' ' 598' ' ' GLU . 6.3 tt -160.32 109.27 1.71 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.212 173.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 97.6 t -116.5 124.89 73.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.923 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -98.01 126.88 43.63 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.855 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 21.9 tp -115.94 142.46 46.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.492 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.481 ' HB2' ' OD1' ' A' ' 575' ' ' ASP . 37.2 mtmm -71.84 163.13 28.38 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.782 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.585 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.9 p -128.44 -176.83 3.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.005 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 63.1 mt -82.11 -41.86 19.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.38 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.52 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 31.9 tt0 -59.25 -29.83 67.84 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.579 0.704 . . . . 0.0 110.255 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.79 -11.06 7.46 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.642 169.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . 0.55 ' OD2' ' HG2' ' A' ' 596' ' ' LYS . 3.7 t70 -94.02 -156.38 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.493 0.646 . . . . 0.0 109.985 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.55 ' HG2' ' OD2' ' A' ' 595' ' ' ASP . 19.9 pttm -117.94 142.02 47.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.863 0.363 . . . . 0.0 111.215 -172.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.645 HD22 ' O ' ' A' ' 571' ' ' TYR . 67.1 mt -92.13 116.83 29.28 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 34.5 tt0 -91.26 85.83 5.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.348 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . 0.53 HG11 HG22 ' A' ' 583' ' ' ILE . 35.0 t -93.21 128.87 44.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.796 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 2.7 p -140.25 148.91 42.17 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.586 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.75 ' HB2' HG21 ' A' ' 583' ' ' ILE . 59.3 tp -119.25 112.8 19.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -131.13 110.42 11.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.967 0.413 . . . . 0.0 110.837 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 59.55 53.0 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.423 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 69.81 -5.56 1.21 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.875 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.59 120.73 46.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.88 0.372 . . . . 0.0 110.438 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.454 HG22 ' HG3' ' A' ' 616' ' ' PRO . 43.1 t -85.77 140.81 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.856 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 40.6 m -132.16 142.56 49.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.603 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.6 p -134.69 123.81 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 120.882 0.373 . . . . 0.0 110.046 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.695 ' ND2' HD11 ' A' ' 632' ' ' LEU . 31.5 m-20 61.15 32.1 19.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.559 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 53.2 mttp 76.56 -0.12 3.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.806 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.481 ' HB3' ' OD1' ' A' ' 630' ' ' ASN . 5.3 mm-40 -99.61 130.13 27.4 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.427 ' HD2' HD22 ' A' ' 630' ' ' ASN . 16.5 Cg_exo -68.81 134.46 30.11 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.988 2.458 . . . . 0.0 113.049 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 49.0 t -86.37 143.17 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.703 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.11 12.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.655 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 616' ' ' PRO . 32.0 tt0 -152.87 104.65 2.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.162 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.479 ' HA ' ' HD1' ' A' ' 626' ' ' HIS . 75.0 Cg_endo -74.39 157.41 45.36 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.569 2.179 . . . . 0.0 113.114 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 580' ' ' SER . 1.3 t70 76.7 59.81 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.734 166.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 22.3 mt -108.81 97.12 5.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 165.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 57.4 mtp -79.93 142.64 34.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.621 0.724 . . . . 0.0 112.846 -167.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.72 -175.43 2.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.251 171.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 12.6 t -82.42 -17.16 46.35 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.316 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.668 HD22 HG21 ' A' ' 505' ' ' VAL . 32.1 p-10 -119.22 14.52 13.03 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 162.76 -160.29 32.69 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.139 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.73 148.96 32.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.746 0.308 . . . . 0.0 110.179 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . 1.016 HG23 HG12 ' A' ' 508' ' ' VAL . 87.5 t -118.28 145.21 24.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.481 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . 0.535 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 74.4 m-70 -132.08 126.43 33.76 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.871 HG23 ' HZ ' ' A' ' 515' ' ' PHE . 82.6 t -79.15 119.08 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.2 145.76 21.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.917 0.389 . . . . 0.0 110.241 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 22.9 p -97.73 9.77 41.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . 0.481 ' OD1' ' HB3' ' A' ' 611' ' ' GLU . 2.6 p30 -140.25 147.89 40.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.666 176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.404 HG11 ' N ' ' A' ' 632' ' ' LEU . 43.9 t -82.23 160.62 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.695 HD11 ' ND2' ' A' ' 609' ' ' ASN . 42.4 mt -116.01 132.45 56.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -167.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.85 152.39 41.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.873 0.368 . . . . 0.0 110.147 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.669 -0.682 . . . . 0.0 110.34 -177.584 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.769 0.319 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -85.34 -137.75 4.24 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.855 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 26.6 mmt -117.73 128.96 55.4 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -98.24 -146.25 20.28 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-O 121.744 0.635 . . . . 0.0 113.398 -175.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 508' ' ' VAL . 72.4 p -86.01 -171.2 3.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.299 -0.951 . . . . 0.0 110.14 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.689 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 36.4 t -43.9 -45.0 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 123.537 0.523 . . . . 0.0 111.185 173.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.499 ' HB2' ' HB2' ' A' ' 531' ' ' LEU . 10.2 tpt -63.78 -42.3 97.78 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.953 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . 0.507 ' HA ' ' HB2' ' A' ' 510' ' ' LYS . 25.3 t70 -67.78 -37.77 82.49 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.818 0.342 . . . . 0.0 110.631 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.518 HG21 ' HB2' ' A' ' 620' ' ' ALA . 82.8 t -50.61 -40.7 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.796 174.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 5.9 mt -82.37 -35.17 28.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.405 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 507' ' ' ASP . 17.3 mmmt -60.41 -40.71 91.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.823 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -90.87 -12.74 60.13 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.815 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -102.86 141.29 35.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.296 0.57 . . . . 0.0 111.092 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -75.94 -25.86 56.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.573 -174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -83.09 -15.98 48.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.1 0.476 . . . . 0.0 110.246 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.826 ' HZ ' HG21 ' A' ' 627' ' ' VAL . 24.6 m-85 -109.34 17.78 21.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.379 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 12.0 p -57.54 -61.38 2.54 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' MET . . . . . 0.444 ' HE3' ' CG ' ' A' ' 547' ' ' PHE . 2.4 ttp -70.57 -20.79 62.76 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.009 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.539 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 49.5 tp -57.42 -45.25 84.81 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.654 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.434 ' O ' ' HB2' ' A' ' 523' ' ' GLN . 9.1 t -51.39 -47.82 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.905 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.28 -39.32 89.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.905 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.46 -42.09 96.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.028 0.442 . . . . 0.0 110.404 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.676 HG12 HD13 ' A' ' 569' ' ' LEU . 49.8 mt -69.74 -29.1 39.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.557 0.694 . . . . 0.0 109.992 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.0 OUTLIER -65.48 -53.54 41.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.877 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.3 m -65.75 -16.19 63.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.986 0.422 . . . . 0.0 110.904 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -80.5 -17.34 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.267 173.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 74.93 17.94 80.19 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.381 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . 0.741 HD12 HD11 ' A' ' 569' ' ' LEU . 82.1 mt -97.31 17.15 18.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.556 -0.379 . . . . 0.0 111.556 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 46.6 m -55.99 -48.75 75.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . 0.654 ' HA ' ' HB2' ' A' ' 532' ' ' ASN . 31.8 tt0 -62.73 -25.04 67.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.621 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 40.6 m -61.23 -50.48 72.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.608 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.66 ' HG ' ' CG1' ' A' ' 505' ' ' VAL . 0.3 OUTLIER -84.82 -21.65 29.79 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.429 176.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . 0.654 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 0.9 OUTLIER -70.03 -22.2 63.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.671 0.272 . . . . 0.0 110.837 175.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -84.97 126.25 33.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . 0.466 ' OE2' ' HA ' ' A' ' 622' ' ' ASN . 13.9 tp10 -70.79 145.99 50.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.663 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 166.42 -132.1 2.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.827 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.557 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.5 m -137.36 127.47 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.656 0.265 . . . . 0.0 110.555 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -149.81 154.63 38.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.967 0.413 . . . . 0.0 110.626 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.7 m -129.02 105.01 7.91 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.779 HG21 HG12 ' A' ' 573' ' ' ILE . 93.5 t -107.26 113.89 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.065 -174.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 60.5 m-85 -83.1 111.25 18.72 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 171.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -104.65 119.71 52.73 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.964 -165.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 541' ' ' ALA . 5.7 Cg_exo -77.89 141.6 19.22 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.335 2.69 . . . . 0.0 112.018 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 81.2 p -83.38 -179.15 7.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.111 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -58.45 -40.47 82.69 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.21 0.529 . . . . 0.0 110.281 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 545' ' ' GLU . 1.5 mp0 -62.78 -23.4 67.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.163 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -78.08 -31.35 50.12 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.275 0.559 . . . . 0.0 111.878 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . 0.496 ' CD1' ' HZ2' ' A' ' 555' ' ' TRP . 41.7 m-85 -67.06 -12.56 60.26 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.238 175.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -91.52 -8.79 46.56 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.73 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -91.16 -8.51 48.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.391 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.55 HD11 ' HE1' ' A' ' 555' ' ' TRP . 40.8 mt -100.3 142.42 24.58 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.411 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.92 142.24 92.4 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.709 2.273 . . . . 0.0 111.665 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.14 -40.38 77.18 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.22 2.613 . . . . 0.0 113.123 -175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -59.61 -51.21 70.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.521 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.518 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 6.9 mp0 -60.43 -41.33 93.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.459 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' TRP . . . . . 0.55 ' HE1' HD11 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -69.17 -45.4 70.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.912 -177.025 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 35.2 p -58.58 -21.93 54.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.263 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -75.98 -49.86 16.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.87 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.606 ' HB3' ' HA ' ' A' ' 565' ' ' LEU . 12.9 mt -61.18 -63.68 1.21 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.728 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . 0.857 HD12 HD12 ' A' ' 565' ' ' LEU . 3.5 mm? -58.53 -12.02 3.57 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.297 0.639 . . . . 0.0 112.542 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -74.68 -35.46 51.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.876 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . 0.517 ' OD2' ' HG3' ' A' ' 563' ' ' LYS . 16.9 t70 -144.67 153.03 41.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.218 0.509 . . . . 0.0 111.127 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -62.49 -47.28 84.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.048 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.517 ' HG3' ' OD2' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -71.31 -17.75 62.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.941 -177.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.444 ' N ' ' HD3' ' A' ' 563' ' ' LYS . 5.6 mm-40 -81.12 -42.41 20.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.676 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.857 HD12 HD12 ' A' ' 559' ' ' LEU . 0.6 OUTLIER -69.89 -48.27 59.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.329 0.585 . . . . 0.0 109.655 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . 0.476 ' HB3' ' HE3' ' A' ' 570' ' ' LYS . . . -62.56 -27.54 69.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.834 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -52.49 -53.9 39.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.852 0.358 . . . . 0.0 110.686 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 66.1 mt -83.43 -39.06 14.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.366 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.741 HD11 HD12 ' A' ' 527' ' ' LEU . 0.8 OUTLIER -54.99 -32.74 61.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.124 -178.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 97.2 mttt -74.91 -13.75 60.57 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.563 ' O ' HD22 ' A' ' 597' ' ' LEU . 44.7 t80 -86.71 -19.11 29.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.048 0.452 . . . . 0.0 110.885 -177.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 15.3 m80 -77.78 -12.62 59.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.137 0.494 . . . . 0.0 110.566 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.779 HG12 HG21 ' A' ' 539' ' ' VAL . 68.3 mt -105.51 120.5 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.292 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.95 155.86 24.92 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.17 -4.86 57.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.29 168.54 23.76 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.506 0.193 . . . . 0.0 110.509 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.557 HG13 ' HB ' ' A' ' 536' ' ' VAL . 33.1 mt -89.0 117.5 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.602 -170.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 53.3 tp -117.66 97.9 6.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 24.4 m -79.24 170.64 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.096 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.605 ' HA ' HD12 ' A' ' 583' ' ' ILE . 17.9 m -55.96 -30.18 61.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.768 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.5 -13.43 65.46 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.135 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.86 -26.82 7.77 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.74 HG23 ' HB2' ' A' ' 601' ' ' LEU . 74.9 mt -60.9 103.89 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.069 0.461 . . . . 0.0 110.035 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -115.49 -137.03 6.13 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.12 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -59.67 -60.52 3.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 0.0 110.509 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 7.9 tt -157.9 112.75 2.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 67.2 t -121.65 133.53 67.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.128 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . 0.828 ' HD3' ' H ' ' A' ' 588' ' ' ARG . 0.0 OUTLIER -99.33 126.82 45.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.849 -179.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.47 125.51 49.09 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -75.02 143.24 43.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.221 0.534 . . . . 0.0 110.603 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.598 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 84.8 p -107.9 -178.62 3.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.735 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.554 ' CD1' HG22 ' A' ' 573' ' ' ILE . 7.0 mp -73.99 -36.14 64.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.38 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -65.97 -30.56 71.15 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 121.559 0.695 . . . . 0.0 110.138 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 126.24 -21.9 6.03 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.08 -0.964 . . . . 0.0 114.006 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 596' ' ' LYS . 5.5 t70 -81.85 -165.52 1.0 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.042 0.921 . . . . 0.0 110.585 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.468 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 0.2 OUTLIER -123.45 135.51 54.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 0.0 111.442 -170.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.563 HD22 ' O ' ' A' ' 571' ' ' TYR . 84.2 mt -84.74 122.09 28.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.482 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 37.3 mt-10 -92.05 90.27 7.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.44 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . 0.481 HG11 HG21 ' A' ' 583' ' ' ILE . 40.4 t -93.32 133.42 34.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.01 -176.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 32.2 t -143.92 136.82 27.35 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.74 ' HB2' HG23 ' A' ' 583' ' ' ILE . 63.7 tp -113.22 112.98 24.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -133.49 112.52 11.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 604' ' ' ASN . 15.3 t-20 60.03 47.14 10.04 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.13 0.491 . . . . 0.0 109.785 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' A' ' 603' ' ' ASN . 10.2 t30 74.11 -14.95 0.64 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.723 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 55.9 t -84.18 115.81 26.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 122.175 -0.328 . . . . 0.0 110.665 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.546 HG22 HD11 ' A' ' 601' ' ' LEU . 43.8 t -84.51 136.09 23.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.599 176.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 44.9 m -126.0 147.98 49.4 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 176.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.49 HG11 ' CD1' ' A' ' 540' ' ' PHE . 7.0 p -141.12 119.57 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 1.036 HD21 HD13 ' A' ' 632' ' ' LEU . 29.5 m-20 62.12 31.43 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 24.4 tptp 86.92 -24.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.215 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 14.4 mm-40 -83.24 132.02 51.53 Favored Pre-proline 0 C--N 1.317 -0.834 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.646 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 13.8 Cg_exo -71.28 135.25 26.48 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.117 2.544 . . . . 0.0 112.856 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.572 HG11 ' HB3' ' A' ' 626' ' ' HIS . 24.7 t -88.74 136.25 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.206 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -88.8 -48.52 7.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.667 -177.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -132.72 89.7 34.6 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.01 159.28 53.79 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.662 2.241 . . . . 0.0 113.431 171.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.482 ' HB2' ' HG ' ' A' ' 580' ' ' SER . 0.3 OUTLIER 75.76 39.02 0.34 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.438 165.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 41.5 mt -87.38 85.76 2.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 166.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 55.7 mtp -80.71 129.57 34.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.645 0.736 . . . . 0.0 112.715 -170.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 508' ' ' VAL . . . -99.65 -171.42 2.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.148 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.401 ' OG1' HG23 ' A' ' 504' ' ' THR . 62.4 p -73.67 -38.46 64.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.498 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.466 ' HA ' ' OE2' ' A' ' 534' ' ' GLU . 30.0 p-10 -99.19 6.06 46.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.47 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 164.27 -152.64 22.53 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.189 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 8.8 p -134.77 144.48 34.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.809 0.338 . . . . 0.0 110.697 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.89 140.55 37.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.709 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . 0.572 ' HB3' HG11 ' A' ' 613' ' ' VAL . 52.3 m-70 -126.9 126.44 43.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.389 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.826 HG21 ' HZ ' ' A' ' 515' ' ' PHE . 69.3 t -76.95 118.74 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.15 149.03 19.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.114 171.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 36.8 p -99.19 15.52 25.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.643 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -138.66 156.03 47.78 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.409 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.425 HG13 ' H ' ' A' ' 632' ' ' LEU . 36.1 t -98.37 160.73 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 174.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 1.036 HD13 HD21 ' A' ' 609' ' ' ASN . 16.2 mt -129.16 111.39 12.88 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.633 -167.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -97.53 134.22 41.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.135 0.493 . . . . 0.0 110.818 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 117.731 -1.128 . . . . 0.0 108.802 177.259 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.747 0.308 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 139.43 -139.07 9.73 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.006 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.41 103.1 0.06 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.484 0.659 . . . . 0.0 110.426 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -89.21 -141.74 8.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.931 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.495 ' HG1' ' HA ' ' A' ' 532' ' ' ASN . 51.9 p -91.0 -170.33 2.64 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.862 -0.669 . . . . 0.0 109.687 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.78 HG13 HG22 ' A' ' 539' ' ' VAL . 99.4 t -47.18 -43.42 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 0.0 110.627 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.538 ' HE1' HG23 ' A' ' 528' ' ' THR . 36.0 tpp -62.7 -41.07 98.95 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.883 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . 0.822 ' HA ' ' HD3' ' A' ' 510' ' ' LYS . 7.7 t70 -68.17 -32.13 72.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.643 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 504' ' ' THR . 99.6 t -51.3 -60.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.432 173.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.606 HD13 ' O ' ' A' ' 505' ' ' VAL . 5.1 mp -57.36 -37.64 72.92 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.055 0.942 . . . . 0.0 112.18 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.822 ' HD3' ' HA ' ' A' ' 507' ' ' ASP . 40.1 mtpt -54.53 -39.82 68.03 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -94.18 -17.05 41.56 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.143 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -85.37 132.78 34.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.084 0.469 . . . . 0.0 111.092 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -76.49 -25.51 54.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.727 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -80.94 -21.77 40.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.791 0.329 . . . . 0.0 110.351 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.559 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 20.7 m-85 -109.6 13.44 23.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.417 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 74.6 m -57.69 -49.82 75.23 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.5 ttp -74.93 -20.77 59.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.51 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.681 HD12 ' HZ ' ' A' ' 547' ' ' PHE . 59.7 tp -59.48 -44.03 93.14 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.735 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 509' ' ' LEU . 9.4 t -51.66 -51.91 24.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.377 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.61 97.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.971 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.5 83.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.382 0.61 . . . . 0.0 110.406 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.77 HG12 HD22 ' A' ' 569' ' ' LEU . 97.5 mt -62.86 -37.68 79.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.619 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -63.32 -49.15 75.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.746 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 8.5 t -60.57 -32.82 71.89 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.059 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 565' ' ' LEU . . . -71.08 -22.26 62.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.031 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 75.98 19.33 78.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.257 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . 0.72 HD21 HD21 ' A' ' 569' ' ' LEU . 3.6 pp -106.79 22.25 16.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.478 0.639 . . . . 0.0 110.646 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.538 HG23 ' HE1' ' A' ' 506' ' ' MET . 42.0 m -54.6 -43.22 71.97 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.864 175.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 533' ' ' ARG . 7.9 pt-20 -57.22 -33.15 67.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.422 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.0 m -63.47 -52.57 60.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 110.401 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.444 HD23 HD11 ' A' ' 573' ' ' ILE . 59.8 mt -74.09 -22.75 59.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.542 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . 0.495 ' HA ' ' HG1' ' A' ' 504' ' ' THR . 1.0 OUTLIER -91.85 9.54 32.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 176.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 529' ' ' GLU . 71.4 ttt180 -101.87 143.32 31.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.831 0.348 . . . . 0.0 110.313 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.66 146.69 54.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.544 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 150.83 -139.96 7.59 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.629 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.462 ' HB ' HG13 ' A' ' 577' ' ' ILE . 8.3 m -135.84 127.47 44.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -149.33 146.82 27.72 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 97.5 m -119.11 102.45 8.74 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 170.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.78 HG22 HG13 ' A' ' 505' ' ' VAL . 93.3 t -99.32 113.47 34.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 -173.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.512 ' HB2' HD12 ' A' ' 632' ' ' LEU . 52.5 m-85 -86.14 103.87 15.19 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 171.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -96.88 115.24 65.64 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.373 -167.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.608 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 70.1 Cg_endo -81.32 135.04 9.3 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.461 2.107 . . . . 0.0 111.821 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.738 ' HG1' ' HG2' ' A' ' 545' ' ' GLU . 47.8 p -70.03 173.69 6.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.441 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . 0.535 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -67.82 -33.04 74.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.944 0.402 . . . . 0.0 110.902 -178.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.738 ' HG2' ' HG1' ' A' ' 543' ' ' THR . 1.7 pm0 -70.17 -19.75 63.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.858 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -76.34 -33.24 58.98 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.004 0.431 . . . . 0.0 111.3 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . 0.681 ' HZ ' HD12 ' A' ' 518' ' ' LEU . 14.8 m-85 -64.79 -14.85 60.54 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . 0.421 ' HD2' ' HA ' ' A' ' 548' ' ' ARG . 12.9 tpt180 -92.95 -14.75 27.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.84 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -80.67 -19.39 45.35 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.278 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.471 HD13 ' HB ' ' A' ' 631' ' ' VAL . 78.9 mt -97.95 137.2 20.89 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.888 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 34.8 Cg_exo -61.64 136.82 65.02 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.583 2.189 . . . . 0.0 112.051 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.64 -37.5 53.45 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.965 2.443 . . . . 0.0 112.437 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -54.31 -34.17 60.39 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.096 0.474 . . . . 0.0 111.245 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.93 -44.39 12.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.731 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' TRP . . . . . 0.475 ' CE3' HD13 ' A' ' 559' ' ' LEU . 0.0 OUTLIER -81.46 -37.94 27.2 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 29.3 t -54.66 -34.91 62.92 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -66.57 -42.88 86.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.506 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.685 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 46.3 mt -59.06 -54.36 47.98 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.858 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . 0.803 ' HG ' HD21 ' A' ' 565' ' ' LEU . 1.0 OUTLIER -70.7 -3.13 16.97 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -76.96 -29.57 56.97 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.681 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . 0.632 ' OD1' ' HG3' ' A' ' 563' ' ' LYS . 11.1 t70 -142.73 150.95 40.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.556 -176.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.05 81.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.632 ' HG3' ' OD1' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -80.52 -18.45 48.47 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.735 -178.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.506 ' HG2' ' HB3' ' A' ' 561' ' ' ASP . 15.5 mm-40 -72.38 -42.89 64.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.803 HD21 ' HG ' ' A' ' 559' ' ' LEU . 16.8 mt -61.93 -57.16 12.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.09 174.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -54.66 -27.27 38.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.991 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -53.41 -61.78 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.168 0.293 . . . . 0.0 111.491 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 68.7 mt -84.85 -37.65 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.873 0.368 . . . . 0.0 110.207 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.77 HD22 HG12 ' A' ' 522' ' ' ILE . 29.3 tp -55.0 -37.43 66.58 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.822 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.654 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 7.8 mtpm? -78.87 -12.91 60.05 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.629 ' HB2' ' CB ' ' A' ' 593' ' ' GLN . 62.0 t80 -84.4 -11.99 55.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.414 0.626 . . . . 0.0 109.666 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . 0.699 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 1.2 m80 -79.49 -16.7 55.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.871 171.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.611 ' HB ' ' HG ' ' A' ' 592' ' ' LEU . 10.7 mm -98.31 115.53 38.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.598 -176.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -80.45 153.83 35.73 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.043 172.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.79 -11.82 59.92 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -171.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.6 177.68 10.1 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.462 HG13 ' HB ' ' A' ' 536' ' ' VAL . 41.7 mt -87.28 120.07 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.572 -172.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 589' ' ' LEU . 4.2 tt -121.36 99.32 6.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.0 167.91 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.918 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.665 ' HB2' ' HB2' ' A' ' 617' ' ' ASP . 36.6 t -56.98 -34.89 68.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.464 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.36 -9.57 61.33 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.345 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -106.03 -9.43 32.19 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.596 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 580' ' ' SER . 76.0 mt -61.97 -44.39 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . 59.14 -99.0 0.12 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.753 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -121.03 -53.18 2.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.937 0.399 . . . . 0.0 110.197 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.411 ' HA ' ' O ' ' A' ' 599' ' ' VAL . 5.3 tt -162.35 107.75 1.21 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 75.1 t -126.73 129.3 71.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . 0.612 ' HD3' ' HD2' ' A' ' 596' ' ' LYS . 4.0 ptp85 -97.09 128.16 43.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.727 0.775 . . . . 0.0 111.753 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.553 ' HB2' HD11 ' A' ' 578' ' ' LEU . 21.4 tp -120.4 131.92 55.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.843 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.61 ' HA ' ' HA ' ' A' ' 596' ' ' LYS . 81.1 tttt -76.51 151.97 36.22 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.169 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.587 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 85.7 p -110.9 -173.69 2.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.51 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.654 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 59.6 mt -80.43 -36.12 34.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.132 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.629 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.3 tt0 -58.46 -30.78 67.21 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.365 0.602 . . . . 0.0 110.502 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.7 6.14 6.16 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.079 -1.058 . . . . 0.0 114.89 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . 0.432 ' CG ' ' H ' ' A' ' 596' ' ' LYS . 7.4 t70 -123.52 -170.54 2.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 118.033 0.917 . . . . 0.0 109.793 174.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.612 ' HD2' ' HD3' ' A' ' 588' ' ' ARG . 23.4 pttm -103.82 142.04 35.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.124 0.487 . . . . 0.0 111.175 -172.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 571' ' ' TYR . 41.8 mt -89.95 117.03 28.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.629 175.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -82.35 94.24 7.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . 0.501 HG13 HG23 ' A' ' 583' ' ' ILE . 45.6 t -100.56 124.25 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.782 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.632 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 32.9 t -122.77 161.52 23.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.67 -176.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.498 HD13 HG23 ' A' ' 606' ' ' VAL . 60.0 tp -142.53 113.22 7.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.586 ' O ' HG13 ' A' ' 605' ' ' VAL . 87.8 tttt -135.13 99.79 4.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.806 0.336 . . . . 0.0 110.443 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.56 67.0 1.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.655 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 69.31 10.38 7.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 171.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 602' ' ' LYS . 11.6 p -122.15 126.84 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.175 0.512 . . . . 0.0 110.962 171.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 40.0 t -93.83 138.15 21.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.537 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' SER . . . . . 0.632 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 19.3 m -124.26 104.47 8.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 540' ' ' PHE . 6.9 p -110.4 117.1 54.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.867 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.643 HD21 ' HB3' ' A' ' 632' ' ' LEU . 9.0 m-20 60.72 33.55 20.16 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.812 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.408 ' HZ1' ' HB2' ' A' ' 610' ' ' LYS . 19.5 mtmm 83.18 -13.1 0.82 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.013 1.325 . . . . 0.0 111.861 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.501 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 19.9 mm-40 -91.7 132.47 33.06 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.96 0.409 . . . . 0.0 110.604 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 2.7 Cg_exo -75.5 125.95 9.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.909 2.406 . . . . 0.0 112.38 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 22.9 t -83.7 133.1 29.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -75.76 -60.28 2.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.972 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -138.89 101.18 7.88 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.606 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.487 ' CB ' ' HD1' ' A' ' 626' ' ' HIS . 80.5 Cg_endo -73.1 168.74 23.96 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.877 2.385 . . . . 0.0 114.137 176.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.665 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 1.4 t70 76.11 42.79 0.18 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.158 165.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 36.7 mt -94.62 92.65 3.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 167.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.486 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 59.5 mtp -80.09 136.16 36.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.243 0.544 . . . . 0.0 112.268 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -99.49 -172.76 2.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.501 172.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 13.2 p -76.76 -26.73 54.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.965 0.412 . . . . 0.0 111.316 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.485 ' OD1' HG21 ' A' ' 505' ' ' VAL . 27.0 p-10 -116.8 15.7 15.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.894 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . 0.425 ' HA2' HG12 ' A' ' 577' ' ' ILE . . . 164.3 -157.53 29.88 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.921 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 13.0 p -133.43 144.73 35.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.826 0.346 . . . . 0.0 110.652 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 79.6 t -114.72 142.27 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.226 0.536 . . . . 0.0 110.48 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . 0.487 ' HD1' ' CB ' ' A' ' 616' ' ' PRO . 68.0 m-70 -126.59 121.9 33.53 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.262 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.559 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 85.4 t -76.16 117.98 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 111.501 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.474 HG13 ' HA ' ' A' ' 542' ' ' PRO . 1.5 pt -119.02 142.53 33.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.291 173.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 39.9 p -96.29 7.41 46.53 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.708 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . 0.427 ' O ' HD11 ' A' ' 628' ' ' ILE . 6.0 m-20 -128.79 144.05 51.07 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.249 176.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.592 HG13 ' HE2' ' A' ' 572' ' ' HIS . 47.0 t -83.43 157.31 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.699 ' HB2' ' CE1' ' A' ' 572' ' ' HIS . 86.9 mt -91.57 116.72 29.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.323 0.582 . . . . 0.0 111.397 -166.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -142.73 118.28 10.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.034 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.421 -176.159 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -71.22 111.31 3.62 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.678 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 14.8 tpt -122.3 141.07 51.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.715 0.293 . . . . 0.0 110.215 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.546 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -139.25 -151.91 5.79 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.105 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 58.3 p -94.46 -170.31 2.23 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.576 ' O ' HD13 ' A' ' 509' ' ' LEU . 73.0 t -46.06 -42.83 4.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.603 170.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.407 ' HE2' HG13 ' A' ' 519' ' ' VAL . 7.7 tpt -59.73 -40.61 88.63 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.659 0.266 . . . . 0.0 111.066 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . 0.546 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 2.2 t70 -68.81 -34.55 75.72 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.207 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 505' ' ' VAL . 99.1 t -51.79 -56.89 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.001 0.429 . . . . 0.0 110.85 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 509' ' ' LEU . 5.4 mp -57.31 -42.33 81.62 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.461 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 510' ' ' LYS . 1.5 tmmt? -67.32 -25.76 66.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -99.49 13.01 61.51 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.872 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -122.63 139.13 54.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.922 0.391 . . . . 0.0 110.895 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -75.46 -16.47 60.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.489 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -91.29 -24.83 19.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.824 0.345 . . . . 0.0 110.901 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.899 ' HZ ' HG21 ' A' ' 627' ' ' VAL . 17.2 m-85 -107.01 8.36 30.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.656 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 13.3 p -54.05 -54.22 42.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' MET . . . . . 0.443 ' HE3' ' HB3' ' A' ' 517' ' ' MET . 3.7 tmm? -67.87 -29.89 69.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.214 0.53 . . . . 0.0 109.866 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 41.8 tp -57.42 -45.83 84.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.404 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 515' ' ' PHE . 10.0 t -52.75 -52.02 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.394 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.54 77.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.181 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -72.67 -49.57 30.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.51 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.494 HG12 HD12 ' A' ' 569' ' ' LEU . 77.1 mt -57.94 -35.1 50.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.502 0.668 . . . . 0.0 109.681 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.0 OUTLIER -56.63 -57.5 12.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.21 173.279 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.2 m -57.4 -26.55 61.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.793 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -77.95 -15.85 58.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.369 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 79.51 8.29 87.86 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.341 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 566' ' ' ALA . 71.2 mt -83.26 9.19 11.3 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.795 0.331 . . . . 0.0 111.06 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 46.4 m -52.99 -43.66 66.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -51.54 -45.89 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.388 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 16.2 m -63.91 -41.87 97.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.337 . . . . 0.0 111.735 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 80.5 mt -91.24 -14.1 31.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.841 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . 0.431 ' N ' HD21 ' A' ' 532' ' ' ASN . 0.9 OUTLIER -87.56 -7.4 57.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.023 0.439 . . . . 0.0 110.341 172.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -92.79 147.47 22.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.468 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.11 151.94 43.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.71 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 153.0 -161.18 29.48 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.892 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.675 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.7 m -120.76 127.71 75.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.808 0.337 . . . . 0.0 110.23 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -141.84 155.53 45.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.083 0.468 . . . . 0.0 111.046 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.1 m -124.42 100.83 6.86 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 167.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.594 HG23 HG12 ' A' ' 573' ' ' ILE . 59.7 t -104.54 113.78 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -173.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.594 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 60.3 m-85 -86.26 113.84 22.59 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -103.58 116.57 61.73 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.97 139.42 29.99 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.251 2.634 . . . . 0.0 112.007 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 628' ' ' ILE . 67.6 p -83.05 -176.42 6.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.138 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.22 -30.95 69.73 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.112 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -64.53 -29.81 70.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -67.79 -35.28 78.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.378 0.609 . . . . 0.0 111.339 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . 0.487 ' O ' HD21 ' A' ' 550' ' ' LEU . 6.2 m-85 -73.25 -13.28 61.11 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.131 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -94.57 -38.53 10.83 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.148 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -90.96 7.24 41.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.393 0.616 . . . . 0.0 111.508 -172.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.757 HD11 ' CD1' ' A' ' 555' ' ' TRP . 0.5 OUTLIER -74.97 163.52 67.65 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.235 -178.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.603 ' HB2' ' OE1' ' A' ' 554' ' ' GLU . 3.3 Cg_exo -81.09 126.36 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.307 2.005 . . . . 0.0 109.916 166.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.7 -43.24 60.97 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.518 2.812 . . . . 0.0 114.263 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' A' ' 553' ' ' ARG . 24.9 mmt180 -71.93 -23.44 61.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 111.486 -172.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.618 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 0.9 OUTLIER -60.88 -53.48 56.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.45 0.643 . . . . 0.0 110.492 175.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' TRP . . . . . 0.757 ' CD1' HD11 ' A' ' 550' ' ' LEU . 4.7 m95 -80.3 -30.34 38.25 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.784 -172.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.425 ' OG ' ' HA ' ' A' ' 553' ' ' ARG . 25.3 p -58.68 -25.45 62.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.337 0.589 . . . . 0.0 109.577 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . 0.753 ' HG3' ' HG2' ' A' ' 564' ' ' GLU . 26.5 tpt180 -84.72 -46.98 10.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.743 173.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 554' ' ' GLU . 74.9 mt -63.19 -60.18 3.76 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . 0.419 HD21 HD12 ' A' ' 565' ' ' LEU . 0.1 OUTLIER -64.57 -12.35 44.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.891 0.376 . . . . 0.0 110.984 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -70.82 -35.84 65.98 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.848 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -145.78 147.3 31.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.319 0.56 . . . . 0.0 110.891 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -67.96 -47.29 69.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.367 -170.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.521 ' H ' ' HD2' ' A' ' 563' ' ' LYS . 0.0 OUTLIER -69.7 -22.85 63.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.061 -177.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.753 ' HG2' ' HG3' ' A' ' 557' ' ' ARG . 7.4 tp10 -77.75 -42.41 34.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.691 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -60.96 -49.43 77.5 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.495 0.664 . . . . 0.0 109.359 175.325 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . 0.492 ' HA ' HD11 ' A' ' 527' ' ' LEU . . . -55.83 -32.81 63.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.537 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . 0.401 ' O ' ' HG2' ' A' ' 570' ' ' LYS . 25.6 t-20 -57.63 -46.97 83.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.458 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.581 HD13 HD11 ' A' ' 558' ' ' LEU . 24.4 mt -83.98 -41.62 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.991 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.494 HD12 HG12 ' A' ' 522' ' ' ILE . 36.0 mt -57.87 -27.34 63.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 592' ' ' LEU . 22.3 ptmt -76.79 -12.66 60.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.014 0.435 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.593 ' O ' HD23 ' A' ' 597' ' ' LEU . 41.1 t80 -83.53 -18.72 37.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.228 0.537 . . . . 0.0 109.79 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . 0.724 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 20.8 m80 -76.16 -10.12 59.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.178 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.594 HG12 HG23 ' A' ' 539' ' ' VAL . 80.1 mt -115.78 119.63 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.056 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -83.83 161.96 38.75 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.902 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -90.15 3.19 54.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -160.68 170.45 20.76 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.436 172.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.675 HG13 ' HB ' ' A' ' 536' ' ' VAL . 64.3 mt -87.9 126.2 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.207 -168.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 589' ' ' LEU . 2.4 tt -121.51 93.51 4.03 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 20.7 m -77.65 166.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 111.81 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.609 ' HA ' HD11 ' A' ' 583' ' ' ILE . 20.9 t -62.24 -28.19 69.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.306 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.66 68.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.082 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.23 -22.54 11.58 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.035 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.85 HG23 ' HB2' ' A' ' 601' ' ' LEU . 74.0 mt -59.99 109.8 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.103 0.478 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -114.22 -154.24 11.02 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.576 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -50.92 -48.56 60.64 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.981 0.39 . . . . 0.0 110.79 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 4.1 tt -164.36 116.62 1.32 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.67 123.96 46.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . 0.463 ' HD3' ' H ' ' A' ' 588' ' ' ARG . 0.1 OUTLIER -97.23 129.66 44.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.544 0.687 . . . . 0.0 110.873 -174.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.756 ' HB2' HD13 ' A' ' 578' ' ' LEU . 1.5 tm? -110.94 120.04 41.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.242 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -67.24 146.93 53.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.111 0.481 . . . . 0.0 111.286 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.678 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.1 p -106.69 -174.78 2.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.835 -176.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 570' ' ' LYS . 72.9 mt -82.03 -41.44 20.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.06 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.51 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.7 tt0 -59.05 -29.76 67.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.126 0.489 . . . . 0.0 111.024 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 126.74 -14.16 6.76 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.573 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -89.9 -164.38 1.15 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.754 0.777 . . . . 0.0 109.601 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -120.79 137.16 54.67 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.904 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 571' ' ' TYR . 90.6 mt -84.57 116.16 23.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.719 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 90.2 mt-10 -85.28 89.69 7.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.293 -175.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . 0.497 HG11 HG21 ' A' ' 583' ' ' ILE . 47.8 t -91.04 122.23 42.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.74 0.305 . . . . 0.0 111.272 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 35.9 t -128.53 154.53 46.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.85 ' HB2' HG23 ' A' ' 583' ' ' ILE . 41.0 tp -126.07 129.07 48.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.475 ' HE2' ' HB2' ' A' ' 602' ' ' LYS . 19.1 ttmm -146.78 102.63 3.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.734 0.302 . . . . 0.0 110.199 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 605' ' ' VAL . 18.7 t-20 58.72 56.88 3.95 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.389 -176.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 68.28 -14.89 0.23 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.983 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' A' ' 603' ' ' ASN . 58.7 t -82.42 110.42 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.582 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 55.9 t -79.38 136.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.837 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' SER . . . . . 0.636 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 36.8 m -124.23 109.42 13.38 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.948 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 11.4 p -112.95 129.14 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.424 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.665 ' ND2' HD11 ' A' ' 632' ' ' LEU . 44.0 m-20 57.86 29.43 17.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm 74.04 22.48 2.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.453 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 0.2 OUTLIER -125.95 149.08 65.05 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 5.9 Cg_exo -78.81 126.27 7.17 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.085 2.524 . . . . 0.0 112.666 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.582 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 61.2 t -77.76 136.0 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.524 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -84.74 -42.17 15.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.957 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.58 95.11 3.78 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.665 0.269 . . . . 0.0 110.731 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.99 167.15 27.68 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.437 2.091 . . . . 0.0 113.873 172.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.554 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 3.3 t70 75.15 28.95 0.98 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.721 165.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.51 86.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 63.1 mtp -78.38 148.08 33.83 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.362 0.601 . . . . 0.0 112.285 -171.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -124.17 -171.14 2.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.646 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.6 p -80.68 -19.71 44.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.748 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.484 ' OD1' HG22 ' A' ' 505' ' ' VAL . 24.4 p-10 -117.47 15.98 14.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.838 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.15 -148.34 19.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.886 -1.149 . . . . 0.0 113.085 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.7 p -132.14 147.6 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.575 0.226 . . . . 0.0 110.541 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 78.6 t -118.79 142.29 34.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.078 0.465 . . . . 0.0 110.768 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . 0.594 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 52.2 m-70 -130.42 126.82 37.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.413 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.899 HG21 ' HZ ' ' A' ' 515' ' ' PHE . 96.2 t -74.47 118.29 19.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.91 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 543' ' ' THR . 1.2 pt -110.49 171.86 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.014 0.435 . . . . 0.0 110.714 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 21.6 p -117.42 -5.89 11.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.711 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -131.39 168.2 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.306 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 76.8 t -84.03 148.21 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.724 ' HB2' ' CE1' ' A' ' 572' ' ' HIS . 82.6 mt -110.36 139.23 45.77 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.291 -170.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -153.28 156.16 37.9 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.941 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.812 0.339 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -116.78 100.45 0.9 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.174 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 78.4 mtp -134.68 -78.02 0.45 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.968 0.413 . . . . 0.0 110.2 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.513 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -178.77 -157.65 19.75 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.454 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.481 HG22 ' OE2' ' A' ' 534' ' ' GLU . 82.0 p -86.17 -168.94 2.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.647 -0.777 . . . . 0.0 110.988 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 4.7 p -56.94 -27.21 26.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.614 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.547 ' HE2' HG22 ' A' ' 522' ' ' ILE . 39.5 tpp -71.05 -44.5 65.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.842 174.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . 0.65 ' HA ' ' HB3' ' A' ' 510' ' ' LYS . 5.9 t70 -68.68 -27.31 65.86 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.031 0.443 . . . . 0.0 110.198 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 504' ' ' THR . 91.4 t -50.02 -41.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.674 171.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.481 ' N ' HD21 ' A' ' 509' ' ' LEU . 0.6 OUTLIER -82.03 -36.36 27.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.887 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.65 ' HB3' ' HA ' ' A' ' 507' ' ' ASP . 28.7 tttm -62.5 -31.45 72.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.802 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -93.78 6.57 73.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.007 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -114.66 137.64 51.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.816 0.341 . . . . 0.0 111.007 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -75.8 -24.08 55.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.589 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -77.56 -28.89 51.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.367 0.603 . . . . 0.0 109.7 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.796 ' HZ ' HG23 ' A' ' 627' ' ' VAL . 26.9 m-85 -105.28 14.78 28.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.877 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 34.8 p -56.45 -53.16 60.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.865 -176.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' MET . . . . . 0.423 ' HE2' ' HB3' ' A' ' 517' ' ' MET . 2.3 tmm? -68.42 -30.53 69.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.07 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.606 HD12 ' HZ ' ' A' ' 547' ' ' PHE . 54.7 tp -55.4 -47.5 75.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.76 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.63 HG23 ' HA ' ' A' ' 510' ' ' LYS . 4.0 t -52.27 -47.2 45.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.716 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.82 74.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.041 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.6 -50.2 39.66 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.283 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.552 HG12 HD12 ' A' ' 569' ' ' LEU . 42.9 mt -60.59 -31.38 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.529 0.681 . . . . 0.0 109.658 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.5 OUTLIER -59.63 -59.33 5.61 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.203 173.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.0 m -58.08 -26.83 63.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.897 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 565' ' ' LEU . . . -75.09 -17.29 60.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.184 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 70.96 50.32 24.0 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.612 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 566' ' ' ALA . 76.9 mt -128.41 15.47 6.6 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.486 ' HA ' ' HE1' ' A' ' 506' ' ' MET . 88.1 m -61.82 -51.57 67.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . 0.658 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 0.0 OUTLIER -60.24 -29.08 68.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.486 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 36.7 m -62.42 -47.95 81.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.962 0.41 . . . . 0.0 110.491 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.545 HD11 ' HE3' ' A' ' 506' ' ' MET . 67.2 mt -91.09 -5.03 55.74 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.693 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 0.9 OUTLIER -83.95 -5.89 59.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.042 172.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 80.5 mtp180 -85.65 135.41 33.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.792 0.33 . . . . 0.0 110.661 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . 0.481 ' OE2' HG22 ' A' ' 504' ' ' THR . 13.3 mm-40 -78.76 137.04 37.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.951 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 164.47 -117.29 0.75 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.053 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 1.049 HG23 HG13 ' A' ' 577' ' ' ILE . 0.7 OUTLIER -145.99 125.56 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.58 0.229 . . . . 0.0 110.709 -178.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -155.03 137.22 14.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.68 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' THR . . . . . 0.563 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 98.1 m -107.35 102.32 11.62 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.704 HG23 HG12 ' A' ' 573' ' ' ILE . 61.3 t -99.84 114.89 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.095 0.474 . . . . 0.0 111.211 -175.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 48.6 m-85 -85.77 108.39 18.06 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -100.56 119.39 58.85 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.057 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.553 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 85.5 Cg_endo -82.76 140.14 10.22 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.53 2.153 . . . . 0.0 112.437 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 75.4 p -78.7 -175.93 4.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.532 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -68.94 -35.23 76.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.378 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 545' ' ' GLU . 1.7 mp0 -61.62 -29.96 70.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.064 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -70.07 -34.48 73.25 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.392 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . 0.606 ' HZ ' HD12 ' A' ' 518' ' ' LEU . 21.9 m-85 -70.87 -15.9 62.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.605 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -91.46 -10.91 39.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.063 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -88.09 -2.06 58.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.362 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.691 HD11 ' HE1' ' A' ' 555' ' ' TRP . 66.5 mt -109.68 144.07 29.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.189 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.74 126.5 18.34 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.506 2.137 . . . . 0.0 111.126 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.27 -24.61 60.54 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.891 2.394 . . . . 0.0 113.499 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -68.27 -40.84 81.73 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.788 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -37.84 79.68 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.677 0.751 . . . . 0.0 109.574 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' TRP . . . . . 0.691 ' HE1' HD11 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -70.35 -38.24 74.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.832 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.4 t -55.16 -28.25 51.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.574 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . 0.889 ' HG2' ' HG2' ' A' ' 564' ' ' GLU . 14.6 ttp85 -75.72 -32.11 59.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.817 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.464 ' HB3' ' HG ' ' A' ' 565' ' ' LEU . 9.1 mt -78.4 -53.74 6.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.056 0.455 . . . . 0.0 110.333 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -70.64 -14.31 62.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.261 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -90.6 -49.01 3.3 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -105.15 114.32 28.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.103 0.477 . . . . 0.0 110.063 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.19 -33.09 73.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.214 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -62.31 -37.36 85.28 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.889 ' HG2' ' HG2' ' A' ' 557' ' ' ARG . 7.8 tp10 -69.48 -44.79 70.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.945 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 558' ' ' LEU . 0.5 OUTLIER -62.28 -42.02 98.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . 0.48 ' HA ' HD13 ' A' ' 527' ' ' LEU . . . -57.94 -38.13 75.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.363 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 564' ' ' GLU . 92.7 m-20 -57.06 -56.83 16.64 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.9 0.381 . . . . 0.0 111.077 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 50.3 mt -67.53 -50.21 63.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.486 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.552 HD12 HG12 ' A' ' 522' ' ' ILE . 83.2 mt -59.73 -23.22 63.01 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 34.7 mttp -70.89 -18.09 62.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.781 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.621 ' O ' HD21 ' A' ' 597' ' ' LEU . 35.3 t80 -92.74 -1.83 56.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.398 0.618 . . . . 0.0 110.167 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . 0.595 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 5.7 m80 -89.58 -15.13 33.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.208 174.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.704 HG12 HG23 ' A' ' 539' ' ' VAL . 76.3 mt -111.02 121.0 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.873 -175.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.635 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -88.23 153.85 24.77 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.295 176.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.9 -21.32 64.24 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . 0.616 ' HA ' ' CG2' ' A' ' 536' ' ' VAL . 15.7 pt-20 -145.4 153.3 41.06 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 122.224 -0.298 . . . . 0.0 110.676 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 1.049 HG13 HG23 ' A' ' 536' ' ' VAL . 75.2 mt -70.24 114.62 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.814 -176.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' A' ' 589' ' ' LEU . 1.6 tt -111.4 98.96 7.85 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 28.5 m -76.59 163.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.534 -176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.663 ' HA ' HD11 ' A' ' 583' ' ' ILE . 28.4 m -56.75 -31.13 64.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.378 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.19 -15.54 67.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.861 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.1 -10.97 40.92 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.219 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.663 HD11 ' HA ' ' A' ' 580' ' ' SER . 71.0 mt -78.18 -3.86 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 122.876 0.47 . . . . 0.0 111.262 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -50.7 129.12 29.86 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.804 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 71.49 -85.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.796 0.838 . . . . 0.0 110.868 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.468 HD21 ' HG3' ' A' ' 598' ' ' GLU . 4.7 tt -167.55 117.56 0.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 89.6 t -132.94 130.72 58.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.941 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . 0.516 ' HB3' ' OE1' ' A' ' 598' ' ' GLU . 0.7 OUTLIER -96.96 128.77 44.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.577 0.703 . . . . 0.0 111.28 -178.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.705 ' HB2' HD13 ' A' ' 578' ' ' LEU . 31.1 tp -116.84 126.73 53.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.369 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -65.9 134.35 52.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.777 0.323 . . . . 0.0 110.373 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.635 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 86.7 p -99.24 -171.63 2.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.554 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 570' ' ' LYS . 79.3 mt -81.64 -39.05 25.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -62.54 -30.36 71.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.559 0.695 . . . . 0.0 110.263 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.44 -17.46 6.96 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.503 170.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . 0.486 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.3 t70 -84.12 -176.77 6.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.461 0.631 . . . . 0.0 109.705 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.21 139.56 39.69 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.871 0.367 . . . . 0.0 110.693 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.621 HD21 ' O ' ' A' ' 571' ' ' TYR . 94.9 mt -81.97 115.52 21.17 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.516 ' OE1' ' HB3' ' A' ' 588' ' ' ARG . 2.3 tp10 -94.07 87.28 5.26 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 608' ' ' VAL . 2.0 t -99.12 128.16 51.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.007 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.611 ' O ' ' HA ' ' A' ' 606' ' ' VAL . 33.1 t -131.29 108.5 9.71 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.365 -174.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 606' ' ' VAL . 56.8 tp -108.16 116.09 31.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.825 0.345 . . . . 0.0 110.442 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -151.37 133.63 15.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.678 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 58.58 40.56 23.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.598 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . 0.458 HD21 ' HA ' ' A' ' 604' ' ' ASN . 7.1 m120 66.15 11.87 8.14 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.597 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.84 107.47 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.022 0.439 . . . . 0.0 110.223 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.863 HG12 ' HB ' ' A' ' 613' ' ' VAL . 1.4 p -98.14 137.84 24.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.668 176.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 50.3 m -132.19 120.57 22.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 599' ' ' VAL . 7.6 p -110.27 123.65 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.067 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.709 ' ND2' HD13 ' A' ' 632' ' ' LEU . 24.0 m-20 61.38 33.88 18.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.468 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 48.5 mtpt 83.31 -14.19 0.73 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.32 1.012 . . . . 0.0 112.03 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 34.0 mm-40 -96.72 122.59 56.57 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.811 0.339 . . . . 0.0 110.547 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 23.7 Cg_exo -63.83 133.71 40.26 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.851 2.367 . . . . 0.0 112.499 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.863 ' HB ' HG12 ' A' ' 606' ' ' VAL . 44.4 t -88.8 137.46 21.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -87.09 -60.61 1.93 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.397 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 16.5 mp0 -128.23 92.44 41.49 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.618 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.28 167.72 26.59 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.606 2.204 . . . . 0.0 113.219 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 74.88 38.28 0.46 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.463 0.705 . . . . 0.0 112.827 166.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 34.0 mt -98.11 89.9 2.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 171.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 53.0 mtp -82.44 160.46 22.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.542 0.686 . . . . 0.0 112.499 -169.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . 0.422 ' HB1' HG22 ' A' ' 508' ' ' VAL . . . -130.95 -171.17 2.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.446 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 26.0 p -72.93 -37.11 67.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.181 0.515 . . . . 0.0 110.811 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.463 ' HB3' ' OE2' ' A' ' 534' ' ' GLU . 33.4 p-10 -109.95 13.41 23.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.172 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 165.3 -138.1 5.05 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.193 -1.479 . . . . 0.0 113.927 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 10.1 p -160.13 148.74 6.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.727 -171.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.49 139.99 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.296 0.57 . . . . 0.0 110.968 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 60.9 m-70 -127.52 117.85 22.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.796 HG23 ' HZ ' ' A' ' 515' ' ' PHE . 58.1 t -72.34 119.0 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -173.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -114.31 150.0 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.074 0.464 . . . . 0.0 110.733 173.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 18.1 p -96.82 6.84 47.9 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.924 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -138.67 155.21 48.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.953 0.406 . . . . 0.0 111.489 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 60.4 t -86.99 157.21 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.709 HD13 ' ND2' ' A' ' 609' ' ' ASN . 38.2 mt -115.65 146.94 41.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.724 0.297 . . . . 0.0 110.899 -167.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -157.72 132.52 8.59 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.712 -0.661 . . . . 0.0 111.105 -179.345 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -54.99 104.76 0.29 Allowed Glycine 0 C--N 1.33 0.218 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.579 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 26.6 ttt -153.2 145.93 24.32 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 73.19 -132.63 17.04 Favored Glycine 0 CA--C 1.504 -0.619 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.673 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 508' ' ' VAL . 68.7 p -124.91 -170.48 2.17 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.686 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 54.8 t -42.54 -42.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.638 0.586 . . . . 0.0 110.727 168.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.476 ' HE3' HG13 ' A' ' 519' ' ' VAL . 0.0 OUTLIER -60.39 -48.9 79.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.261 -178.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -71.54 -28.32 63.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.816 0.341 . . . . 0.0 110.456 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 504' ' ' THR . 71.5 t -53.98 -42.7 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.588 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 4.8 mt -82.18 -33.18 29.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.162 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.526 ' HA ' HG21 ' A' ' 519' ' ' VAL . 1.9 tmmm? -59.9 -40.02 87.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.991 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -89.13 -2.81 76.96 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.785 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.35 144.98 30.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.645 0.723 . . . . 0.0 110.811 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -75.25 -35.0 61.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.578 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -78.43 -13.37 59.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.881 0.372 . . . . 0.0 110.445 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.631 ' HZ ' HG21 ' A' ' 627' ' ' VAL . 24.1 m-85 -113.41 9.63 18.19 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.003 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 64.5 m -58.54 -44.53 89.65 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -173.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.0 ptm -83.24 -20.15 35.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.701 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.56 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 46.9 tp -57.95 -41.67 83.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.38 0.609 . . . . 0.0 109.462 172.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.526 HG21 ' HA ' ' A' ' 510' ' ' LYS . 18.6 t -52.04 -52.97 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.666 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -60.32 -32.84 71.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.6 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.11 -49.87 46.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.951 0.405 . . . . 0.0 110.508 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.457 HG22 ' HB2' ' A' ' 527' ' ' LEU . 58.6 mt -59.42 -34.2 53.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.486 0.66 . . . . 0.0 109.953 175.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -66.56 -49.51 66.16 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.924 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.3 m -57.12 -34.27 68.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.378 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.88 ' HB3' HD21 ' A' ' 565' ' ' LEU . . . -78.18 -17.97 56.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.142 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 74.58 18.62 79.99 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.005 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . 0.457 ' HB2' HG22 ' A' ' 522' ' ' ILE . 93.3 mt -84.6 5.83 26.31 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.547 -0.384 . . . . 0.0 111.466 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 19.0 m -56.76 -44.13 81.48 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.097 0.475 . . . . 0.0 109.954 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -53.99 -35.23 61.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.029 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 8.3 m -69.49 -36.76 76.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 111.447 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 97.2 mt -96.3 -27.41 14.99 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -173.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -84.58 23.27 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -118.46 152.42 35.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.815 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -69.77 115.68 9.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -178.13 -163.78 30.23 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.659 ' HB ' HG13 ' A' ' 577' ' ' ILE . 20.8 m -119.52 127.93 75.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . 0.503 ' O ' ' HA3' ' A' ' 623' ' ' GLY . 96.5 m-85 -148.54 140.6 23.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.795 0.331 . . . . 0.0 110.683 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 93.5 m -113.74 101.58 9.43 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 170.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.561 HG21 HG12 ' A' ' 505' ' ' VAL . 56.6 t -101.41 119.78 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.419 -174.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.605 ' CD2' HG11 ' A' ' 608' ' ' VAL . 51.5 m-85 -86.43 111.98 21.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -106.99 112.88 63.07 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.705 -167.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.804 ' HA ' HG13 ' A' ' 628' ' ' ILE . 3.3 Cg_exo -79.7 143.21 16.59 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.243 2.628 . . . . 0.0 112.709 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 68.9 p -85.73 -177.44 6.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.585 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -67.86 -25.57 65.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.767 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -71.13 -22.03 62.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.548 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -83.67 -34.62 24.95 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.059 0.457 . . . . 0.0 111.467 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . 0.493 ' HZ ' HD12 ' A' ' 518' ' ' LEU . 5.0 m-85 -68.55 -13.98 62.7 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -93.57 -17.11 23.7 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.615 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -82.8 -13.03 56.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.019 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.515 HD13 ' HE1' ' A' ' 555' ' ' TRP . 46.4 mt -101.63 133.64 20.68 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.8 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.8 135.28 67.09 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.384 2.056 . . . . 0.0 110.925 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.54 -33.56 23.91 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.199 2.599 . . . . 0.0 113.579 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 553' ' ' ARG . 11.4 ptt180 -60.24 -36.24 77.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.656 0.265 . . . . 0.0 111.388 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 557' ' ' ARG . 0.4 OUTLIER -72.72 -40.84 65.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.92 0.39 . . . . 0.0 110.777 -175.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' TRP . . . . . 0.515 ' HE1' HD13 ' A' ' 550' ' ' LEU . 1.1 m95 -80.69 -29.04 36.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.227 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 37.5 t -57.03 -29.65 63.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.332 168.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 554' ' ' GLU . 50.0 mtt180 -75.52 -40.04 57.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.206 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.505 ' HG ' ' HA ' ' A' ' 555' ' ' TRP . 5.3 mt -75.77 -54.66 6.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.882 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 559' ' ' LEU . 0.2 OUTLIER -64.36 -14.21 55.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.666 0.269 . . . . 0.0 111.583 178.19 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -98.65 -21.53 16.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.46 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . 0.458 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 25.9 t70 -135.75 118.77 16.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.081 0.467 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.78 68.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.792 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.458 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 5.1 tmtm? -59.63 -43.32 93.88 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.096 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 567' ' ' ASN . 8.2 tp10 -75.76 -34.81 60.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.554 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.88 HD21 ' HB3' ' A' ' 525' ' ' ALA . 5.6 tt -68.57 -45.27 72.5 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.11 0.481 . . . . 0.0 109.759 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -64.2 -30.36 71.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.518 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . 0.778 ' HA ' ' NE2' ' A' ' 593' ' ' GLN . 39.0 t30 -55.93 -45.03 78.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.439 0.638 . . . . 0.0 110.506 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 60.6 mt -85.85 -62.53 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.442 -178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.439 ' O ' HD22 ' A' ' 569' ' ' LEU . 3.2 tt -55.12 -35.76 65.0 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.509 ' HG2' ' HB2' ' A' ' 592' ' ' LEU . 19.7 ttpp -72.25 -12.34 61.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.647 ' O ' HD23 ' A' ' 597' ' ' LEU . 41.7 t80 -89.28 -18.71 26.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.589 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . 0.728 ' HE2' HG22 ' A' ' 631' ' ' VAL . 2.0 m-70 -73.3 -14.12 61.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.309 0.575 . . . . 0.0 109.91 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.537 HG12 HG22 ' A' ' 539' ' ' VAL . 61.2 mt -101.81 121.78 53.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.839 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.65 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -84.74 164.18 39.1 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.873 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.03 -33.35 75.6 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.171 0.588 . . . . 0.0 112.072 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . 0.402 ' HA ' HG21 ' A' ' 536' ' ' VAL . 13.6 pt-20 -146.37 -178.29 6.08 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.191 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.722 HG22 HG22 ' A' ' 624' ' ' VAL . 14.9 mt -82.28 110.56 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 123.395 0.434 . . . . 0.0 111.114 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -117.67 94.54 4.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 27.5 m -81.96 172.18 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.473 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.565 ' HA ' HD13 ' A' ' 583' ' ' ILE . 15.8 m -63.03 -20.4 65.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.472 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.01 -13.14 63.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.437 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -103.55 -20.07 11.4 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.565 HD13 ' HA ' ' A' ' 580' ' ' SER . 76.5 mt -74.85 90.12 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.202 0.525 . . . . 0.0 110.396 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -102.83 -123.98 5.37 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.876 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -66.5 -57.94 6.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.073 0.463 . . . . 0.0 110.23 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 55.0 tp -156.86 114.42 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.644 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 10.1 p -132.18 132.29 60.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 120.945 0.402 . . . . 0.0 110.126 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . 0.686 ' HG2' ' HA ' ' A' ' 598' ' ' GLU . 40.0 mtp180 -112.5 127.09 55.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.33 0.586 . . . . 0.0 110.899 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.61 126.83 55.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.912 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 3.7 tmmt? -62.95 140.77 58.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.65 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.8 p -103.6 -174.52 2.56 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.744 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.509 ' HB2' ' HG2' ' A' ' 570' ' ' LYS . 78.9 mt -81.56 -42.26 20.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.89 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.778 ' NE2' ' HA ' ' A' ' 567' ' ' ASN . 6.4 tp-100 -61.64 -29.26 69.95 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 127.18 11.7 3.37 Favored Glycine 0 C--N 1.321 -0.267 0 C-N-CA 120.028 -1.082 . . . . 0.0 114.521 166.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 596' ' ' LYS . 8.8 t70 -117.43 -156.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 172.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.422 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 16.0 ptpt -135.46 130.81 35.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.214 0.53 . . . . 0.0 111.922 -176.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 571' ' ' TYR . 92.7 mt -68.6 122.33 18.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.851 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.686 ' HA ' ' HG2' ' A' ' 588' ' ' ARG . 30.0 tt0 -86.35 94.46 9.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . 0.454 HG12 HG21 ' A' ' 583' ' ' ILE . 36.1 t -105.52 133.82 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.802 -175.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 606' ' ' VAL . 7.7 p -140.5 161.84 36.76 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.748 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.456 ' HB2' HG23 ' A' ' 583' ' ' ILE . 67.6 tp -127.46 113.26 15.94 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -136.84 126.21 24.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.443 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 54.59 44.05 29.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.344 0.593 . . . . 0.0 110.546 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 65.3 t30 70.44 -0.39 2.9 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.355 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.76 119.68 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.489 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.781 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 25.9 t -77.59 148.48 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 611' ' ' GLU . 49.1 m -140.21 112.32 7.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.065 0.46 . . . . 0.0 111.968 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.605 HG11 ' CD2' ' A' ' 540' ' ' PHE . 7.5 p -117.17 135.71 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.156 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 1.053 ' HB2' HD21 ' A' ' 632' ' ' LEU . 77.1 m-20 53.58 33.18 15.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.177 0.513 . . . . 0.0 110.397 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt 77.22 9.09 2.71 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.373 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 608' ' ' VAL . 0.3 OUTLIER -113.97 149.65 42.24 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.447 ' HD2' ' ND2' ' A' ' 630' ' ' ASN . 1.4 Cg_endo -85.98 124.84 2.61 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.986 2.457 . . . . 0.0 113.161 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.781 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 49.9 t -76.19 143.94 12.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.383 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' A' ' 629' ' ' THR . . . -89.98 -43.98 10.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.415 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -151.06 92.07 3.86 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 120.971 0.415 . . . . 0.0 111.787 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.548 ' HG3' HG22 ' A' ' 606' ' ' VAL . 83.1 Cg_endo -76.28 169.45 21.97 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.914 2.409 . . . . 0.0 114.124 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 74.47 27.92 1.35 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.693 -1.139 . . . . 0.0 113.15 166.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 45.0 mt -87.33 91.84 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 170.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.753 ' HG2' HG13 ' A' ' 624' ' ' VAL . 51.7 mtp -80.18 128.97 34.14 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.585 0.707 . . . . 0.0 112.176 -170.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -100.73 166.92 10.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.341 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -15.13 53.98 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.505 ' OD1' HG22 ' A' ' 505' ' ' VAL . 25.2 p-10 -116.62 15.51 15.51 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 537' ' ' TYR . . . 147.03 -133.51 4.81 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 119.765 -1.207 . . . . 0.0 113.455 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . 0.753 HG13 ' HG2' ' A' ' 619' ' ' MET . 0.0 OUTLIER -129.32 152.7 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.109 0.481 . . . . 0.0 111.597 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . 0.473 HG21 HG11 ' A' ' 505' ' ' VAL . 43.7 t -122.65 131.14 73.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.586 170.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . 0.489 ' HB2' ' CD2' ' A' ' 540' ' ' PHE . 77.6 m-70 -120.14 110.56 16.77 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.18 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.631 HG21 ' HZ ' ' A' ' 515' ' ' PHE . 98.9 t -66.93 118.39 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.691 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.804 HG13 ' HA ' ' A' ' 542' ' ' PRO . 5.1 pt -115.77 143.97 24.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.616 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' THR . . . . . 0.522 HG23 ' HB1' ' A' ' 614' ' ' ALA . 24.5 p -94.73 1.4 55.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.797 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . 0.447 ' ND2' ' HD2' ' A' ' 612' ' ' PRO . 6.5 m-80 -135.92 135.9 40.02 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.898 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.728 HG22 ' HE2' ' A' ' 572' ' ' HIS . 0.2 OUTLIER -90.3 147.18 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 172.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 1.053 HD21 ' HB2' ' A' ' 609' ' ' ASN . 1.5 mp -109.89 157.65 19.0 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.12 -158.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -160.79 156.86 25.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.576 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.838 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.558 -178.834 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -102.97 46.72 1.18 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.69 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 61.0 ttp -80.87 -26.83 36.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.363 0.601 . . . . 0.0 109.572 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.559 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -148.67 -155.26 6.61 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.928 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.422 ' HA ' HG23 ' A' ' 621' ' ' THR . 76.4 p -88.2 -171.67 3.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.838 175.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.571 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 93.5 t -45.16 -46.15 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 123.35 0.406 . . . . 0.0 111.33 174.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.798 ' HE3' HG21 ' A' ' 522' ' ' ILE . 0.0 OUTLIER -60.64 -38.11 83.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.886 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . 0.559 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 16.9 t70 -68.19 -38.52 82.09 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 505' ' ' VAL . 96.0 t -53.1 -40.42 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.421 176.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 8.1 mt -77.7 -20.38 53.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.099 -174.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -83.32 -26.24 30.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.162 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -89.38 -0.7 79.44 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.105 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -122.26 141.18 51.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.996 0.398 . . . . 0.0 111.441 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -75.5 -22.59 57.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.102 -177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -73.52 -20.24 60.71 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 110.374 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.715 ' HZ ' HG23 ' A' ' 627' ' ' VAL . 15.9 m-85 -114.74 19.2 16.14 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.788 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 32.9 t -59.05 -57.31 13.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.75 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -64.5 -30.09 71.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.933 0.397 . . . . 0.0 110.237 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.555 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 57.8 tp -53.85 -45.43 70.92 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.873 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 14.8 t -50.94 -51.32 21.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.856 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.42 82.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.143 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -65.53 -51.18 61.8 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.42 . . . . 0.0 109.871 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.798 HG21 ' HE3' ' A' ' 506' ' ' MET . 96.6 mt -56.76 -33.63 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.698 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -38.82 92.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.427 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 22.3 m -66.43 -22.22 66.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.035 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -89.51 -30.0 18.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.613 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.41 67.4 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 114.489 0.556 . . . . 0.0 114.489 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 2.0 pp -82.48 24.68 0.68 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.973 0.887 . . . . 0.0 112.531 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.524 ' HA ' ' HE2' ' A' ' 506' ' ' MET . 58.5 m -57.98 -42.06 84.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.414 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.44 -30.7 65.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.974 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 85.1 m -58.9 -48.61 80.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.802 0.334 . . . . 0.0 111.273 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.727 ' HB2' ' SD ' ' A' ' 506' ' ' MET . 82.9 mt -96.95 -1.22 46.15 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.214 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 528' ' ' THR . 2.1 t-20 -81.29 -19.01 43.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.964 0.412 . . . . 0.0 110.976 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . 0.448 ' HG2' ' H ' ' A' ' 534' ' ' GLU . 33.0 ttt180 -104.06 168.33 9.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.868 0.366 . . . . 0.0 111.238 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' A' ' 533' ' ' ARG . 10.7 tp10 -58.02 147.73 28.43 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.407 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 154.85 -178.3 31.64 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.688 ' HB ' HG13 ' A' ' 577' ' ' ILE . 14.9 m -116.85 126.45 74.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -149.7 142.81 24.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.067 0.461 . . . . 0.0 110.884 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 97.9 m -112.23 110.41 20.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.624 HG22 HG12 ' A' ' 573' ' ' ILE . 65.0 t -109.29 114.94 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 120.879 0.371 . . . . 0.0 111.031 -175.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.619 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 80.4 m-85 -86.33 109.79 19.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -101.7 118.74 58.98 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.528 -166.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.649 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 72.3 Cg_endo -77.51 140.06 18.76 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.63 2.22 . . . . 0.0 111.778 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 69.5 p -78.8 -177.81 5.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.146 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . 0.536 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -73.58 -26.67 60.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.148 0.499 . . . . 0.0 110.152 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 548' ' ' ARG . 1.7 mp0 -68.36 -23.84 64.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.145 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -74.97 -31.37 61.44 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.883 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . 0.536 ' CD2' ' HA ' ' A' ' 544' ' ' ASN . 22.9 m-85 -65.64 -14.53 61.38 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . 0.62 ' HA ' ' HE ' ' A' ' 548' ' ' ARG . 3.3 mmp_? -93.93 -1.44 54.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.487 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -98.67 -11.38 22.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.7 HD12 ' HE1' ' A' ' 555' ' ' TRP . 32.5 mt -98.92 136.81 20.5 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.322 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 4.7 Cg_exo -74.8 140.25 25.83 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.884 2.389 . . . . 0.0 111.379 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.57 -16.8 25.52 Favored 'Trans proline' 0 C--O 1.224 -0.187 0 C-N-CA 123.043 2.495 . . . . 0.0 112.397 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -53.33 -46.76 69.6 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.768 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.468 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 27.4 mm-40 -87.07 -40.5 14.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.239 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' TRP . . . . . 0.7 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.1 OUTLIER -62.26 -38.13 88.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.738 -173.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 24.4 t -52.24 -33.02 39.59 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.579 0.55 . . . . 0.0 111.195 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 -83.95 -37.0 22.85 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 120.531 0.205 . . . . 0.0 110.611 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.813 ' HB3' HD12 ' A' ' 565' ' ' LEU . 41.4 mt -64.78 -49.36 71.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.762 0.315 . . . . 0.0 111.336 -175.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.45 1.98 14.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.872 0.367 . . . . 0.0 111.316 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -108.47 -48.09 0.88 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.879 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . 0.577 ' CG ' ' HZ1' ' A' ' 563' ' ' LYS . 13.3 t70 -104.11 126.79 51.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.966 0.413 . . . . 0.0 109.906 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.64 66.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.268 -170.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.577 ' HZ1' ' CG ' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -79.68 -20.88 45.54 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.295 -177.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.13 -38.82 69.19 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.022 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.813 HD12 ' HB3' ' A' ' 558' ' ' LEU . 18.1 tp -71.41 -41.43 69.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 563' ' ' LYS . . . -59.54 -40.55 87.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.15 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -55.08 -44.53 74.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 632' ' ' LEU . 63.3 mt -72.29 -45.45 61.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.453 HD13 HG12 ' A' ' 522' ' ' ILE . 89.5 mt -64.65 -25.55 68.0 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 97.3 mttt -74.13 -13.72 60.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.69 0.281 . . . . 0.0 111.44 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.55 ' O ' HD22 ' A' ' 597' ' ' LEU . 57.6 t80 -91.51 -18.46 24.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.089 0.471 . . . . 0.0 110.03 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . 0.649 ' HD2' ' HD3' ' A' ' 542' ' ' PRO . 12.0 m80 -74.84 -13.08 60.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.74 HG22 HD22 ' A' ' 592' ' ' LEU . 55.5 mt -109.3 137.91 39.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.857 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -106.67 164.45 13.39 Favored Glycine 0 CA--C 1.516 0.156 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 172.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.61 -10.23 59.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.246 0.523 . . . . 0.0 112.407 -171.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -144.46 169.86 17.15 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 122.502 -0.123 . . . . 0.0 110.811 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.688 HG13 ' HB ' ' A' ' 536' ' ' VAL . 8.3 mt -88.03 122.99 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.635 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 56.0 tp -126.92 93.7 3.83 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.645 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.17 179.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.036 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 10.9 m -62.25 -23.42 66.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.902 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.58 -17.47 72.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.566 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.26 -34.14 4.91 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.92 HG21 ' HB2' ' A' ' 601' ' ' LEU . 77.7 mt -62.52 99.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 122.968 0.507 . . . . 0.0 110.031 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . -121.05 -73.16 0.32 Allowed Glycine 0 C--O 1.226 -0.367 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.87 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -98.82 -82.25 0.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.839 0.352 . . . . 0.0 110.332 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 5.2 tt -155.18 117.42 4.19 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.49 133.68 67.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.492 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -105.38 110.0 22.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.82 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.72 127.66 53.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -175.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -71.87 147.28 47.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.873 0.368 . . . . 0.0 110.091 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.467 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 85.8 p -108.98 -178.1 3.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.971 0.415 . . . . 0.0 110.443 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.74 HD22 HG22 ' A' ' 573' ' ' ILE . 1.6 mm? -73.62 -37.82 65.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.837 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -64.18 -31.46 72.67 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.459 0.647 . . . . 0.0 110.085 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.29 -17.82 6.98 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.889 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . 0.438 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 4.3 t70 -85.6 -165.84 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.975 0.888 . . . . 0.0 110.563 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.424 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 13.8 pttp -115.74 134.18 55.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.19 0.519 . . . . 0.0 111.746 -171.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.55 HD22 ' O ' ' A' ' 571' ' ' TYR . 87.1 mt -90.93 115.34 27.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 39.6 mt-10 -92.9 101.02 13.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.244 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 607' ' ' SER . 39.7 t -108.29 130.87 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 123.353 0.408 . . . . 0.0 111.345 -175.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 22.7 t -134.0 157.93 44.82 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.35 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.92 ' HB2' HG21 ' A' ' 583' ' ' ILE . 55.7 tp -128.92 118.78 23.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 172.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -152.28 129.9 11.52 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.17 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 58.86 33.29 22.96 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.417 0.448 . . . . 0.0 110.57 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 75.58 -2.55 2.77 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.384 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.61 113.94 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.104 0.478 . . . . 0.0 110.864 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 600' ' ' SER . 61.5 t -77.47 134.12 29.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.446 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 15.9 m -120.52 105.91 11.29 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.656 HG21 ' OD1' ' A' ' 609' ' ' ASN . 12.6 p -111.03 139.79 33.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.656 ' OD1' HG21 ' A' ' 608' ' ' VAL . 3.1 m120 58.36 25.61 13.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.887 ' HB2' ' HZ2' ' A' ' 610' ' ' LYS . 3.7 ttmp? 69.58 22.59 6.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.946 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -130.96 147.5 66.54 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 121.079 0.466 . . . . 0.0 109.952 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -60.76 128.8 26.78 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.55 2.833 . . . . 0.0 113.85 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.631 HG21 HG13 ' A' ' 608' ' ' VAL . 47.8 t -81.47 143.19 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 172.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -79.25 -61.38 2.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.38 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -139.41 100.87 7.55 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.404 ' CB ' ' HD1' ' A' ' 626' ' ' HIS . 74.1 Cg_endo -72.27 162.51 41.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.846 2.364 . . . . 0.0 114.15 174.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 74.89 45.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.533 164.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 34.9 mt -96.03 87.2 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 165.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 49.9 mtp -76.5 146.19 38.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.519 0.675 . . . . 0.0 112.575 -171.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.48 -171.51 1.85 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.549 -1.205 . . . . 0.0 107.928 172.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 504' ' ' THR . 12.6 t -82.69 -15.71 50.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.863 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.465 ' OD1' HG22 ' A' ' 505' ' ' VAL . 27.9 p-10 -118.72 19.3 13.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.944 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.57 -148.38 19.35 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.69 -1.243 . . . . 0.0 112.993 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 15.0 p -139.31 146.35 25.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.916 0.389 . . . . 0.0 111.093 -175.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 69.9 t -115.34 139.96 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.65 176.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . 0.619 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 67.0 m-70 -125.59 126.99 45.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.251 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.715 HG23 ' HZ ' ' A' ' 515' ' ' PHE . 91.6 t -77.19 119.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -174.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.2 153.0 16.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.038 0.447 . . . . 0.0 110.447 172.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 20.8 p -100.68 3.86 42.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -130.2 152.47 49.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.853 0.359 . . . . 0.0 110.137 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.45 ' HB ' HD11 ' A' ' 550' ' ' LEU . 43.6 t -87.82 151.77 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 172.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.571 ' HB2' ' CE1' ' A' ' 572' ' ' HIS . 36.8 mt -106.77 112.45 25.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.906 0.384 . . . . 0.0 110.741 -168.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -102.39 123.29 45.92 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.834 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.079 -0.963 . . . . 0.0 109.712 177.92 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.579 0.228 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 94.11 71.22 1.13 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.962 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 20.3 ptp -177.26 30.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.108 0.48 . . . . 0.0 110.081 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.403 ' HA3' ' HB2' ' A' ' 507' ' ' ASP . . . -106.4 -148.22 15.55 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.9 -175.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.467 ' HA ' HG23 ' A' ' 621' ' ' THR . 68.6 p -92.74 -170.02 2.34 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.282 -0.459 . . . . 0.0 110.497 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.545 ' O ' HD11 ' A' ' 509' ' ' LEU . 94.6 t -43.87 -41.26 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.084 169.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 39.7 tpp -60.02 -46.06 90.76 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.148 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . 0.403 ' HB2' ' HA3' ' A' ' 503' ' ' GLY . 32.7 t70 -62.16 -42.32 99.15 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.949 0.404 . . . . 0.0 110.412 176.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.541 HG23 ' HB2' ' A' ' 620' ' ' ALA . 91.2 t -52.82 -46.98 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.266 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.545 HD11 ' O ' ' A' ' 505' ' ' VAL . 3.2 mp -75.67 -37.28 59.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.065 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.587 ' HA ' HG21 ' A' ' 519' ' ' VAL . 64.2 tttp -71.75 -29.9 65.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.957 0.408 . . . . 0.0 111.023 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -84.86 -10.25 79.29 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.726 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . 0.731 ' OD1' ' HG2' ' A' ' 514' ' ' ARG . 34.1 t0 -98.95 134.36 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.241 0.543 . . . . 0.0 110.782 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.41 -35.05 79.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.284 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . 0.731 ' HG2' ' OD1' ' A' ' 512' ' ' ASP . 23.7 ptt180 -83.08 -8.92 59.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.249 -173.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.864 ' HZ ' HG23 ' A' ' 627' ' ' VAL . 23.3 m-85 -116.27 13.0 15.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.943 0.401 . . . . 0.0 110.445 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 25.6 p -57.91 -49.57 76.29 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.272 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -69.4 -31.79 70.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.046 0.45 . . . . 0.0 110.113 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.572 HD12 ' HZ ' ' A' ' 547' ' ' PHE . 56.8 tp -54.57 -47.04 73.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.573 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 510' ' ' LYS . 6.5 t -50.57 -48.66 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.043 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 523' ' ' GLN . . . -63.64 -30.95 71.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.021 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.67 51.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.077 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.797 HG12 HD23 ' A' ' 569' ' ' LEU . 35.7 mt -57.1 -38.21 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.484 0.659 . . . . 0.0 109.612 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' A' ' 520' ' ' ALA . 18.5 tp60 -58.52 -58.91 6.47 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.281 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.0 m -58.81 -23.44 60.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.754 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -86.13 -13.69 46.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.179 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 75.14 12.46 83.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.758 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . 0.637 HD12 HD22 ' A' ' 569' ' ' LEU . 78.5 mt -86.27 13.66 7.7 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.541 -0.388 . . . . 0.0 111.516 -176.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 532' ' ' ASN . 36.7 m -55.57 -47.49 76.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . 0.66 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 12.7 pt-20 -69.2 -16.52 63.63 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.336 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 32.4 m -82.16 -44.67 16.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.623 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 531' ' ' LEU . 27.2 mt -82.47 -20.02 37.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.712 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . 0.496 ' HB2' ' O ' ' A' ' 528' ' ' THR . 16.6 m-20 -91.01 22.89 3.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.003 0.43 . . . . 0.0 111.122 175.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . 0.66 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 11.7 mmt180 -103.15 163.86 11.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.551 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.09 153.76 17.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.183 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 137.9 -138.87 9.93 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.887 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.735 ' HB ' HG12 ' A' ' 577' ' ' ILE . 17.8 m -129.08 127.59 66.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -144.81 128.9 17.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.216 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 87.1 m -106.77 100.25 9.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 170.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.61 HG22 HG12 ' A' ' 573' ' ' ILE . 90.4 t -101.9 116.65 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.18 -173.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.561 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 54.2 m-85 -86.41 111.07 20.17 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 172.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -98.4 115.15 65.85 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.698 -168.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.592 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 73.3 Cg_endo -79.0 134.4 11.72 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.652 2.235 . . . . 0.0 111.181 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 71.4 p -75.95 -179.45 4.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.279 0.561 . . . . 0.0 111.595 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -74.0 -16.76 61.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.796 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 548' ' ' ARG . 39.0 tt0 -76.66 -25.85 54.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.792 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.409 ' HB1' ' N ' ' A' ' 631' ' ' VAL . . . -72.18 -42.36 65.96 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.568 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . 0.572 ' HZ ' HD12 ' A' ' 518' ' ' LEU . 9.1 m-85 -67.27 -13.91 62.42 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.647 0.737 . . . . 0.0 109.315 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . 0.407 ' HB3' ' O ' ' A' ' 545' ' ' GLU . 37.1 ttm180 -90.22 -10.53 44.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.325 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -97.47 -29.04 13.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.107 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.459 HD11 HG11 ' A' ' 631' ' ' VAL . 7.2 mp -78.67 140.58 59.3 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.018 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.408 ' HG2' ' CB ' ' A' ' 554' ' ' GLU . 23.1 Cg_endo -63.3 134.21 44.19 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.655 2.237 . . . . 0.0 112.052 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.66 -41.24 46.01 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.163 2.575 . . . . 0.0 112.534 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' A' ' 557' ' ' ARG . 40.0 ttm180 -57.32 -47.86 80.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.707 0.289 . . . . 0.0 110.751 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.408 ' CB ' ' HG2' ' A' ' 551' ' ' PRO . 41.3 tt0 -66.88 -46.25 75.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.098 0.475 . . . . 0.0 110.602 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' TRP . . . . . 0.438 ' CZ2' ' CD1' ' A' ' 547' ' ' PHE . 0.0 OUTLIER -72.44 -42.21 65.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.351 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 51.0 p -55.6 -26.15 42.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.564 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 553' ' ' ARG . 1.8 mmp_? -71.72 -35.57 70.24 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.608 HD21 HG13 ' A' ' 568' ' ' ILE . 16.0 mt -68.64 -50.29 52.43 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.25 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . 0.492 HD23 HD22 ' A' ' 565' ' ' LEU . 0.5 OUTLIER -70.25 0.98 5.36 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 178.013 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -78.03 -46.37 9.41 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.082 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . 0.418 ' OD2' ' HG2' ' A' ' 564' ' ' GLU . 32.1 t70 -125.24 142.65 51.37 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -72.46 -39.88 67.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.014 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.498 ' H ' ' HD2' ' A' ' 563' ' ' LYS . 0.0 OUTLIER -66.16 -35.78 81.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.65 -178.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.418 ' HG2' ' OD2' ' A' ' 561' ' ' ASP . 8.1 mm-40 -74.97 -39.99 60.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.728 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.538 ' HB2' ' O ' ' A' ' 558' ' ' LEU . 39.1 tp -65.32 -43.97 89.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.38 74.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.358 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -53.64 -51.6 62.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.173 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.608 HG13 HD21 ' A' ' 558' ' ' LEU . 24.2 mm -67.07 -52.77 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.797 HD23 HG12 ' A' ' 522' ' ' ILE . 26.7 tp -58.75 -24.56 61.86 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.97 -177.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 87.9 mttt -70.37 -18.08 63.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 0.0 111.627 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.508 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 37.5 t80 -89.77 10.08 24.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.992 0.901 . . . . 0.0 109.485 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . 0.592 ' HD2' ' HD3' ' A' ' 542' ' ' PRO . 13.4 m80 -103.78 -15.26 15.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.177 173.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 539' ' ' VAL . 64.5 mt -109.89 115.89 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.882 -175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.628 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -83.28 150.52 27.39 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.112 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -67.48 -21.7 65.5 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . 0.605 ' HG2' HD21 ' A' ' 589' ' ' LEU . 15.9 pt-20 -129.35 -178.32 4.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.596 -173.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.735 HG12 ' HB ' ' A' ' 536' ' ' VAL . 48.4 mm -96.16 110.38 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.504 174.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.546 HD23 HG11 ' A' ' 587' ' ' VAL . 57.5 tp -113.32 93.18 4.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . 0.467 HG11 HG22 ' A' ' 577' ' ' ILE . 21.3 m -79.15 168.53 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.689 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.6 ' HA ' HD11 ' A' ' 583' ' ' ILE . 3.5 m -53.16 -32.73 49.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.835 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.62 -17.88 71.42 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.175 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -95.76 -15.47 42.77 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.938 HG23 ' HB2' ' A' ' 601' ' ' LEU . 57.6 mt -75.54 119.59 23.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 601' ' ' LEU . . . -168.22 125.35 1.28 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 62.51 -82.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 O-C-N 124.168 0.569 . . . . 0.0 110.562 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 6.4 tt -163.27 117.24 1.61 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . 0.546 HG11 HD23 ' A' ' 578' ' ' LEU . 6.8 p -128.75 139.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -100.74 135.75 41.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.301 0.572 . . . . 0.0 111.585 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.605 HD21 ' HG2' ' A' ' 576' ' ' GLU . 1.0 OUTLIER -126.7 115.55 19.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.36 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -64.47 128.08 34.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 110.811 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.628 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 89.9 p -95.6 -173.53 2.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.537 -177.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 60.2 mt -76.69 -38.96 53.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.413 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.4 tt0 -61.21 -30.55 70.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.456 0.645 . . . . 0.0 110.501 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.95 -19.51 6.5 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.477 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . 0.508 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.7 t70 -84.6 -169.15 2.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.711 0.756 . . . . 0.0 109.951 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.457 ' HG2' ' OD1' ' A' ' 595' ' ' ASP . 14.2 pttm -110.11 136.33 49.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.923 -172.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.626 ' HA ' ' OD1' ' A' ' 609' ' ' ASN . 91.5 mt -84.22 114.97 22.2 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 170.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 45.8 mt-10 -86.52 84.91 7.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.393 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 607' ' ' SER . 46.2 t -86.46 118.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.688 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.862 ' HB2' ' HB2' ' A' ' 607' ' ' SER . 13.6 m -118.57 157.02 28.13 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.825 -176.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.938 ' HB2' HG23 ' A' ' 583' ' ' ILE . 58.4 tp -141.79 113.5 7.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -156.41 137.88 13.99 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 60.93 27.06 16.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 64.9 t30 63.84 11.68 6.14 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.436 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 60.0 t -95.13 118.45 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.573 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.55 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 48.9 t -82.17 147.9 5.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.848 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' SER . . . . . 0.862 ' HB2' ' HB2' ' A' ' 600' ' ' SER . 16.9 m -134.38 158.13 44.64 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.583 0.23 . . . . 0.0 110.868 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.6 p -153.27 121.23 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.648 175.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.769 HD21 HD11 ' A' ' 632' ' ' LEU . 19.6 m-20 61.46 37.61 16.51 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.986 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 80.1 -12.48 1.04 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.481 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 63.1 mm-40 -95.44 143.17 25.65 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.615 0.245 . . . . 0.0 110.79 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 3.1 Cg_exo -78.81 136.62 13.53 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.134 2.556 . . . . 0.0 112.791 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.55 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 40.4 t -89.22 134.38 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -89.29 -35.74 15.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.946 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . 0.461 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 29.5 tt0 -150.36 89.08 4.56 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.732 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.38 173.19 13.53 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.125 2.55 . . . . 0.0 113.47 171.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 t70 77.78 23.34 0.8 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.059 164.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 34.2 mt -94.36 90.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 122.05 -0.406 . . . . 0.0 110.135 174.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.545 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 60.6 mtp -85.91 149.49 25.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.472 0.654 . . . . 0.0 112.33 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . 0.541 ' HB2' HG23 ' A' ' 508' ' ' VAL . . . -113.22 -171.77 1.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.613 174.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 504' ' ' THR . 13.1 t -81.73 -17.46 47.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.414 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.429 ' OD1' HG23 ' A' ' 505' ' ' VAL . 28.7 p-10 -117.87 2.5 12.18 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . 0.421 ' HA2' HD12 ' A' ' 577' ' ' ILE . . . 173.14 -154.77 21.27 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.418 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 8.1 p -137.55 145.47 29.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 539' ' ' VAL . 75.6 t -117.4 140.87 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.978 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . 0.561 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 66.4 m-70 -126.74 118.86 25.56 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.039 175.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.864 HG23 ' HZ ' ' A' ' 515' ' ' PHE . 96.8 t -72.51 122.59 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.0 151.13 21.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.206 0.527 . . . . 0.0 110.592 172.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 11.9 p -94.04 3.22 55.63 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.153 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -136.6 146.27 45.87 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.123 0.487 . . . . 0.0 111.204 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.459 HG11 HD11 ' A' ' 550' ' ' LEU . 0.2 OUTLIER -92.68 158.25 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.769 HD11 HD21 ' A' ' 609' ' ' ASN . 16.6 mt -117.97 147.97 42.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.867 0.365 . . . . 0.0 111.647 -156.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -144.13 122.1 12.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.113 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.06 176.717 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 503' ' ' GLY . . . -76.31 -23.65 70.42 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.946 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 5.4 tpt 75.72 -30.09 0.19 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.069 0.948 . . . . 0.0 110.859 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.681 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -173.39 -155.17 11.32 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 175.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 508' ' ' VAL . 75.6 p -95.28 -173.96 3.07 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.678 ' O ' HD12 ' A' ' 509' ' ' LEU . 96.4 t -47.42 -41.06 7.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.396 170.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -41.89 97.86 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.697 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . 0.681 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 9.1 m-20 -68.65 -33.42 73.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.52 0.2 . . . . 0.0 111.159 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 504' ' ' THR . 96.0 t -51.66 -60.54 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.089 0.471 . . . . 0.0 110.958 174.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 505' ' ' VAL . 3.4 mp -59.27 -35.45 73.76 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.625 0.77 . . . . 0.0 111.269 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.592 ' HB3' ' HA ' ' A' ' 507' ' ' ASP . 43.5 tttt -63.75 -29.85 71.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.324 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -97.49 -23.3 14.41 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.237 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.75 132.22 35.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.934 0.397 . . . . 0.0 110.489 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.19 -18.98 58.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -175.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -78.92 -29.43 44.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.017 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.76 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 16.5 m-85 -101.71 18.76 19.59 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.008 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 21.0 p -57.94 -57.27 13.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' MET . . . . . 0.44 ' HE3' ' HB3' ' A' ' 517' ' ' MET . 7.8 ttp -74.13 -20.69 60.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.926 0.393 . . . . 0.0 110.158 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.508 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 50.5 tp -57.94 -41.96 83.92 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.909 176.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' A' ' 509' ' ' LEU . 15.2 t -53.45 -54.77 16.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.261 177.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.23 -31.52 72.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.087 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.13 -56.18 8.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.794 0.33 . . . . 0.0 110.37 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.462 ' HA ' HD11 ' A' ' 569' ' ' LEU . 61.6 mt -59.33 -32.24 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.231 0.539 . . . . 0.0 110.235 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.6 OUTLIER -55.59 -60.7 3.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.095 173.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.7 m -61.99 -19.11 62.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.351 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -85.44 -10.91 55.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 70.14 37.68 72.49 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.671 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.55 5.6 29.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.524 0.662 . . . . 0.0 111.044 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 27.2 m -53.46 -49.93 66.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.686 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . 0.632 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 28.3 mt-10 -66.03 -19.21 65.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.551 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 35.1 m -74.07 -34.32 63.99 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.083 0.468 . . . . 0.0 109.818 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.459 HD22 HD13 ' A' ' 573' ' ' ILE . 89.6 mt -93.07 -18.14 23.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.647 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . 0.52 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 0.9 OUTLIER -84.55 17.72 2.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 177.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . 0.632 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 21.9 mmt180 -111.25 172.25 6.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.305 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.13 146.28 24.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 153.97 -147.13 16.04 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.896 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.58 ' HB ' HG13 ' A' ' 577' ' ' ILE . 11.2 m -131.7 128.29 60.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -148.15 132.21 17.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.968 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 95.7 m -104.68 105.23 15.23 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 172.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.759 HG23 HG12 ' A' ' 573' ' ' ILE . 62.6 t -104.78 112.57 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 120.888 0.375 . . . . 0.0 111.378 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.595 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 68.4 m-85 -85.95 108.98 18.45 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -104.66 122.41 43.65 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.069 -168.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.76 138.91 19.39 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.936 2.424 . . . . 0.0 112.491 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 67.4 p -82.78 -176.59 6.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.965 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . 0.463 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 10.8 m120 -62.07 -39.65 93.14 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.67 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -66.1 -21.49 66.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -76.88 -36.45 56.72 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.099 177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . 0.492 ' HZ ' ' HB2' ' A' ' 518' ' ' LEU . 9.5 m-85 -65.31 -13.02 57.49 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 170.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -94.91 -36.42 11.62 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.975 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -91.24 11.02 24.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.13 0.491 . . . . 0.0 111.724 -174.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.81 HD13 ' CD1' ' A' ' 555' ' ' TRP . 0.2 OUTLIER -76.8 167.32 37.73 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.643 -178.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.44 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 7.6 Cg_exo -73.91 125.93 10.27 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.21 1.94 . . . . 0.0 109.952 166.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.97 -54.52 5.31 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.909 2.406 . . . . 0.0 114.138 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -70.81 -18.77 62.72 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.638 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 5.9 tp10 -60.6 -54.87 40.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.609 0.718 . . . . 0.0 109.902 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' TRP . . . . . 0.81 ' CD1' HD13 ' A' ' 550' ' ' LEU . 6.7 m95 -77.79 -24.78 48.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.889 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 52.5 m -51.28 -35.04 35.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.43 0.633 . . . . 0.0 109.616 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -84.69 -50.9 7.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.154 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.674 HD22 ' HG3' ' A' ' 564' ' ' GLU . 40.6 mt -57.61 -55.31 36.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.983 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . 0.43 HD21 ' HA ' ' A' ' 559' ' ' LEU . 0.1 OUTLIER -70.44 -1.34 10.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -98.27 -31.47 6.5 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.651 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . 0.468 ' OD1' ' HG2' ' A' ' 563' ' ' LYS . 12.9 t70 -130.5 137.84 49.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.633 0.254 . . . . 0.0 110.42 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.7 63.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.63 ' HD3' ' H ' ' A' ' 563' ' ' LYS . 0.1 OUTLIER -73.82 -18.6 60.93 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.717 -178.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.674 ' HG3' HD22 ' A' ' 558' ' ' LEU . 3.7 tp10 -69.63 -46.45 66.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 558' ' ' LEU . 20.0 tp -68.04 -45.57 73.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.087 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . 0.475 ' HB2' ' HZ3' ' A' ' 570' ' ' LYS . . . -60.76 -23.57 65.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.403 178.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . 0.824 ' HA ' ' NE2' ' A' ' 593' ' ' GLN . 52.7 t30 -55.87 -50.84 69.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.578 0.704 . . . . 0.0 110.811 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.59 HD11 HD13 ' A' ' 558' ' ' LEU . 46.2 mt -84.53 -39.58 14.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.875 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 522' ' ' ILE . 75.0 mt -61.1 -28.25 68.96 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.475 ' HZ3' ' HB2' ' A' ' 566' ' ' ALA . 50.1 mttp -77.59 -10.15 59.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.907 177.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 50.5 t80 -100.3 -19.16 16.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.085 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -66.34 -24.94 66.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.381 0.61 . . . . 0.0 110.526 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.759 HG12 HG23 ' A' ' 539' ' ' VAL . 83.7 mt -105.43 141.16 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.486 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -102.81 165.92 16.54 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.29 -30.29 67.26 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . 0.484 ' O ' HD13 ' A' ' 589' ' ' LEU . 14.4 pt-20 -148.04 178.4 8.56 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 122.274 -0.266 . . . . 0.0 110.529 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.58 HG13 ' HB ' ' A' ' 536' ' ' VAL . 57.5 mt -81.16 122.23 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.143 0.497 . . . . 0.0 111.961 -171.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.502 HD22 HG11 ' A' ' 587' ' ' VAL . 55.0 tp -122.31 93.26 3.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.424 174.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 26.7 m -83.81 169.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.469 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.441 ' HA ' HD13 ' A' ' 583' ' ' ILE . 26.1 m -60.41 -15.65 28.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.887 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.76 -16.37 70.02 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 172.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.69 -28.11 6.81 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.809 HG21 ' HB2' ' A' ' 601' ' ' LEU . 53.4 mt -72.14 89.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.226 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -113.8 -58.59 0.39 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.327 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -113.46 -71.6 0.74 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 175.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 599' ' ' VAL . 6.2 tt -157.83 129.58 6.88 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . 0.502 HG11 HD22 ' A' ' 578' ' ' LEU . 6.8 p -143.86 139.64 25.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.22 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . 0.521 ' HB3' ' HG2' ' A' ' 598' ' ' GLU . 6.3 ptp180 -107.9 140.22 41.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.342 0.591 . . . . 0.0 111.491 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.484 HD13 ' O ' ' A' ' 576' ' ' GLU . 0.5 OUTLIER -124.45 121.63 35.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.298 -179.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.413 ' HD2' ' O ' ' A' ' 595' ' ' ASP . 24.2 tptm -63.62 140.94 58.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.69 0.281 . . . . 0.0 110.26 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.524 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 60.2 p -102.11 -177.83 3.52 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.721 ' H ' HD22 ' A' ' 592' ' ' LEU . 0.9 OUTLIER -76.68 -44.88 31.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 110.474 178.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.824 ' NE2' ' HA ' ' A' ' 567' ' ' ASN . 6.5 tp-100 -63.4 -30.8 71.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.491 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 124.62 16.02 3.15 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 119.731 -1.224 . . . . 0.0 114.438 168.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . 0.579 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 10.4 t70 -110.66 -164.87 0.95 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.878 0.839 . . . . 0.0 108.789 174.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.454 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 18.3 pttp -127.24 120.0 27.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.092 0.472 . . . . 0.0 111.35 -172.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 571' ' ' TYR . 98.3 mt -79.2 115.37 18.82 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.521 ' HG2' ' HB3' ' A' ' 588' ' ' ARG . 33.7 mt-10 -108.75 112.36 24.6 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.29 0.567 . . . . 0.0 110.782 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 586' ' ' LEU . 21.3 t -107.59 133.6 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.532 -171.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.741 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 37.9 t -126.02 160.81 29.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.809 ' HB2' HG21 ' A' ' 583' ' ' ILE . 48.8 tp -132.73 127.1 33.97 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.476 ' HG2' ' OD1' ' A' ' 603' ' ' ASN . 60.6 tttp -156.42 129.1 7.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . 0.476 ' OD1' ' HG2' ' A' ' 602' ' ' LYS . 18.6 m120 61.15 28.03 17.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.03 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 56.9 t30 68.64 18.49 8.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.708 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.69 126.53 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.741 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.724 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 59.7 t -88.24 137.46 21.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.318 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' SER . . . . . 0.741 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 6.9 m -125.19 103.54 8.02 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.502 HG13 ' CD1' ' A' ' 540' ' ' PHE . 7.4 p -109.28 117.96 55.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.528 ' ND2' HD11 ' A' ' 632' ' ' LEU . 12.9 m-20 63.16 29.75 16.06 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 60.0 tttp 77.02 -2.39 2.67 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.311 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.509 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 70.0 mm-40 -92.42 129.57 40.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.397 . . . . 0.0 110.879 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 13.0 Cg_exo -70.51 126.58 12.96 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.295 2.663 . . . . 0.0 112.518 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.724 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 32.8 t -86.72 136.62 22.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.887 176.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -83.04 -57.0 3.47 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.128 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -133.66 100.74 13.37 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.451 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.479 ' CB ' ' HD1' ' A' ' 626' ' ' HIS . 89.0 Cg_endo -75.29 164.26 33.15 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.824 2.349 . . . . 0.0 112.628 171.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 71.64 31.46 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 50.6 mt -85.66 90.21 2.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 168.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 66.6 mtp -79.7 148.39 31.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -169.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -118.45 -175.58 2.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.621 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.3 t -83.64 -9.45 58.88 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.528 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.491 ' OD1' HG23 ' A' ' 505' ' ' VAL . 28.7 p-10 -117.68 7.72 12.62 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.499 0.19 . . . . 0.0 111.481 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 159.25 -143.59 9.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.003 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.1 p -139.34 147.64 24.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.595 0.236 . . . . 0.0 110.589 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.5 141.76 34.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.322 0.582 . . . . 0.0 111.217 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . 0.595 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 46.7 m-70 -126.75 125.28 41.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.76 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 85.5 t -78.18 118.59 25.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.49 155.59 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 120.943 0.401 . . . . 0.0 110.716 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 19.9 p -102.65 4.06 37.84 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.444 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -137.4 163.3 31.38 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.982 0.42 . . . . 0.0 111.254 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.74 142.98 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.779 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.528 HD11 ' ND2' ' A' ' 609' ' ' ASN . 69.9 mt -95.34 167.7 11.17 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 120.635 0.255 . . . . 0.0 110.473 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -161.58 138.64 8.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.886 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.215 179.574 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.602 0.239 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -74.65 80.46 0.91 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.335 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 19.3 ptm -86.32 89.92 8.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.499 0.666 . . . . 0.0 110.203 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.568 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -103.39 -160.32 25.12 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.513 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 508' ' ' VAL . 79.0 p -85.98 -172.48 4.11 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.694 HG23 ' HB3' ' A' ' 531' ' ' LEU . 7.4 m -46.79 -37.97 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.222 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -45.13 90.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.274 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . 0.568 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 6.1 t70 -68.76 -33.35 73.75 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 504' ' ' THR . 94.3 t -52.65 -40.07 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.22 0.533 . . . . 0.0 110.538 174.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 5.6 mt -82.27 -34.51 28.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.405 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.587 ' HA ' HG21 ' A' ' 519' ' ' VAL . 58.1 tttp -66.51 -34.61 78.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.062 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -88.15 -5.4 76.6 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.645 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -106.75 142.04 37.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.29 0.545 . . . . 0.0 111.387 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -68.37 -32.8 73.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.786 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . 0.484 ' H ' ' HD2' ' A' ' 514' ' ' ARG . 3.1 mpt_? -83.02 -19.27 37.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -173.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.717 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 19.9 m-85 -107.75 5.55 26.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.172 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 68.5 m -59.98 -38.1 81.57 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.754 0.312 . . . . 0.0 111.579 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -82.56 -26.01 32.79 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 45.6 tp -58.02 -43.68 86.87 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.913 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 510' ' ' LYS . 7.2 t -50.69 -51.04 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.931 176.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -64.74 -32.8 74.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.926 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.89 -50.19 44.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.158 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.575 HG12 HD11 ' A' ' 569' ' ' LEU . 68.4 mt -57.94 -34.45 48.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.31 0.576 . . . . 0.0 109.789 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.55 -57.72 11.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.452 173.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.2 m -58.63 -26.56 63.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.995 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -74.63 -23.94 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.869 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 68.25 19.62 72.45 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.104 -0.57 . . . . 0.0 114.153 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . 0.595 HD22 ' HB3' ' A' ' 569' ' ' LEU . 3.8 pp -104.36 22.44 14.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.579 0.69 . . . . 0.0 111.135 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 88.8 m -53.81 -41.97 67.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.951 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . 0.599 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 1.0 OUTLIER -60.23 -16.38 33.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.226 -178.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 26.2 m -76.18 -51.0 13.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.906 0.384 . . . . 0.0 109.991 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.694 ' HB3' HG23 ' A' ' 505' ' ' VAL . 61.2 mt -81.39 -13.69 58.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.679 -177.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -72.89 -20.01 61.17 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.822 0.344 . . . . 0.0 111.416 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . 0.599 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 59.8 mtt180 -74.09 139.67 44.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.1 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -84.06 131.74 34.78 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 167.54 -120.64 0.92 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.425 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.8 m -137.99 126.81 32.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.716 0.294 . . . . 0.0 111.06 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -151.64 143.91 24.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.786 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.2 m -115.96 111.09 19.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.706 HG21 HG12 ' A' ' 573' ' ' ILE . 88.5 t -111.04 114.23 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.618 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 61.5 m-85 -84.87 108.99 17.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -100.11 121.13 54.84 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.969 -166.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.46 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 93.5 Cg_endo -83.51 138.93 8.76 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.789 2.326 . . . . 0.0 112.158 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 66.8 p -83.35 -178.02 6.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.244 0.545 . . . . 0.0 112.087 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . 0.427 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -62.57 -37.84 87.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.322 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -34.19 71.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.522 0.677 . . . . 0.0 110.238 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -70.54 -36.85 73.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.373 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . 0.434 ' HZ ' HD11 ' A' ' 518' ' ' LEU . 17.3 m-85 -66.44 -18.01 65.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.222 0.534 . . . . 0.0 109.655 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 548' ' ' ARG . 21.2 ttp85 -92.79 -16.26 25.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.047 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -80.51 -13.92 58.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.005 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.618 HD12 ' HB ' ' A' ' 631' ' ' VAL . 78.8 mt -95.34 143.36 25.98 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.017 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 24.6 Cg_exo -63.05 134.39 45.83 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.766 2.311 . . . . 0.0 111.755 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.45 -32.43 73.11 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.039 2.493 . . . . 0.0 112.234 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 44.2 mtm105 -57.87 -30.96 66.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.46 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -86.21 -52.18 5.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.255 0.55 . . . . 0.0 110.539 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' TRP . . . . . 0.463 ' HE1' HD13 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -68.84 -38.27 79.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -170.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.0 t -54.6 -24.97 23.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.195 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -82.92 -33.39 26.85 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.412 -0.18 . . . . 0.0 111.0 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.598 ' HB3' ' HG ' ' A' ' 565' ' ' LEU . 14.5 mt -65.26 -50.57 65.26 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 121.002 0.43 . . . . 0.0 110.292 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.34 -16.51 63.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.848 0.356 . . . . 0.0 111.424 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -85.95 -38.34 8.69 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.024 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -124.66 135.28 52.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 111.267 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -73.57 -31.34 63.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.11 -170.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.459 ' H ' ' HD2' ' A' ' 563' ' ' LYS . 9.6 mptt -71.2 -37.05 72.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.85 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.1 -34.52 73.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.676 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.598 ' HG ' ' HB3' ' A' ' 558' ' ' LEU . 0.4 OUTLIER -75.73 -47.27 26.74 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.892 0.377 . . . . 0.0 110.443 177.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -59.67 -33.99 72.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.426 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -56.3 -52.79 63.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.946 0.403 . . . . 0.0 111.033 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 632' ' ' LEU . 73.9 mt -71.46 -46.67 62.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.429 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.595 ' HB3' HD22 ' A' ' 527' ' ' LEU . 0.1 OUTLIER -51.96 -34.23 41.3 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.404 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 47.2 mttp -69.47 -26.05 64.38 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.583 ' O ' HD21 ' A' ' 597' ' ' LEU . 52.4 t80 -80.31 -17.04 53.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.959 0.409 . . . . 0.0 110.708 -176.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . 0.6 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 16.7 m80 -79.89 -6.18 56.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.257 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.706 HG12 HG21 ' A' ' 539' ' ' VAL . 69.1 mt -117.12 117.47 55.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.04 -175.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.1 167.49 34.48 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.64 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.553 ' OD2' ' HB2' ' A' ' 590' ' ' LYS . 8.0 m-20 -54.63 -42.22 70.97 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.06 -176.56 5.71 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.748 -168.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.509 HG12 ' HA2' ' A' ' 623' ' ' GLY . 58.6 mt -82.08 118.23 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.314 -173.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 4.6 tt -118.49 93.47 4.13 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.9 m -73.5 167.53 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.573 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.62 ' HA ' HD11 ' A' ' 583' ' ' ILE . 13.1 t -62.37 -24.15 67.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.2 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -71.04 -10.89 69.38 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.036 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -99.9 -17.51 25.3 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.737 HG21 ' HB2' ' A' ' 601' ' ' LEU . 77.4 mt -71.47 94.47 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.362 0.601 . . . . 0.0 110.394 176.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -109.15 -121.47 4.47 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.975 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -58.96 -62.79 1.62 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 110.528 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.427 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 7.9 tt -168.48 129.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.61 136.05 60.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.95 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -97.98 120.84 39.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.141 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.76 116.67 32.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.553 ' HB2' ' OD2' ' A' ' 575' ' ' ASP . 23.7 mmmt -63.88 139.23 58.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.723 0.296 . . . . 0.0 110.336 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.568 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 86.5 p -106.14 -173.92 2.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.346 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 76.3 mt -80.79 -39.69 26.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.829 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.5 ' OE1' ' HB3' ' A' ' 634' ' ' ALA . 24.4 tt0 -61.84 -29.58 70.27 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.088 0.47 . . . . 0.0 110.833 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 127.03 -18.83 6.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.268 -0.968 . . . . 0.0 114.509 170.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 596' ' ' LYS . 8.8 t70 -88.52 -158.88 0.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.466 1.133 . . . . 0.0 109.893 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.475 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 10.8 pttm -124.75 135.98 53.46 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.862 0.363 . . . . 0.0 111.07 -169.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.583 HD21 ' O ' ' A' ' 571' ' ' TYR . 94.6 mt -83.85 115.34 22.21 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 172.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -91.32 84.84 5.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.69 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 608' ' ' VAL . 2.4 p -110.08 132.05 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.248 0.547 . . . . 0.0 111.69 -175.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.427 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 5.8 p -144.33 168.76 19.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.148 -176.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.737 ' HB2' HG21 ' A' ' 583' ' ' ILE . 1.8 tt -117.84 112.49 20.45 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -141.14 135.89 31.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.138 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 64.9 t30 61.41 36.29 17.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.279 0.561 . . . . 0.0 110.281 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 67.2 t30 73.24 -2.17 2.82 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.773 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 9.6 p -122.81 147.37 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.852 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.49 HG21 ' HG3' ' A' ' 616' ' ' PRO . 57.6 t -77.68 132.12 33.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.219 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 5.8 p -123.84 112.29 17.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.06 0.457 . . . . 0.0 111.21 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 599' ' ' VAL . 10.7 p -114.89 135.29 55.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.485 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.581 ' OD1' HG21 ' A' ' 608' ' ' VAL . 0.5 OUTLIER 57.75 26.36 12.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -177.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 62.8 mttm 76.09 1.4 3.44 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.205 1.002 . . . . 0.0 111.915 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 29.7 mm-40 -101.37 137.35 19.63 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.276 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 11.6 Cg_exo -72.45 126.58 11.7 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.021 2.48 . . . . 0.0 112.294 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.07 141.95 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.996 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -75.65 -60.3 2.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.857 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -141.68 113.48 6.54 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.615 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.495 ' CB ' ' HD1' ' A' ' 626' ' ' HIS . 65.0 Cg_endo -81.51 169.88 15.03 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.833 2.355 . . . . 0.0 113.053 174.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 2.5 t70 72.95 28.28 1.99 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.479 165.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 52.3 mt -80.9 89.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.497 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 53.2 mtp -78.97 137.07 37.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.635 0.731 . . . . 0.0 112.74 -171.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -106.26 -177.74 3.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.017 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.444 HG23 ' HA ' ' A' ' 504' ' ' THR . 15.0 t -74.74 -16.54 60.73 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.332 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.615 HD22 HG22 ' A' ' 505' ' ' VAL . 30.7 p-10 -119.37 10.51 11.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . 0.509 ' HA2' HG12 ' A' ' 577' ' ' ILE . . . 161.79 -147.05 12.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.415 -1.374 . . . . 0.0 113.52 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.4 p -139.97 145.06 26.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.86 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 76.8 t -118.74 143.61 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.657 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . 0.618 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 34.9 m-70 -130.16 127.19 39.23 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.717 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 98.2 t -79.94 119.3 29.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.7 148.21 17.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.028 0.442 . . . . 0.0 110.581 172.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 33.0 p -95.74 10.5 36.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.65 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -136.03 155.63 49.94 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.618 ' HB ' HD12 ' A' ' 550' ' ' LEU . 52.0 t -96.83 157.29 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.6 ' HB2' ' CE1' ' A' ' 572' ' ' HIS . 46.4 mt -114.68 112.74 23.34 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.856 0.36 . . . . 0.0 110.277 -170.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -115.73 105.57 12.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.22 0.533 . . . . 0.0 110.746 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' ALA . . . . . 0.5 ' HB3' ' OE1' ' A' ' 593' ' ' GLN . . . . . . . . 0 C--N 1.315 -0.906 0 CA-C-O 118.277 -0.868 . . . . 0.0 109.326 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.441 -1.0 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.4 ' HA ' HG22 ' A' ' 621' ' ' THR . 67.1 p -91.94 -172.12 3.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.712 0.291 . . . . 0.0 110.366 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.858 HG23 ' HB3' ' A' ' 531' ' ' LEU . 4.4 m -49.42 -29.89 4.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.897 170.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.5 ' HG2' ' CB ' ' A' ' 531' ' ' LEU . 85.3 mmm -67.64 -50.43 57.97 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.352 -0.217 . . . . 0.0 110.93 172.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 507' ' ' ASP . . . . . 0.449 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 1.0 OUTLIER -72.09 -29.77 64.45 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.136 -174.191 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 1.016 HG11 HG21 ' A' ' 625' ' ' VAL . 8.7 p -58.06 -35.02 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.504 0.669 . . . . 0.0 110.693 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.897 HD23 HG13 ' A' ' 508' ' ' VAL . 7.2 mt -81.65 -33.99 31.03 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.593 177.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -66.03 -25.02 66.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.856 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -102.24 1.88 50.66 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.76 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -111.5 141.83 44.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.522 0.661 . . . . 0.0 111.358 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' ASN . . . . . 0.453 ' HA ' ' OG ' ' A' ' 516' ' ' SER . 17.2 m120 -75.32 -23.99 57.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.035 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -87.07 -15.37 38.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.075 0.464 . . . . 0.0 110.418 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.883 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 25.5 m-85 -109.51 8.1 25.04 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.898 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 513' ' ' ASN . 67.8 m -57.24 -45.92 83.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -174.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.3 ttp -76.04 -24.02 55.16 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.218 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.532 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 46.8 tp -60.45 -45.22 94.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.984 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 515' ' ' PHE . 5.8 t -53.45 -46.61 59.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.553 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.2 72.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.685 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -71.81 -48.37 46.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.008 0.432 . . . . 0.0 109.931 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.811 HG12 HD21 ' A' ' 569' ' ' LEU . 43.3 mt -56.61 -39.0 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.612 0.72 . . . . 0.0 109.985 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -59.22 -53.25 60.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.909 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.0 m -59.23 -27.33 65.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.859 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -79.12 -28.25 42.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 65.02 32.58 84.67 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.675 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' LEU . . . . . 0.696 HD21 HD23 ' A' ' 569' ' ' LEU . 3.6 pp -102.65 24.58 10.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.356 0.578 . . . . 0.0 110.486 177.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 56.7 m -46.47 -53.12 11.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.295 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.41 -28.23 58.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -174.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 53.5 m -59.98 -52.47 65.25 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.715 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.858 ' HB3' HG23 ' A' ' 505' ' ' VAL . 27.2 mt -96.21 -8.43 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -175.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -92.88 -9.47 40.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.68 0.752 . . . . 0.0 110.409 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 533' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 533' ' ' ARG . 7.9 tpp180 -94.15 157.7 15.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.318 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -77.39 149.76 35.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.02 0.438 . . . . 0.0 110.785 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 164.66 -146.7 11.61 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.691 ' HB ' HG13 ' A' ' 577' ' ' ILE . 16.9 m -129.41 127.39 64.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -149.81 151.29 33.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 0.0 110.931 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 96.9 m -124.4 101.45 7.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.554 HG22 HG12 ' A' ' 573' ' ' ILE . 87.3 t -98.77 111.48 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.832 -174.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 56.3 m-85 -83.47 106.61 15.36 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -98.6 117.0 65.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.451 -166.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.49 135.22 13.03 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.819 2.346 . . . . 0.0 112.121 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.3 p -78.45 -176.0 4.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.243 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 544' ' ' ASN . . . . . 0.51 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 83.5 m-20 -73.68 -34.52 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.323 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 548' ' ' ARG . 1.5 pm0 -70.17 -18.99 63.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.099 0.476 . . . . 0.0 110.342 175.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.12 64.37 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.212 0.53 . . . . 0.0 110.789 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 547' ' ' PHE . . . . . 0.51 ' CD2' ' HA ' ' A' ' 544' ' ' ASN . 19.2 m-85 -66.49 -12.78 59.17 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.195 172.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 548' ' ' ARG . . . . . 0.509 ' HA ' ' HE ' ' A' ' 548' ' ' ARG . 3.3 mmp_? -92.57 -13.63 29.44 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.323 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -92.36 4.61 53.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.917 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.466 HD12 ' NE1' ' A' ' 555' ' ' TRP . 66.5 mt -113.05 142.71 27.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 0.0 111.588 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 31.3 Cg_exo -59.08 128.07 26.45 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.358 2.039 . . . . 0.0 111.179 174.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 552' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 50.1 Cg_exo -54.08 -29.07 53.63 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.955 2.437 . . . . 0.0 113.389 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -59.13 -53.82 54.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.524 0.202 . . . . 0.0 111.47 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.5 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 32.3 mm-40 -63.89 -37.33 86.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.313 0.577 . . . . 0.0 110.633 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 555' ' ' TRP . . . . . 0.466 ' NE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -73.72 -40.22 63.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.817 -177.571 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 70.8 m -59.38 -22.96 62.15 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.65 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 557' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 554' ' ' GLU . 73.5 mtp180 -73.34 -45.14 56.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.298 173.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.626 ' HB3' ' HA ' ' A' ' 565' ' ' LEU . 13.1 mt -67.71 -53.42 27.67 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.559 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -15.58 63.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.802 0.334 . . . . 0.0 111.623 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -88.4 -29.44 19.37 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.44 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 561' ' ' ASP . . . . . 0.654 ' OD2' ' HG3' ' A' ' 563' ' ' LYS . 24.5 t70 -131.05 124.69 31.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.793 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -62.43 -47.06 85.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -171.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.654 ' HG3' ' OD2' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -72.31 -24.82 61.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.973 -177.73 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.568 ' HG3' HD23 ' A' ' 558' ' ' LEU . 5.2 tp10 -68.52 -42.71 78.11 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.626 ' HA ' ' HB3' ' A' ' 558' ' ' LEU . 3.4 tt -65.75 -50.97 62.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 566' ' ' ALA . . . . . 0.46 ' HB1' ' HE2' ' A' ' 570' ' ' LYS . . . -54.87 -32.16 60.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.693 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -52.77 -53.64 45.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.455 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 59.2 mt -82.57 -39.79 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.811 HD21 HG12 ' A' ' 522' ' ' ILE . 22.4 tp -55.75 -36.48 67.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.612 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 68.6 mttm -68.24 -22.64 64.76 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.805 0.336 . . . . 0.0 111.872 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.628 ' O ' HD21 ' A' ' 597' ' ' LEU . 32.5 t80 -80.15 -17.28 52.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.892 0.377 . . . . 0.0 110.842 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 572' ' ' HIS . . . . . 0.442 ' NE2' ' HB2' ' A' ' 632' ' ' LEU . 10.6 m-70 -77.87 -8.89 58.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.263 0.554 . . . . 0.0 110.872 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 539' ' ' VAL . 36.2 mt -110.8 116.67 53.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.929 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -78.71 161.77 48.32 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.23 175.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.49 ' OD1' ' HB2' ' A' ' 590' ' ' LYS . 5.2 p-10 -81.57 -10.13 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -172.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -156.69 178.02 10.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 176.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.691 HG13 ' HB ' ' A' ' 536' ' ' VAL . 36.7 mt -89.87 114.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.113 0.482 . . . . 0.0 112.208 -168.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 5.6 tt -112.96 96.16 5.79 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.5 m -80.61 169.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.795 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 580' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 617' ' ' ASP . 35.5 p -47.46 -43.28 24.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.376 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -70.42 -6.87 59.4 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.988 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.76 -7.63 47.43 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.226 -0.511 . . . . 0.0 111.927 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.775 HG22 ' HB2' ' A' ' 601' ' ' LEU . 58.2 mt -76.76 104.97 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.982 0.42 . . . . 0.0 110.16 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -103.64 -152.11 22.81 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.003 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -50.91 -56.75 10.83 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.011 0.434 . . . . 0.0 110.534 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 598' ' ' GLU . 6.3 tt -160.32 109.27 1.71 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.212 173.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 97.6 t -116.5 124.89 73.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.923 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 588' ' ' ARG . . . . . 0.418 ' HD2' ' HD2' ' A' ' 596' ' ' LYS . 85.2 mtm180 -98.01 126.88 43.63 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.855 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 21.9 tp -115.94 142.46 46.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.492 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.498 ' O ' ' HA2' ' A' ' 574' ' ' GLY . 37.2 mtmm -71.84 163.13 28.38 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.782 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.586 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.9 p -128.44 -176.83 3.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.005 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 63.1 mt -82.11 -41.86 19.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.38 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 593' ' ' GLN . . . . . 0.521 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 31.9 tt0 -59.25 -29.83 67.84 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.579 0.704 . . . . 0.0 110.255 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.79 -11.06 7.46 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.642 169.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 595' ' ' ASP . . . . . 0.566 ' OD2' ' HG2' ' A' ' 596' ' ' LYS . 3.7 t70 -94.02 -156.38 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.493 0.646 . . . . 0.0 109.985 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.566 ' HG2' ' OD2' ' A' ' 595' ' ' ASP . 19.9 pttm -117.94 142.02 47.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.863 0.363 . . . . 0.0 111.215 -172.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.628 HD21 ' O ' ' A' ' 571' ' ' TYR . 67.1 mt -92.13 116.83 29.28 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 34.5 tt0 -91.26 85.83 5.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.348 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 599' ' ' VAL . . . . . 0.535 HG12 HG23 ' A' ' 583' ' ' ILE . 35.0 t -93.21 128.87 44.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.796 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 2.7 p -140.25 148.91 42.17 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.586 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.775 ' HB2' HG22 ' A' ' 583' ' ' ILE . 59.3 tp -119.25 112.8 19.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -131.13 110.42 11.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.967 0.413 . . . . 0.0 110.837 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 59.55 53.0 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.423 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 46.6 t30 69.81 -5.56 1.21 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.875 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.59 120.73 46.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.88 0.372 . . . . 0.0 110.438 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.434 HG21 ' HG3' ' A' ' 616' ' ' PRO . 43.1 t -85.77 140.81 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.856 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 607' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 40.6 m -132.16 142.56 49.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.603 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.6 p -134.69 123.81 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 120.882 0.373 . . . . 0.0 110.046 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.713 ' ND2' HD13 ' A' ' 632' ' ' LEU . 31.5 m-20 61.15 32.1 19.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.559 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 610' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 53.2 mttp 76.56 -0.12 3.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.806 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.492 ' HB3' ' OD1' ' A' ' 630' ' ' ASN . 5.3 mm-40 -99.61 130.13 27.4 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.501 ' HD2' HD21 ' A' ' 630' ' ' ASN . 16.5 Cg_exo -68.81 134.46 30.11 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.988 2.458 . . . . 0.0 113.049 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 49.0 t -86.37 143.17 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.703 177.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.11 12.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.655 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 615' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 616' ' ' PRO . 32.0 tt0 -152.87 104.65 2.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.162 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 616' ' ' PRO . . . . . 0.434 ' HG3' HG21 ' A' ' 606' ' ' VAL . 75.0 Cg_endo -74.39 157.41 45.36 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.569 2.179 . . . . 0.0 113.114 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.53 ' HB2' ' HB3' ' A' ' 580' ' ' SER . 1.3 t70 76.7 59.81 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.734 166.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 22.3 mt -108.81 97.12 5.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 165.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 57.4 mtp -79.93 142.64 34.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.621 0.724 . . . . 0.0 112.846 -167.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.72 -175.43 2.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.251 171.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 504' ' ' THR . 12.6 t -82.42 -17.16 46.35 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.316 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.743 HD21 HG22 ' A' ' 505' ' ' VAL . 32.1 p-10 -119.22 14.52 13.03 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 162.76 -160.29 32.69 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.139 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.73 148.96 32.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.746 0.308 . . . . 0.0 110.179 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 625' ' ' VAL . . . . . 1.016 HG21 HG11 ' A' ' 508' ' ' VAL . 87.5 t -118.28 145.21 24.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.481 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 626' ' ' HIS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 74.4 m-70 -132.08 126.43 33.76 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.883 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 82.6 t -79.15 119.08 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.2 145.76 21.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.917 0.389 . . . . 0.0 110.241 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 22.9 p -97.73 9.77 41.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 630' ' ' ASN . . . . . 0.501 HD21 ' HD2' ' A' ' 612' ' ' PRO . 2.6 p30 -140.25 147.89 40.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.666 176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.439 ' HB ' HD11 ' A' ' 550' ' ' LEU . 43.9 t -82.23 160.62 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.713 HD13 ' ND2' ' A' ' 609' ' ' ASN . 42.4 mt . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -167.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.688 0 CA-C-O 121.744 0.635 . . . . 0.0 113.398 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 508' ' ' VAL . 72.4 p -86.01 -171.2 3.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.299 -0.951 . . . . 0.0 110.14 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.7 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 36.4 t -43.9 -45.0 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 123.537 0.523 . . . . 0.0 111.185 173.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.513 ' HB2' ' HB2' ' A' ' 531' ' ' LEU . 10.2 tpt -63.78 -42.3 97.78 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.953 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 507' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 510' ' ' LYS . 25.3 t70 -67.78 -37.77 82.49 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.818 0.342 . . . . 0.0 110.631 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.518 HG21 ' HB2' ' A' ' 620' ' ' ALA . 82.8 t -50.61 -40.7 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.796 174.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 5.9 mt -82.37 -35.17 28.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.405 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 507' ' ' ASP . 17.3 mmmt -60.41 -40.71 91.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.823 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -90.87 -12.74 60.13 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.815 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -102.86 141.29 35.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.296 0.57 . . . . 0.0 111.092 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -75.94 -25.86 56.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.573 -174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -83.09 -15.98 48.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.1 0.476 . . . . 0.0 110.246 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.805 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 24.6 m-85 -109.34 17.78 21.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.379 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 12.0 p -57.54 -61.38 2.54 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' MET . . . . . 0.492 ' HE1' ' HH2' ' A' ' 555' ' ' TRP . 2.4 ttp -70.57 -20.79 62.76 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.009 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.552 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 49.5 tp -57.42 -45.25 84.81 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.654 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 523' ' ' GLN . 9.1 t -51.39 -47.82 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.905 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.28 -39.32 89.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.905 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.46 -42.09 96.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.028 0.442 . . . . 0.0 110.404 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.685 HG12 HD11 ' A' ' 569' ' ' LEU . 49.8 mt -69.74 -29.1 39.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.557 0.694 . . . . 0.0 109.992 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 523' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.0 OUTLIER -65.48 -53.54 41.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.877 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.3 m -65.75 -16.19 63.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.986 0.422 . . . . 0.0 110.904 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -80.5 -17.34 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.267 173.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 74.93 17.94 80.19 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.381 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 527' ' ' LEU . . . . . 0.743 HD12 HD12 ' A' ' 569' ' ' LEU . 82.1 mt -97.31 17.15 18.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.556 -0.379 . . . . 0.0 111.556 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 46.6 m -55.99 -48.75 75.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 529' ' ' GLU . . . . . 0.676 ' HA ' ' HB2' ' A' ' 532' ' ' ASN . 31.8 tt0 -62.73 -25.04 67.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.621 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 40.6 m -61.23 -50.48 72.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.608 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.676 ' HG ' ' CG1' ' A' ' 505' ' ' VAL . 0.3 OUTLIER -84.82 -21.65 29.79 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.429 176.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 532' ' ' ASN . . . . . 0.676 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 4.4 m-20 -70.03 -22.2 63.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.671 0.272 . . . . 0.0 110.837 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -84.97 126.25 33.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 534' ' ' GLU . . . . . 0.459 ' OE2' ' HA ' ' A' ' 622' ' ' ASN . 13.9 tp10 -70.79 145.99 50.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.663 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 166.42 -132.1 2.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.827 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.5 m -137.36 127.47 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.656 0.265 . . . . 0.0 110.555 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -149.81 154.63 38.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.967 0.413 . . . . 0.0 110.626 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.7 m -129.02 105.01 7.91 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.758 HG22 HG12 ' A' ' 573' ' ' ILE . 93.5 t -107.26 113.89 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.065 -174.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 60.5 m-85 -83.1 111.25 18.72 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 171.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -104.65 119.71 52.73 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.964 -165.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 541' ' ' ALA . 5.7 Cg_exo -77.89 141.6 19.22 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.335 2.69 . . . . 0.0 112.018 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 81.2 p -83.38 -179.15 7.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.111 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -58.45 -40.47 82.69 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.21 0.529 . . . . 0.0 110.281 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 545' ' ' GLU . 1.5 mp0 -62.78 -23.4 67.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.163 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -78.08 -31.35 50.12 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.275 0.559 . . . . 0.0 111.878 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 547' ' ' PHE . . . . . 0.497 ' CD1' ' HZ2' ' A' ' 555' ' ' TRP . 41.7 m-85 -67.06 -12.56 60.26 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.238 175.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -91.52 -8.79 46.56 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.73 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -91.16 -8.51 48.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.391 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.62 HD12 ' HE1' ' A' ' 555' ' ' TRP . 40.8 mt -100.3 142.42 24.58 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.411 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 551' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.92 142.24 92.4 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.709 2.273 . . . . 0.0 111.665 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.14 -40.38 77.18 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.22 2.613 . . . . 0.0 113.123 -175.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -59.61 -51.21 70.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.521 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.527 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 6.9 mp0 -60.43 -41.33 93.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.459 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 555' ' ' TRP . . . . . 0.62 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -69.17 -45.4 70.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.912 -177.025 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 35.2 p -58.58 -21.93 54.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.263 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -75.98 -49.86 16.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.87 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.615 ' HB3' ' HA ' ' A' ' 565' ' ' LEU . 12.9 mt -61.18 -63.68 1.21 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.728 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.838 HD13 HD11 ' A' ' 565' ' ' LEU . 3.5 mm? -58.53 -12.02 3.57 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.297 0.639 . . . . 0.0 112.542 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -74.68 -35.46 51.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.876 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 561' ' ' ASP . . . . . 0.527 ' OD2' ' HG3' ' A' ' 563' ' ' LYS . 16.9 t70 -144.67 153.03 41.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.218 0.509 . . . . 0.0 111.127 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -62.49 -47.28 84.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.048 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.527 ' HG3' ' OD2' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -71.31 -17.75 62.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.941 -177.532 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.444 ' N ' ' HD3' ' A' ' 563' ' ' LYS . 5.6 mm-40 -81.12 -42.41 20.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.676 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.838 HD11 HD13 ' A' ' 559' ' ' LEU . 0.6 OUTLIER -69.89 -48.27 59.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.329 0.585 . . . . 0.0 109.655 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 566' ' ' ALA . . . . . 0.52 ' HB1' ' HE3' ' A' ' 570' ' ' LYS . . . -62.56 -27.54 69.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.834 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -52.49 -53.9 39.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.852 0.358 . . . . 0.0 110.686 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 66.1 mt -83.43 -39.06 14.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.366 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.743 HD12 HD12 ' A' ' 527' ' ' LEU . 0.8 OUTLIER -54.99 -32.74 61.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.124 -178.012 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 97.2 mttt -74.91 -13.75 60.57 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.561 ' O ' HD21 ' A' ' 597' ' ' LEU . 44.7 t80 -86.71 -19.11 29.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.048 0.452 . . . . 0.0 110.885 -177.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 572' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 13.5 m-70 -77.78 -12.62 59.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.137 0.494 . . . . 0.0 110.566 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.758 HG12 HG22 ' A' ' 539' ' ' VAL . 68.3 mt -105.51 120.5 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.292 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.95 155.86 24.92 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.17 -4.86 57.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.29 168.54 23.76 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.506 0.193 . . . . 0.0 110.509 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.577 HG13 ' HB ' ' A' ' 536' ' ' VAL . 33.1 mt -89.0 117.5 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.602 -170.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 53.3 tp -117.66 97.9 6.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 24.4 m -79.24 170.64 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.096 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 580' ' ' SER . . . . . 0.613 ' HA ' HD12 ' A' ' 583' ' ' ILE . 17.9 m -55.96 -30.18 61.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.768 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.5 -13.43 65.46 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.135 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.86 -26.82 7.77 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.769 HG22 ' HB2' ' A' ' 601' ' ' LEU . 74.9 mt -60.9 103.89 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.069 0.461 . . . . 0.0 110.035 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -115.49 -137.03 6.13 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.12 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -59.67 -60.52 3.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 0.0 110.509 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 7.9 tt -157.9 112.75 2.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 67.2 t -121.65 133.53 67.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.128 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 588' ' ' ARG . . . . . 0.907 ' HD3' ' H ' ' A' ' 588' ' ' ARG . 0.0 OUTLIER -99.33 126.82 45.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.849 -179.069 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.47 125.51 49.09 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -75.02 143.24 43.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.221 0.534 . . . . 0.0 110.603 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.602 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 84.8 p -107.9 -178.62 3.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.735 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 573' ' ' ILE . 7.0 mp -73.99 -36.14 64.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.38 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -65.97 -30.56 71.15 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 121.559 0.695 . . . . 0.0 110.138 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 126.24 -21.9 6.03 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.08 -0.964 . . . . 0.0 114.006 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 595' ' ' ASP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 5.5 t70 -81.85 -165.52 1.0 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.042 0.921 . . . . 0.0 110.585 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.43 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 0.2 OUTLIER -123.45 135.51 54.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 0.0 111.442 -170.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.561 HD21 ' O ' ' A' ' 571' ' ' TYR . 84.2 mt -84.74 122.09 28.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.482 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 37.3 mt-10 -92.05 90.27 7.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.44 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 599' ' ' VAL . . . . . 0.492 HG12 HG23 ' A' ' 583' ' ' ILE . 40.4 t -93.32 133.42 34.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.01 -176.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 32.2 t -143.92 136.82 27.35 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.769 ' HB2' HG22 ' A' ' 583' ' ' ILE . 63.7 tp -113.22 112.98 24.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -133.49 112.52 11.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 603' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 604' ' ' ASN . 15.3 t-20 60.03 47.14 10.04 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.13 0.491 . . . . 0.0 109.785 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 604' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 603' ' ' ASN . 10.2 t30 74.11 -14.95 0.64 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.723 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 55.9 t -84.18 115.81 26.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 122.175 -0.328 . . . . 0.0 110.665 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.55 HG22 HD13 ' A' ' 601' ' ' LEU . 43.8 t -84.51 136.09 23.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.599 176.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 607' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 44.9 m -126.0 147.98 49.4 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 176.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.514 HG11 ' CD1' ' A' ' 540' ' ' PHE . 7.0 p -141.12 119.57 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 1.075 HD22 HD13 ' A' ' 632' ' ' LEU . 29.5 m-20 62.12 31.43 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 610' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 24.4 tptp 86.92 -24.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.215 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.509 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 14.4 mm-40 -83.24 132.02 51.53 Favored Pre-proline 0 C--N 1.317 -0.834 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.646 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 13.8 Cg_exo -71.28 135.25 26.48 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.117 2.544 . . . . 0.0 112.856 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.592 HG11 ' HB3' ' A' ' 626' ' ' HIS . 24.7 t -88.74 136.25 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.206 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -88.8 -48.52 7.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.667 -177.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -132.72 89.7 34.6 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.01 159.28 53.79 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.662 2.241 . . . . 0.0 113.431 171.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 75.76 39.02 0.34 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.438 165.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 41.5 mt -87.38 85.76 2.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 166.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 619' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 55.7 mtp -80.71 129.57 34.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.645 0.736 . . . . 0.0 112.715 -170.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 620' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 508' ' ' VAL . . . -99.65 -171.42 2.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.148 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.405 ' OG1' HG22 ' A' ' 504' ' ' THR . 62.4 p -73.67 -38.46 64.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.498 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.459 ' HA ' ' OE2' ' A' ' 534' ' ' GLU . 30.0 p-10 -99.19 6.06 46.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.47 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 164.27 -152.64 22.53 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.189 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 624' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 8.8 p -134.77 144.48 34.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.809 0.338 . . . . 0.0 110.697 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.89 140.55 37.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.709 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 626' ' ' HIS . . . . . 0.592 ' HB3' HG11 ' A' ' 613' ' ' VAL . 52.3 m-70 -126.9 126.44 43.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.389 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.805 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 69.3 t -76.95 118.74 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 542' ' ' PRO . 0.5 OUTLIER -117.15 149.03 19.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.114 171.567 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 36.8 p -99.19 15.52 25.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.643 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -138.66 156.03 47.78 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.409 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 632' ' ' LEU . 36.1 t -98.37 160.73 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 174.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 1.075 HD13 HD22 ' A' ' 609' ' ' ASN . 16.2 mt . . . . . 0 C--N 1.319 -0.755 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.633 -167.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.444 -0.779 0 CA-C-O 121.747 0.637 . . . . 0.0 112.931 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 508' ' ' VAL . 51.9 p -91.0 -170.33 2.64 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.862 -0.669 . . . . 0.0 109.687 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.797 HG11 HG21 ' A' ' 539' ' ' VAL . 99.4 t -47.18 -43.42 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 0.0 110.627 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.416 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 36.0 tpp -62.7 -41.07 98.95 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.883 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 507' ' ' ASP . . . . . 0.833 ' HA ' ' HD3' ' A' ' 510' ' ' LYS . 7.7 t70 -68.17 -32.13 72.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.643 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 504' ' ' THR . 99.6 t -51.3 -60.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.432 173.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.704 HD13 ' O ' ' A' ' 505' ' ' VAL . 5.1 mp -57.36 -37.64 72.92 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.055 0.942 . . . . 0.0 112.18 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.833 ' HD3' ' HA ' ' A' ' 507' ' ' ASP . 40.1 mtpt -54.53 -39.82 68.03 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -94.18 -17.05 41.56 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.143 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -85.37 132.78 34.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.084 0.469 . . . . 0.0 111.092 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -76.49 -25.51 54.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.727 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -80.94 -21.77 40.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.791 0.329 . . . . 0.0 110.351 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.574 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 20.7 m-85 -109.6 13.44 23.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.417 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 74.6 m -57.69 -49.82 75.23 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.5 ttp -74.93 -20.77 59.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.51 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.691 HD13 ' HZ ' ' A' ' 547' ' ' PHE . 59.7 tp -59.48 -44.03 93.14 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.735 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 509' ' ' LEU . 9.4 t -51.66 -51.91 24.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.377 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.61 97.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.971 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.5 83.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.382 0.61 . . . . 0.0 110.406 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.782 HG12 HD21 ' A' ' 569' ' ' LEU . 97.5 mt -62.86 -37.68 79.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.619 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -63.32 -49.15 75.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.746 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 8.5 t -60.57 -32.82 71.89 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.059 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -71.08 -22.26 62.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.031 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 75.98 19.33 78.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.257 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' LEU . . . . . 0.731 HD21 HD23 ' A' ' 569' ' ' LEU . 3.6 pp -106.79 22.25 16.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.478 0.639 . . . . 0.0 110.646 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 42.0 m -54.6 -43.22 71.97 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.864 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 529' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 533' ' ' ARG . 7.9 pt-20 -57.22 -33.15 67.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.422 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.0 m -63.47 -52.57 60.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 110.401 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.418 HD21 HD12 ' A' ' 573' ' ' ILE . 59.8 mt -74.09 -22.75 59.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.542 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.85 9.54 32.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 533' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 529' ' ' GLU . 71.4 ttt180 -101.87 143.32 31.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.831 0.348 . . . . 0.0 110.313 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.66 146.69 54.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.544 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 150.83 -139.96 7.59 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.629 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.483 ' HB ' HG13 ' A' ' 577' ' ' ILE . 8.3 m -135.84 127.47 44.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -149.33 146.82 27.72 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 97.5 m -119.11 102.45 8.74 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 170.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.797 HG21 HG11 ' A' ' 505' ' ' VAL . 93.3 t -99.32 113.47 34.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 -173.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 632' ' ' LEU . 52.5 m-85 -86.14 103.87 15.19 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 171.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -96.88 115.24 65.64 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.373 -167.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.511 ' HG2' ' CE1' ' A' ' 547' ' ' PHE . 70.1 Cg_endo -81.32 135.04 9.3 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.461 2.107 . . . . 0.0 111.821 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.519 ' HB ' ' OE2' ' A' ' 545' ' ' GLU . 47.8 p -70.03 173.69 6.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.441 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 544' ' ' ASN . . . . . 0.545 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -67.82 -33.04 74.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.944 0.402 . . . . 0.0 110.902 -178.142 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.519 ' OE2' ' HB ' ' A' ' 543' ' ' THR . 1.7 pm0 -70.17 -19.75 63.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.858 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -76.34 -33.24 58.98 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.004 0.431 . . . . 0.0 111.3 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 547' ' ' PHE . . . . . 0.691 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 14.8 m-85 -64.79 -14.85 60.54 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 548' ' ' ARG . . . . . 0.438 ' HD2' ' HA ' ' A' ' 548' ' ' ARG . 12.9 tpt180 -92.95 -14.75 27.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.84 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -80.67 -19.39 45.35 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.278 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.583 HD11 ' HB ' ' A' ' 631' ' ' VAL . 78.9 mt -97.95 137.2 20.89 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.888 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 34.8 Cg_exo -61.64 136.82 65.02 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.583 2.189 . . . . 0.0 112.051 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.64 -37.5 53.45 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.965 2.443 . . . . 0.0 112.437 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -54.31 -34.17 60.39 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.096 0.474 . . . . 0.0 111.245 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.93 -44.39 12.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.731 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 555' ' ' TRP . . . . . 0.463 ' HE3' HD12 ' A' ' 559' ' ' LEU . 0.0 OUTLIER -81.46 -37.94 27.2 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 29.3 t -54.66 -34.91 62.92 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -66.57 -42.88 86.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.506 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.702 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 46.3 mt -59.06 -54.36 47.98 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.858 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.842 ' HG ' HD21 ' A' ' 565' ' ' LEU . 1.0 OUTLIER -70.7 -3.13 16.97 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -76.96 -29.57 56.97 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.681 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 561' ' ' ASP . . . . . 0.635 ' OD1' ' HG3' ' A' ' 563' ' ' LYS . 11.1 t70 -142.73 150.95 40.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.556 -176.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.05 81.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.635 ' HG3' ' OD1' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -80.52 -18.45 48.47 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.735 -178.786 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.53 ' HG2' ' HB3' ' A' ' 561' ' ' ASP . 15.5 mm-40 -72.38 -42.89 64.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.842 HD21 ' HG ' ' A' ' 559' ' ' LEU . 16.8 mt -61.93 -57.16 12.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.09 174.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -54.66 -27.27 38.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.991 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -53.41 -61.78 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.168 0.293 . . . . 0.0 111.491 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 68.7 mt -84.85 -37.65 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.873 0.368 . . . . 0.0 110.207 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.782 HD21 HG12 ' A' ' 522' ' ' ILE . 29.3 tp -55.0 -37.43 66.58 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.822 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 7.8 mtpm? -78.87 -12.91 60.05 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.627 ' HB2' ' CB ' ' A' ' 593' ' ' GLN . 62.0 t80 -84.4 -11.99 55.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.414 0.626 . . . . 0.0 109.666 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 572' ' ' HIS . . . . . 0.61 ' HE1' HG13 ' A' ' 631' ' ' VAL . 12.3 m170 -79.49 -16.7 55.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.871 171.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.587 ' HB ' ' HG ' ' A' ' 592' ' ' LEU . 10.7 mm -98.31 115.53 38.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.598 -176.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -80.45 153.83 35.73 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.043 172.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.79 -11.82 59.92 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -171.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.6 177.68 10.1 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.483 HG13 ' HB ' ' A' ' 536' ' ' VAL . 41.7 mt -87.28 120.07 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.572 -172.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' ' 589' ' ' LEU . 4.2 tt -121.36 99.32 6.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.0 167.91 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.918 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 580' ' ' SER . . . . . 0.687 ' HB2' ' HB2' ' A' ' 617' ' ' ASP . 36.6 t -56.98 -34.89 68.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.464 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.36 -9.57 61.33 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.345 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -106.03 -9.43 32.19 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.596 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 580' ' ' SER . 76.0 mt -61.97 -44.39 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 584' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . 59.14 -99.0 0.12 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.753 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -121.03 -53.18 2.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.937 0.399 . . . . 0.0 110.197 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 599' ' ' VAL . 5.3 tt -162.35 107.75 1.21 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 75.1 t -126.73 129.3 71.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 588' ' ' ARG . . . . . 0.626 ' HD3' ' HD2' ' A' ' 596' ' ' LYS . 4.0 ptp85 -97.09 128.16 43.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.727 0.775 . . . . 0.0 111.753 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.54 ' HB2' HD12 ' A' ' 578' ' ' LEU . 21.4 tp -120.4 131.92 55.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.843 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 596' ' ' LYS . 81.1 tttt -76.51 151.97 36.22 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.169 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.591 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 85.7 p -110.9 -173.69 2.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.51 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 59.6 mt -80.43 -36.12 34.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.132 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 593' ' ' GLN . . . . . 0.627 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.3 tt0 -58.46 -30.78 67.21 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.365 0.602 . . . . 0.0 110.502 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.7 6.14 6.16 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.079 -1.058 . . . . 0.0 114.89 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -123.52 -170.54 2.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 118.033 0.917 . . . . 0.0 109.793 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.626 ' HD2' ' HD3' ' A' ' 588' ' ' ARG . 23.4 pttm -103.82 142.04 35.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.124 0.487 . . . . 0.0 111.175 -172.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.486 HD21 ' O ' ' A' ' 571' ' ' TYR . 41.8 mt -89.95 117.03 28.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.629 175.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -82.35 94.24 7.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 599' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 583' ' ' ILE . 45.6 t -100.56 124.25 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.782 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.645 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 32.9 t -122.77 161.52 23.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.67 -176.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 606' ' ' VAL . 60.0 tp -142.53 113.22 7.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 602' ' ' LYS . . . . . 0.587 ' O ' HG12 ' A' ' 605' ' ' VAL . 87.8 tttt -135.13 99.79 4.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.806 0.336 . . . . 0.0 110.443 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.56 67.0 1.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.655 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 69.31 10.38 7.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 171.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 605' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 602' ' ' LYS . 11.6 p -122.15 126.84 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.175 0.512 . . . . 0.0 110.962 171.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.774 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 40.0 t -93.83 138.15 21.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.537 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 607' ' ' SER . . . . . 0.645 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 19.3 m -124.26 104.47 8.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.424 HG11 ' CD1' ' A' ' 540' ' ' PHE . 6.9 p -110.4 117.1 54.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.867 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.412 HD22 HD22 ' A' ' 597' ' ' LEU . 2.9 m120 60.72 33.55 20.16 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.812 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm 83.18 -13.1 0.82 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.013 1.325 . . . . 0.0 111.861 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.501 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 19.9 mm-40 -91.7 132.47 33.06 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.96 0.409 . . . . 0.0 110.604 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 606' ' ' VAL . 2.7 Cg_exo -75.5 125.95 9.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.909 2.406 . . . . 0.0 112.38 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.774 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 22.9 t -83.7 133.1 29.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -75.76 -60.28 2.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.972 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 615' ' ' GLU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 616' ' ' PRO . 38.7 mt-10 -138.89 101.18 7.88 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 616' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 615' ' ' GLU . 80.5 Cg_endo -73.1 168.74 23.96 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.877 2.385 . . . . 0.0 114.137 176.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.687 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 1.4 t70 76.11 42.79 0.18 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.158 165.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 36.7 mt -94.62 92.65 3.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 167.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 619' ' ' MET . . . . . 0.503 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 59.5 mtp -80.09 136.16 36.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.243 0.544 . . . . 0.0 112.268 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -99.49 -172.76 2.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.501 172.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 13.2 p -76.76 -26.73 54.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.965 0.412 . . . . 0.0 111.316 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.493 ' OD1' HG23 ' A' ' 505' ' ' VAL . 27.0 p-10 -116.8 15.7 15.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.894 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 623' ' ' GLY . . . . . 0.429 ' HA2' HG12 ' A' ' 577' ' ' ILE . . . 164.3 -157.53 29.88 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.921 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 624' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 13.0 p -133.43 144.73 35.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.826 0.346 . . . . 0.0 110.652 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 79.6 t -114.72 142.27 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.226 0.536 . . . . 0.0 110.48 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 626' ' ' HIS . . . . . 0.463 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 68.0 m-70 -126.59 121.9 33.53 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.262 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.574 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 85.4 t -76.16 117.98 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 111.501 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.433 HD12 ' O ' ' A' ' 630' ' ' ASN . 1.5 pt -119.02 142.53 33.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.291 173.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 39.9 p -96.29 7.41 46.53 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.708 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 630' ' ' ASN . . . . . 0.433 ' O ' HD12 ' A' ' 628' ' ' ILE . 6.0 m-20 -128.79 144.05 51.07 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.249 176.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.61 HG13 ' HE1' ' A' ' 572' ' ' HIS . 47.0 t -83.43 157.31 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 540' ' ' PHE . 86.9 mt . . . . . 0 C--N 1.32 -0.689 0 CA-C-O 121.323 0.582 . . . . 0.0 111.397 -166.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.681 0 N-CA-C 112.105 -0.398 . . . . 0.0 112.105 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 508' ' ' VAL . 58.3 p -94.46 -170.31 2.23 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.694 ' O ' HD13 ' A' ' 509' ' ' LEU . 73.0 t -46.06 -42.83 4.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.603 170.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.7 tpt -59.73 -40.61 88.63 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.659 0.266 . . . . 0.0 111.066 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 507' ' ' ASP . . . . . 0.528 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 2.2 t70 -68.81 -34.55 75.72 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.207 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 505' ' ' VAL . 99.1 t -51.79 -56.89 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.001 0.429 . . . . 0.0 110.85 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.694 HD13 ' O ' ' A' ' 505' ' ' VAL . 5.4 mp -57.31 -42.33 81.62 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.461 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 510' ' ' LYS . 1.5 tmmt? -67.32 -25.76 66.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -99.49 13.01 61.51 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.872 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -122.63 139.13 54.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.922 0.391 . . . . 0.0 110.895 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -75.46 -16.47 60.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.489 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -91.29 -24.83 19.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.824 0.345 . . . . 0.0 110.901 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.923 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 17.2 m-85 -107.01 8.36 30.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.656 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 13.3 p -54.05 -54.22 42.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -67.87 -29.89 69.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.214 0.53 . . . . 0.0 109.866 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.473 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 41.8 tp -57.42 -45.83 84.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.404 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 515' ' ' PHE . 10.0 t -52.75 -52.02 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.394 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.54 77.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.181 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -72.67 -49.57 30.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.51 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.529 HG12 HD13 ' A' ' 569' ' ' LEU . 77.1 mt -57.94 -35.1 50.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.502 0.668 . . . . 0.0 109.681 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 523' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.2 OUTLIER -56.63 -57.5 12.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.21 173.279 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.2 m -57.4 -26.55 61.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.793 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -77.95 -15.85 58.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.369 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 79.51 8.29 87.86 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.341 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 527' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 566' ' ' ALA . 71.2 mt -83.26 9.19 11.3 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.795 0.331 . . . . 0.0 111.06 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 46.4 m -52.99 -43.66 66.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -51.54 -45.89 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.388 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 16.2 m -63.91 -41.87 97.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.337 . . . . 0.0 111.735 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 80.5 mt -91.24 -14.1 31.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.841 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -87.56 -7.4 57.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.023 0.439 . . . . 0.0 110.341 172.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -92.79 147.47 22.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.468 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.11 151.94 43.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.71 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 153.0 -161.18 29.48 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.892 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.684 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.7 m -120.76 127.71 75.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.808 0.337 . . . . 0.0 110.23 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -141.84 155.53 45.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.083 0.468 . . . . 0.0 111.046 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.1 m -124.42 100.83 6.86 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 167.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.609 HG22 HG12 ' A' ' 573' ' ' ILE . 59.7 t -104.54 113.78 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -173.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 60.3 m-85 -86.26 113.84 22.59 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -103.58 116.57 61.73 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -169.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 541' ' ' ALA . 8.2 Cg_exo -72.97 139.42 29.99 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.251 2.634 . . . . 0.0 112.007 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 628' ' ' ILE . 67.6 p -83.05 -176.42 6.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.138 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.22 -30.95 69.73 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.112 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -64.53 -29.81 70.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -67.79 -35.28 78.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.378 0.609 . . . . 0.0 111.339 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 547' ' ' PHE . . . . . 0.448 ' O ' HD22 ' A' ' 550' ' ' LEU . 6.2 m-85 -73.25 -13.28 61.11 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.131 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -94.57 -38.53 10.83 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.148 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -90.96 7.24 41.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.393 0.616 . . . . 0.0 111.508 -172.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.799 HD12 ' CD1' ' A' ' 555' ' ' TRP . 0.5 OUTLIER -74.97 163.52 67.65 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.235 -178.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.626 ' HB2' ' OE1' ' A' ' 554' ' ' GLU . 3.3 Cg_exo -81.09 126.36 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.307 2.005 . . . . 0.0 109.916 166.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.7 -43.24 60.97 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.518 2.812 . . . . 0.0 114.263 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 553' ' ' ARG . . . . . 0.447 ' HD3' ' HA ' ' A' ' 553' ' ' ARG . 24.9 mmt180 -71.93 -23.44 61.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 111.486 -172.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.63 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 0.9 OUTLIER -60.88 -53.48 56.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.45 0.643 . . . . 0.0 110.492 175.539 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 555' ' ' TRP . . . . . 0.799 ' CD1' HD12 ' A' ' 550' ' ' LEU . 4.7 m95 -80.3 -30.34 38.25 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.784 -172.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 556' ' ' SER . . . . . 0.44 ' OG ' ' HA ' ' A' ' 553' ' ' ARG . 25.3 p -58.68 -25.45 62.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.337 0.589 . . . . 0.0 109.577 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 557' ' ' ARG . . . . . 0.774 ' HG3' ' HG2' ' A' ' 564' ' ' GLU . 26.5 tpt180 -84.72 -46.98 10.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.743 173.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 554' ' ' GLU . 74.9 mt -63.19 -60.18 3.76 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.6 HD22 HD11 ' A' ' 565' ' ' LEU . 0.1 OUTLIER -64.57 -12.35 44.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.891 0.376 . . . . 0.0 110.984 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -70.82 -35.84 65.98 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.848 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -145.78 147.3 31.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.319 0.56 . . . . 0.0 110.891 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -67.96 -47.29 69.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.367 -170.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.565 ' H ' ' HD2' ' A' ' 563' ' ' LYS . 0.0 OUTLIER -69.7 -22.85 63.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.061 -177.033 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.774 ' HG2' ' HG3' ' A' ' 557' ' ' ARG . 7.4 tp10 -77.75 -42.41 34.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.691 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.6 HD11 HD22 ' A' ' 559' ' ' LEU . 0.3 OUTLIER -60.96 -49.43 77.5 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.495 0.664 . . . . 0.0 109.359 175.325 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 566' ' ' ALA . . . . . 0.485 ' HA ' HD11 ' A' ' 527' ' ' LEU . . . -55.83 -32.81 63.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.537 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 567' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 570' ' ' LYS . 25.6 t-20 -57.63 -46.97 83.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.458 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 558' ' ' LEU . 24.4 mt -83.98 -41.62 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.991 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.529 HD13 HG12 ' A' ' 522' ' ' ILE . 36.0 mt -57.87 -27.34 63.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 592' ' ' LEU . 22.3 ptmt -76.79 -12.66 60.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.014 0.435 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.6 ' O ' HD21 ' A' ' 597' ' ' LEU . 41.1 t80 -83.53 -18.72 37.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.228 0.537 . . . . 0.0 109.79 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 572' ' ' HIS . . . . . 0.521 ' NE2' ' HB2' ' A' ' 632' ' ' LEU . 13.4 m-70 -76.16 -10.12 59.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.178 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.609 HG12 HG22 ' A' ' 539' ' ' VAL . 80.1 mt -115.78 119.63 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.056 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.708 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -83.83 161.96 38.75 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.902 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -90.15 3.19 54.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 576' ' ' GLU . . . . . 0.416 ' HA ' HG23 ' A' ' 536' ' ' VAL . 11.4 pt-20 -160.68 170.45 20.76 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.436 172.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.684 HG13 ' HB ' ' A' ' 536' ' ' VAL . 64.3 mt -87.9 126.2 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.207 -168.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' A' ' 589' ' ' LEU . 2.4 tt -121.51 93.51 4.03 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 20.7 m -77.65 166.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 111.81 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 580' ' ' SER . . . . . 0.627 ' HA ' HD12 ' A' ' 583' ' ' ILE . 20.9 t -62.24 -28.19 69.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.306 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.66 68.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.082 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.23 -22.54 11.58 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.035 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.866 HG22 ' HB2' ' A' ' 601' ' ' LEU . 74.0 mt -59.99 109.8 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.103 0.478 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -114.22 -154.24 11.02 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.576 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -50.92 -48.56 60.64 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.981 0.39 . . . . 0.0 110.79 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 4.1 tt -164.36 116.62 1.32 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 587' ' ' VAL . . . . . 0.443 HG13 HD11 ' A' ' 578' ' ' LEU . 7.3 p -133.67 123.96 46.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 588' ' ' ARG . . . . . 0.567 ' HD3' ' H ' ' A' ' 588' ' ' ARG . 0.1 OUTLIER -97.23 129.66 44.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.544 0.687 . . . . 0.0 110.873 -174.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.698 ' HB2' HD12 ' A' ' 578' ' ' LEU . 1.5 tm? -110.94 120.04 41.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.242 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -67.24 146.93 53.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.111 0.481 . . . . 0.0 111.286 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.708 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.1 p -106.69 -174.78 2.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.835 -176.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 570' ' ' LYS . 72.9 mt -82.03 -41.44 20.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.06 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 593' ' ' GLN . . . . . 0.518 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.7 tt0 -59.05 -29.76 67.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.126 0.489 . . . . 0.0 111.024 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 126.74 -14.16 6.76 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.573 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -89.9 -164.38 1.15 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.754 0.777 . . . . 0.0 109.601 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -120.79 137.16 54.67 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.904 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.6 HD21 ' O ' ' A' ' 571' ' ' TYR . 90.6 mt -84.57 116.16 23.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.724 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 90.2 mt-10 -85.28 89.69 7.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.293 -175.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 599' ' ' VAL . . . . . 0.493 HG12 HG23 ' A' ' 583' ' ' ILE . 47.8 t -91.04 122.23 42.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.74 0.305 . . . . 0.0 111.272 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.647 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 35.9 t -128.53 154.53 46.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.866 ' HB2' HG22 ' A' ' 583' ' ' ILE . 41.0 tp -126.07 129.07 48.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 602' ' ' LYS . . . . . 0.458 ' HE2' ' HB2' ' A' ' 602' ' ' LYS . 19.1 ttmm -146.78 102.63 3.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.734 0.302 . . . . 0.0 110.199 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 603' ' ' ASN . . . . . 0.441 ' C ' ' H ' ' A' ' 605' ' ' VAL . 18.7 t-20 58.72 56.88 3.95 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.389 -176.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 64.7 t30 68.28 -14.89 0.23 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.983 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 605' ' ' VAL . . . . . 0.441 ' H ' ' C ' ' A' ' 603' ' ' ASN . 58.7 t -82.42 110.42 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 55.9 t -79.38 136.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.837 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 607' ' ' SER . . . . . 0.647 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 36.8 m -124.23 109.42 13.38 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.948 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 11.4 p -112.95 129.14 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.424 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.661 ' ND2' HD13 ' A' ' 632' ' ' LEU . 44.0 m-20 57.86 29.43 17.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm 74.04 22.48 2.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.453 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 0.2 OUTLIER -125.95 149.08 65.05 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 5.9 Cg_exo -78.81 126.27 7.17 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.085 2.524 . . . . 0.0 112.666 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 61.2 t -77.76 136.0 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.524 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -84.74 -42.17 15.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.957 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.58 95.11 3.78 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.665 0.269 . . . . 0.0 110.731 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.99 167.15 27.68 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.437 2.091 . . . . 0.0 113.873 172.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 3.3 t70 75.15 28.95 0.98 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.721 165.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.51 86.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 619' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 63.1 mtp -78.38 148.08 33.83 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.362 0.601 . . . . 0.0 112.285 -171.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -124.17 -171.14 2.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.646 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.6 p -80.68 -19.71 44.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.748 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.495 ' OD1' HG23 ' A' ' 505' ' ' VAL . 24.4 p-10 -117.47 15.98 14.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.838 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.15 -148.34 19.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.886 -1.149 . . . . 0.0 113.085 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 624' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.7 p -132.14 147.6 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.575 0.226 . . . . 0.0 110.541 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 78.6 t -118.79 142.29 34.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.078 0.465 . . . . 0.0 110.768 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 626' ' ' HIS . . . . . 0.607 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 52.2 m-70 -130.42 126.82 37.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.413 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.923 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 96.2 t -74.47 118.29 19.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.91 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 543' ' ' THR . 1.2 pt -110.49 171.86 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.014 0.435 . . . . 0.0 110.714 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 21.6 p -117.42 -5.89 11.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.711 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -131.39 168.2 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.306 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 76.8 t -84.03 148.21 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.661 HD13 ' ND2' ' A' ' 609' ' ' ASN . 82.6 mt . . . . . 0 C--N 1.32 -0.697 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.291 -170.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.441 -0.968 0 CA-C-O 121.282 0.379 . . . . 0.0 112.454 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.477 HG22 ' OE2' ' A' ' 534' ' ' GLU . 82.0 p -86.17 -168.94 2.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.647 -0.777 . . . . 0.0 110.988 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.422 ' CG2' HG23 ' A' ' 625' ' ' VAL . 4.7 p -56.94 -27.21 26.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.614 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.557 ' HE2' ' HB2' ' A' ' 531' ' ' LEU . 39.5 tpp -71.05 -44.5 65.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.842 174.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 507' ' ' ASP . . . . . 0.669 ' HA ' ' HB3' ' A' ' 510' ' ' LYS . 5.9 t70 -68.68 -27.31 65.86 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.031 0.443 . . . . 0.0 110.198 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 504' ' ' THR . 91.4 t -50.02 -41.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.674 171.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.487 ' N ' HD23 ' A' ' 509' ' ' LEU . 0.6 OUTLIER -82.03 -36.36 27.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.887 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.679 ' HA ' HG21 ' A' ' 519' ' ' VAL . 28.7 tttm -62.5 -31.45 72.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.802 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -93.78 6.57 73.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.007 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -114.66 137.64 51.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.816 0.341 . . . . 0.0 111.007 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -75.8 -24.08 55.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.589 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -77.56 -28.89 51.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.367 0.603 . . . . 0.0 109.7 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.796 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 26.9 m-85 -105.28 14.78 28.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.877 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 34.8 p -56.45 -53.16 60.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.865 -176.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -68.42 -30.53 69.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.07 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.612 HD13 ' HZ ' ' A' ' 547' ' ' PHE . 54.7 tp -55.4 -47.5 75.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.76 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' A' ' 510' ' ' LYS . 4.0 t -52.27 -47.2 45.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.716 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.82 74.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.041 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.6 -50.2 39.66 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.283 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.58 HG12 HD13 ' A' ' 569' ' ' LEU . 42.9 mt -60.59 -31.38 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.529 0.681 . . . . 0.0 109.658 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 523' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.6 OUTLIER -59.63 -59.33 5.61 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.203 173.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.0 m -58.08 -26.83 63.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.897 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -75.09 -17.29 60.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.184 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 70.96 50.32 24.0 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.612 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 566' ' ' ALA . 76.9 mt -128.41 15.47 6.6 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 88.1 m -61.82 -51.57 67.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 529' ' ' GLU . . . . . 0.665 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 0.0 OUTLIER -60.24 -29.08 68.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.486 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 36.7 m -62.42 -47.95 81.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.962 0.41 . . . . 0.0 110.491 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.557 ' HB2' ' HE2' ' A' ' 506' ' ' MET . 67.2 mt -91.09 -5.03 55.74 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.693 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 532' ' ' ASN . . . . . 0.584 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 5.4 m-20 -83.95 -5.89 59.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.042 172.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 533' ' ' ARG . . . . . 0.665 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 80.5 mtp180 -85.65 135.41 33.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.792 0.33 . . . . 0.0 110.661 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 534' ' ' GLU . . . . . 0.477 ' OE2' HG22 ' A' ' 504' ' ' THR . 13.3 mm-40 -78.76 137.04 37.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.951 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 164.47 -117.29 0.75 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.053 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 1.089 HG23 HG13 ' A' ' 577' ' ' ILE . 0.7 OUTLIER -145.99 125.56 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.58 0.229 . . . . 0.0 110.709 -178.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -155.03 137.22 14.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.68 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 98.1 m -107.35 102.32 11.62 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.715 HG22 HG12 ' A' ' 573' ' ' ILE . 61.3 t -99.84 114.89 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.095 0.474 . . . . 0.0 111.211 -175.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 48.6 m-85 -85.77 108.39 18.06 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -100.56 119.39 58.85 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.057 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 628' ' ' ILE . 85.5 Cg_endo -82.76 140.14 10.22 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.53 2.153 . . . . 0.0 112.437 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 75.4 p -78.7 -175.93 4.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.532 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -68.94 -35.23 76.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.378 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 545' ' ' GLU . 1.7 mp0 -61.62 -29.96 70.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.064 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -70.07 -34.48 73.25 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.392 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 547' ' ' PHE . . . . . 0.612 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 21.9 m-85 -70.87 -15.9 62.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.605 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -91.46 -10.91 39.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.063 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -88.09 -2.06 58.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.362 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.77 HD12 ' HE1' ' A' ' 555' ' ' TRP . 66.5 mt -109.68 144.07 29.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.189 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 26.3 Cg_exo -62.74 126.5 18.34 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.506 2.137 . . . . 0.0 111.126 173.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.27 -24.61 60.54 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.891 2.394 . . . . 0.0 113.499 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -68.27 -40.84 81.73 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.788 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -37.84 79.68 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.677 0.751 . . . . 0.0 109.574 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 555' ' ' TRP . . . . . 0.77 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -70.35 -38.24 74.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.832 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.4 t -55.16 -28.25 51.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.574 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 557' ' ' ARG . . . . . 0.907 ' HG2' ' HG2' ' A' ' 564' ' ' GLU . 14.6 ttp85 -75.72 -32.11 59.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.817 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.496 ' HB3' ' HG ' ' A' ' 565' ' ' LEU . 9.1 mt -78.4 -53.74 6.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.056 0.455 . . . . 0.0 110.333 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 565' ' ' LEU . 1.1 mm? -70.64 -14.31 62.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.261 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -90.6 -49.01 3.3 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -105.15 114.32 28.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.103 0.477 . . . . 0.0 110.063 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.19 -33.09 73.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.214 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -62.31 -37.36 85.28 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.907 ' HG2' ' HG2' ' A' ' 557' ' ' ARG . 7.8 tp10 -69.48 -44.79 70.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.945 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -62.28 -42.02 98.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.014 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 566' ' ' ALA . . . . . 0.524 ' HA ' HD11 ' A' ' 527' ' ' LEU . . . -57.94 -38.13 75.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.363 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 567' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 564' ' ' GLU . 92.7 m-20 -57.06 -56.83 16.64 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.9 0.381 . . . . 0.0 111.077 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 50.3 mt -67.53 -50.21 63.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.486 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.58 HD13 HG12 ' A' ' 522' ' ' ILE . 83.2 mt -59.73 -23.22 63.01 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 34.7 mttp -70.89 -18.09 62.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.781 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.626 ' O ' HD21 ' A' ' 597' ' ' LEU . 35.3 t80 -92.74 -1.83 56.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.398 0.618 . . . . 0.0 110.167 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -89.58 -15.13 33.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.208 174.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.715 HG12 HG22 ' A' ' 539' ' ' VAL . 76.3 mt -111.02 121.0 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.873 -175.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -88.23 153.85 24.77 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.295 176.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.9 -21.32 64.24 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 576' ' ' GLU . . . . . 0.626 ' HA ' ' CG2' ' A' ' 536' ' ' VAL . 15.7 pt-20 -145.4 153.3 41.06 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 122.224 -0.298 . . . . 0.0 110.676 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 1.089 HG13 HG23 ' A' ' 536' ' ' VAL . 75.2 mt -70.24 114.62 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.814 -176.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.726 HD12 ' HB2' ' A' ' 589' ' ' LEU . 1.6 tt -111.4 98.96 7.85 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 583' ' ' ILE . 28.5 m -76.59 163.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.534 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 580' ' ' SER . . . . . 0.731 ' HA ' HD12 ' A' ' 583' ' ' ILE . 28.4 m -56.75 -31.13 64.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.378 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.19 -15.54 67.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.861 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.1 -10.97 40.92 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.219 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 580' ' ' SER . 71.0 mt -78.18 -3.86 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 122.876 0.47 . . . . 0.0 111.262 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -50.7 129.12 29.86 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.804 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 71.49 -85.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.796 0.838 . . . . 0.0 110.868 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.474 HD21 ' HG3' ' A' ' 598' ' ' GLU . 4.7 tt -167.55 117.56 0.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 89.6 t -132.94 130.72 58.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.941 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 588' ' ' ARG . . . . . 0.525 ' HB3' ' OE1' ' A' ' 598' ' ' GLU . 0.7 OUTLIER -96.96 128.77 44.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.577 0.703 . . . . 0.0 111.28 -178.201 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.726 ' HB2' HD12 ' A' ' 578' ' ' LEU . 31.1 tp -116.84 126.73 53.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.369 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -65.9 134.35 52.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.777 0.323 . . . . 0.0 110.373 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.644 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 86.7 p -99.24 -171.63 2.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.554 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 570' ' ' LYS . 79.3 mt -81.64 -39.05 25.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -62.54 -30.36 71.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.559 0.695 . . . . 0.0 110.263 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.44 -17.46 6.96 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.503 170.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 595' ' ' ASP . . . . . 0.497 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.3 t70 -84.12 -176.77 6.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.461 0.631 . . . . 0.0 109.705 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.21 139.56 39.69 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.871 0.367 . . . . 0.0 110.693 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.626 HD21 ' O ' ' A' ' 571' ' ' TYR . 94.9 mt -81.97 115.52 21.17 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.525 ' OE1' ' HB3' ' A' ' 588' ' ' ARG . 2.3 tp10 -94.07 87.28 5.26 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 599' ' ' VAL . . . . . 0.639 HG22 HG23 ' A' ' 608' ' ' VAL . 2.0 t -99.12 128.16 51.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.007 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' A' ' 606' ' ' VAL . 33.1 t -131.29 108.5 9.71 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.365 -174.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 606' ' ' VAL . 56.8 tp -108.16 116.09 31.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.825 0.345 . . . . 0.0 110.442 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -151.37 133.63 15.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.678 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 58.58 40.56 23.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.598 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 66.15 11.87 8.14 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.597 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.84 107.47 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.022 0.439 . . . . 0.0 110.223 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 613' ' ' VAL . 1.4 p -98.14 137.84 24.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.668 176.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 50.3 m -132.19 120.57 22.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 599' ' ' VAL . 7.6 p -110.27 123.65 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.067 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.706 ' ND2' HD13 ' A' ' 632' ' ' LEU . 24.0 m-20 61.38 33.88 18.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.468 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 610' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 48.5 mtpt 83.31 -14.19 0.73 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.32 1.012 . . . . 0.0 112.03 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 34.0 mm-40 -96.72 122.59 56.57 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.811 0.339 . . . . 0.0 110.547 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 23.7 Cg_exo -63.83 133.71 40.26 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.851 2.367 . . . . 0.0 112.499 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.915 ' HB ' HG13 ' A' ' 606' ' ' VAL . 44.4 t -88.8 137.46 21.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -87.09 -60.61 1.93 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.397 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 615' ' ' GLU . . . . . 0.451 ' H ' ' HB ' ' A' ' 627' ' ' VAL . 16.5 mp0 -128.23 92.44 41.49 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.618 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.28 167.72 26.59 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.606 2.204 . . . . 0.0 113.219 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 74.88 38.28 0.46 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.463 0.705 . . . . 0.0 112.827 166.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 34.0 mt -98.11 89.9 2.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 171.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 619' ' ' MET . . . . . 0.602 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 53.0 mtp -82.44 160.46 22.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.542 0.686 . . . . 0.0 112.499 -169.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 620' ' ' ALA . . . . . 0.415 ' HB2' HG21 ' A' ' 508' ' ' VAL . . . -130.95 -171.17 2.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.446 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 26.0 p -72.93 -37.11 67.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.181 0.515 . . . . 0.0 110.811 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.46 ' HB3' ' OE2' ' A' ' 534' ' ' GLU . 33.4 p-10 -109.95 13.41 23.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.172 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 165.3 -138.1 5.05 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.193 -1.479 . . . . 0.0 113.927 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 624' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 10.1 p -160.13 148.74 6.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.727 -171.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 625' ' ' VAL . . . . . 0.422 HG23 ' CG2' ' A' ' 505' ' ' VAL . 47.8 t -119.49 139.99 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.296 0.57 . . . . 0.0 110.968 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 626' ' ' HIS . . . . . 0.548 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 60.9 m-70 -127.52 117.85 22.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.796 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 58.1 t -72.34 119.0 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -173.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 542' ' ' PRO . 0.6 OUTLIER -114.31 150.0 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.074 0.464 . . . . 0.0 110.733 173.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 18.1 p -96.82 6.84 47.9 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.924 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -138.67 155.21 48.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.953 0.406 . . . . 0.0 111.489 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 60.4 t -86.99 157.21 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.706 HD13 ' ND2' ' A' ' 609' ' ' ASN . 38.2 mt . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 120.724 0.297 . . . . 0.0 110.899 -167.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.619 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 508' ' ' VAL . 68.7 p -124.91 -170.48 2.17 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.691 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 54.8 t -42.54 -42.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.638 0.586 . . . . 0.0 110.727 168.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -48.9 79.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.261 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -71.54 -28.32 63.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.816 0.341 . . . . 0.0 110.456 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 504' ' ' THR . 71.5 t -53.98 -42.7 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.588 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 4.8 mt -82.18 -33.18 29.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.162 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.514 ' HA ' HG21 ' A' ' 519' ' ' VAL . 1.9 tmmm? -59.9 -40.02 87.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.991 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -89.13 -2.81 76.96 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.785 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.35 144.98 30.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.645 0.723 . . . . 0.0 110.811 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -75.25 -35.0 61.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.578 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -78.43 -13.37 59.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.881 0.372 . . . . 0.0 110.445 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.621 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 24.1 m-85 -113.41 9.63 18.19 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.003 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 64.5 m -58.54 -44.53 89.65 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -173.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.0 ptm -83.24 -20.15 35.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.701 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.57 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 46.9 tp -57.95 -41.67 83.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.38 0.609 . . . . 0.0 109.462 172.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 510' ' ' LYS . 18.6 t -52.04 -52.97 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.666 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -60.32 -32.84 71.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.6 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.11 -49.87 46.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.951 0.405 . . . . 0.0 110.508 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 527' ' ' LEU . 58.6 mt -59.42 -34.2 53.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.486 0.66 . . . . 0.0 109.953 175.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -66.56 -49.51 66.16 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.924 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.3 m -57.12 -34.27 68.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.378 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.945 ' HB2' HD22 ' A' ' 565' ' ' LEU . . . -78.18 -17.97 56.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.142 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 74.58 18.62 79.99 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.005 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 527' ' ' LEU . . . . . 0.464 ' HB2' HG23 ' A' ' 522' ' ' ILE . 93.3 mt -84.6 5.83 26.31 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.547 -0.384 . . . . 0.0 111.466 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 19.0 m -56.76 -44.13 81.48 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.097 0.475 . . . . 0.0 109.954 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -53.99 -35.23 61.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.029 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 8.3 m -69.49 -36.76 76.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 111.447 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 97.2 mt -96.3 -27.41 14.99 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -173.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -84.58 23.27 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -118.46 152.42 35.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.815 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -69.77 115.68 9.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -178.13 -163.78 30.23 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.68 ' HB ' HG13 ' A' ' 577' ' ' ILE . 20.8 m -119.52 127.93 75.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 537' ' ' TYR . . . . . 0.512 ' O ' ' HA3' ' A' ' 623' ' ' GLY . 96.5 m-85 -148.54 140.6 23.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.795 0.331 . . . . 0.0 110.683 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 93.5 m -113.74 101.58 9.43 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 170.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.575 HG21 HG11 ' A' ' 505' ' ' VAL . 56.6 t -101.41 119.78 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.419 -174.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.631 ' CD2' HG11 ' A' ' 608' ' ' VAL . 51.5 m-85 -86.43 111.98 21.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -106.99 112.88 63.07 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.705 -167.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.767 ' HA ' HG13 ' A' ' 628' ' ' ILE . 3.3 Cg_exo -79.7 143.21 16.59 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.243 2.628 . . . . 0.0 112.709 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 68.9 p -85.73 -177.44 6.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.585 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -67.86 -25.57 65.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.767 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -71.13 -22.03 62.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.548 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -83.67 -34.62 24.95 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.059 0.457 . . . . 0.0 111.467 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 547' ' ' PHE . . . . . 0.504 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 5.0 m-85 -68.55 -13.98 62.7 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -93.57 -17.11 23.7 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.615 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -82.8 -13.03 56.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.019 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.577 HD12 ' HE1' ' A' ' 555' ' ' TRP . 46.4 mt -101.63 133.64 20.68 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.8 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 551' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.8 135.28 67.09 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.384 2.056 . . . . 0.0 110.925 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.54 -33.56 23.91 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.199 2.599 . . . . 0.0 113.579 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 553' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 553' ' ' ARG . 11.4 ptt180 -60.24 -36.24 77.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.656 0.265 . . . . 0.0 111.388 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 557' ' ' ARG . 0.4 OUTLIER -72.72 -40.84 65.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.92 0.39 . . . . 0.0 110.777 -175.495 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 555' ' ' TRP . . . . . 0.577 ' HE1' HD12 ' A' ' 550' ' ' LEU . 1.1 m95 -80.69 -29.04 36.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.227 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 37.5 t -57.03 -29.65 63.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.332 168.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 557' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 554' ' ' GLU . 50.0 mtt180 -75.52 -40.04 57.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.206 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.516 ' HG ' ' HA ' ' A' ' 555' ' ' TRP . 5.3 mt -75.77 -54.66 6.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.882 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 559' ' ' LEU . 0.2 OUTLIER -64.36 -14.21 55.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.666 0.269 . . . . 0.0 111.583 178.19 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -98.65 -21.53 16.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.46 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 561' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 25.9 t70 -135.75 118.77 16.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.081 0.467 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.78 68.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.792 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.47 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 5.1 tmtm? -59.63 -43.32 93.88 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.096 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 567' ' ' ASN . 8.2 tp10 -75.76 -34.81 60.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.554 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.945 HD22 ' HB2' ' A' ' 525' ' ' ALA . 5.6 tt -68.57 -45.27 72.5 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.11 0.481 . . . . 0.0 109.759 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -64.2 -30.36 71.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.518 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 567' ' ' ASN . . . . . 0.639 ' HA ' ' OE1' ' A' ' 593' ' ' GLN . 39.0 t30 -55.93 -45.03 78.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.439 0.638 . . . . 0.0 110.506 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 60.6 mt -85.85 -62.53 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.442 -178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.45 HD11 HG12 ' A' ' 522' ' ' ILE . 3.2 tt -55.12 -35.76 65.0 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.548 ' HG2' ' HB2' ' A' ' 592' ' ' LEU . 19.7 ttpp -72.25 -12.34 61.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.62 ' O ' HD21 ' A' ' 597' ' ' LEU . 41.7 t80 -89.28 -18.71 26.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.589 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 572' ' ' HIS . . . . . 0.475 ' NE2' HG23 ' A' ' 631' ' ' VAL . 2.0 m-70 -73.3 -14.12 61.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.309 0.575 . . . . 0.0 109.91 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.538 HG12 HG22 ' A' ' 539' ' ' VAL . 61.2 mt -101.81 121.78 53.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.839 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.67 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -84.74 164.18 39.1 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.873 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.03 -33.35 75.6 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.171 0.588 . . . . 0.0 112.072 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 576' ' ' GLU . . . . . 0.469 ' HA ' HG23 ' A' ' 536' ' ' VAL . 13.6 pt-20 -146.37 -178.29 6.08 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.191 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.731 HG23 HG22 ' A' ' 624' ' ' VAL . 14.9 mt -82.28 110.56 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 123.395 0.434 . . . . 0.0 111.114 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 578' ' ' LEU . 1.2 tm? -117.67 94.54 4.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 27.5 m -81.96 172.18 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.473 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 580' ' ' SER . . . . . 0.562 ' HA ' HD12 ' A' ' 583' ' ' ILE . 15.8 m -63.03 -20.4 65.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.472 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.01 -13.14 63.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.437 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -103.55 -20.07 11.4 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 580' ' ' SER . 76.5 mt -74.85 90.12 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.202 0.525 . . . . 0.0 110.396 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -102.83 -123.98 5.37 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.876 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -66.5 -57.94 6.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.073 0.463 . . . . 0.0 110.23 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 55.0 tp -156.86 114.42 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.644 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 10.1 p -132.18 132.29 60.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 120.945 0.402 . . . . 0.0 110.126 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 588' ' ' ARG . . . . . 0.71 ' HG2' ' HA ' ' A' ' 598' ' ' GLU . 40.0 mtp180 -112.5 127.09 55.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.33 0.586 . . . . 0.0 110.899 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.61 126.83 55.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.912 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 3.7 tmmt? -62.95 140.77 58.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.67 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.8 p -103.6 -174.52 2.56 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.744 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.548 ' HB2' ' HG2' ' A' ' 570' ' ' LYS . 78.9 mt -81.56 -42.26 20.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.89 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 593' ' ' GLN . . . . . 0.639 ' OE1' ' HA ' ' A' ' 567' ' ' ASN . 20.4 tp60 -61.64 -29.26 69.95 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 127.18 11.7 3.37 Favored Glycine 0 C--N 1.321 -0.267 0 C-N-CA 120.028 -1.082 . . . . 0.0 114.521 166.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -117.43 -156.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -135.46 130.81 35.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.214 0.53 . . . . 0.0 111.922 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 588' ' ' ARG . 92.7 mt -68.6 122.33 18.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.851 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.71 ' HA ' ' HG2' ' A' ' 588' ' ' ARG . 30.0 tt0 -86.35 94.46 9.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 599' ' ' VAL . . . . . 0.451 HG12 HG23 ' A' ' 583' ' ' ILE . 36.1 t -105.52 133.82 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.802 -175.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 606' ' ' VAL . 7.7 p -140.5 161.84 36.76 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.748 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.473 ' HB2' HG22 ' A' ' 583' ' ' ILE . 67.6 tp -127.46 113.26 15.94 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -136.84 126.21 24.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.443 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 60.6 t30 54.59 44.05 29.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.344 0.593 . . . . 0.0 110.546 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 65.3 t30 70.44 -0.39 2.9 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.355 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.76 119.68 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.489 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.788 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 25.9 t -77.59 148.48 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 607' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 611' ' ' GLU . 49.1 m -140.21 112.32 7.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.065 0.46 . . . . 0.0 111.968 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.631 HG11 ' CD2' ' A' ' 540' ' ' PHE . 7.5 p -117.17 135.71 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.156 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 1.061 ' HB2' HD23 ' A' ' 632' ' ' LEU . 77.1 m-20 53.58 33.18 15.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.177 0.513 . . . . 0.0 110.397 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt 77.22 9.09 2.71 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.373 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 608' ' ' VAL . 0.3 OUTLIER -113.97 149.65 42.24 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.433 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 1.4 Cg_endo -85.98 124.84 2.61 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.986 2.457 . . . . 0.0 113.161 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.788 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 49.9 t -76.19 143.94 12.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.383 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 614' ' ' ALA . . . . . 0.567 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -89.98 -43.98 10.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.415 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 615' ' ' GLU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 21.9 tt0 -151.06 92.07 3.86 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 120.971 0.415 . . . . 0.0 111.787 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 616' ' ' PRO . . . . . 0.524 ' HG3' HG21 ' A' ' 606' ' ' VAL . 83.1 Cg_endo -76.28 169.45 21.97 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.914 2.409 . . . . 0.0 114.124 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 74.47 27.92 1.35 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.693 -1.139 . . . . 0.0 113.15 166.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 618' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 627' ' ' VAL . 45.0 mt -87.33 91.84 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 170.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 619' ' ' MET . . . . . 0.717 ' HG2' HG13 ' A' ' 624' ' ' VAL . 51.7 mtp -80.18 128.97 34.14 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.585 0.707 . . . . 0.0 112.176 -170.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -100.73 166.92 10.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.341 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -15.13 53.98 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.512 ' OD1' HG23 ' A' ' 505' ' ' VAL . 25.2 p-10 -116.62 15.51 15.51 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 623' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 537' ' ' TYR . . . 147.03 -133.51 4.81 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 119.765 -1.207 . . . . 0.0 113.455 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 624' ' ' VAL . . . . . 0.731 HG22 HG23 ' A' ' 577' ' ' ILE . 0.0 OUTLIER -129.32 152.7 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.109 0.481 . . . . 0.0 111.597 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 625' ' ' VAL . . . . . 0.513 HG22 HG13 ' A' ' 505' ' ' VAL . 43.7 t -122.65 131.14 73.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.586 170.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 626' ' ' HIS . . . . . 0.506 ' HB2' ' CD2' ' A' ' 540' ' ' PHE . 77.6 m-70 -120.14 110.56 16.77 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.18 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.621 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 98.9 t -66.93 118.39 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.691 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.767 HG13 ' HA ' ' A' ' 542' ' ' PRO . 5.1 pt -115.77 143.97 24.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.616 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 629' ' ' THR . . . . . 0.567 HG23 ' HB2' ' A' ' 614' ' ' ALA . 24.5 p -94.73 1.4 55.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.797 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 630' ' ' ASN . . . . . 0.462 ' ND2' ' HD2' ' A' ' 612' ' ' PRO . 6.5 m-80 -135.92 135.9 40.02 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.898 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.475 HG23 ' NE2' ' A' ' 572' ' ' HIS . 0.2 OUTLIER -90.3 147.18 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 172.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 1.061 HD23 ' HB2' ' A' ' 609' ' ' ASN . 1.5 mp . . . . . 0 N--CA 1.437 -1.079 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.12 -158.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.443 -0.86 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.439 ' HA ' HG22 ' A' ' 621' ' ' THR . 76.4 p -88.2 -171.67 3.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.838 175.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.579 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 93.5 t -45.16 -46.15 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 123.35 0.406 . . . . 0.0 111.33 174.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.74 ' SD ' ' HB2' ' A' ' 531' ' ' LEU . 0.0 OUTLIER -60.64 -38.11 83.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.886 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 507' ' ' ASP . . . . . 0.538 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 16.9 t70 -68.19 -38.52 82.09 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 505' ' ' VAL . 96.0 t -53.1 -40.42 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.421 176.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 8.1 mt -77.7 -20.38 53.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.099 -174.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -83.32 -26.24 30.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.162 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -89.38 -0.7 79.44 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.105 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -122.26 141.18 51.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.996 0.398 . . . . 0.0 111.441 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -75.5 -22.59 57.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.102 -177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -73.52 -20.24 60.71 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 110.374 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.726 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 15.9 m-85 -114.74 19.2 16.14 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.788 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 32.9 t -59.05 -57.31 13.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.75 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -64.5 -30.09 71.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.933 0.397 . . . . 0.0 110.237 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.563 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 57.8 tp -53.85 -45.43 70.92 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.873 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 515' ' ' PHE . 14.8 t -50.94 -51.32 21.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.856 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.42 82.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.143 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -65.53 -51.18 61.8 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.42 . . . . 0.0 109.871 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.542 HG21 ' HE3' ' A' ' 506' ' ' MET . 96.6 mt -56.76 -33.63 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.698 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -38.82 92.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.427 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 22.3 m -66.43 -22.22 66.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.035 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -89.51 -30.0 18.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.613 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.41 67.4 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 114.489 0.556 . . . . 0.0 114.489 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 2.0 pp -82.48 24.68 0.68 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.973 0.887 . . . . 0.0 112.531 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.471 HG23 ' HG2' ' A' ' 506' ' ' MET . 58.5 m -57.98 -42.06 84.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.414 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.44 -30.7 65.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.974 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 85.1 m -58.9 -48.61 80.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.802 0.334 . . . . 0.0 111.273 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.74 ' HB2' ' SD ' ' A' ' 506' ' ' MET . 82.9 mt -96.95 -1.22 46.15 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.214 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 532' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 528' ' ' THR . 2.1 t-20 -81.29 -19.01 43.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.964 0.412 . . . . 0.0 110.976 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 533' ' ' ARG . . . . . 0.453 ' HG2' ' H ' ' A' ' 534' ' ' GLU . 33.0 ttt180 -104.06 168.33 9.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.868 0.366 . . . . 0.0 111.238 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 534' ' ' GLU . . . . . 0.453 ' H ' ' HG2' ' A' ' 533' ' ' ARG . 10.7 tp10 -58.02 147.73 28.43 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.407 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 154.85 -178.3 31.64 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.707 ' HB ' HG13 ' A' ' 577' ' ' ILE . 14.9 m -116.85 126.45 74.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -149.7 142.81 24.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.067 0.461 . . . . 0.0 110.884 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 97.9 m -112.23 110.41 20.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.655 HG22 HG12 ' A' ' 573' ' ' ILE . 65.0 t -109.29 114.94 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 120.879 0.371 . . . . 0.0 111.031 -175.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.63 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 80.4 m-85 -86.33 109.79 19.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -101.7 118.74 58.98 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.528 -166.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.51 140.06 18.76 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.63 2.22 . . . . 0.0 111.778 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 69.5 p -78.8 -177.81 5.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.146 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 544' ' ' ASN . . . . . 0.545 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -73.58 -26.67 60.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.148 0.499 . . . . 0.0 110.152 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 548' ' ' ARG . 1.7 mp0 -68.36 -23.84 64.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.145 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -74.97 -31.37 61.44 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.883 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 547' ' ' PHE . . . . . 0.545 ' CD2' ' HA ' ' A' ' 544' ' ' ASN . 22.9 m-85 -65.64 -14.53 61.38 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 548' ' ' ARG . . . . . 0.641 ' HA ' ' HE ' ' A' ' 548' ' ' ARG . 3.3 mmp_? -93.93 -1.44 54.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.487 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -98.67 -11.38 22.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.769 HD12 ' HE1' ' A' ' 555' ' ' TRP . 32.5 mt -98.92 136.81 20.5 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.322 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 4.7 Cg_exo -74.8 140.25 25.83 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.884 2.389 . . . . 0.0 111.379 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 552' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 52.7 Cg_exo -57.57 -16.8 25.52 Favored 'Trans proline' 0 C--O 1.224 -0.187 0 C-N-CA 123.043 2.495 . . . . 0.0 112.397 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -53.33 -46.76 69.6 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.768 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 27.4 mm-40 -87.07 -40.5 14.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.239 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 555' ' ' TRP . . . . . 0.769 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.1 OUTLIER -62.26 -38.13 88.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.738 -173.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 24.4 t -52.24 -33.02 39.59 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.579 0.55 . . . . 0.0 111.195 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 -83.95 -37.0 22.85 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 120.531 0.205 . . . . 0.0 110.611 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.862 ' HB3' HD13 ' A' ' 565' ' ' LEU . 41.4 mt -64.78 -49.36 71.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.762 0.315 . . . . 0.0 111.336 -175.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.45 1.98 14.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.872 0.367 . . . . 0.0 111.316 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -108.47 -48.09 0.88 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.879 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -104.11 126.79 51.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.966 0.413 . . . . 0.0 109.906 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.64 66.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.268 -170.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 566' ' ' ALA . 0.0 OUTLIER -79.68 -20.88 45.54 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.295 -177.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.13 -38.82 69.19 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.022 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.862 HD13 ' HB3' ' A' ' 558' ' ' LEU . 18.1 tp -71.41 -41.43 69.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 566' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 563' ' ' LYS . . . -59.54 -40.55 87.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.15 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -55.08 -44.53 74.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 632' ' ' LEU . 63.3 mt -72.29 -45.45 61.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.493 HD13 HG12 ' A' ' 522' ' ' ILE . 89.5 mt -64.65 -25.55 68.0 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 97.3 mttt -74.13 -13.72 60.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.69 0.281 . . . . 0.0 111.44 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.557 ' O ' HD21 ' A' ' 597' ' ' LEU . 57.6 t80 -91.51 -18.46 24.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.089 0.471 . . . . 0.0 110.03 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 572' ' ' HIS . . . . . 0.443 ' CE1' ' H ' ' A' ' 632' ' ' LEU . 13.0 m-70 -74.84 -13.08 60.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.655 HG12 HG22 ' A' ' 539' ' ' VAL . 55.5 mt -109.3 137.91 39.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.857 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -106.67 164.45 13.39 Favored Glycine 0 CA--C 1.516 0.156 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 172.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.61 -10.23 59.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.246 0.523 . . . . 0.0 112.407 -171.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 576' ' ' GLU . . . . . 0.418 ' HG2' HD21 ' A' ' 589' ' ' LEU . 11.3 pt-20 -144.46 169.86 17.15 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 122.502 -0.123 . . . . 0.0 110.811 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.707 HG13 ' HB ' ' A' ' 536' ' ' VAL . 8.3 mt -88.03 122.99 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.635 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 56.0 tp -126.92 93.7 3.83 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.645 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.17 179.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.036 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 10.9 m -62.25 -23.42 66.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.902 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.58 -17.47 72.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.566 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.26 -34.14 4.91 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.927 HG22 ' HB2' ' A' ' 601' ' ' LEU . 77.7 mt -62.52 99.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 122.968 0.507 . . . . 0.0 110.031 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 584' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . -121.05 -73.16 0.32 Allowed Glycine 0 C--O 1.226 -0.367 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.87 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -98.82 -82.25 0.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.839 0.352 . . . . 0.0 110.332 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 5.2 tt -155.18 117.42 4.19 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.49 133.68 67.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.492 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -105.38 110.0 22.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.82 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.418 HD21 ' HG2' ' A' ' 576' ' ' GLU . 0.9 OUTLIER -106.72 127.66 53.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -175.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -71.87 147.28 47.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.873 0.368 . . . . 0.0 110.091 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.479 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 85.8 p -108.98 -178.1 3.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.971 0.415 . . . . 0.0 110.443 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.632 HD23 ' HB ' ' A' ' 573' ' ' ILE . 1.6 mm? -73.62 -37.82 65.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.837 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -64.18 -31.46 72.67 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.459 0.647 . . . . 0.0 110.085 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.29 -17.82 6.98 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.889 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 595' ' ' ASP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 4.3 t70 -85.6 -165.84 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.975 0.888 . . . . 0.0 110.563 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -115.74 134.18 55.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.19 0.519 . . . . 0.0 111.746 -171.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.557 HD21 ' O ' ' A' ' 571' ' ' TYR . 87.1 mt -90.93 115.34 27.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 39.6 mt-10 -92.9 101.02 13.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.244 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 599' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 607' ' ' SER . 39.7 t -108.29 130.87 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 123.353 0.408 . . . . 0.0 111.345 -175.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.558 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 22.7 t -134.0 157.93 44.82 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.35 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.927 ' HB2' HG22 ' A' ' 583' ' ' ILE . 55.7 tp -128.92 118.78 23.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 172.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 602' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 602' ' ' LYS . 22.7 tptp -152.28 129.9 11.52 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.17 176.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 58.86 33.29 22.96 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.417 0.448 . . . . 0.0 110.57 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 65.5 t30 75.58 -2.55 2.77 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.384 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.61 113.94 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.104 0.478 . . . . 0.0 110.864 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.453 HG13 HG21 ' A' ' 583' ' ' ILE . 61.5 t -77.47 134.12 29.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.446 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 607' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 15.9 m -120.52 105.91 11.29 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.599 HG22 ' OD1' ' A' ' 609' ' ' ASN . 12.6 p -111.03 139.79 33.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.599 ' OD1' HG22 ' A' ' 608' ' ' VAL . 3.1 m120 58.36 25.61 13.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 610' ' ' LYS . . . . . 0.536 ' NZ ' ' HB2' ' A' ' 610' ' ' LYS . 3.7 ttmp? 69.58 22.59 6.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.946 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -130.96 147.5 66.54 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 121.079 0.466 . . . . 0.0 109.952 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -60.76 128.8 26.78 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.55 2.833 . . . . 0.0 113.85 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.558 HG22 HG12 ' A' ' 608' ' ' VAL . 47.8 t -81.47 143.19 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 172.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -79.25 -61.38 2.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.38 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 615' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 616' ' ' PRO . 3.1 mt-10 -139.41 100.87 7.55 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 616' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 615' ' ' GLU . 74.1 Cg_endo -72.27 162.51 41.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.846 2.364 . . . . 0.0 114.15 174.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 74.89 45.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.533 164.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 34.9 mt -96.03 87.2 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 165.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 619' ' ' MET . . . . . 0.525 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 49.9 mtp -76.5 146.19 38.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.519 0.675 . . . . 0.0 112.575 -171.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.48 -171.51 1.85 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.549 -1.205 . . . . 0.0 107.928 172.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 504' ' ' THR . 12.6 t -82.69 -15.71 50.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.863 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.473 ' OD1' HG23 ' A' ' 505' ' ' VAL . 27.9 p-10 -118.72 19.3 13.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.944 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.57 -148.38 19.35 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.69 -1.243 . . . . 0.0 112.993 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 624' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 15.0 p -139.31 146.35 25.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.916 0.389 . . . . 0.0 111.093 -175.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 69.9 t -115.34 139.96 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.65 176.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 626' ' ' HIS . . . . . 0.63 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 67.0 m-70 -125.59 126.99 45.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.251 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.726 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 91.6 t -77.19 119.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -174.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.2 153.0 16.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.038 0.447 . . . . 0.0 110.447 172.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 20.8 p -100.68 3.86 42.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -130.2 152.47 49.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.853 0.359 . . . . 0.0 110.137 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.47 ' HB ' HD11 ' A' ' 550' ' ' LEU . 43.6 t -87.82 151.77 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 172.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.578 HD13 ' ND2' ' A' ' 609' ' ' ASN . 36.8 mt . . . . . 0 C--N 1.318 -0.761 0 CA-C-O 120.906 0.384 . . . . 0.0 110.741 -168.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 CA-C-O 121.303 0.391 . . . . 0.0 112.9 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.506 ' HA ' HG22 ' A' ' 621' ' ' THR . 68.6 p -92.74 -170.02 2.34 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.282 -0.459 . . . . 0.0 110.497 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.604 ' O ' HD13 ' A' ' 509' ' ' LEU . 94.6 t -43.87 -41.26 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.084 169.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 39.7 tpp -60.02 -46.06 90.76 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.148 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.16 -42.32 99.15 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.949 0.404 . . . . 0.0 110.412 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 620' ' ' ALA . 91.2 t -52.82 -46.98 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.266 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.604 HD13 ' O ' ' A' ' 505' ' ' VAL . 3.2 mp -75.67 -37.28 59.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.065 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.578 ' HA ' HG21 ' A' ' 519' ' ' VAL . 64.2 tttp -71.75 -29.9 65.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.957 0.408 . . . . 0.0 111.023 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -84.86 -10.25 79.29 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.726 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 512' ' ' ASP . . . . . 0.74 ' OD1' ' HG2' ' A' ' 514' ' ' ARG . 34.1 t0 -98.95 134.36 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.241 0.543 . . . . 0.0 110.782 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.41 -35.05 79.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.284 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 514' ' ' ARG . . . . . 0.74 ' HG2' ' OD1' ' A' ' 512' ' ' ASP . 23.7 ptt180 -83.08 -8.92 59.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.249 -173.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.876 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 23.3 m-85 -116.27 13.0 15.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.943 0.401 . . . . 0.0 110.445 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 25.6 p -57.91 -49.57 76.29 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.272 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -69.4 -31.79 70.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.046 0.45 . . . . 0.0 110.113 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.568 HD13 ' HZ ' ' A' ' 547' ' ' PHE . 56.8 tp -54.57 -47.04 73.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.573 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 510' ' ' LYS . 6.5 t -50.57 -48.66 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.043 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 520' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 523' ' ' GLN . . . -63.64 -30.95 71.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.021 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.67 51.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.077 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.845 HG12 HD21 ' A' ' 569' ' ' LEU . 35.7 mt -57.1 -38.21 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.484 0.659 . . . . 0.0 109.612 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 523' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' A' ' 520' ' ' ALA . 18.5 tp60 -58.52 -58.91 6.47 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.281 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.0 m -58.81 -23.44 60.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.754 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -86.13 -13.69 46.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.179 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 75.14 12.46 83.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.758 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 527' ' ' LEU . . . . . 0.667 HD12 HD23 ' A' ' 569' ' ' LEU . 78.5 mt -86.27 13.66 7.7 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.541 -0.388 . . . . 0.0 111.516 -176.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 532' ' ' ASN . 36.7 m -55.57 -47.49 76.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 529' ' ' GLU . . . . . 0.673 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 12.7 pt-20 -69.2 -16.52 63.63 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.336 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 32.4 m -82.16 -44.67 16.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.623 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 531' ' ' LEU . 27.2 mt -82.47 -20.02 37.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.712 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 532' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 528' ' ' THR . 16.6 m-20 -91.01 22.89 3.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.003 0.43 . . . . 0.0 111.122 175.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 533' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 11.7 mmt180 -103.15 163.86 11.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.551 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.09 153.76 17.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.183 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 137.9 -138.87 9.93 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.887 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.726 ' HB ' HG12 ' A' ' 577' ' ' ILE . 17.8 m -129.08 127.59 66.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -144.81 128.9 17.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.216 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 87.1 m -106.77 100.25 9.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 170.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.619 HG22 HG12 ' A' ' 573' ' ' ILE . 90.4 t -101.9 116.65 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.18 -173.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.575 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 54.2 m-85 -86.41 111.07 20.17 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 172.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -98.4 115.15 65.85 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.698 -168.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.0 134.4 11.72 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.652 2.235 . . . . 0.0 111.181 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 71.4 p -75.95 -179.45 4.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.279 0.561 . . . . 0.0 111.595 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -74.0 -16.76 61.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.796 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 548' ' ' ARG . 39.0 tt0 -76.66 -25.85 54.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.792 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.417 ' HB1' ' N ' ' A' ' 631' ' ' VAL . . . -72.18 -42.36 65.96 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.568 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 547' ' ' PHE . . . . . 0.568 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 9.1 m-85 -67.27 -13.91 62.42 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.647 0.737 . . . . 0.0 109.315 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 548' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 545' ' ' GLU . 37.1 ttm180 -90.22 -10.53 44.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.325 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -97.47 -29.04 13.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.107 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.49 HD13 HG13 ' A' ' 631' ' ' VAL . 7.2 mp -78.67 140.58 59.3 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.018 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.416 ' HG2' ' CB ' ' A' ' 554' ' ' GLU . 23.1 Cg_endo -63.3 134.21 44.19 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.655 2.237 . . . . 0.0 112.052 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.66 -41.24 46.01 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.163 2.575 . . . . 0.0 112.534 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 553' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 557' ' ' ARG . 40.0 ttm180 -57.32 -47.86 80.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.707 0.289 . . . . 0.0 110.751 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.416 ' CB ' ' HG2' ' A' ' 551' ' ' PRO . 41.3 tt0 -66.88 -46.25 75.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.098 0.475 . . . . 0.0 110.602 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 555' ' ' TRP . . . . . 0.438 ' CZ2' ' CD1' ' A' ' 547' ' ' PHE . 0.0 OUTLIER -72.44 -42.21 65.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.351 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 51.0 p -55.6 -26.15 42.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.564 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 557' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 553' ' ' ARG . 1.8 mmp_? -71.72 -35.57 70.24 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.669 HD22 HG13 ' A' ' 568' ' ' ILE . 16.0 mt -68.64 -50.29 52.43 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.25 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.604 HD22 HD22 ' A' ' 565' ' ' LEU . 0.5 OUTLIER -70.25 0.98 5.36 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 178.013 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -78.03 -46.37 9.41 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.082 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 561' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 564' ' ' GLU . 32.1 t70 -125.24 142.65 51.37 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -72.46 -39.88 67.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.014 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.551 ' H ' ' HD2' ' A' ' 563' ' ' LYS . 0.0 OUTLIER -66.16 -35.78 81.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.65 -178.43 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.426 ' HG2' ' OD2' ' A' ' 561' ' ' ASP . 8.1 mm-40 -74.97 -39.99 60.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.728 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.604 HD22 HD22 ' A' ' 559' ' ' LEU . 39.1 tp -65.32 -43.97 89.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.38 74.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.358 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -53.64 -51.6 62.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.173 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.669 HG13 HD22 ' A' ' 558' ' ' LEU . 24.2 mm -67.07 -52.77 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.845 HD21 HG12 ' A' ' 522' ' ' ILE . 26.7 tp -58.75 -24.56 61.86 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.97 -177.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 87.9 mttt -70.37 -18.08 63.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 0.0 111.627 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 37.5 t80 -89.77 10.08 24.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.992 0.901 . . . . 0.0 109.485 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -103.78 -15.26 15.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.177 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.619 HG12 HG22 ' A' ' 539' ' ' VAL . 64.5 mt -109.89 115.89 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.882 -175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.643 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -83.28 150.52 27.39 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.112 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -67.48 -21.7 65.5 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 576' ' ' GLU . . . . . 0.633 ' HG2' HD21 ' A' ' 589' ' ' LEU . 15.9 pt-20 -129.35 -178.32 4.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.596 -173.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.726 HG12 ' HB ' ' A' ' 536' ' ' VAL . 48.4 mm -96.16 110.38 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.504 174.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.532 HD21 HG13 ' A' ' 587' ' ' VAL . 57.5 tp -113.32 93.18 4.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.489 HG13 HG22 ' A' ' 577' ' ' ILE . 21.3 m -79.15 168.53 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.689 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 580' ' ' SER . . . . . 0.611 ' HA ' HD12 ' A' ' 583' ' ' ILE . 3.5 m -53.16 -32.73 49.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.835 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.62 -17.88 71.42 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.175 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -95.76 -15.47 42.77 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.968 HG22 ' HB2' ' A' ' 601' ' ' LEU . 57.6 mt -75.54 119.59 23.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 584' ' ' GLY . . . . . 0.601 ' HA2' ' HB3' ' A' ' 601' ' ' LEU . . . -168.22 125.35 1.28 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 62.51 -82.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 O-C-N 124.168 0.569 . . . . 0.0 110.562 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 6.4 tt -163.27 117.24 1.61 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 587' ' ' VAL . . . . . 0.532 HG13 HD21 ' A' ' 578' ' ' LEU . 6.8 p -128.75 139.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -100.74 135.75 41.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.301 0.572 . . . . 0.0 111.585 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.633 HD21 ' HG2' ' A' ' 576' ' ' GLU . 1.0 OUTLIER -126.7 115.55 19.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.36 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -64.47 128.08 34.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 110.811 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.643 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 89.9 p -95.6 -173.53 2.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.537 -177.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 60.2 mt -76.69 -38.96 53.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 593' ' ' GLN . . . . . 0.415 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.4 tt0 -61.21 -30.55 70.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.456 0.645 . . . . 0.0 110.501 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.95 -19.51 6.5 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.477 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 595' ' ' ASP . . . . . 0.521 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.7 t70 -84.6 -169.15 2.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.711 0.756 . . . . 0.0 109.951 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.468 ' HG2' ' OD1' ' A' ' 595' ' ' ASP . 14.2 pttm -110.11 136.33 49.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.923 -172.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.637 ' HA ' ' OD1' ' A' ' 609' ' ' ASN . 91.5 mt -84.22 114.97 22.2 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 170.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.588 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 45.8 mt-10 -86.52 84.91 7.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.393 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 599' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 607' ' ' SER . 46.2 t -86.46 118.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.688 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.841 ' HB2' ' HB2' ' A' ' 607' ' ' SER . 13.6 m -118.57 157.02 28.13 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.825 -176.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.968 ' HB2' HG22 ' A' ' 583' ' ' ILE . 58.4 tp -141.79 113.5 7.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -156.41 137.88 13.99 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 60.93 27.06 16.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 64.9 t30 63.84 11.68 6.14 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.436 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 60.0 t -95.13 118.45 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.573 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.582 HG13 HG21 ' A' ' 583' ' ' ILE . 48.9 t -82.17 147.9 5.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.848 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 607' ' ' SER . . . . . 0.841 ' HB2' ' HB2' ' A' ' 600' ' ' SER . 16.9 m -134.38 158.13 44.64 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.583 0.23 . . . . 0.0 110.868 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.6 p -153.27 121.23 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.648 175.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.818 HD22 HD13 ' A' ' 632' ' ' LEU . 19.6 m-20 61.46 37.61 16.51 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.986 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 80.1 -12.48 1.04 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.481 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 63.1 mm-40 -95.44 143.17 25.65 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.615 0.245 . . . . 0.0 110.79 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 3.1 Cg_exo -78.81 136.62 13.53 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.134 2.556 . . . . 0.0 112.791 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 40.4 t -89.22 134.38 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -89.29 -35.74 15.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.946 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 615' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 29.5 tt0 -150.36 89.08 4.56 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.732 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.38 173.19 13.53 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.125 2.55 . . . . 0.0 113.47 171.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 t70 77.78 23.34 0.8 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.059 164.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 618' ' ' ILE . . . . . 0.4 HD12 HG23 ' A' ' 627' ' ' VAL . 34.2 mt -94.36 90.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 122.05 -0.406 . . . . 0.0 110.135 174.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 619' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 60.6 mtp -85.91 149.49 25.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.472 0.654 . . . . 0.0 112.33 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 620' ' ' ALA . . . . . 0.509 ' HB2' HG21 ' A' ' 508' ' ' VAL . . . -113.22 -171.77 1.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.613 174.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 504' ' ' THR . 13.1 t -81.73 -17.46 47.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.414 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.436 ' OD1' HG23 ' A' ' 505' ' ' VAL . 28.7 p-10 -117.87 2.5 12.18 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 623' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 173.14 -154.77 21.27 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.418 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 624' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 8.1 p -137.55 145.47 29.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 625' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 539' ' ' VAL . 75.6 t -117.4 140.87 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.978 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 626' ' ' HIS . . . . . 0.575 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 66.4 m-70 -126.74 118.86 25.56 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.039 175.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.876 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 96.8 t -72.51 122.59 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.0 151.13 21.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.206 0.527 . . . . 0.0 110.592 172.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 11.9 p -94.04 3.22 55.63 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.153 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -136.6 146.27 45.87 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.123 0.487 . . . . 0.0 111.204 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.49 HG13 HD13 ' A' ' 550' ' ' LEU . 0.2 OUTLIER -92.68 158.25 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.035 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.818 HD13 HD22 ' A' ' 609' ' ' ASN . 16.6 mt . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 120.867 0.365 . . . . 0.0 111.647 -156.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.668 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.439 -1.113 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 508' ' ' VAL . 75.6 p -95.28 -173.96 3.07 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.749 ' O ' HD13 ' A' ' 509' ' ' LEU . 96.4 t -47.42 -41.06 7.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.396 170.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -41.89 97.86 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.697 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 507' ' ' ASP . . . . . 0.668 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 9.1 m-20 -68.65 -33.42 73.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.52 0.2 . . . . 0.0 111.159 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 504' ' ' THR . 96.0 t -51.66 -60.54 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.089 0.471 . . . . 0.0 110.958 174.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.749 HD13 ' O ' ' A' ' 505' ' ' VAL . 3.4 mp -59.27 -35.45 73.76 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.625 0.77 . . . . 0.0 111.269 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.61 ' HB3' ' HA ' ' A' ' 507' ' ' ASP . 43.5 tttt -63.75 -29.85 71.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.324 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -97.49 -23.3 14.41 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.237 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.75 132.22 35.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.934 0.397 . . . . 0.0 110.489 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -76.19 -18.98 58.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -78.92 -29.43 44.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.017 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.771 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 16.5 m-85 -101.71 18.76 19.59 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.008 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 21.0 p -57.94 -57.27 13.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 517' ' ' MET . . . . . 0.418 ' HB3' ' HE2' ' A' ' 517' ' ' MET . 7.8 ttp -74.13 -20.69 60.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.926 0.393 . . . . 0.0 110.158 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 50.5 tp -57.94 -41.96 83.92 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.909 176.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 509' ' ' LEU . 15.2 t -53.45 -54.77 16.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.261 177.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.23 -31.52 72.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.087 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.13 -56.18 8.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.794 0.33 . . . . 0.0 110.37 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.473 ' HA ' HD13 ' A' ' 569' ' ' LEU . 61.6 mt -59.33 -32.24 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.231 0.539 . . . . 0.0 110.235 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 523' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.6 OUTLIER -55.59 -60.7 3.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.095 173.092 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.7 m -61.99 -19.11 62.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.351 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -85.44 -10.91 55.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 70.14 37.68 72.49 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.671 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.55 5.6 29.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.524 0.662 . . . . 0.0 111.044 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 27.2 m -53.46 -49.93 66.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.686 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 529' ' ' GLU . . . . . 0.649 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 28.3 mt-10 -66.03 -19.21 65.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.551 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 35.1 m -74.07 -34.32 63.99 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.083 0.468 . . . . 0.0 109.818 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.518 HD21 HD13 ' A' ' 573' ' ' ILE . 89.6 mt -93.07 -18.14 23.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.647 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 532' ' ' ASN . . . . . 0.544 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 5.8 m-20 -84.55 17.72 2.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 533' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 21.9 mmt180 -111.25 172.25 6.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.305 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.13 146.28 24.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 153.97 -147.13 16.04 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.896 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.602 ' HB ' HG13 ' A' ' 577' ' ' ILE . 11.2 m -131.7 128.29 60.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -148.15 132.21 17.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.968 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 538' ' ' THR . . . . . 0.432 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 95.7 m -104.68 105.23 15.23 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 172.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.785 HG22 HG12 ' A' ' 573' ' ' ILE . 62.6 t -104.78 112.57 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 120.888 0.375 . . . . 0.0 111.378 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.606 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 68.4 m-85 -85.95 108.98 18.45 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -104.66 122.41 43.65 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.069 -168.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.76 138.91 19.39 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.936 2.424 . . . . 0.0 112.491 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 67.4 p -82.78 -176.59 6.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.965 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 544' ' ' ASN . . . . . 0.471 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 88.2 m-20 -62.07 -39.65 93.14 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.67 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -66.1 -21.49 66.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -76.88 -36.45 56.72 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.099 177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 547' ' ' PHE . . . . . 0.502 ' HZ ' ' HB2' ' A' ' 518' ' ' LEU . 9.5 m-85 -65.31 -13.02 57.49 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 170.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -94.91 -36.42 11.62 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.975 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -91.24 11.02 24.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.13 0.491 . . . . 0.0 111.724 -174.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.799 HD12 ' CD1' ' A' ' 555' ' ' TRP . 0.2 OUTLIER -76.8 167.32 37.73 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.643 -178.183 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.449 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 7.6 Cg_exo -73.91 125.93 10.27 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.21 1.94 . . . . 0.0 109.952 166.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.97 -54.52 5.31 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.909 2.406 . . . . 0.0 114.138 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -70.81 -18.77 62.72 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.65 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 5.9 tp10 -60.6 -54.87 40.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.609 0.718 . . . . 0.0 109.902 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 555' ' ' TRP . . . . . 0.799 ' CD1' HD12 ' A' ' 550' ' ' LEU . 6.7 m95 -77.79 -24.78 48.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.889 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 52.5 m -51.28 -35.04 35.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.43 0.633 . . . . 0.0 109.616 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -84.69 -50.9 7.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.154 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.698 HD23 ' HG3' ' A' ' 564' ' ' GLU . 40.6 mt -57.61 -55.31 36.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.983 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.42 HD22 HD22 ' A' ' 565' ' ' LEU . 0.1 OUTLIER -70.44 -1.34 10.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -98.27 -31.47 6.5 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.651 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 561' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 563' ' ' LYS . 12.9 t70 -130.5 137.84 49.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.633 0.254 . . . . 0.0 110.42 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.7 63.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.681 ' HD3' ' H ' ' A' ' 563' ' ' LYS . 0.1 OUTLIER -73.82 -18.6 60.93 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.717 -178.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.698 ' HG3' HD23 ' A' ' 558' ' ' LEU . 3.7 tp10 -69.63 -46.45 66.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 558' ' ' LEU . 20.0 tp -68.04 -45.57 73.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.087 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -60.76 -23.57 65.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.403 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 567' ' ' ASN . . . . . 0.689 ' HA ' ' OE1' ' A' ' 593' ' ' GLN . 2.9 t-20 -55.87 -50.84 69.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.578 0.704 . . . . 0.0 110.811 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.614 HD12 HD11 ' A' ' 558' ' ' LEU . 46.2 mt -84.53 -39.58 14.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.875 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 522' ' ' ILE . 75.0 mt -61.1 -28.25 68.96 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -77.59 -10.15 59.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.907 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.58 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 50.5 t80 -100.3 -19.16 16.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.085 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -66.34 -24.94 66.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.381 0.61 . . . . 0.0 110.526 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.785 HG12 HG22 ' A' ' 539' ' ' VAL . 83.7 mt -105.43 141.16 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.486 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -102.81 165.92 16.54 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.29 -30.29 67.26 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 576' ' ' GLU . . . . . 0.5 ' O ' HD11 ' A' ' 589' ' ' LEU . 14.4 pt-20 -148.04 178.4 8.56 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 122.274 -0.266 . . . . 0.0 110.529 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.602 HG13 ' HB ' ' A' ' 536' ' ' VAL . 57.5 mt -81.16 122.23 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.143 0.497 . . . . 0.0 111.961 -171.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.586 HD21 HG13 ' A' ' 587' ' ' VAL . 55.0 tp -122.31 93.26 3.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.424 174.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.4 HG13 HG22 ' A' ' 577' ' ' ILE . 26.7 m -83.81 169.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.469 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 580' ' ' SER . . . . . 0.413 ' HA ' HD12 ' A' ' 583' ' ' ILE . 26.1 m -60.41 -15.65 28.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.887 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.76 -16.37 70.02 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 172.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.69 -28.11 6.81 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.846 HG22 ' HB2' ' A' ' 601' ' ' LEU . 53.4 mt -72.14 89.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.226 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 584' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . -113.8 -58.59 0.39 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.327 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -113.46 -71.6 0.74 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 175.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 599' ' ' VAL . 6.2 tt -157.83 129.58 6.88 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 587' ' ' VAL . . . . . 0.586 HG13 HD21 ' A' ' 578' ' ' LEU . 6.8 p -143.86 139.64 25.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.22 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 588' ' ' ARG . . . . . 0.538 ' HB3' ' HG2' ' A' ' 598' ' ' GLU . 6.3 ptp180 -107.9 140.22 41.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.342 0.591 . . . . 0.0 111.491 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.5 HD11 ' O ' ' A' ' 576' ' ' GLU . 0.5 OUTLIER -124.45 121.63 35.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.298 -179.31 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.417 ' HE2' ' HA2' ' A' ' 594' ' ' GLY . 24.2 tptm -63.62 140.94 58.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.69 0.281 . . . . 0.0 110.26 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.534 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 60.2 p -102.11 -177.83 3.52 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.72 ' H ' HD22 ' A' ' 592' ' ' LEU . 0.9 OUTLIER -76.68 -44.88 31.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 110.474 178.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 593' ' ' GLN . . . . . 0.689 ' OE1' ' HA ' ' A' ' 567' ' ' ASN . 23.9 tp60 -63.4 -30.8 71.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.491 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 594' ' ' GLY . . . . . 0.417 ' HA2' ' HE2' ' A' ' 590' ' ' LYS . . . 124.62 16.02 3.15 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 119.731 -1.224 . . . . 0.0 114.438 168.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 595' ' ' ASP . . . . . 0.58 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 10.4 t70 -110.66 -164.87 0.95 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.878 0.839 . . . . 0.0 108.789 174.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.419 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 18.3 pttp -127.24 120.0 27.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.092 0.472 . . . . 0.0 111.35 -172.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.716 ' HA ' HD22 ' A' ' 609' ' ' ASN . 98.3 mt -79.2 115.37 18.82 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.538 ' HG2' ' HB3' ' A' ' 588' ' ' ARG . 33.7 mt-10 -108.75 112.36 24.6 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.29 0.567 . . . . 0.0 110.782 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 599' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 586' ' ' LEU . 21.3 t -107.59 133.6 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.532 -171.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.757 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 37.9 t -126.02 160.81 29.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.846 ' HB2' HG22 ' A' ' 583' ' ' ILE . 48.8 tp -132.73 127.1 33.97 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 602' ' ' LYS . . . . . 0.489 ' HG2' ' OD1' ' A' ' 603' ' ' ASN . 60.6 tttp -156.42 129.1 7.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 603' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 602' ' ' LYS . 18.6 m120 61.15 28.03 17.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.03 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 56.9 t30 68.64 18.49 8.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.708 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.69 126.53 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.741 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 59.7 t -88.24 137.46 21.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.318 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 607' ' ' SER . . . . . 0.757 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 6.9 m -125.19 103.54 8.02 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.503 HG11 ' CD1' ' A' ' 540' ' ' PHE . 7.4 p -109.28 117.96 55.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.716 HD22 ' HA ' ' A' ' 597' ' ' LEU . 4.2 m120 63.16 29.75 16.06 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 610' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 60.0 tttp 77.02 -2.39 2.67 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.311 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.516 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 70.0 mm-40 -92.42 129.57 40.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.397 . . . . 0.0 110.879 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 13.0 Cg_exo -70.51 126.58 12.96 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.295 2.663 . . . . 0.0 112.518 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 32.8 t -86.72 136.62 22.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.887 176.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -83.04 -57.0 3.47 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.128 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -133.66 100.74 13.37 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.451 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.29 164.26 33.15 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.824 2.349 . . . . 0.0 112.628 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 71.64 31.46 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 50.6 mt -85.66 90.21 2.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 168.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 619' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 66.6 mtp -79.7 148.39 31.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -169.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -118.45 -175.58 2.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.621 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.3 t -83.64 -9.45 58.88 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.528 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.5 ' OD1' HG23 ' A' ' 505' ' ' VAL . 28.7 p-10 -117.68 7.72 12.62 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.499 0.19 . . . . 0.0 111.481 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 159.25 -143.59 9.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.003 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 624' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.1 p -139.34 147.64 24.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.595 0.236 . . . . 0.0 110.589 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.5 141.76 34.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.322 0.582 . . . . 0.0 111.217 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 626' ' ' HIS . . . . . 0.606 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 46.7 m-70 -126.75 125.28 41.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.771 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 85.5 t -78.18 118.59 25.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.49 155.59 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 120.943 0.401 . . . . 0.0 110.716 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 19.9 p -102.65 4.06 37.84 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.444 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -137.4 163.3 31.38 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.982 0.42 . . . . 0.0 111.254 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.74 142.98 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.779 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 69.9 mt . . . . . 0 N--CA 1.432 -1.371 0 CA-C-O 120.635 0.255 . . . . 0.0 110.473 -175.716 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 121.251 0.362 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.489 ' HA ' HG22 ' A' ' 621' ' ' THR . 79.0 p -85.98 -172.48 4.11 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.887 HG21 HD22 ' A' ' 531' ' ' LEU . 7.4 m -46.79 -37.97 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.222 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -45.13 90.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.274 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 507' ' ' ASP . . . . . 0.552 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 6.1 t70 -68.76 -33.35 73.75 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 504' ' ' THR . 94.3 t -52.65 -40.07 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.22 0.533 . . . . 0.0 110.538 174.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 5.6 mt -82.27 -34.51 28.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.405 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.594 ' HA ' HG21 ' A' ' 519' ' ' VAL . 58.1 tttp -66.51 -34.61 78.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.062 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -88.15 -5.4 76.6 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.645 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -106.75 142.04 37.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.29 0.545 . . . . 0.0 111.387 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -68.37 -32.8 73.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.786 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 514' ' ' ARG . . . . . 0.568 ' H ' ' HD2' ' A' ' 514' ' ' ARG . 3.1 mpt_? -83.02 -19.27 37.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -173.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.732 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 19.9 m-85 -107.75 5.55 26.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.172 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 68.5 m -59.98 -38.1 81.57 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.754 0.312 . . . . 0.0 111.579 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -82.56 -26.01 32.79 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 45.6 tp -58.02 -43.68 86.87 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.913 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 510' ' ' LYS . 7.2 t -50.69 -51.04 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.931 176.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -64.74 -32.8 74.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.926 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.89 -50.19 44.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.158 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.584 HG12 HD11 ' A' ' 569' ' ' LEU . 68.4 mt -57.94 -34.45 48.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.31 0.576 . . . . 0.0 109.789 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.55 -57.72 11.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.452 173.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.2 m -58.63 -26.56 63.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.995 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -74.63 -23.94 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.869 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 68.25 19.62 72.45 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.104 -0.57 . . . . 0.0 114.153 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 527' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 569' ' ' LEU . 3.8 pp -104.36 22.44 14.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.579 0.69 . . . . 0.0 111.135 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 88.8 m -53.81 -41.97 67.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.951 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 529' ' ' GLU . . . . . 0.617 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 1.0 OUTLIER -60.23 -16.38 33.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.226 -178.515 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 26.2 m -76.18 -51.0 13.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.906 0.384 . . . . 0.0 109.991 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.887 HD22 HG21 ' A' ' 505' ' ' VAL . 61.2 mt -81.39 -13.69 58.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.679 -177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -20.01 61.17 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.822 0.344 . . . . 0.0 111.416 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 533' ' ' ARG . . . . . 0.617 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 59.8 mtt180 -74.09 139.67 44.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.1 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -84.06 131.74 34.78 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 167.54 -120.64 0.92 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.447 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.8 m -137.99 126.81 32.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.716 0.294 . . . . 0.0 111.06 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -151.64 143.91 24.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.786 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.2 m -115.96 111.09 19.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.707 HG22 HG12 ' A' ' 573' ' ' ILE . 88.5 t -111.04 114.23 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.629 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 61.5 m-85 -84.87 108.99 17.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -100.11 121.13 54.84 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.969 -166.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.51 138.93 8.76 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.789 2.326 . . . . 0.0 112.158 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 66.8 p -83.35 -178.02 6.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.244 0.545 . . . . 0.0 112.087 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 544' ' ' ASN . . . . . 0.438 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -62.57 -37.84 87.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.322 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -34.19 71.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.522 0.677 . . . . 0.0 110.238 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.502 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -70.54 -36.85 73.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.373 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 547' ' ' PHE . . . . . 0.456 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 17.3 m-85 -66.44 -18.01 65.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.222 0.534 . . . . 0.0 109.655 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -92.79 -16.26 25.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.047 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -80.51 -13.92 58.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.005 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.696 HD11 ' HB ' ' A' ' 631' ' ' VAL . 78.8 mt -95.34 143.36 25.98 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.017 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 24.6 Cg_exo -63.05 134.39 45.83 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.766 2.311 . . . . 0.0 111.755 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 552' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 52.7 Cg_exo -54.45 -32.43 73.11 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.039 2.493 . . . . 0.0 112.234 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 44.2 mtm105 -57.87 -30.96 66.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.46 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -86.21 -52.18 5.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.255 0.55 . . . . 0.0 110.539 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 555' ' ' TRP . . . . . 0.516 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -68.84 -38.27 79.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -170.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.0 t -54.6 -24.97 23.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.195 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -82.92 -33.39 26.85 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.412 -0.18 . . . . 0.0 111.0 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.624 ' HB3' ' HG ' ' A' ' 565' ' ' LEU . 14.5 mt -65.26 -50.57 65.26 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 121.002 0.43 . . . . 0.0 110.292 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.462 HD22 HD11 ' A' ' 565' ' ' LEU . 0.6 OUTLIER -69.34 -16.51 63.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.848 0.356 . . . . 0.0 111.424 177.25 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -85.95 -38.34 8.69 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.024 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -124.66 135.28 52.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 111.267 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -73.57 -31.34 63.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.11 -170.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.536 ' H ' ' HD2' ' A' ' 563' ' ' LYS . 9.6 mptt -71.2 -37.05 72.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.85 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.1 -34.52 73.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.676 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.624 ' HG ' ' HB3' ' A' ' 558' ' ' LEU . 0.4 OUTLIER -75.73 -47.27 26.74 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.892 0.377 . . . . 0.0 110.443 177.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 566' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -59.67 -33.99 72.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.426 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -56.3 -52.79 63.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.946 0.403 . . . . 0.0 111.033 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 632' ' ' LEU . 73.9 mt -71.46 -46.67 62.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.429 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' A' ' 527' ' ' LEU . 0.1 OUTLIER -51.96 -34.23 41.3 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.404 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 47.2 mttp -69.47 -26.05 64.38 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.578 ' O ' HD21 ' A' ' 597' ' ' LEU . 52.4 t80 -80.31 -17.04 53.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.959 0.409 . . . . 0.0 110.708 -176.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 572' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 16.4 m-70 -79.89 -6.18 56.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.257 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.707 HG12 HG22 ' A' ' 539' ' ' VAL . 69.1 mt -117.12 117.47 55.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.04 -175.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.1 167.49 34.48 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.64 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.568 ' OD2' ' HB2' ' A' ' 590' ' ' LYS . 8.0 m-20 -54.63 -42.22 70.97 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.06 -176.56 5.71 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.748 -168.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.516 HG12 ' HA2' ' A' ' 623' ' ' GLY . 58.6 mt -82.08 118.23 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.314 -173.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.413 HD11 HG11 ' A' ' 587' ' ' VAL . 4.6 tt -118.49 93.47 4.13 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.9 m -73.5 167.53 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.573 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 580' ' ' SER . . . . . 0.646 ' HA ' HD12 ' A' ' 583' ' ' ILE . 13.1 t -62.37 -24.15 67.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.2 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -71.04 -10.89 69.38 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.036 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -99.9 -17.51 25.3 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.741 HG22 ' HB2' ' A' ' 601' ' ' LEU . 77.4 mt -71.47 94.47 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.362 0.601 . . . . 0.0 110.394 176.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -109.15 -121.47 4.47 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.975 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -58.96 -62.79 1.62 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 110.528 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 7.9 tt -168.48 129.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 587' ' ' VAL . . . . . 0.413 HG11 HD11 ' A' ' 578' ' ' LEU . 47.3 t -129.61 136.05 60.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.95 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 588' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 588' ' ' ARG . 14.7 mtm180 -97.98 120.84 39.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.141 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.76 116.67 32.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.568 ' HB2' ' OD2' ' A' ' 575' ' ' ASP . 23.7 mmmt -63.88 139.23 58.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.723 0.296 . . . . 0.0 110.336 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.581 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 86.5 p -106.14 -173.92 2.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.346 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 76.3 mt -80.79 -39.69 26.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.829 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 593' ' ' GLN . . . . . 0.443 ' HB3' ' HB2' ' A' ' 571' ' ' TYR . 24.4 tt0 -61.84 -29.58 70.27 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.088 0.47 . . . . 0.0 110.833 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 127.03 -18.83 6.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.268 -0.968 . . . . 0.0 114.509 170.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 595' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 596' ' ' LYS . 8.8 t70 -88.52 -158.88 0.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.466 1.133 . . . . 0.0 109.893 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.472 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 10.8 pttm -124.75 135.98 53.46 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.862 0.363 . . . . 0.0 111.07 -169.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 571' ' ' TYR . 94.6 mt -83.85 115.34 22.21 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 172.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -91.32 84.84 5.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.69 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 599' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 608' ' ' VAL . 2.4 p -110.08 132.05 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.248 0.547 . . . . 0.0 111.69 -175.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.439 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 5.8 p -144.33 168.76 19.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.148 -176.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.741 ' HB2' HG22 ' A' ' 583' ' ' ILE . 1.8 tt -117.84 112.49 20.45 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -141.14 135.89 31.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.138 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 64.9 t30 61.41 36.29 17.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.279 0.561 . . . . 0.0 110.281 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 67.2 t30 73.24 -2.17 2.82 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.773 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 9.6 p -122.81 147.37 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.852 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.476 HG13 HG21 ' A' ' 583' ' ' ILE . 57.6 t -77.68 132.12 33.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.219 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 5.8 p -123.84 112.29 17.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.06 0.457 . . . . 0.0 111.21 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.622 HG23 ' HB ' ' A' ' 599' ' ' VAL . 10.7 p -114.89 135.29 55.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.485 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.551 ' OD1' HG22 ' A' ' 608' ' ' VAL . 0.5 OUTLIER 57.75 26.36 12.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -177.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 62.8 mttm 76.09 1.4 3.44 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.205 1.002 . . . . 0.0 111.915 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 29.7 mm-40 -101.37 137.35 19.63 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.276 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 11.6 Cg_exo -72.45 126.58 11.7 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.021 2.48 . . . . 0.0 112.294 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.07 141.95 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.996 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -75.65 -60.3 2.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.857 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -141.68 113.48 6.54 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.615 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 616' ' ' PRO . . . . . 0.432 ' HG3' HG21 ' A' ' 606' ' ' VAL . 65.0 Cg_endo -81.51 169.88 15.03 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.833 2.355 . . . . 0.0 113.053 174.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 2.5 t70 72.95 28.28 1.99 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.479 165.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 52.3 mt -80.9 89.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 619' ' ' MET . . . . . 0.516 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 53.2 mtp -78.97 137.07 37.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.635 0.731 . . . . 0.0 112.74 -171.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -106.26 -177.74 3.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.017 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.489 HG22 ' HA ' ' A' ' 504' ' ' THR . 15.0 t -74.74 -16.54 60.73 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.332 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.788 HD21 HG22 ' A' ' 505' ' ' VAL . 30.7 p-10 -119.37 10.51 11.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 623' ' ' GLY . . . . . 0.516 ' HA2' HG12 ' A' ' 577' ' ' ILE . . . 161.79 -147.05 12.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.415 -1.374 . . . . 0.0 113.52 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 624' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.4 p -139.97 145.06 26.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.86 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 76.8 t -118.74 143.61 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.657 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 626' ' ' HIS . . . . . 0.629 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 34.9 m-70 -130.16 127.19 39.23 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.732 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 98.2 t -79.94 119.3 29.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.7 148.21 17.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.028 0.442 . . . . 0.0 110.581 172.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 33.0 p -95.74 10.5 36.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.65 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -136.03 155.63 49.94 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.696 ' HB ' HD11 ' A' ' 550' ' ' LEU . 52.0 t -96.83 157.29 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.458 HD13 ' ND2' ' A' ' 609' ' ' ASN . 46.4 mt . . . . . 0 C--N 1.315 -0.896 0 CA-C-O 120.856 0.36 . . . . 0.0 110.277 -170.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.691 0.282 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 501' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 507' ' ' ASP . . . 103.32 13.24 29.09 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.527 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 27.2 ttt -78.92 96.38 5.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.107 0.48 . . . . 0.0 110.125 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . 174.99 -146.7 8.56 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.736 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.4 ' HA ' HG22 ' A' ' 621' ' ' THR . 67.1 p -91.94 -172.12 3.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.712 0.291 . . . . 0.0 110.366 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.858 HG23 ' HB3' ' A' ' 531' ' ' LEU . 4.4 m -49.42 -29.89 4.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.897 170.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.5 ' HG2' ' CB ' ' A' ' 531' ' ' LEU . 85.3 mmm -67.64 -50.43 57.97 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.352 -0.217 . . . . 0.0 110.93 172.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 507' ' ' ASP . . . . . 0.449 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 1.0 OUTLIER -72.09 -29.77 64.45 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.136 -174.191 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 1.016 HG11 HG21 ' A' ' 625' ' ' VAL . 8.7 p -58.06 -35.02 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.504 0.669 . . . . 0.0 110.693 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.897 HD23 HG13 ' A' ' 508' ' ' VAL . 7.2 mt -81.65 -33.99 31.03 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.593 177.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -66.03 -25.02 66.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.856 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -102.24 1.88 50.66 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.76 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -111.5 141.83 44.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.522 0.661 . . . . 0.0 111.358 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' ASN . . . . . 0.453 ' HA ' ' OG ' ' A' ' 516' ' ' SER . 17.2 m120 -75.32 -23.99 57.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.035 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -87.07 -15.37 38.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.075 0.464 . . . . 0.0 110.418 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.883 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 25.5 m-85 -109.51 8.1 25.04 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.898 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 513' ' ' ASN . 67.8 m -57.24 -45.92 83.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -174.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.3 ttp -76.04 -24.02 55.16 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.218 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.532 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 46.8 tp -60.45 -45.22 94.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.984 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 515' ' ' PHE . 5.8 t -53.45 -46.61 59.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.553 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.2 72.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.685 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -71.81 -48.37 46.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.008 0.432 . . . . 0.0 109.931 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.811 HG12 HD21 ' A' ' 569' ' ' LEU . 43.3 mt -56.61 -39.0 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.612 0.72 . . . . 0.0 109.985 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -59.22 -53.25 60.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.909 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.0 m -59.23 -27.33 65.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.859 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -79.12 -28.25 42.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 65.02 32.58 84.67 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.675 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' LEU . . . . . 0.696 HD21 HD23 ' A' ' 569' ' ' LEU . 3.6 pp -102.65 24.58 10.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.356 0.578 . . . . 0.0 110.486 177.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 56.7 m -46.47 -53.12 11.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.295 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.41 -28.23 58.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -174.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 53.5 m -59.98 -52.47 65.25 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.715 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.858 ' HB3' HG23 ' A' ' 505' ' ' VAL . 27.2 mt -96.21 -8.43 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -175.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -92.88 -9.47 40.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.68 0.752 . . . . 0.0 110.409 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 533' ' ' ARG . 7.9 tpp180 -94.15 157.7 15.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.318 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -77.39 149.76 35.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.02 0.438 . . . . 0.0 110.785 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 164.66 -146.7 11.61 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.691 ' HB ' HG13 ' A' ' 577' ' ' ILE . 16.9 m -129.41 127.39 64.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -149.81 151.29 33.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 0.0 110.931 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 96.9 m -124.4 101.45 7.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.554 HG22 HG12 ' A' ' 573' ' ' ILE . 87.3 t -98.77 111.48 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.832 -174.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 56.3 m-85 -83.47 106.61 15.36 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -98.6 117.0 65.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.451 -166.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.49 135.22 13.03 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.819 2.346 . . . . 0.0 112.121 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.3 p -78.45 -176.0 4.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.243 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 544' ' ' ASN . . . . . 0.51 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 83.5 m-20 -73.68 -34.52 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.323 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 548' ' ' ARG . 1.5 pm0 -70.17 -18.99 63.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.099 0.476 . . . . 0.0 110.342 175.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.12 64.37 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.212 0.53 . . . . 0.0 110.789 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 547' ' ' PHE . . . . . 0.51 ' CD2' ' HA ' ' A' ' 544' ' ' ASN . 19.2 m-85 -66.49 -12.78 59.17 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.195 172.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 548' ' ' ARG . . . . . 0.509 ' HA ' ' HE ' ' A' ' 548' ' ' ARG . 3.3 mmp_? -92.57 -13.63 29.44 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.323 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -92.36 4.61 53.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.917 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.466 HD12 ' NE1' ' A' ' 555' ' ' TRP . 66.5 mt -113.05 142.71 27.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 0.0 111.588 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 31.3 Cg_exo -59.08 128.07 26.45 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.358 2.039 . . . . 0.0 111.179 174.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 552' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 50.1 Cg_exo -54.08 -29.07 53.63 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.955 2.437 . . . . 0.0 113.389 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -59.13 -53.82 54.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.524 0.202 . . . . 0.0 111.47 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.5 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 32.3 mm-40 -63.89 -37.33 86.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.313 0.577 . . . . 0.0 110.633 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 555' ' ' TRP . . . . . 0.466 ' NE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -73.72 -40.22 63.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.817 -177.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 70.8 m -59.38 -22.96 62.15 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.65 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 557' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 554' ' ' GLU . 73.5 mtp180 -73.34 -45.14 56.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.298 173.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.626 ' HB3' ' HA ' ' A' ' 565' ' ' LEU . 13.1 mt -67.71 -53.42 27.67 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.559 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -15.58 63.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.802 0.334 . . . . 0.0 111.623 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -88.4 -29.44 19.37 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.44 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 561' ' ' ASP . . . . . 0.654 ' OD2' ' HG3' ' A' ' 563' ' ' LYS . 24.5 t70 -131.05 124.69 31.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.793 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -62.43 -47.06 85.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -171.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.654 ' HG3' ' OD2' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -72.31 -24.82 61.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.973 -177.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.568 ' HG3' HD23 ' A' ' 558' ' ' LEU . 5.2 tp10 -68.52 -42.71 78.11 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.626 ' HA ' ' HB3' ' A' ' 558' ' ' LEU . 3.4 tt -65.75 -50.97 62.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 566' ' ' ALA . . . . . 0.46 ' HB1' ' HE2' ' A' ' 570' ' ' LYS . . . -54.87 -32.16 60.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.693 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -52.77 -53.64 45.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.455 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 59.2 mt -82.57 -39.79 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.811 HD21 HG12 ' A' ' 522' ' ' ILE . 22.4 tp -55.75 -36.48 67.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.612 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 68.6 mttm -68.24 -22.64 64.76 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.805 0.336 . . . . 0.0 111.872 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.628 ' O ' HD21 ' A' ' 597' ' ' LEU . 32.5 t80 -80.15 -17.28 52.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.892 0.377 . . . . 0.0 110.842 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 572' ' ' HIS . . . . . 0.442 ' NE2' ' HB2' ' A' ' 632' ' ' LEU . 10.6 m-70 -77.87 -8.89 58.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.263 0.554 . . . . 0.0 110.872 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 539' ' ' VAL . 36.2 mt -110.8 116.67 53.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.929 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -78.71 161.77 48.32 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.23 175.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.49 ' OD1' ' HB2' ' A' ' 590' ' ' LYS . 5.2 p-10 -81.57 -10.13 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -172.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -156.69 178.02 10.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 176.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.691 HG13 ' HB ' ' A' ' 536' ' ' VAL . 36.7 mt -89.87 114.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.113 0.482 . . . . 0.0 112.208 -168.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 5.6 tt -112.96 96.16 5.79 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.5 m -80.61 169.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.795 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 580' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 617' ' ' ASP . 35.5 p -47.46 -43.28 24.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.376 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -70.42 -6.87 59.4 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.988 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.76 -7.63 47.43 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.226 -0.511 . . . . 0.0 111.927 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.775 HG22 ' HB2' ' A' ' 601' ' ' LEU . 58.2 mt -76.76 104.97 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.982 0.42 . . . . 0.0 110.16 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -103.64 -152.11 22.81 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.003 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -50.91 -56.75 10.83 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.011 0.434 . . . . 0.0 110.534 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 598' ' ' GLU . 6.3 tt -160.32 109.27 1.71 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.212 173.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 97.6 t -116.5 124.89 73.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.923 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 588' ' ' ARG . . . . . 0.418 ' HD2' ' HD2' ' A' ' 596' ' ' LYS . 85.2 mtm180 -98.01 126.88 43.63 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.855 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 21.9 tp -115.94 142.46 46.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.492 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.498 ' O ' ' HA2' ' A' ' 574' ' ' GLY . 37.2 mtmm -71.84 163.13 28.38 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.782 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.586 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.9 p -128.44 -176.83 3.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.005 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 63.1 mt -82.11 -41.86 19.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.38 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 593' ' ' GLN . . . . . 0.521 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 31.9 tt0 -59.25 -29.83 67.84 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.579 0.704 . . . . 0.0 110.255 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.79 -11.06 7.46 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.642 169.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 595' ' ' ASP . . . . . 0.566 ' OD2' ' HG2' ' A' ' 596' ' ' LYS . 3.7 t70 -94.02 -156.38 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.493 0.646 . . . . 0.0 109.985 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.566 ' HG2' ' OD2' ' A' ' 595' ' ' ASP . 19.9 pttm -117.94 142.02 47.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.863 0.363 . . . . 0.0 111.215 -172.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.628 HD21 ' O ' ' A' ' 571' ' ' TYR . 67.1 mt -92.13 116.83 29.28 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 34.5 tt0 -91.26 85.83 5.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.348 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.535 HG12 HG23 ' A' ' 583' ' ' ILE . 35.0 t -93.21 128.87 44.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.796 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 2.7 p -140.25 148.91 42.17 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.586 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.775 ' HB2' HG22 ' A' ' 583' ' ' ILE . 59.3 tp -119.25 112.8 19.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -131.13 110.42 11.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.967 0.413 . . . . 0.0 110.837 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 59.55 53.0 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.423 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 46.6 t30 69.81 -5.56 1.21 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.875 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.59 120.73 46.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.88 0.372 . . . . 0.0 110.438 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.434 HG21 ' HG3' ' A' ' 616' ' ' PRO . 43.1 t -85.77 140.81 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.856 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 607' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 40.6 m -132.16 142.56 49.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.603 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.6 p -134.69 123.81 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 120.882 0.373 . . . . 0.0 110.046 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.713 ' ND2' HD13 ' A' ' 632' ' ' LEU . 31.5 m-20 61.15 32.1 19.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.559 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 53.2 mttp 76.56 -0.12 3.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.806 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.492 ' HB3' ' OD1' ' A' ' 630' ' ' ASN . 5.3 mm-40 -99.61 130.13 27.4 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.501 ' HD2' HD21 ' A' ' 630' ' ' ASN . 16.5 Cg_exo -68.81 134.46 30.11 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.988 2.458 . . . . 0.0 113.049 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 49.0 t -86.37 143.17 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.703 177.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.11 12.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.655 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 615' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 616' ' ' PRO . 32.0 tt0 -152.87 104.65 2.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.162 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.434 ' HG3' HG21 ' A' ' 606' ' ' VAL . 75.0 Cg_endo -74.39 157.41 45.36 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.569 2.179 . . . . 0.0 113.114 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.53 ' HB2' ' HB3' ' A' ' 580' ' ' SER . 1.3 t70 76.7 59.81 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.734 166.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 22.3 mt -108.81 97.12 5.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 165.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 57.4 mtp -79.93 142.64 34.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.621 0.724 . . . . 0.0 112.846 -167.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.72 -175.43 2.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.251 171.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 504' ' ' THR . 12.6 t -82.42 -17.16 46.35 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.316 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.743 HD21 HG22 ' A' ' 505' ' ' VAL . 32.1 p-10 -119.22 14.52 13.03 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 162.76 -160.29 32.69 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.139 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.73 148.96 32.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.746 0.308 . . . . 0.0 110.179 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 625' ' ' VAL . . . . . 1.016 HG21 HG11 ' A' ' 508' ' ' VAL . 87.5 t -118.28 145.21 24.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.481 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 626' ' ' HIS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 74.4 m-70 -132.08 126.43 33.76 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.883 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 82.6 t -79.15 119.08 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.2 145.76 21.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.917 0.389 . . . . 0.0 110.241 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 22.9 p -97.73 9.77 41.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 630' ' ' ASN . . . . . 0.501 HD21 ' HD2' ' A' ' 612' ' ' PRO . 2.6 p30 -140.25 147.89 40.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.666 176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.439 ' HB ' HD11 ' A' ' 550' ' ' LEU . 43.9 t -82.23 160.62 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.713 HD13 ' ND2' ' A' ' 609' ' ' ASN . 42.4 mt -116.01 132.45 56.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -167.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.85 152.39 41.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.873 0.368 . . . . 0.0 110.147 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.669 -0.682 . . . . 0.0 110.34 -177.584 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.769 0.319 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -85.34 -137.75 4.24 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.855 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 26.6 mmt -117.73 128.96 55.4 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -98.24 -146.25 20.28 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-O 121.744 0.635 . . . . 0.0 113.398 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 508' ' ' VAL . 72.4 p -86.01 -171.2 3.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.299 -0.951 . . . . 0.0 110.14 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.7 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 36.4 t -43.9 -45.0 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 123.537 0.523 . . . . 0.0 111.185 173.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.513 ' HB2' ' HB2' ' A' ' 531' ' ' LEU . 10.2 tpt -63.78 -42.3 97.78 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.953 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 507' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 510' ' ' LYS . 25.3 t70 -67.78 -37.77 82.49 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.818 0.342 . . . . 0.0 110.631 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.518 HG21 ' HB2' ' A' ' 620' ' ' ALA . 82.8 t -50.61 -40.7 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.796 174.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 5.9 mt -82.37 -35.17 28.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.405 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 507' ' ' ASP . 17.3 mmmt -60.41 -40.71 91.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.823 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -90.87 -12.74 60.13 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.815 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -102.86 141.29 35.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.296 0.57 . . . . 0.0 111.092 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -75.94 -25.86 56.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.573 -174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -83.09 -15.98 48.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.1 0.476 . . . . 0.0 110.246 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.805 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 24.6 m-85 -109.34 17.78 21.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.379 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 12.0 p -57.54 -61.38 2.54 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 517' ' ' MET . . . . . 0.492 ' HE1' ' HH2' ' A' ' 555' ' ' TRP . 2.4 ttp -70.57 -20.79 62.76 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.009 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.552 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 49.5 tp -57.42 -45.25 84.81 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.654 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 523' ' ' GLN . 9.1 t -51.39 -47.82 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.905 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.28 -39.32 89.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.905 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.46 -42.09 96.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.028 0.442 . . . . 0.0 110.404 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.685 HG12 HD11 ' A' ' 569' ' ' LEU . 49.8 mt -69.74 -29.1 39.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.557 0.694 . . . . 0.0 109.992 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 523' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.0 OUTLIER -65.48 -53.54 41.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.877 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.3 m -65.75 -16.19 63.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.986 0.422 . . . . 0.0 110.904 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -80.5 -17.34 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.267 173.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 74.93 17.94 80.19 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.381 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 527' ' ' LEU . . . . . 0.743 HD12 HD12 ' A' ' 569' ' ' LEU . 82.1 mt -97.31 17.15 18.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.556 -0.379 . . . . 0.0 111.556 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 46.6 m -55.99 -48.75 75.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 529' ' ' GLU . . . . . 0.676 ' HA ' ' HB2' ' A' ' 532' ' ' ASN . 31.8 tt0 -62.73 -25.04 67.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.621 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 40.6 m -61.23 -50.48 72.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.608 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.676 ' HG ' ' CG1' ' A' ' 505' ' ' VAL . 0.3 OUTLIER -84.82 -21.65 29.79 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.429 176.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 532' ' ' ASN . . . . . 0.676 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 4.4 m-20 -70.03 -22.2 63.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.671 0.272 . . . . 0.0 110.837 175.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -84.97 126.25 33.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 534' ' ' GLU . . . . . 0.459 ' OE2' ' HA ' ' A' ' 622' ' ' ASN . 13.9 tp10 -70.79 145.99 50.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.663 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 166.42 -132.1 2.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.827 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.5 m -137.36 127.47 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.656 0.265 . . . . 0.0 110.555 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -149.81 154.63 38.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.967 0.413 . . . . 0.0 110.626 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.7 m -129.02 105.01 7.91 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.758 HG22 HG12 ' A' ' 573' ' ' ILE . 93.5 t -107.26 113.89 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.065 -174.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 60.5 m-85 -83.1 111.25 18.72 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 171.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -104.65 119.71 52.73 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.964 -165.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 541' ' ' ALA . 5.7 Cg_exo -77.89 141.6 19.22 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.335 2.69 . . . . 0.0 112.018 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 81.2 p -83.38 -179.15 7.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.111 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -58.45 -40.47 82.69 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.21 0.529 . . . . 0.0 110.281 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 545' ' ' GLU . 1.5 mp0 -62.78 -23.4 67.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.163 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -78.08 -31.35 50.12 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.275 0.559 . . . . 0.0 111.878 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 547' ' ' PHE . . . . . 0.497 ' CD1' ' HZ2' ' A' ' 555' ' ' TRP . 41.7 m-85 -67.06 -12.56 60.26 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.238 175.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -91.52 -8.79 46.56 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.73 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -91.16 -8.51 48.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.391 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.62 HD12 ' HE1' ' A' ' 555' ' ' TRP . 40.8 mt -100.3 142.42 24.58 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.411 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 551' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.92 142.24 92.4 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.709 2.273 . . . . 0.0 111.665 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.14 -40.38 77.18 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.22 2.613 . . . . 0.0 113.123 -175.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -59.61 -51.21 70.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.521 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.527 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 6.9 mp0 -60.43 -41.33 93.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.459 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 555' ' ' TRP . . . . . 0.62 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -69.17 -45.4 70.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.912 -177.025 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 35.2 p -58.58 -21.93 54.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.263 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -75.98 -49.86 16.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.87 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.615 ' HB3' ' HA ' ' A' ' 565' ' ' LEU . 12.9 mt -61.18 -63.68 1.21 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.728 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.838 HD13 HD11 ' A' ' 565' ' ' LEU . 3.5 mm? -58.53 -12.02 3.57 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.297 0.639 . . . . 0.0 112.542 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -74.68 -35.46 51.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.876 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 561' ' ' ASP . . . . . 0.527 ' OD2' ' HG3' ' A' ' 563' ' ' LYS . 16.9 t70 -144.67 153.03 41.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.218 0.509 . . . . 0.0 111.127 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -62.49 -47.28 84.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.048 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.527 ' HG3' ' OD2' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -71.31 -17.75 62.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.941 -177.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.444 ' N ' ' HD3' ' A' ' 563' ' ' LYS . 5.6 mm-40 -81.12 -42.41 20.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.676 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.838 HD11 HD13 ' A' ' 559' ' ' LEU . 0.6 OUTLIER -69.89 -48.27 59.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.329 0.585 . . . . 0.0 109.655 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 566' ' ' ALA . . . . . 0.52 ' HB1' ' HE3' ' A' ' 570' ' ' LYS . . . -62.56 -27.54 69.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.834 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -52.49 -53.9 39.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.852 0.358 . . . . 0.0 110.686 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 66.1 mt -83.43 -39.06 14.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.366 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.743 HD12 HD12 ' A' ' 527' ' ' LEU . 0.8 OUTLIER -54.99 -32.74 61.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.124 -178.012 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 97.2 mttt -74.91 -13.75 60.57 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.561 ' O ' HD21 ' A' ' 597' ' ' LEU . 44.7 t80 -86.71 -19.11 29.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.048 0.452 . . . . 0.0 110.885 -177.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 572' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 13.5 m-70 -77.78 -12.62 59.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.137 0.494 . . . . 0.0 110.566 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.758 HG12 HG22 ' A' ' 539' ' ' VAL . 68.3 mt -105.51 120.5 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.292 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.95 155.86 24.92 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.17 -4.86 57.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.29 168.54 23.76 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.506 0.193 . . . . 0.0 110.509 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.577 HG13 ' HB ' ' A' ' 536' ' ' VAL . 33.1 mt -89.0 117.5 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.602 -170.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 53.3 tp -117.66 97.9 6.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 24.4 m -79.24 170.64 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.096 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 580' ' ' SER . . . . . 0.613 ' HA ' HD12 ' A' ' 583' ' ' ILE . 17.9 m -55.96 -30.18 61.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.768 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.5 -13.43 65.46 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.135 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.86 -26.82 7.77 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.769 HG22 ' HB2' ' A' ' 601' ' ' LEU . 74.9 mt -60.9 103.89 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.069 0.461 . . . . 0.0 110.035 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -115.49 -137.03 6.13 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.12 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -59.67 -60.52 3.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 0.0 110.509 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 7.9 tt -157.9 112.75 2.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 67.2 t -121.65 133.53 67.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.128 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 588' ' ' ARG . . . . . 0.907 ' HD3' ' H ' ' A' ' 588' ' ' ARG . 0.0 OUTLIER -99.33 126.82 45.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.849 -179.069 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.47 125.51 49.09 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -75.02 143.24 43.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.221 0.534 . . . . 0.0 110.603 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.602 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 84.8 p -107.9 -178.62 3.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.735 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 573' ' ' ILE . 7.0 mp -73.99 -36.14 64.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.38 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -65.97 -30.56 71.15 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 121.559 0.695 . . . . 0.0 110.138 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 126.24 -21.9 6.03 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.08 -0.964 . . . . 0.0 114.006 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 595' ' ' ASP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 5.5 t70 -81.85 -165.52 1.0 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.042 0.921 . . . . 0.0 110.585 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.43 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 0.2 OUTLIER -123.45 135.51 54.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 0.0 111.442 -170.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.561 HD21 ' O ' ' A' ' 571' ' ' TYR . 84.2 mt -84.74 122.09 28.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.482 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 37.3 mt-10 -92.05 90.27 7.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.44 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.492 HG12 HG23 ' A' ' 583' ' ' ILE . 40.4 t -93.32 133.42 34.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.01 -176.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 32.2 t -143.92 136.82 27.35 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.769 ' HB2' HG22 ' A' ' 583' ' ' ILE . 63.7 tp -113.22 112.98 24.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -133.49 112.52 11.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 603' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 604' ' ' ASN . 15.3 t-20 60.03 47.14 10.04 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.13 0.491 . . . . 0.0 109.785 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 604' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 603' ' ' ASN . 10.2 t30 74.11 -14.95 0.64 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.723 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 55.9 t -84.18 115.81 26.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 122.175 -0.328 . . . . 0.0 110.665 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.55 HG22 HD13 ' A' ' 601' ' ' LEU . 43.8 t -84.51 136.09 23.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.599 176.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 607' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 44.9 m -126.0 147.98 49.4 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 176.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.514 HG11 ' CD1' ' A' ' 540' ' ' PHE . 7.0 p -141.12 119.57 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 1.075 HD22 HD13 ' A' ' 632' ' ' LEU . 29.5 m-20 62.12 31.43 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 24.4 tptp 86.92 -24.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.215 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.509 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 14.4 mm-40 -83.24 132.02 51.53 Favored Pre-proline 0 C--N 1.317 -0.834 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.646 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 13.8 Cg_exo -71.28 135.25 26.48 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.117 2.544 . . . . 0.0 112.856 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.592 HG11 ' HB3' ' A' ' 626' ' ' HIS . 24.7 t -88.74 136.25 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.206 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -88.8 -48.52 7.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.667 -177.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -132.72 89.7 34.6 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.01 159.28 53.79 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.662 2.241 . . . . 0.0 113.431 171.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 75.76 39.02 0.34 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.438 165.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 41.5 mt -87.38 85.76 2.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 166.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 619' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 55.7 mtp -80.71 129.57 34.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.645 0.736 . . . . 0.0 112.715 -170.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 620' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 508' ' ' VAL . . . -99.65 -171.42 2.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.148 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.405 ' OG1' HG22 ' A' ' 504' ' ' THR . 62.4 p -73.67 -38.46 64.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.498 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.459 ' HA ' ' OE2' ' A' ' 534' ' ' GLU . 30.0 p-10 -99.19 6.06 46.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.47 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 164.27 -152.64 22.53 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.189 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 624' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 8.8 p -134.77 144.48 34.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.809 0.338 . . . . 0.0 110.697 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.89 140.55 37.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.709 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 626' ' ' HIS . . . . . 0.592 ' HB3' HG11 ' A' ' 613' ' ' VAL . 52.3 m-70 -126.9 126.44 43.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.389 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.805 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 69.3 t -76.95 118.74 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 542' ' ' PRO . 0.5 OUTLIER -117.15 149.03 19.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.114 171.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 36.8 p -99.19 15.52 25.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.643 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -138.66 156.03 47.78 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.409 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 632' ' ' LEU . 36.1 t -98.37 160.73 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 174.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 1.075 HD13 HD22 ' A' ' 609' ' ' ASN . 16.2 mt -129.16 111.39 12.88 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.633 -167.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -97.53 134.22 41.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.135 0.493 . . . . 0.0 110.818 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 117.731 -1.128 . . . . 0.0 108.802 177.259 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.747 0.308 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 139.43 -139.07 9.73 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.006 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.41 103.1 0.06 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.484 0.659 . . . . 0.0 110.426 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -89.21 -141.74 8.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.931 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 508' ' ' VAL . 51.9 p -91.0 -170.33 2.64 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.862 -0.669 . . . . 0.0 109.687 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.797 HG11 HG21 ' A' ' 539' ' ' VAL . 99.4 t -47.18 -43.42 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 0.0 110.627 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.416 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 36.0 tpp -62.7 -41.07 98.95 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.883 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 507' ' ' ASP . . . . . 0.833 ' HA ' ' HD3' ' A' ' 510' ' ' LYS . 7.7 t70 -68.17 -32.13 72.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.643 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 504' ' ' THR . 99.6 t -51.3 -60.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.432 173.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.704 HD13 ' O ' ' A' ' 505' ' ' VAL . 5.1 mp -57.36 -37.64 72.92 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.055 0.942 . . . . 0.0 112.18 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.833 ' HD3' ' HA ' ' A' ' 507' ' ' ASP . 40.1 mtpt -54.53 -39.82 68.03 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -94.18 -17.05 41.56 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.143 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -85.37 132.78 34.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.084 0.469 . . . . 0.0 111.092 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -76.49 -25.51 54.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.727 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -80.94 -21.77 40.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.791 0.329 . . . . 0.0 110.351 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.574 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 20.7 m-85 -109.6 13.44 23.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.417 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 74.6 m -57.69 -49.82 75.23 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.5 ttp -74.93 -20.77 59.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.51 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.691 HD13 ' HZ ' ' A' ' 547' ' ' PHE . 59.7 tp -59.48 -44.03 93.14 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.735 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 509' ' ' LEU . 9.4 t -51.66 -51.91 24.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.377 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.61 97.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.971 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.5 83.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.382 0.61 . . . . 0.0 110.406 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.782 HG12 HD21 ' A' ' 569' ' ' LEU . 97.5 mt -62.86 -37.68 79.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.619 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -63.32 -49.15 75.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.746 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 8.5 t -60.57 -32.82 71.89 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.059 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -71.08 -22.26 62.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.031 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 75.98 19.33 78.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.257 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' LEU . . . . . 0.731 HD21 HD23 ' A' ' 569' ' ' LEU . 3.6 pp -106.79 22.25 16.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.478 0.639 . . . . 0.0 110.646 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 42.0 m -54.6 -43.22 71.97 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.864 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 529' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 533' ' ' ARG . 7.9 pt-20 -57.22 -33.15 67.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.422 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.0 m -63.47 -52.57 60.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 110.401 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.418 HD21 HD12 ' A' ' 573' ' ' ILE . 59.8 mt -74.09 -22.75 59.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.542 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.85 9.54 32.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 533' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 529' ' ' GLU . 71.4 ttt180 -101.87 143.32 31.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.831 0.348 . . . . 0.0 110.313 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.66 146.69 54.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.544 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 150.83 -139.96 7.59 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.629 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.483 ' HB ' HG13 ' A' ' 577' ' ' ILE . 8.3 m -135.84 127.47 44.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -149.33 146.82 27.72 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 97.5 m -119.11 102.45 8.74 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 170.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.797 HG21 HG11 ' A' ' 505' ' ' VAL . 93.3 t -99.32 113.47 34.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 -173.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 632' ' ' LEU . 52.5 m-85 -86.14 103.87 15.19 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 171.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -96.88 115.24 65.64 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.373 -167.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.511 ' HG2' ' CE1' ' A' ' 547' ' ' PHE . 70.1 Cg_endo -81.32 135.04 9.3 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.461 2.107 . . . . 0.0 111.821 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.519 ' HB ' ' OE2' ' A' ' 545' ' ' GLU . 47.8 p -70.03 173.69 6.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.441 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 544' ' ' ASN . . . . . 0.545 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -67.82 -33.04 74.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.944 0.402 . . . . 0.0 110.902 -178.142 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.519 ' OE2' ' HB ' ' A' ' 543' ' ' THR . 1.7 pm0 -70.17 -19.75 63.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.858 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -76.34 -33.24 58.98 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.004 0.431 . . . . 0.0 111.3 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 547' ' ' PHE . . . . . 0.691 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 14.8 m-85 -64.79 -14.85 60.54 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 548' ' ' ARG . . . . . 0.438 ' HD2' ' HA ' ' A' ' 548' ' ' ARG . 12.9 tpt180 -92.95 -14.75 27.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.84 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -80.67 -19.39 45.35 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.278 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.583 HD11 ' HB ' ' A' ' 631' ' ' VAL . 78.9 mt -97.95 137.2 20.89 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.888 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 34.8 Cg_exo -61.64 136.82 65.02 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.583 2.189 . . . . 0.0 112.051 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.64 -37.5 53.45 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.965 2.443 . . . . 0.0 112.437 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -54.31 -34.17 60.39 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.096 0.474 . . . . 0.0 111.245 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.93 -44.39 12.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.731 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 555' ' ' TRP . . . . . 0.463 ' HE3' HD12 ' A' ' 559' ' ' LEU . 0.0 OUTLIER -81.46 -37.94 27.2 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 29.3 t -54.66 -34.91 62.92 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -66.57 -42.88 86.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.506 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.702 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 46.3 mt -59.06 -54.36 47.98 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.858 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.842 ' HG ' HD21 ' A' ' 565' ' ' LEU . 1.0 OUTLIER -70.7 -3.13 16.97 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -76.96 -29.57 56.97 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.681 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 561' ' ' ASP . . . . . 0.635 ' OD1' ' HG3' ' A' ' 563' ' ' LYS . 11.1 t70 -142.73 150.95 40.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.556 -176.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.05 81.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.635 ' HG3' ' OD1' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -80.52 -18.45 48.47 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.735 -178.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.53 ' HG2' ' HB3' ' A' ' 561' ' ' ASP . 15.5 mm-40 -72.38 -42.89 64.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.842 HD21 ' HG ' ' A' ' 559' ' ' LEU . 16.8 mt -61.93 -57.16 12.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.09 174.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -54.66 -27.27 38.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.991 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -53.41 -61.78 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.168 0.293 . . . . 0.0 111.491 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 68.7 mt -84.85 -37.65 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.873 0.368 . . . . 0.0 110.207 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.782 HD21 HG12 ' A' ' 522' ' ' ILE . 29.3 tp -55.0 -37.43 66.58 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.822 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 7.8 mtpm? -78.87 -12.91 60.05 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.627 ' HB2' ' CB ' ' A' ' 593' ' ' GLN . 62.0 t80 -84.4 -11.99 55.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.414 0.626 . . . . 0.0 109.666 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 572' ' ' HIS . . . . . 0.61 ' HE1' HG13 ' A' ' 631' ' ' VAL . 12.3 m170 -79.49 -16.7 55.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.871 171.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.587 ' HB ' ' HG ' ' A' ' 592' ' ' LEU . 10.7 mm -98.31 115.53 38.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.598 -176.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -80.45 153.83 35.73 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.043 172.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.79 -11.82 59.92 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -171.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.6 177.68 10.1 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.483 HG13 ' HB ' ' A' ' 536' ' ' VAL . 41.7 mt -87.28 120.07 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.572 -172.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' ' 589' ' ' LEU . 4.2 tt -121.36 99.32 6.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.0 167.91 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.918 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 580' ' ' SER . . . . . 0.687 ' HB2' ' HB2' ' A' ' 617' ' ' ASP . 36.6 t -56.98 -34.89 68.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.464 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.36 -9.57 61.33 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.345 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -106.03 -9.43 32.19 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.596 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 580' ' ' SER . 76.0 mt -61.97 -44.39 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 584' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . 59.14 -99.0 0.12 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.753 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -121.03 -53.18 2.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.937 0.399 . . . . 0.0 110.197 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 599' ' ' VAL . 5.3 tt -162.35 107.75 1.21 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 75.1 t -126.73 129.3 71.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 588' ' ' ARG . . . . . 0.626 ' HD3' ' HD2' ' A' ' 596' ' ' LYS . 4.0 ptp85 -97.09 128.16 43.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.727 0.775 . . . . 0.0 111.753 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.54 ' HB2' HD12 ' A' ' 578' ' ' LEU . 21.4 tp -120.4 131.92 55.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.843 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 596' ' ' LYS . 81.1 tttt -76.51 151.97 36.22 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.169 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.591 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 85.7 p -110.9 -173.69 2.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.51 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 59.6 mt -80.43 -36.12 34.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.132 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 593' ' ' GLN . . . . . 0.627 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.3 tt0 -58.46 -30.78 67.21 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.365 0.602 . . . . 0.0 110.502 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.7 6.14 6.16 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.079 -1.058 . . . . 0.0 114.89 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -123.52 -170.54 2.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 118.033 0.917 . . . . 0.0 109.793 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.626 ' HD2' ' HD3' ' A' ' 588' ' ' ARG . 23.4 pttm -103.82 142.04 35.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.124 0.487 . . . . 0.0 111.175 -172.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.486 HD21 ' O ' ' A' ' 571' ' ' TYR . 41.8 mt -89.95 117.03 28.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.629 175.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -82.35 94.24 7.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 583' ' ' ILE . 45.6 t -100.56 124.25 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.782 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.645 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 32.9 t -122.77 161.52 23.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.67 -176.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 606' ' ' VAL . 60.0 tp -142.53 113.22 7.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.587 ' O ' HG12 ' A' ' 605' ' ' VAL . 87.8 tttt -135.13 99.79 4.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.806 0.336 . . . . 0.0 110.443 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.56 67.0 1.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.655 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 69.31 10.38 7.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 171.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 605' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 602' ' ' LYS . 11.6 p -122.15 126.84 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.175 0.512 . . . . 0.0 110.962 171.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.774 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 40.0 t -93.83 138.15 21.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.537 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 607' ' ' SER . . . . . 0.645 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 19.3 m -124.26 104.47 8.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.424 HG11 ' CD1' ' A' ' 540' ' ' PHE . 6.9 p -110.4 117.1 54.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.867 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.412 HD22 HD22 ' A' ' 597' ' ' LEU . 2.9 m120 60.72 33.55 20.16 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.812 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm 83.18 -13.1 0.82 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.013 1.325 . . . . 0.0 111.861 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.501 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 19.9 mm-40 -91.7 132.47 33.06 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.96 0.409 . . . . 0.0 110.604 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 606' ' ' VAL . 2.7 Cg_exo -75.5 125.95 9.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.909 2.406 . . . . 0.0 112.38 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.774 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 22.9 t -83.7 133.1 29.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -75.76 -60.28 2.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.972 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 615' ' ' GLU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 616' ' ' PRO . 38.7 mt-10 -138.89 101.18 7.88 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 615' ' ' GLU . 80.5 Cg_endo -73.1 168.74 23.96 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.877 2.385 . . . . 0.0 114.137 176.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.687 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 1.4 t70 76.11 42.79 0.18 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.158 165.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 36.7 mt -94.62 92.65 3.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 167.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 619' ' ' MET . . . . . 0.503 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 59.5 mtp -80.09 136.16 36.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.243 0.544 . . . . 0.0 112.268 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -99.49 -172.76 2.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.501 172.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 13.2 p -76.76 -26.73 54.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.965 0.412 . . . . 0.0 111.316 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.493 ' OD1' HG23 ' A' ' 505' ' ' VAL . 27.0 p-10 -116.8 15.7 15.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.894 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 623' ' ' GLY . . . . . 0.429 ' HA2' HG12 ' A' ' 577' ' ' ILE . . . 164.3 -157.53 29.88 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.921 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 624' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 13.0 p -133.43 144.73 35.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.826 0.346 . . . . 0.0 110.652 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 79.6 t -114.72 142.27 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.226 0.536 . . . . 0.0 110.48 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 626' ' ' HIS . . . . . 0.463 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 68.0 m-70 -126.59 121.9 33.53 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.262 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.574 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 85.4 t -76.16 117.98 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 111.501 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.433 HD12 ' O ' ' A' ' 630' ' ' ASN . 1.5 pt -119.02 142.53 33.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.291 173.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 39.9 p -96.29 7.41 46.53 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.708 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 630' ' ' ASN . . . . . 0.433 ' O ' HD12 ' A' ' 628' ' ' ILE . 6.0 m-20 -128.79 144.05 51.07 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.249 176.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.61 HG13 ' HE1' ' A' ' 572' ' ' HIS . 47.0 t -83.43 157.31 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 540' ' ' PHE . 86.9 mt -91.57 116.72 29.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.323 0.582 . . . . 0.0 111.397 -166.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -142.73 118.28 10.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.034 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.421 -176.159 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -71.22 111.31 3.62 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.678 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 14.8 tpt -122.3 141.07 51.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.715 0.293 . . . . 0.0 110.215 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -139.25 -151.91 5.79 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.105 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 508' ' ' VAL . 58.3 p -94.46 -170.31 2.23 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.694 ' O ' HD13 ' A' ' 509' ' ' LEU . 73.0 t -46.06 -42.83 4.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.603 170.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.7 tpt -59.73 -40.61 88.63 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.659 0.266 . . . . 0.0 111.066 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' ASP . . . . . 0.528 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 2.2 t70 -68.81 -34.55 75.72 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.207 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 505' ' ' VAL . 99.1 t -51.79 -56.89 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.001 0.429 . . . . 0.0 110.85 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.694 HD13 ' O ' ' A' ' 505' ' ' VAL . 5.4 mp -57.31 -42.33 81.62 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.461 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 510' ' ' LYS . 1.5 tmmt? -67.32 -25.76 66.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -99.49 13.01 61.51 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.872 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -122.63 139.13 54.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.922 0.391 . . . . 0.0 110.895 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -75.46 -16.47 60.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.489 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -91.29 -24.83 19.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.824 0.345 . . . . 0.0 110.901 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.923 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 17.2 m-85 -107.01 8.36 30.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.656 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 13.3 p -54.05 -54.22 42.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -67.87 -29.89 69.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.214 0.53 . . . . 0.0 109.866 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.473 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 41.8 tp -57.42 -45.83 84.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.404 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 515' ' ' PHE . 10.0 t -52.75 -52.02 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.394 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.54 77.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.181 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -72.67 -49.57 30.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.51 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.529 HG12 HD13 ' A' ' 569' ' ' LEU . 77.1 mt -57.94 -35.1 50.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.502 0.668 . . . . 0.0 109.681 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 523' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.2 OUTLIER -56.63 -57.5 12.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.21 173.279 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.2 m -57.4 -26.55 61.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.793 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -77.95 -15.85 58.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.369 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 79.51 8.29 87.86 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.341 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 527' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 566' ' ' ALA . 71.2 mt -83.26 9.19 11.3 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.795 0.331 . . . . 0.0 111.06 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 46.4 m -52.99 -43.66 66.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -51.54 -45.89 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.388 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 16.2 m -63.91 -41.87 97.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.337 . . . . 0.0 111.735 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 80.5 mt -91.24 -14.1 31.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.841 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -87.56 -7.4 57.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.023 0.439 . . . . 0.0 110.341 172.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -92.79 147.47 22.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.468 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.11 151.94 43.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.71 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 153.0 -161.18 29.48 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.892 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.684 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.7 m -120.76 127.71 75.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.808 0.337 . . . . 0.0 110.23 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -141.84 155.53 45.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.083 0.468 . . . . 0.0 111.046 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.1 m -124.42 100.83 6.86 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 167.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.609 HG22 HG12 ' A' ' 573' ' ' ILE . 59.7 t -104.54 113.78 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -173.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 60.3 m-85 -86.26 113.84 22.59 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -103.58 116.57 61.73 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -169.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 541' ' ' ALA . 8.2 Cg_exo -72.97 139.42 29.99 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.251 2.634 . . . . 0.0 112.007 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 628' ' ' ILE . 67.6 p -83.05 -176.42 6.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.138 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.22 -30.95 69.73 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.112 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -64.53 -29.81 70.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -67.79 -35.28 78.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.378 0.609 . . . . 0.0 111.339 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 547' ' ' PHE . . . . . 0.448 ' O ' HD22 ' A' ' 550' ' ' LEU . 6.2 m-85 -73.25 -13.28 61.11 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.131 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -94.57 -38.53 10.83 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.148 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -90.96 7.24 41.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.393 0.616 . . . . 0.0 111.508 -172.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.799 HD12 ' CD1' ' A' ' 555' ' ' TRP . 0.5 OUTLIER -74.97 163.52 67.65 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.235 -178.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.626 ' HB2' ' OE1' ' A' ' 554' ' ' GLU . 3.3 Cg_exo -81.09 126.36 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.307 2.005 . . . . 0.0 109.916 166.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.7 -43.24 60.97 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.518 2.812 . . . . 0.0 114.263 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 553' ' ' ARG . . . . . 0.447 ' HD3' ' HA ' ' A' ' 553' ' ' ARG . 24.9 mmt180 -71.93 -23.44 61.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 111.486 -172.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.63 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 0.9 OUTLIER -60.88 -53.48 56.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.45 0.643 . . . . 0.0 110.492 175.539 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 555' ' ' TRP . . . . . 0.799 ' CD1' HD12 ' A' ' 550' ' ' LEU . 4.7 m95 -80.3 -30.34 38.25 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.784 -172.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 556' ' ' SER . . . . . 0.44 ' OG ' ' HA ' ' A' ' 553' ' ' ARG . 25.3 p -58.68 -25.45 62.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.337 0.589 . . . . 0.0 109.577 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 557' ' ' ARG . . . . . 0.774 ' HG3' ' HG2' ' A' ' 564' ' ' GLU . 26.5 tpt180 -84.72 -46.98 10.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.743 173.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 554' ' ' GLU . 74.9 mt -63.19 -60.18 3.76 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.6 HD22 HD11 ' A' ' 565' ' ' LEU . 0.1 OUTLIER -64.57 -12.35 44.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.891 0.376 . . . . 0.0 110.984 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -70.82 -35.84 65.98 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.848 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -145.78 147.3 31.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.319 0.56 . . . . 0.0 110.891 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -67.96 -47.29 69.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.367 -170.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.565 ' H ' ' HD2' ' A' ' 563' ' ' LYS . 0.0 OUTLIER -69.7 -22.85 63.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.061 -177.033 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.774 ' HG2' ' HG3' ' A' ' 557' ' ' ARG . 7.4 tp10 -77.75 -42.41 34.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.691 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.6 HD11 HD22 ' A' ' 559' ' ' LEU . 0.3 OUTLIER -60.96 -49.43 77.5 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.495 0.664 . . . . 0.0 109.359 175.325 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 566' ' ' ALA . . . . . 0.485 ' HA ' HD11 ' A' ' 527' ' ' LEU . . . -55.83 -32.81 63.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.537 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 567' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 570' ' ' LYS . 25.6 t-20 -57.63 -46.97 83.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.458 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 558' ' ' LEU . 24.4 mt -83.98 -41.62 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.991 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.529 HD13 HG12 ' A' ' 522' ' ' ILE . 36.0 mt -57.87 -27.34 63.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 592' ' ' LEU . 22.3 ptmt -76.79 -12.66 60.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.014 0.435 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.6 ' O ' HD21 ' A' ' 597' ' ' LEU . 41.1 t80 -83.53 -18.72 37.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.228 0.537 . . . . 0.0 109.79 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 572' ' ' HIS . . . . . 0.521 ' NE2' ' HB2' ' A' ' 632' ' ' LEU . 13.4 m-70 -76.16 -10.12 59.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.178 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.609 HG12 HG22 ' A' ' 539' ' ' VAL . 80.1 mt -115.78 119.63 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.056 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.708 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -83.83 161.96 38.75 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.902 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -90.15 3.19 54.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 576' ' ' GLU . . . . . 0.416 ' HA ' HG23 ' A' ' 536' ' ' VAL . 11.4 pt-20 -160.68 170.45 20.76 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.436 172.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.684 HG13 ' HB ' ' A' ' 536' ' ' VAL . 64.3 mt -87.9 126.2 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.207 -168.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' A' ' 589' ' ' LEU . 2.4 tt -121.51 93.51 4.03 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 20.7 m -77.65 166.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 111.81 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 580' ' ' SER . . . . . 0.627 ' HA ' HD12 ' A' ' 583' ' ' ILE . 20.9 t -62.24 -28.19 69.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.306 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.66 68.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.082 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.23 -22.54 11.58 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.035 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.866 HG22 ' HB2' ' A' ' 601' ' ' LEU . 74.0 mt -59.99 109.8 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.103 0.478 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -114.22 -154.24 11.02 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.576 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -50.92 -48.56 60.64 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.981 0.39 . . . . 0.0 110.79 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 4.1 tt -164.36 116.62 1.32 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 587' ' ' VAL . . . . . 0.443 HG13 HD11 ' A' ' 578' ' ' LEU . 7.3 p -133.67 123.96 46.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 588' ' ' ARG . . . . . 0.567 ' HD3' ' H ' ' A' ' 588' ' ' ARG . 0.1 OUTLIER -97.23 129.66 44.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.544 0.687 . . . . 0.0 110.873 -174.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.698 ' HB2' HD12 ' A' ' 578' ' ' LEU . 1.5 tm? -110.94 120.04 41.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.242 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -67.24 146.93 53.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.111 0.481 . . . . 0.0 111.286 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.708 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.1 p -106.69 -174.78 2.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.835 -176.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 570' ' ' LYS . 72.9 mt -82.03 -41.44 20.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.06 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 593' ' ' GLN . . . . . 0.518 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.7 tt0 -59.05 -29.76 67.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.126 0.489 . . . . 0.0 111.024 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 126.74 -14.16 6.76 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.573 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -89.9 -164.38 1.15 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.754 0.777 . . . . 0.0 109.601 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -120.79 137.16 54.67 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.904 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.6 HD21 ' O ' ' A' ' 571' ' ' TYR . 90.6 mt -84.57 116.16 23.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.724 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 90.2 mt-10 -85.28 89.69 7.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.293 -175.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.493 HG12 HG23 ' A' ' 583' ' ' ILE . 47.8 t -91.04 122.23 42.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.74 0.305 . . . . 0.0 111.272 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.647 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 35.9 t -128.53 154.53 46.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.866 ' HB2' HG22 ' A' ' 583' ' ' ILE . 41.0 tp -126.07 129.07 48.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.458 ' HE2' ' HB2' ' A' ' 602' ' ' LYS . 19.1 ttmm -146.78 102.63 3.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.734 0.302 . . . . 0.0 110.199 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 603' ' ' ASN . . . . . 0.441 ' C ' ' H ' ' A' ' 605' ' ' VAL . 18.7 t-20 58.72 56.88 3.95 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.389 -176.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 64.7 t30 68.28 -14.89 0.23 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.983 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 605' ' ' VAL . . . . . 0.441 ' H ' ' C ' ' A' ' 603' ' ' ASN . 58.7 t -82.42 110.42 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 55.9 t -79.38 136.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.837 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 607' ' ' SER . . . . . 0.647 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 36.8 m -124.23 109.42 13.38 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.948 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 11.4 p -112.95 129.14 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.424 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.661 ' ND2' HD13 ' A' ' 632' ' ' LEU . 44.0 m-20 57.86 29.43 17.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm 74.04 22.48 2.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.453 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 0.2 OUTLIER -125.95 149.08 65.05 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 5.9 Cg_exo -78.81 126.27 7.17 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.085 2.524 . . . . 0.0 112.666 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 61.2 t -77.76 136.0 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.524 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -84.74 -42.17 15.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.957 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.58 95.11 3.78 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.665 0.269 . . . . 0.0 110.731 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.99 167.15 27.68 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.437 2.091 . . . . 0.0 113.873 172.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 3.3 t70 75.15 28.95 0.98 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.721 165.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.51 86.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 619' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 63.1 mtp -78.38 148.08 33.83 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.362 0.601 . . . . 0.0 112.285 -171.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -124.17 -171.14 2.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.646 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.6 p -80.68 -19.71 44.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.748 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.495 ' OD1' HG23 ' A' ' 505' ' ' VAL . 24.4 p-10 -117.47 15.98 14.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.838 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.15 -148.34 19.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.886 -1.149 . . . . 0.0 113.085 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 624' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.7 p -132.14 147.6 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.575 0.226 . . . . 0.0 110.541 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 78.6 t -118.79 142.29 34.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.078 0.465 . . . . 0.0 110.768 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 626' ' ' HIS . . . . . 0.607 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 52.2 m-70 -130.42 126.82 37.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.413 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.923 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 96.2 t -74.47 118.29 19.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.91 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 543' ' ' THR . 1.2 pt -110.49 171.86 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.014 0.435 . . . . 0.0 110.714 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 21.6 p -117.42 -5.89 11.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.711 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -131.39 168.2 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.306 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 76.8 t -84.03 148.21 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.661 HD13 ' ND2' ' A' ' 609' ' ' ASN . 82.6 mt -110.36 139.23 45.77 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.291 -170.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -153.28 156.16 37.9 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.941 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.812 0.339 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -116.78 100.45 0.9 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.174 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 78.4 mtp -134.68 -78.02 0.45 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.968 0.413 . . . . 0.0 110.2 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -178.77 -157.65 19.75 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.454 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.477 HG22 ' OE2' ' A' ' 534' ' ' GLU . 82.0 p -86.17 -168.94 2.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.647 -0.777 . . . . 0.0 110.988 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.422 ' CG2' HG23 ' A' ' 625' ' ' VAL . 4.7 p -56.94 -27.21 26.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.614 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.557 ' HE2' ' HB2' ' A' ' 531' ' ' LEU . 39.5 tpp -71.05 -44.5 65.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.842 174.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 507' ' ' ASP . . . . . 0.669 ' HA ' ' HB3' ' A' ' 510' ' ' LYS . 5.9 t70 -68.68 -27.31 65.86 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.031 0.443 . . . . 0.0 110.198 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 504' ' ' THR . 91.4 t -50.02 -41.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.674 171.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.487 ' N ' HD23 ' A' ' 509' ' ' LEU . 0.6 OUTLIER -82.03 -36.36 27.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.887 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.679 ' HA ' HG21 ' A' ' 519' ' ' VAL . 28.7 tttm -62.5 -31.45 72.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.802 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -93.78 6.57 73.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.007 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -114.66 137.64 51.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.816 0.341 . . . . 0.0 111.007 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -75.8 -24.08 55.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.589 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -77.56 -28.89 51.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.367 0.603 . . . . 0.0 109.7 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.796 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 26.9 m-85 -105.28 14.78 28.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.877 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 34.8 p -56.45 -53.16 60.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.865 -176.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -68.42 -30.53 69.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.07 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.612 HD13 ' HZ ' ' A' ' 547' ' ' PHE . 54.7 tp -55.4 -47.5 75.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.76 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' A' ' 510' ' ' LYS . 4.0 t -52.27 -47.2 45.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.716 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.82 74.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.041 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.6 -50.2 39.66 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.283 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.58 HG12 HD13 ' A' ' 569' ' ' LEU . 42.9 mt -60.59 -31.38 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.529 0.681 . . . . 0.0 109.658 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 523' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.6 OUTLIER -59.63 -59.33 5.61 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.203 173.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.0 m -58.08 -26.83 63.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.897 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -75.09 -17.29 60.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.184 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 70.96 50.32 24.0 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.612 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 566' ' ' ALA . 76.9 mt -128.41 15.47 6.6 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 88.1 m -61.82 -51.57 67.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' GLU . . . . . 0.665 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 0.0 OUTLIER -60.24 -29.08 68.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.486 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 36.7 m -62.42 -47.95 81.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.962 0.41 . . . . 0.0 110.491 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.557 ' HB2' ' HE2' ' A' ' 506' ' ' MET . 67.2 mt -91.09 -5.03 55.74 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.693 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 532' ' ' ASN . . . . . 0.584 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 5.4 m-20 -83.95 -5.89 59.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.042 172.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 533' ' ' ARG . . . . . 0.665 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 80.5 mtp180 -85.65 135.41 33.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.792 0.33 . . . . 0.0 110.661 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 534' ' ' GLU . . . . . 0.477 ' OE2' HG22 ' A' ' 504' ' ' THR . 13.3 mm-40 -78.76 137.04 37.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.951 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 164.47 -117.29 0.75 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.053 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 1.089 HG23 HG13 ' A' ' 577' ' ' ILE . 0.7 OUTLIER -145.99 125.56 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.58 0.229 . . . . 0.0 110.709 -178.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -155.03 137.22 14.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.68 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 98.1 m -107.35 102.32 11.62 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.715 HG22 HG12 ' A' ' 573' ' ' ILE . 61.3 t -99.84 114.89 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.095 0.474 . . . . 0.0 111.211 -175.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 48.6 m-85 -85.77 108.39 18.06 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -100.56 119.39 58.85 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.057 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 628' ' ' ILE . 85.5 Cg_endo -82.76 140.14 10.22 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.53 2.153 . . . . 0.0 112.437 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 75.4 p -78.7 -175.93 4.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.532 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -68.94 -35.23 76.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.378 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 545' ' ' GLU . 1.7 mp0 -61.62 -29.96 70.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.064 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -70.07 -34.48 73.25 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.392 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 547' ' ' PHE . . . . . 0.612 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 21.9 m-85 -70.87 -15.9 62.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.605 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -91.46 -10.91 39.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.063 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -88.09 -2.06 58.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.362 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.77 HD12 ' HE1' ' A' ' 555' ' ' TRP . 66.5 mt -109.68 144.07 29.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.189 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 26.3 Cg_exo -62.74 126.5 18.34 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.506 2.137 . . . . 0.0 111.126 173.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.27 -24.61 60.54 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.891 2.394 . . . . 0.0 113.499 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -68.27 -40.84 81.73 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.788 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -37.84 79.68 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.677 0.751 . . . . 0.0 109.574 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 555' ' ' TRP . . . . . 0.77 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -70.35 -38.24 74.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.832 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.4 t -55.16 -28.25 51.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.574 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 557' ' ' ARG . . . . . 0.907 ' HG2' ' HG2' ' A' ' 564' ' ' GLU . 14.6 ttp85 -75.72 -32.11 59.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.817 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.496 ' HB3' ' HG ' ' A' ' 565' ' ' LEU . 9.1 mt -78.4 -53.74 6.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.056 0.455 . . . . 0.0 110.333 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 565' ' ' LEU . 1.1 mm? -70.64 -14.31 62.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.261 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -90.6 -49.01 3.3 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -105.15 114.32 28.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.103 0.477 . . . . 0.0 110.063 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.19 -33.09 73.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.214 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -62.31 -37.36 85.28 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.907 ' HG2' ' HG2' ' A' ' 557' ' ' ARG . 7.8 tp10 -69.48 -44.79 70.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.945 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -62.28 -42.02 98.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.014 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 566' ' ' ALA . . . . . 0.524 ' HA ' HD11 ' A' ' 527' ' ' LEU . . . -57.94 -38.13 75.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.363 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 567' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 564' ' ' GLU . 92.7 m-20 -57.06 -56.83 16.64 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.9 0.381 . . . . 0.0 111.077 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 50.3 mt -67.53 -50.21 63.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.486 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.58 HD13 HG12 ' A' ' 522' ' ' ILE . 83.2 mt -59.73 -23.22 63.01 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 34.7 mttp -70.89 -18.09 62.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.781 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.626 ' O ' HD21 ' A' ' 597' ' ' LEU . 35.3 t80 -92.74 -1.83 56.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.398 0.618 . . . . 0.0 110.167 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -89.58 -15.13 33.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.208 174.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.715 HG12 HG22 ' A' ' 539' ' ' VAL . 76.3 mt -111.02 121.0 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.873 -175.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -88.23 153.85 24.77 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.295 176.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.9 -21.32 64.24 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 576' ' ' GLU . . . . . 0.626 ' HA ' ' CG2' ' A' ' 536' ' ' VAL . 15.7 pt-20 -145.4 153.3 41.06 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 122.224 -0.298 . . . . 0.0 110.676 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 1.089 HG13 HG23 ' A' ' 536' ' ' VAL . 75.2 mt -70.24 114.62 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.814 -176.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.726 HD12 ' HB2' ' A' ' 589' ' ' LEU . 1.6 tt -111.4 98.96 7.85 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 583' ' ' ILE . 28.5 m -76.59 163.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.534 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 580' ' ' SER . . . . . 0.731 ' HA ' HD12 ' A' ' 583' ' ' ILE . 28.4 m -56.75 -31.13 64.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.378 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.19 -15.54 67.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.861 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.1 -10.97 40.92 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.219 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 580' ' ' SER . 71.0 mt -78.18 -3.86 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 122.876 0.47 . . . . 0.0 111.262 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -50.7 129.12 29.86 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.804 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 71.49 -85.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.796 0.838 . . . . 0.0 110.868 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.474 HD21 ' HG3' ' A' ' 598' ' ' GLU . 4.7 tt -167.55 117.56 0.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 89.6 t -132.94 130.72 58.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.941 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 588' ' ' ARG . . . . . 0.525 ' HB3' ' OE1' ' A' ' 598' ' ' GLU . 0.7 OUTLIER -96.96 128.77 44.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.577 0.703 . . . . 0.0 111.28 -178.201 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.726 ' HB2' HD12 ' A' ' 578' ' ' LEU . 31.1 tp -116.84 126.73 53.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.369 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -65.9 134.35 52.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.777 0.323 . . . . 0.0 110.373 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.644 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 86.7 p -99.24 -171.63 2.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.554 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 570' ' ' LYS . 79.3 mt -81.64 -39.05 25.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -62.54 -30.36 71.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.559 0.695 . . . . 0.0 110.263 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.44 -17.46 6.96 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.503 170.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 595' ' ' ASP . . . . . 0.497 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.3 t70 -84.12 -176.77 6.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.461 0.631 . . . . 0.0 109.705 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.21 139.56 39.69 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.871 0.367 . . . . 0.0 110.693 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.626 HD21 ' O ' ' A' ' 571' ' ' TYR . 94.9 mt -81.97 115.52 21.17 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.525 ' OE1' ' HB3' ' A' ' 588' ' ' ARG . 2.3 tp10 -94.07 87.28 5.26 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.639 HG22 HG23 ' A' ' 608' ' ' VAL . 2.0 t -99.12 128.16 51.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.007 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' A' ' 606' ' ' VAL . 33.1 t -131.29 108.5 9.71 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.365 -174.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 606' ' ' VAL . 56.8 tp -108.16 116.09 31.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.825 0.345 . . . . 0.0 110.442 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -151.37 133.63 15.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.678 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 58.58 40.56 23.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.598 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 66.15 11.87 8.14 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.597 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.84 107.47 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.022 0.439 . . . . 0.0 110.223 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 613' ' ' VAL . 1.4 p -98.14 137.84 24.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.668 176.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 50.3 m -132.19 120.57 22.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 599' ' ' VAL . 7.6 p -110.27 123.65 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.067 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.706 ' ND2' HD13 ' A' ' 632' ' ' LEU . 24.0 m-20 61.38 33.88 18.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.468 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 48.5 mtpt 83.31 -14.19 0.73 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.32 1.012 . . . . 0.0 112.03 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 34.0 mm-40 -96.72 122.59 56.57 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.811 0.339 . . . . 0.0 110.547 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 23.7 Cg_exo -63.83 133.71 40.26 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.851 2.367 . . . . 0.0 112.499 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.915 ' HB ' HG13 ' A' ' 606' ' ' VAL . 44.4 t -88.8 137.46 21.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -87.09 -60.61 1.93 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.397 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 615' ' ' GLU . . . . . 0.451 ' H ' ' HB ' ' A' ' 627' ' ' VAL . 16.5 mp0 -128.23 92.44 41.49 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.618 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.28 167.72 26.59 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.606 2.204 . . . . 0.0 113.219 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 74.88 38.28 0.46 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.463 0.705 . . . . 0.0 112.827 166.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 34.0 mt -98.11 89.9 2.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 171.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 619' ' ' MET . . . . . 0.602 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 53.0 mtp -82.44 160.46 22.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.542 0.686 . . . . 0.0 112.499 -169.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 620' ' ' ALA . . . . . 0.415 ' HB2' HG21 ' A' ' 508' ' ' VAL . . . -130.95 -171.17 2.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.446 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 26.0 p -72.93 -37.11 67.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.181 0.515 . . . . 0.0 110.811 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.46 ' HB3' ' OE2' ' A' ' 534' ' ' GLU . 33.4 p-10 -109.95 13.41 23.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.172 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 165.3 -138.1 5.05 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.193 -1.479 . . . . 0.0 113.927 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 624' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 10.1 p -160.13 148.74 6.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.727 -171.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 625' ' ' VAL . . . . . 0.422 HG23 ' CG2' ' A' ' 505' ' ' VAL . 47.8 t -119.49 139.99 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.296 0.57 . . . . 0.0 110.968 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 626' ' ' HIS . . . . . 0.548 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 60.9 m-70 -127.52 117.85 22.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.796 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 58.1 t -72.34 119.0 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -173.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 542' ' ' PRO . 0.6 OUTLIER -114.31 150.0 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.074 0.464 . . . . 0.0 110.733 173.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 18.1 p -96.82 6.84 47.9 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.924 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -138.67 155.21 48.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.953 0.406 . . . . 0.0 111.489 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 60.4 t -86.99 157.21 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.706 HD13 ' ND2' ' A' ' 609' ' ' ASN . 38.2 mt -115.65 146.94 41.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.724 0.297 . . . . 0.0 110.899 -167.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -157.72 132.52 8.59 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 634' ' ' ALA . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 571' ' ' TYR . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.712 -0.661 . . . . 0.0 111.105 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -54.99 104.76 0.29 Allowed Glycine 0 C--N 1.33 0.218 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.579 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 26.6 ttt -153.2 145.93 24.32 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 73.19 -132.63 17.04 Favored Glycine 0 CA--C 1.504 -0.619 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.673 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 508' ' ' VAL . 68.7 p -124.91 -170.48 2.17 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.691 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 54.8 t -42.54 -42.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.638 0.586 . . . . 0.0 110.727 168.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -48.9 79.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.261 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -71.54 -28.32 63.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.816 0.341 . . . . 0.0 110.456 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 504' ' ' THR . 71.5 t -53.98 -42.7 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.588 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 4.8 mt -82.18 -33.18 29.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.162 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.514 ' HA ' HG21 ' A' ' 519' ' ' VAL . 1.9 tmmm? -59.9 -40.02 87.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.991 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -89.13 -2.81 76.96 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.785 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.35 144.98 30.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.645 0.723 . . . . 0.0 110.811 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -75.25 -35.0 61.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.578 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -78.43 -13.37 59.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.881 0.372 . . . . 0.0 110.445 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.621 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 24.1 m-85 -113.41 9.63 18.19 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.003 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 64.5 m -58.54 -44.53 89.65 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -173.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.0 ptm -83.24 -20.15 35.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.701 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.57 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 46.9 tp -57.95 -41.67 83.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.38 0.609 . . . . 0.0 109.462 172.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 510' ' ' LYS . 18.6 t -52.04 -52.97 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.666 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -60.32 -32.84 71.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.6 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.11 -49.87 46.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.951 0.405 . . . . 0.0 110.508 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 527' ' ' LEU . 58.6 mt -59.42 -34.2 53.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.486 0.66 . . . . 0.0 109.953 175.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -66.56 -49.51 66.16 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.924 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.3 m -57.12 -34.27 68.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.378 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.945 ' HB2' HD22 ' A' ' 565' ' ' LEU . . . -78.18 -17.97 56.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.142 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 74.58 18.62 79.99 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.005 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 527' ' ' LEU . . . . . 0.464 ' HB2' HG23 ' A' ' 522' ' ' ILE . 93.3 mt -84.6 5.83 26.31 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.547 -0.384 . . . . 0.0 111.466 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 19.0 m -56.76 -44.13 81.48 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.097 0.475 . . . . 0.0 109.954 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -53.99 -35.23 61.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.029 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 8.3 m -69.49 -36.76 76.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 111.447 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 97.2 mt -96.3 -27.41 14.99 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -173.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -84.58 23.27 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -118.46 152.42 35.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.815 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -69.77 115.68 9.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -178.13 -163.78 30.23 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.68 ' HB ' HG13 ' A' ' 577' ' ' ILE . 20.8 m -119.52 127.93 75.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 537' ' ' TYR . . . . . 0.512 ' O ' ' HA3' ' A' ' 623' ' ' GLY . 96.5 m-85 -148.54 140.6 23.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.795 0.331 . . . . 0.0 110.683 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 93.5 m -113.74 101.58 9.43 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 170.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.575 HG21 HG11 ' A' ' 505' ' ' VAL . 56.6 t -101.41 119.78 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.419 -174.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.631 ' CD2' HG11 ' A' ' 608' ' ' VAL . 51.5 m-85 -86.43 111.98 21.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -106.99 112.88 63.07 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.705 -167.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.767 ' HA ' HG13 ' A' ' 628' ' ' ILE . 3.3 Cg_exo -79.7 143.21 16.59 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.243 2.628 . . . . 0.0 112.709 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 68.9 p -85.73 -177.44 6.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.585 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -67.86 -25.57 65.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.767 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -71.13 -22.03 62.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.548 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -83.67 -34.62 24.95 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.059 0.457 . . . . 0.0 111.467 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 547' ' ' PHE . . . . . 0.504 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 5.0 m-85 -68.55 -13.98 62.7 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -93.57 -17.11 23.7 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.615 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -82.8 -13.03 56.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.019 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.577 HD12 ' HE1' ' A' ' 555' ' ' TRP . 46.4 mt -101.63 133.64 20.68 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.8 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 551' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.8 135.28 67.09 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.384 2.056 . . . . 0.0 110.925 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.54 -33.56 23.91 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.199 2.599 . . . . 0.0 113.579 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 553' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 553' ' ' ARG . 11.4 ptt180 -60.24 -36.24 77.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.656 0.265 . . . . 0.0 111.388 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 557' ' ' ARG . 0.4 OUTLIER -72.72 -40.84 65.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.92 0.39 . . . . 0.0 110.777 -175.495 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 555' ' ' TRP . . . . . 0.577 ' HE1' HD12 ' A' ' 550' ' ' LEU . 1.1 m95 -80.69 -29.04 36.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.227 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 37.5 t -57.03 -29.65 63.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.332 168.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 557' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 554' ' ' GLU . 50.0 mtt180 -75.52 -40.04 57.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.206 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.516 ' HG ' ' HA ' ' A' ' 555' ' ' TRP . 5.3 mt -75.77 -54.66 6.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.882 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 559' ' ' LEU . 0.2 OUTLIER -64.36 -14.21 55.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.666 0.269 . . . . 0.0 111.583 178.19 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -98.65 -21.53 16.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.46 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 561' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 25.9 t70 -135.75 118.77 16.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.081 0.467 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.78 68.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.792 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.47 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 5.1 tmtm? -59.63 -43.32 93.88 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.096 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 567' ' ' ASN . 8.2 tp10 -75.76 -34.81 60.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.554 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.945 HD22 ' HB2' ' A' ' 525' ' ' ALA . 5.6 tt -68.57 -45.27 72.5 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.11 0.481 . . . . 0.0 109.759 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -64.2 -30.36 71.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.518 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 567' ' ' ASN . . . . . 0.639 ' HA ' ' OE1' ' A' ' 593' ' ' GLN . 39.0 t30 -55.93 -45.03 78.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.439 0.638 . . . . 0.0 110.506 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 60.6 mt -85.85 -62.53 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.442 -178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.45 HD11 HG12 ' A' ' 522' ' ' ILE . 3.2 tt -55.12 -35.76 65.0 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.548 ' HG2' ' HB2' ' A' ' 592' ' ' LEU . 19.7 ttpp -72.25 -12.34 61.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.62 ' O ' HD21 ' A' ' 597' ' ' LEU . 41.7 t80 -89.28 -18.71 26.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.589 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 572' ' ' HIS . . . . . 0.475 ' NE2' HG23 ' A' ' 631' ' ' VAL . 2.0 m-70 -73.3 -14.12 61.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.309 0.575 . . . . 0.0 109.91 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.538 HG12 HG22 ' A' ' 539' ' ' VAL . 61.2 mt -101.81 121.78 53.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.839 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.67 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -84.74 164.18 39.1 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.873 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.03 -33.35 75.6 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.171 0.588 . . . . 0.0 112.072 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 576' ' ' GLU . . . . . 0.469 ' HA ' HG23 ' A' ' 536' ' ' VAL . 13.6 pt-20 -146.37 -178.29 6.08 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.191 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.731 HG23 HG22 ' A' ' 624' ' ' VAL . 14.9 mt -82.28 110.56 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 123.395 0.434 . . . . 0.0 111.114 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 578' ' ' LEU . 1.2 tm? -117.67 94.54 4.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 27.5 m -81.96 172.18 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.473 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 580' ' ' SER . . . . . 0.562 ' HA ' HD12 ' A' ' 583' ' ' ILE . 15.8 m -63.03 -20.4 65.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.472 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.01 -13.14 63.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.437 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -103.55 -20.07 11.4 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 580' ' ' SER . 76.5 mt -74.85 90.12 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.202 0.525 . . . . 0.0 110.396 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -102.83 -123.98 5.37 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.876 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -66.5 -57.94 6.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.073 0.463 . . . . 0.0 110.23 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 55.0 tp -156.86 114.42 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.644 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 10.1 p -132.18 132.29 60.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 120.945 0.402 . . . . 0.0 110.126 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 588' ' ' ARG . . . . . 0.71 ' HG2' ' HA ' ' A' ' 598' ' ' GLU . 40.0 mtp180 -112.5 127.09 55.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.33 0.586 . . . . 0.0 110.899 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.61 126.83 55.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.912 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 3.7 tmmt? -62.95 140.77 58.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.67 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.8 p -103.6 -174.52 2.56 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.744 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.548 ' HB2' ' HG2' ' A' ' 570' ' ' LYS . 78.9 mt -81.56 -42.26 20.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.89 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 593' ' ' GLN . . . . . 0.639 ' OE1' ' HA ' ' A' ' 567' ' ' ASN . 20.4 tp60 -61.64 -29.26 69.95 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 127.18 11.7 3.37 Favored Glycine 0 C--N 1.321 -0.267 0 C-N-CA 120.028 -1.082 . . . . 0.0 114.521 166.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -117.43 -156.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -135.46 130.81 35.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.214 0.53 . . . . 0.0 111.922 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 588' ' ' ARG . 92.7 mt -68.6 122.33 18.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.851 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.71 ' HA ' ' HG2' ' A' ' 588' ' ' ARG . 30.0 tt0 -86.35 94.46 9.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.451 HG12 HG23 ' A' ' 583' ' ' ILE . 36.1 t -105.52 133.82 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.802 -175.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 606' ' ' VAL . 7.7 p -140.5 161.84 36.76 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.748 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.473 ' HB2' HG22 ' A' ' 583' ' ' ILE . 67.6 tp -127.46 113.26 15.94 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -136.84 126.21 24.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.443 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 60.6 t30 54.59 44.05 29.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.344 0.593 . . . . 0.0 110.546 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 65.3 t30 70.44 -0.39 2.9 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.355 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.76 119.68 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.489 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.788 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 25.9 t -77.59 148.48 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 607' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 611' ' ' GLU . 49.1 m -140.21 112.32 7.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.065 0.46 . . . . 0.0 111.968 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.631 HG11 ' CD2' ' A' ' 540' ' ' PHE . 7.5 p -117.17 135.71 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.156 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 1.061 ' HB2' HD23 ' A' ' 632' ' ' LEU . 77.1 m-20 53.58 33.18 15.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.177 0.513 . . . . 0.0 110.397 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt 77.22 9.09 2.71 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.373 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 608' ' ' VAL . 0.3 OUTLIER -113.97 149.65 42.24 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.433 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 1.4 Cg_endo -85.98 124.84 2.61 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.986 2.457 . . . . 0.0 113.161 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.788 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 49.9 t -76.19 143.94 12.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.383 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 614' ' ' ALA . . . . . 0.567 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -89.98 -43.98 10.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.415 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 615' ' ' GLU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 21.9 tt0 -151.06 92.07 3.86 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 120.971 0.415 . . . . 0.0 111.787 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.524 ' HG3' HG21 ' A' ' 606' ' ' VAL . 83.1 Cg_endo -76.28 169.45 21.97 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.914 2.409 . . . . 0.0 114.124 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 74.47 27.92 1.35 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.693 -1.139 . . . . 0.0 113.15 166.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 618' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 627' ' ' VAL . 45.0 mt -87.33 91.84 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 170.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 619' ' ' MET . . . . . 0.717 ' HG2' HG13 ' A' ' 624' ' ' VAL . 51.7 mtp -80.18 128.97 34.14 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.585 0.707 . . . . 0.0 112.176 -170.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -100.73 166.92 10.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.341 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -15.13 53.98 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.512 ' OD1' HG23 ' A' ' 505' ' ' VAL . 25.2 p-10 -116.62 15.51 15.51 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 623' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 537' ' ' TYR . . . 147.03 -133.51 4.81 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 119.765 -1.207 . . . . 0.0 113.455 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 624' ' ' VAL . . . . . 0.731 HG22 HG23 ' A' ' 577' ' ' ILE . 0.0 OUTLIER -129.32 152.7 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.109 0.481 . . . . 0.0 111.597 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 625' ' ' VAL . . . . . 0.513 HG22 HG13 ' A' ' 505' ' ' VAL . 43.7 t -122.65 131.14 73.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.586 170.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 626' ' ' HIS . . . . . 0.506 ' HB2' ' CD2' ' A' ' 540' ' ' PHE . 77.6 m-70 -120.14 110.56 16.77 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.18 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.621 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 98.9 t -66.93 118.39 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.691 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.767 HG13 ' HA ' ' A' ' 542' ' ' PRO . 5.1 pt -115.77 143.97 24.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.616 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 629' ' ' THR . . . . . 0.567 HG23 ' HB2' ' A' ' 614' ' ' ALA . 24.5 p -94.73 1.4 55.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.797 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 630' ' ' ASN . . . . . 0.462 ' ND2' ' HD2' ' A' ' 612' ' ' PRO . 6.5 m-80 -135.92 135.9 40.02 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.898 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.475 HG23 ' NE2' ' A' ' 572' ' ' HIS . 0.2 OUTLIER -90.3 147.18 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 172.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 1.061 HD23 ' HB2' ' A' ' 609' ' ' ASN . 1.5 mp -109.89 157.65 19.0 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.12 -158.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -160.79 156.86 25.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.576 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.838 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.558 -178.834 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -102.97 46.72 1.18 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.69 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 61.0 ttp -80.87 -26.83 36.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.363 0.601 . . . . 0.0 109.572 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -148.67 -155.26 6.61 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.928 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.439 ' HA ' HG22 ' A' ' 621' ' ' THR . 76.4 p -88.2 -171.67 3.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.838 175.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.579 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 93.5 t -45.16 -46.15 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 123.35 0.406 . . . . 0.0 111.33 174.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.74 ' SD ' ' HB2' ' A' ' 531' ' ' LEU . 0.0 OUTLIER -60.64 -38.11 83.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.886 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 507' ' ' ASP . . . . . 0.538 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 16.9 t70 -68.19 -38.52 82.09 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 505' ' ' VAL . 96.0 t -53.1 -40.42 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.421 176.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 8.1 mt -77.7 -20.38 53.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.099 -174.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -83.32 -26.24 30.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.162 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -89.38 -0.7 79.44 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.105 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -122.26 141.18 51.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.996 0.398 . . . . 0.0 111.441 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -75.5 -22.59 57.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.102 -177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -73.52 -20.24 60.71 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 110.374 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.726 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 15.9 m-85 -114.74 19.2 16.14 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.788 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 32.9 t -59.05 -57.31 13.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.75 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -64.5 -30.09 71.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.933 0.397 . . . . 0.0 110.237 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.563 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 57.8 tp -53.85 -45.43 70.92 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.873 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 515' ' ' PHE . 14.8 t -50.94 -51.32 21.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.856 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.42 82.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.143 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -65.53 -51.18 61.8 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.42 . . . . 0.0 109.871 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.542 HG21 ' HE3' ' A' ' 506' ' ' MET . 96.6 mt -56.76 -33.63 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.698 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -38.82 92.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.427 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 22.3 m -66.43 -22.22 66.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.035 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -89.51 -30.0 18.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.613 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.41 67.4 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 114.489 0.556 . . . . 0.0 114.489 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 2.0 pp -82.48 24.68 0.68 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.973 0.887 . . . . 0.0 112.531 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.471 HG23 ' HG2' ' A' ' 506' ' ' MET . 58.5 m -57.98 -42.06 84.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.414 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.44 -30.7 65.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.974 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 85.1 m -58.9 -48.61 80.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.802 0.334 . . . . 0.0 111.273 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.74 ' HB2' ' SD ' ' A' ' 506' ' ' MET . 82.9 mt -96.95 -1.22 46.15 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.214 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 532' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 528' ' ' THR . 2.1 t-20 -81.29 -19.01 43.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.964 0.412 . . . . 0.0 110.976 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 533' ' ' ARG . . . . . 0.453 ' HG2' ' H ' ' A' ' 534' ' ' GLU . 33.0 ttt180 -104.06 168.33 9.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.868 0.366 . . . . 0.0 111.238 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 534' ' ' GLU . . . . . 0.453 ' H ' ' HG2' ' A' ' 533' ' ' ARG . 10.7 tp10 -58.02 147.73 28.43 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.407 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 154.85 -178.3 31.64 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.707 ' HB ' HG13 ' A' ' 577' ' ' ILE . 14.9 m -116.85 126.45 74.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -149.7 142.81 24.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.067 0.461 . . . . 0.0 110.884 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 97.9 m -112.23 110.41 20.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.655 HG22 HG12 ' A' ' 573' ' ' ILE . 65.0 t -109.29 114.94 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 120.879 0.371 . . . . 0.0 111.031 -175.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.63 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 80.4 m-85 -86.33 109.79 19.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -101.7 118.74 58.98 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.528 -166.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.51 140.06 18.76 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.63 2.22 . . . . 0.0 111.778 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 69.5 p -78.8 -177.81 5.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.146 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 544' ' ' ASN . . . . . 0.545 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -73.58 -26.67 60.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.148 0.499 . . . . 0.0 110.152 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 548' ' ' ARG . 1.7 mp0 -68.36 -23.84 64.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.145 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -74.97 -31.37 61.44 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.883 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 547' ' ' PHE . . . . . 0.545 ' CD2' ' HA ' ' A' ' 544' ' ' ASN . 22.9 m-85 -65.64 -14.53 61.38 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 548' ' ' ARG . . . . . 0.641 ' HA ' ' HE ' ' A' ' 548' ' ' ARG . 3.3 mmp_? -93.93 -1.44 54.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.487 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -98.67 -11.38 22.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.769 HD12 ' HE1' ' A' ' 555' ' ' TRP . 32.5 mt -98.92 136.81 20.5 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.322 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 4.7 Cg_exo -74.8 140.25 25.83 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.884 2.389 . . . . 0.0 111.379 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 552' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 52.7 Cg_exo -57.57 -16.8 25.52 Favored 'Trans proline' 0 C--O 1.224 -0.187 0 C-N-CA 123.043 2.495 . . . . 0.0 112.397 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -53.33 -46.76 69.6 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.768 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 27.4 mm-40 -87.07 -40.5 14.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.239 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 555' ' ' TRP . . . . . 0.769 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.1 OUTLIER -62.26 -38.13 88.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.738 -173.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 24.4 t -52.24 -33.02 39.59 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.579 0.55 . . . . 0.0 111.195 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 -83.95 -37.0 22.85 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 120.531 0.205 . . . . 0.0 110.611 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.862 ' HB3' HD13 ' A' ' 565' ' ' LEU . 41.4 mt -64.78 -49.36 71.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.762 0.315 . . . . 0.0 111.336 -175.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.45 1.98 14.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.872 0.367 . . . . 0.0 111.316 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -108.47 -48.09 0.88 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.879 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -104.11 126.79 51.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.966 0.413 . . . . 0.0 109.906 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.64 66.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.268 -170.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 566' ' ' ALA . 0.0 OUTLIER -79.68 -20.88 45.54 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.295 -177.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.13 -38.82 69.19 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.022 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.862 HD13 ' HB3' ' A' ' 558' ' ' LEU . 18.1 tp -71.41 -41.43 69.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 566' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 563' ' ' LYS . . . -59.54 -40.55 87.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.15 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -55.08 -44.53 74.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 632' ' ' LEU . 63.3 mt -72.29 -45.45 61.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.493 HD13 HG12 ' A' ' 522' ' ' ILE . 89.5 mt -64.65 -25.55 68.0 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 97.3 mttt -74.13 -13.72 60.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.69 0.281 . . . . 0.0 111.44 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.557 ' O ' HD21 ' A' ' 597' ' ' LEU . 57.6 t80 -91.51 -18.46 24.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.089 0.471 . . . . 0.0 110.03 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 572' ' ' HIS . . . . . 0.443 ' CE1' ' H ' ' A' ' 632' ' ' LEU . 13.0 m-70 -74.84 -13.08 60.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.655 HG12 HG22 ' A' ' 539' ' ' VAL . 55.5 mt -109.3 137.91 39.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.857 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -106.67 164.45 13.39 Favored Glycine 0 CA--C 1.516 0.156 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 172.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.61 -10.23 59.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.246 0.523 . . . . 0.0 112.407 -171.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 576' ' ' GLU . . . . . 0.418 ' HG2' HD21 ' A' ' 589' ' ' LEU . 11.3 pt-20 -144.46 169.86 17.15 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 122.502 -0.123 . . . . 0.0 110.811 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.707 HG13 ' HB ' ' A' ' 536' ' ' VAL . 8.3 mt -88.03 122.99 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.635 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 56.0 tp -126.92 93.7 3.83 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.645 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.17 179.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.036 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 10.9 m -62.25 -23.42 66.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.902 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.58 -17.47 72.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.566 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.26 -34.14 4.91 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.927 HG22 ' HB2' ' A' ' 601' ' ' LEU . 77.7 mt -62.52 99.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 122.968 0.507 . . . . 0.0 110.031 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 584' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . -121.05 -73.16 0.32 Allowed Glycine 0 C--O 1.226 -0.367 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.87 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -98.82 -82.25 0.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.839 0.352 . . . . 0.0 110.332 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 5.2 tt -155.18 117.42 4.19 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.49 133.68 67.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.492 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -105.38 110.0 22.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.82 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.418 HD21 ' HG2' ' A' ' 576' ' ' GLU . 0.9 OUTLIER -106.72 127.66 53.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -175.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -71.87 147.28 47.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.873 0.368 . . . . 0.0 110.091 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.479 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 85.8 p -108.98 -178.1 3.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.971 0.415 . . . . 0.0 110.443 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.632 HD23 ' HB ' ' A' ' 573' ' ' ILE . 1.6 mm? -73.62 -37.82 65.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.837 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -64.18 -31.46 72.67 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.459 0.647 . . . . 0.0 110.085 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.29 -17.82 6.98 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.889 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 595' ' ' ASP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 4.3 t70 -85.6 -165.84 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.975 0.888 . . . . 0.0 110.563 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -115.74 134.18 55.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.19 0.519 . . . . 0.0 111.746 -171.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.557 HD21 ' O ' ' A' ' 571' ' ' TYR . 87.1 mt -90.93 115.34 27.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 39.6 mt-10 -92.9 101.02 13.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.244 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 607' ' ' SER . 39.7 t -108.29 130.87 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 123.353 0.408 . . . . 0.0 111.345 -175.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.558 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 22.7 t -134.0 157.93 44.82 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.35 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.927 ' HB2' HG22 ' A' ' 583' ' ' ILE . 55.7 tp -128.92 118.78 23.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 172.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 602' ' ' LYS . 22.7 tptp -152.28 129.9 11.52 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.17 176.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 58.86 33.29 22.96 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.417 0.448 . . . . 0.0 110.57 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 65.5 t30 75.58 -2.55 2.77 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.384 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.61 113.94 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.104 0.478 . . . . 0.0 110.864 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.453 HG13 HG21 ' A' ' 583' ' ' ILE . 61.5 t -77.47 134.12 29.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.446 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 607' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 15.9 m -120.52 105.91 11.29 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.599 HG22 ' OD1' ' A' ' 609' ' ' ASN . 12.6 p -111.03 139.79 33.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.599 ' OD1' HG22 ' A' ' 608' ' ' VAL . 3.1 m120 58.36 25.61 13.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.536 ' NZ ' ' HB2' ' A' ' 610' ' ' LYS . 3.7 ttmp? 69.58 22.59 6.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.946 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -130.96 147.5 66.54 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 121.079 0.466 . . . . 0.0 109.952 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -60.76 128.8 26.78 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.55 2.833 . . . . 0.0 113.85 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.558 HG22 HG12 ' A' ' 608' ' ' VAL . 47.8 t -81.47 143.19 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 172.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -79.25 -61.38 2.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.38 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 615' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 616' ' ' PRO . 3.1 mt-10 -139.41 100.87 7.55 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 615' ' ' GLU . 74.1 Cg_endo -72.27 162.51 41.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.846 2.364 . . . . 0.0 114.15 174.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 74.89 45.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.533 164.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 34.9 mt -96.03 87.2 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 165.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 619' ' ' MET . . . . . 0.525 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 49.9 mtp -76.5 146.19 38.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.519 0.675 . . . . 0.0 112.575 -171.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.48 -171.51 1.85 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.549 -1.205 . . . . 0.0 107.928 172.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 504' ' ' THR . 12.6 t -82.69 -15.71 50.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.863 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.473 ' OD1' HG23 ' A' ' 505' ' ' VAL . 27.9 p-10 -118.72 19.3 13.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.944 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.57 -148.38 19.35 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.69 -1.243 . . . . 0.0 112.993 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 624' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 15.0 p -139.31 146.35 25.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.916 0.389 . . . . 0.0 111.093 -175.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 69.9 t -115.34 139.96 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.65 176.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 626' ' ' HIS . . . . . 0.63 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 67.0 m-70 -125.59 126.99 45.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.251 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.726 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 91.6 t -77.19 119.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -174.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.2 153.0 16.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.038 0.447 . . . . 0.0 110.447 172.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 20.8 p -100.68 3.86 42.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -130.2 152.47 49.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.853 0.359 . . . . 0.0 110.137 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.47 ' HB ' HD11 ' A' ' 550' ' ' LEU . 43.6 t -87.82 151.77 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 172.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.578 HD13 ' ND2' ' A' ' 609' ' ' ASN . 36.8 mt -106.77 112.45 25.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.906 0.384 . . . . 0.0 110.741 -168.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -102.39 123.29 45.92 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.834 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.079 -0.963 . . . . 0.0 109.712 177.92 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.579 0.228 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 94.11 71.22 1.13 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.962 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 20.3 ptp -177.26 30.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.108 0.48 . . . . 0.0 110.081 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -106.4 -148.22 15.55 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.9 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.506 ' HA ' HG22 ' A' ' 621' ' ' THR . 68.6 p -92.74 -170.02 2.34 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.282 -0.459 . . . . 0.0 110.497 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.604 ' O ' HD13 ' A' ' 509' ' ' LEU . 94.6 t -43.87 -41.26 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.084 169.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 39.7 tpp -60.02 -46.06 90.76 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.148 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.16 -42.32 99.15 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.949 0.404 . . . . 0.0 110.412 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 620' ' ' ALA . 91.2 t -52.82 -46.98 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.266 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.604 HD13 ' O ' ' A' ' 505' ' ' VAL . 3.2 mp -75.67 -37.28 59.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.065 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.578 ' HA ' HG21 ' A' ' 519' ' ' VAL . 64.2 tttp -71.75 -29.9 65.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.957 0.408 . . . . 0.0 111.023 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -84.86 -10.25 79.29 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.726 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' ASP . . . . . 0.74 ' OD1' ' HG2' ' A' ' 514' ' ' ARG . 34.1 t0 -98.95 134.36 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.241 0.543 . . . . 0.0 110.782 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.41 -35.05 79.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.284 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' ARG . . . . . 0.74 ' HG2' ' OD1' ' A' ' 512' ' ' ASP . 23.7 ptt180 -83.08 -8.92 59.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.249 -173.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.876 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 23.3 m-85 -116.27 13.0 15.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.943 0.401 . . . . 0.0 110.445 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 25.6 p -57.91 -49.57 76.29 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.272 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -69.4 -31.79 70.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.046 0.45 . . . . 0.0 110.113 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.568 HD13 ' HZ ' ' A' ' 547' ' ' PHE . 56.8 tp -54.57 -47.04 73.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.573 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 510' ' ' LYS . 6.5 t -50.57 -48.66 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.043 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 520' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 523' ' ' GLN . . . -63.64 -30.95 71.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.021 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.67 51.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.077 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.845 HG12 HD21 ' A' ' 569' ' ' LEU . 35.7 mt -57.1 -38.21 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.484 0.659 . . . . 0.0 109.612 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 523' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' A' ' 520' ' ' ALA . 18.5 tp60 -58.52 -58.91 6.47 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.281 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.0 m -58.81 -23.44 60.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.754 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -86.13 -13.69 46.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.179 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 75.14 12.46 83.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.758 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' LEU . . . . . 0.667 HD12 HD23 ' A' ' 569' ' ' LEU . 78.5 mt -86.27 13.66 7.7 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.541 -0.388 . . . . 0.0 111.516 -176.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 532' ' ' ASN . 36.7 m -55.57 -47.49 76.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 529' ' ' GLU . . . . . 0.673 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 12.7 pt-20 -69.2 -16.52 63.63 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.336 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 32.4 m -82.16 -44.67 16.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.623 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 531' ' ' LEU . 27.2 mt -82.47 -20.02 37.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.712 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 532' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 528' ' ' THR . 16.6 m-20 -91.01 22.89 3.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.003 0.43 . . . . 0.0 111.122 175.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 533' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 11.7 mmt180 -103.15 163.86 11.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.551 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.09 153.76 17.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.183 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 137.9 -138.87 9.93 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.887 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.726 ' HB ' HG12 ' A' ' 577' ' ' ILE . 17.8 m -129.08 127.59 66.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -144.81 128.9 17.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.216 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 87.1 m -106.77 100.25 9.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 170.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.619 HG22 HG12 ' A' ' 573' ' ' ILE . 90.4 t -101.9 116.65 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.18 -173.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.575 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 54.2 m-85 -86.41 111.07 20.17 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 172.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -98.4 115.15 65.85 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.698 -168.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.0 134.4 11.72 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.652 2.235 . . . . 0.0 111.181 177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 71.4 p -75.95 -179.45 4.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.279 0.561 . . . . 0.0 111.595 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -74.0 -16.76 61.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.796 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 548' ' ' ARG . 39.0 tt0 -76.66 -25.85 54.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.792 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.417 ' HB1' ' N ' ' A' ' 631' ' ' VAL . . . -72.18 -42.36 65.96 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.568 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 547' ' ' PHE . . . . . 0.568 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 9.1 m-85 -67.27 -13.91 62.42 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.647 0.737 . . . . 0.0 109.315 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 548' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 545' ' ' GLU . 37.1 ttm180 -90.22 -10.53 44.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.325 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -97.47 -29.04 13.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.107 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.49 HD13 HG13 ' A' ' 631' ' ' VAL . 7.2 mp -78.67 140.58 59.3 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.018 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.416 ' HG2' ' CB ' ' A' ' 554' ' ' GLU . 23.1 Cg_endo -63.3 134.21 44.19 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.655 2.237 . . . . 0.0 112.052 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.66 -41.24 46.01 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.163 2.575 . . . . 0.0 112.534 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 553' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 557' ' ' ARG . 40.0 ttm180 -57.32 -47.86 80.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.707 0.289 . . . . 0.0 110.751 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.416 ' CB ' ' HG2' ' A' ' 551' ' ' PRO . 41.3 tt0 -66.88 -46.25 75.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.098 0.475 . . . . 0.0 110.602 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 555' ' ' TRP . . . . . 0.438 ' CZ2' ' CD1' ' A' ' 547' ' ' PHE . 0.0 OUTLIER -72.44 -42.21 65.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.351 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 51.0 p -55.6 -26.15 42.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.564 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 557' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 553' ' ' ARG . 1.8 mmp_? -71.72 -35.57 70.24 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.669 HD22 HG13 ' A' ' 568' ' ' ILE . 16.0 mt -68.64 -50.29 52.43 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.25 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.604 HD22 HD22 ' A' ' 565' ' ' LEU . 0.5 OUTLIER -70.25 0.98 5.36 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 178.013 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -78.03 -46.37 9.41 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.082 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 561' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 564' ' ' GLU . 32.1 t70 -125.24 142.65 51.37 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -72.46 -39.88 67.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.014 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.551 ' H ' ' HD2' ' A' ' 563' ' ' LYS . 0.0 OUTLIER -66.16 -35.78 81.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.65 -178.43 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.426 ' HG2' ' OD2' ' A' ' 561' ' ' ASP . 8.1 mm-40 -74.97 -39.99 60.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.728 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.604 HD22 HD22 ' A' ' 559' ' ' LEU . 39.1 tp -65.32 -43.97 89.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.38 74.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.358 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -53.64 -51.6 62.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.173 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.669 HG13 HD22 ' A' ' 558' ' ' LEU . 24.2 mm -67.07 -52.77 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.845 HD21 HG12 ' A' ' 522' ' ' ILE . 26.7 tp -58.75 -24.56 61.86 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.97 -177.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 87.9 mttt -70.37 -18.08 63.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 0.0 111.627 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 37.5 t80 -89.77 10.08 24.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.992 0.901 . . . . 0.0 109.485 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -103.78 -15.26 15.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.177 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.619 HG12 HG22 ' A' ' 539' ' ' VAL . 64.5 mt -109.89 115.89 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.882 -175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.643 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -83.28 150.52 27.39 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.112 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -67.48 -21.7 65.5 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 576' ' ' GLU . . . . . 0.633 ' HG2' HD21 ' A' ' 589' ' ' LEU . 15.9 pt-20 -129.35 -178.32 4.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.596 -173.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.726 HG12 ' HB ' ' A' ' 536' ' ' VAL . 48.4 mm -96.16 110.38 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.504 174.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.532 HD21 HG13 ' A' ' 587' ' ' VAL . 57.5 tp -113.32 93.18 4.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.489 HG13 HG22 ' A' ' 577' ' ' ILE . 21.3 m -79.15 168.53 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.689 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 580' ' ' SER . . . . . 0.611 ' HA ' HD12 ' A' ' 583' ' ' ILE . 3.5 m -53.16 -32.73 49.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.835 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.62 -17.88 71.42 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.175 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -95.76 -15.47 42.77 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.968 HG22 ' HB2' ' A' ' 601' ' ' LEU . 57.6 mt -75.54 119.59 23.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 584' ' ' GLY . . . . . 0.601 ' HA2' ' HB3' ' A' ' 601' ' ' LEU . . . -168.22 125.35 1.28 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 62.51 -82.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 O-C-N 124.168 0.569 . . . . 0.0 110.562 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 6.4 tt -163.27 117.24 1.61 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 587' ' ' VAL . . . . . 0.532 HG13 HD21 ' A' ' 578' ' ' LEU . 6.8 p -128.75 139.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -100.74 135.75 41.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.301 0.572 . . . . 0.0 111.585 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.633 HD21 ' HG2' ' A' ' 576' ' ' GLU . 1.0 OUTLIER -126.7 115.55 19.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.36 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -64.47 128.08 34.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 110.811 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.643 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 89.9 p -95.6 -173.53 2.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.537 -177.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 60.2 mt -76.69 -38.96 53.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 593' ' ' GLN . . . . . 0.415 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.4 tt0 -61.21 -30.55 70.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.456 0.645 . . . . 0.0 110.501 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.95 -19.51 6.5 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.477 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 595' ' ' ASP . . . . . 0.521 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.7 t70 -84.6 -169.15 2.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.711 0.756 . . . . 0.0 109.951 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.468 ' HG2' ' OD1' ' A' ' 595' ' ' ASP . 14.2 pttm -110.11 136.33 49.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.923 -172.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.637 ' HA ' ' OD1' ' A' ' 609' ' ' ASN . 91.5 mt -84.22 114.97 22.2 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 170.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.588 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 45.8 mt-10 -86.52 84.91 7.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.393 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 607' ' ' SER . 46.2 t -86.46 118.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.688 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.841 ' HB2' ' HB2' ' A' ' 607' ' ' SER . 13.6 m -118.57 157.02 28.13 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.825 -176.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.968 ' HB2' HG22 ' A' ' 583' ' ' ILE . 58.4 tp -141.79 113.5 7.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -156.41 137.88 13.99 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 60.93 27.06 16.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 64.9 t30 63.84 11.68 6.14 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.436 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 60.0 t -95.13 118.45 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.573 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.582 HG13 HG21 ' A' ' 583' ' ' ILE . 48.9 t -82.17 147.9 5.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.848 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 607' ' ' SER . . . . . 0.841 ' HB2' ' HB2' ' A' ' 600' ' ' SER . 16.9 m -134.38 158.13 44.64 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.583 0.23 . . . . 0.0 110.868 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.6 p -153.27 121.23 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.648 175.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.818 HD22 HD13 ' A' ' 632' ' ' LEU . 19.6 m-20 61.46 37.61 16.51 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.986 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 80.1 -12.48 1.04 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.481 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 63.1 mm-40 -95.44 143.17 25.65 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.615 0.245 . . . . 0.0 110.79 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 3.1 Cg_exo -78.81 136.62 13.53 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.134 2.556 . . . . 0.0 112.791 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 40.4 t -89.22 134.38 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -89.29 -35.74 15.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.946 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 615' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 29.5 tt0 -150.36 89.08 4.56 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.732 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.38 173.19 13.53 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.125 2.55 . . . . 0.0 113.47 171.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 t70 77.78 23.34 0.8 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.059 164.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 618' ' ' ILE . . . . . 0.4 HD12 HG23 ' A' ' 627' ' ' VAL . 34.2 mt -94.36 90.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 122.05 -0.406 . . . . 0.0 110.135 174.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 619' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 60.6 mtp -85.91 149.49 25.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.472 0.654 . . . . 0.0 112.33 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 620' ' ' ALA . . . . . 0.509 ' HB2' HG21 ' A' ' 508' ' ' VAL . . . -113.22 -171.77 1.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.613 174.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 504' ' ' THR . 13.1 t -81.73 -17.46 47.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.414 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.436 ' OD1' HG23 ' A' ' 505' ' ' VAL . 28.7 p-10 -117.87 2.5 12.18 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 623' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 173.14 -154.77 21.27 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.418 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 624' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 8.1 p -137.55 145.47 29.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 625' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 539' ' ' VAL . 75.6 t -117.4 140.87 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.978 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 626' ' ' HIS . . . . . 0.575 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 66.4 m-70 -126.74 118.86 25.56 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.039 175.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.876 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 96.8 t -72.51 122.59 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.0 151.13 21.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.206 0.527 . . . . 0.0 110.592 172.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 11.9 p -94.04 3.22 55.63 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.153 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -136.6 146.27 45.87 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.123 0.487 . . . . 0.0 111.204 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.49 HG13 HD13 ' A' ' 550' ' ' LEU . 0.2 OUTLIER -92.68 158.25 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.818 HD13 HD22 ' A' ' 609' ' ' ASN . 16.6 mt -117.97 147.97 42.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.867 0.365 . . . . 0.0 111.647 -156.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -144.13 122.1 12.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.113 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.06 176.717 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 501' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 503' ' ' GLY . . . -76.31 -23.65 70.42 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.946 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 5.4 tpt 75.72 -30.09 0.19 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.069 0.948 . . . . 0.0 110.859 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.668 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -173.39 -155.17 11.32 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 175.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 508' ' ' VAL . 75.6 p -95.28 -173.96 3.07 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.749 ' O ' HD13 ' A' ' 509' ' ' LEU . 96.4 t -47.42 -41.06 7.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.396 170.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -41.89 97.86 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.697 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 507' ' ' ASP . . . . . 0.668 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 9.1 m-20 -68.65 -33.42 73.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.52 0.2 . . . . 0.0 111.159 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 504' ' ' THR . 96.0 t -51.66 -60.54 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.089 0.471 . . . . 0.0 110.958 174.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.749 HD13 ' O ' ' A' ' 505' ' ' VAL . 3.4 mp -59.27 -35.45 73.76 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.625 0.77 . . . . 0.0 111.269 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.61 ' HB3' ' HA ' ' A' ' 507' ' ' ASP . 43.5 tttt -63.75 -29.85 71.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.324 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -97.49 -23.3 14.41 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.237 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.75 132.22 35.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.934 0.397 . . . . 0.0 110.489 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -76.19 -18.98 58.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -175.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -78.92 -29.43 44.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.017 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.771 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 16.5 m-85 -101.71 18.76 19.59 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.008 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 21.0 p -57.94 -57.27 13.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 517' ' ' MET . . . . . 0.418 ' HB3' ' HE2' ' A' ' 517' ' ' MET . 7.8 ttp -74.13 -20.69 60.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.926 0.393 . . . . 0.0 110.158 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 50.5 tp -57.94 -41.96 83.92 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.909 176.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 509' ' ' LEU . 15.2 t -53.45 -54.77 16.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.261 177.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.23 -31.52 72.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.087 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.13 -56.18 8.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.794 0.33 . . . . 0.0 110.37 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.473 ' HA ' HD13 ' A' ' 569' ' ' LEU . 61.6 mt -59.33 -32.24 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.231 0.539 . . . . 0.0 110.235 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 523' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.6 OUTLIER -55.59 -60.7 3.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.095 173.092 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.7 m -61.99 -19.11 62.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.351 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -85.44 -10.91 55.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 70.14 37.68 72.49 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.671 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.55 5.6 29.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.524 0.662 . . . . 0.0 111.044 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 27.2 m -53.46 -49.93 66.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.686 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 529' ' ' GLU . . . . . 0.649 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 28.3 mt-10 -66.03 -19.21 65.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.551 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 35.1 m -74.07 -34.32 63.99 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.083 0.468 . . . . 0.0 109.818 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.518 HD21 HD13 ' A' ' 573' ' ' ILE . 89.6 mt -93.07 -18.14 23.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.647 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 532' ' ' ASN . . . . . 0.544 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 5.8 m-20 -84.55 17.72 2.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 533' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 21.9 mmt180 -111.25 172.25 6.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.305 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.13 146.28 24.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 153.97 -147.13 16.04 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.896 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.602 ' HB ' HG13 ' A' ' 577' ' ' ILE . 11.2 m -131.7 128.29 60.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -148.15 132.21 17.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.968 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' THR . . . . . 0.432 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 95.7 m -104.68 105.23 15.23 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 172.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.785 HG22 HG12 ' A' ' 573' ' ' ILE . 62.6 t -104.78 112.57 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 120.888 0.375 . . . . 0.0 111.378 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.606 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 68.4 m-85 -85.95 108.98 18.45 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -104.66 122.41 43.65 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.069 -168.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.76 138.91 19.39 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.936 2.424 . . . . 0.0 112.491 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 67.4 p -82.78 -176.59 6.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.965 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 544' ' ' ASN . . . . . 0.471 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 88.2 m-20 -62.07 -39.65 93.14 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.67 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -66.1 -21.49 66.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -76.88 -36.45 56.72 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.099 177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 547' ' ' PHE . . . . . 0.502 ' HZ ' ' HB2' ' A' ' 518' ' ' LEU . 9.5 m-85 -65.31 -13.02 57.49 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 170.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -94.91 -36.42 11.62 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.975 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -91.24 11.02 24.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.13 0.491 . . . . 0.0 111.724 -174.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.799 HD12 ' CD1' ' A' ' 555' ' ' TRP . 0.2 OUTLIER -76.8 167.32 37.73 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.643 -178.183 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.449 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 7.6 Cg_exo -73.91 125.93 10.27 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.21 1.94 . . . . 0.0 109.952 166.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.97 -54.52 5.31 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.909 2.406 . . . . 0.0 114.138 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -70.81 -18.77 62.72 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.65 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 5.9 tp10 -60.6 -54.87 40.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.609 0.718 . . . . 0.0 109.902 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 555' ' ' TRP . . . . . 0.799 ' CD1' HD12 ' A' ' 550' ' ' LEU . 6.7 m95 -77.79 -24.78 48.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.889 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 52.5 m -51.28 -35.04 35.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.43 0.633 . . . . 0.0 109.616 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -84.69 -50.9 7.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.154 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.698 HD23 ' HG3' ' A' ' 564' ' ' GLU . 40.6 mt -57.61 -55.31 36.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.983 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.42 HD22 HD22 ' A' ' 565' ' ' LEU . 0.1 OUTLIER -70.44 -1.34 10.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -98.27 -31.47 6.5 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.651 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 561' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 563' ' ' LYS . 12.9 t70 -130.5 137.84 49.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.633 0.254 . . . . 0.0 110.42 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.7 63.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.681 ' HD3' ' H ' ' A' ' 563' ' ' LYS . 0.1 OUTLIER -73.82 -18.6 60.93 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.717 -178.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.698 ' HG3' HD23 ' A' ' 558' ' ' LEU . 3.7 tp10 -69.63 -46.45 66.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 558' ' ' LEU . 20.0 tp -68.04 -45.57 73.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.087 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -60.76 -23.57 65.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.403 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 567' ' ' ASN . . . . . 0.689 ' HA ' ' OE1' ' A' ' 593' ' ' GLN . 2.9 t-20 -55.87 -50.84 69.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.578 0.704 . . . . 0.0 110.811 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.614 HD12 HD11 ' A' ' 558' ' ' LEU . 46.2 mt -84.53 -39.58 14.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.875 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 522' ' ' ILE . 75.0 mt -61.1 -28.25 68.96 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -77.59 -10.15 59.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.907 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.58 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 50.5 t80 -100.3 -19.16 16.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.085 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -66.34 -24.94 66.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.381 0.61 . . . . 0.0 110.526 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.785 HG12 HG22 ' A' ' 539' ' ' VAL . 83.7 mt -105.43 141.16 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.486 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -102.81 165.92 16.54 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.29 -30.29 67.26 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 576' ' ' GLU . . . . . 0.5 ' O ' HD11 ' A' ' 589' ' ' LEU . 14.4 pt-20 -148.04 178.4 8.56 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 122.274 -0.266 . . . . 0.0 110.529 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.602 HG13 ' HB ' ' A' ' 536' ' ' VAL . 57.5 mt -81.16 122.23 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.143 0.497 . . . . 0.0 111.961 -171.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.586 HD21 HG13 ' A' ' 587' ' ' VAL . 55.0 tp -122.31 93.26 3.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.424 174.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.4 HG13 HG22 ' A' ' 577' ' ' ILE . 26.7 m -83.81 169.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.469 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 580' ' ' SER . . . . . 0.413 ' HA ' HD12 ' A' ' 583' ' ' ILE . 26.1 m -60.41 -15.65 28.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.887 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.76 -16.37 70.02 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 172.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.69 -28.11 6.81 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.846 HG22 ' HB2' ' A' ' 601' ' ' LEU . 53.4 mt -72.14 89.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.226 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 584' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . -113.8 -58.59 0.39 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.327 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -113.46 -71.6 0.74 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 175.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 599' ' ' VAL . 6.2 tt -157.83 129.58 6.88 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 587' ' ' VAL . . . . . 0.586 HG13 HD21 ' A' ' 578' ' ' LEU . 6.8 p -143.86 139.64 25.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.22 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 588' ' ' ARG . . . . . 0.538 ' HB3' ' HG2' ' A' ' 598' ' ' GLU . 6.3 ptp180 -107.9 140.22 41.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.342 0.591 . . . . 0.0 111.491 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.5 HD11 ' O ' ' A' ' 576' ' ' GLU . 0.5 OUTLIER -124.45 121.63 35.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.298 -179.31 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.417 ' HE2' ' HA2' ' A' ' 594' ' ' GLY . 24.2 tptm -63.62 140.94 58.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.69 0.281 . . . . 0.0 110.26 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.534 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 60.2 p -102.11 -177.83 3.52 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.72 ' H ' HD22 ' A' ' 592' ' ' LEU . 0.9 OUTLIER -76.68 -44.88 31.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 110.474 178.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 593' ' ' GLN . . . . . 0.689 ' OE1' ' HA ' ' A' ' 567' ' ' ASN . 23.9 tp60 -63.4 -30.8 71.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.491 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 594' ' ' GLY . . . . . 0.417 ' HA2' ' HE2' ' A' ' 590' ' ' LYS . . . 124.62 16.02 3.15 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 119.731 -1.224 . . . . 0.0 114.438 168.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 595' ' ' ASP . . . . . 0.58 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 10.4 t70 -110.66 -164.87 0.95 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.878 0.839 . . . . 0.0 108.789 174.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.419 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 18.3 pttp -127.24 120.0 27.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.092 0.472 . . . . 0.0 111.35 -172.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.716 ' HA ' HD22 ' A' ' 609' ' ' ASN . 98.3 mt -79.2 115.37 18.82 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.538 ' HG2' ' HB3' ' A' ' 588' ' ' ARG . 33.7 mt-10 -108.75 112.36 24.6 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.29 0.567 . . . . 0.0 110.782 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 586' ' ' LEU . 21.3 t -107.59 133.6 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.532 -171.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.757 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 37.9 t -126.02 160.81 29.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.846 ' HB2' HG22 ' A' ' 583' ' ' ILE . 48.8 tp -132.73 127.1 33.97 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.489 ' HG2' ' OD1' ' A' ' 603' ' ' ASN . 60.6 tttp -156.42 129.1 7.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 603' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 602' ' ' LYS . 18.6 m120 61.15 28.03 17.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.03 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 56.9 t30 68.64 18.49 8.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.708 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.69 126.53 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.741 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 59.7 t -88.24 137.46 21.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.318 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 607' ' ' SER . . . . . 0.757 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 6.9 m -125.19 103.54 8.02 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.503 HG11 ' CD1' ' A' ' 540' ' ' PHE . 7.4 p -109.28 117.96 55.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.716 HD22 ' HA ' ' A' ' 597' ' ' LEU . 4.2 m120 63.16 29.75 16.06 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 60.0 tttp 77.02 -2.39 2.67 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.311 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.516 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 70.0 mm-40 -92.42 129.57 40.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.397 . . . . 0.0 110.879 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 13.0 Cg_exo -70.51 126.58 12.96 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.295 2.663 . . . . 0.0 112.518 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 32.8 t -86.72 136.62 22.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.887 176.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -83.04 -57.0 3.47 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.128 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -133.66 100.74 13.37 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.451 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.29 164.26 33.15 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.824 2.349 . . . . 0.0 112.628 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 71.64 31.46 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 50.6 mt -85.66 90.21 2.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 168.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 619' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 66.6 mtp -79.7 148.39 31.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -169.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -118.45 -175.58 2.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.621 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.3 t -83.64 -9.45 58.88 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.528 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.5 ' OD1' HG23 ' A' ' 505' ' ' VAL . 28.7 p-10 -117.68 7.72 12.62 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.499 0.19 . . . . 0.0 111.481 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 159.25 -143.59 9.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.003 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 624' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.1 p -139.34 147.64 24.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.595 0.236 . . . . 0.0 110.589 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.5 141.76 34.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.322 0.582 . . . . 0.0 111.217 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 626' ' ' HIS . . . . . 0.606 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 46.7 m-70 -126.75 125.28 41.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.771 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 85.5 t -78.18 118.59 25.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.49 155.59 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 120.943 0.401 . . . . 0.0 110.716 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 19.9 p -102.65 4.06 37.84 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.444 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -137.4 163.3 31.38 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.982 0.42 . . . . 0.0 111.254 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.74 142.98 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.779 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 69.9 mt -95.34 167.7 11.17 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 120.635 0.255 . . . . 0.0 110.473 -175.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -161.58 138.64 8.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.886 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.215 179.574 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.602 0.239 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -74.65 80.46 0.91 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.335 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 19.3 ptm -86.32 89.92 8.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.499 0.666 . . . . 0.0 110.203 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -103.39 -160.32 25.12 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.513 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.489 ' HA ' HG22 ' A' ' 621' ' ' THR . 79.0 p -85.98 -172.48 4.11 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.887 HG21 HD22 ' A' ' 531' ' ' LEU . 7.4 m -46.79 -37.97 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.222 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -45.13 90.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.274 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 507' ' ' ASP . . . . . 0.552 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 6.1 t70 -68.76 -33.35 73.75 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 504' ' ' THR . 94.3 t -52.65 -40.07 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.22 0.533 . . . . 0.0 110.538 174.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 5.6 mt -82.27 -34.51 28.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.405 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.594 ' HA ' HG21 ' A' ' 519' ' ' VAL . 58.1 tttp -66.51 -34.61 78.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.062 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -88.15 -5.4 76.6 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.645 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -106.75 142.04 37.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.29 0.545 . . . . 0.0 111.387 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -68.37 -32.8 73.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.786 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 514' ' ' ARG . . . . . 0.568 ' H ' ' HD2' ' A' ' 514' ' ' ARG . 3.1 mpt_? -83.02 -19.27 37.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -173.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.732 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 19.9 m-85 -107.75 5.55 26.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.172 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 68.5 m -59.98 -38.1 81.57 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.754 0.312 . . . . 0.0 111.579 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -82.56 -26.01 32.79 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 45.6 tp -58.02 -43.68 86.87 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.913 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 510' ' ' LYS . 7.2 t -50.69 -51.04 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.931 176.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -64.74 -32.8 74.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.926 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.89 -50.19 44.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.158 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.584 HG12 HD11 ' A' ' 569' ' ' LEU . 68.4 mt -57.94 -34.45 48.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.31 0.576 . . . . 0.0 109.789 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.55 -57.72 11.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.452 173.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.2 m -58.63 -26.56 63.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.995 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -74.63 -23.94 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.869 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 68.25 19.62 72.45 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.104 -0.57 . . . . 0.0 114.153 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 527' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 569' ' ' LEU . 3.8 pp -104.36 22.44 14.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.579 0.69 . . . . 0.0 111.135 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 88.8 m -53.81 -41.97 67.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.951 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 529' ' ' GLU . . . . . 0.617 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 1.0 OUTLIER -60.23 -16.38 33.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.226 -178.515 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 26.2 m -76.18 -51.0 13.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.906 0.384 . . . . 0.0 109.991 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.887 HD22 HG21 ' A' ' 505' ' ' VAL . 61.2 mt -81.39 -13.69 58.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.679 -177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.89 -20.01 61.17 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.822 0.344 . . . . 0.0 111.416 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 533' ' ' ARG . . . . . 0.617 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 59.8 mtt180 -74.09 139.67 44.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.1 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -84.06 131.74 34.78 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 167.54 -120.64 0.92 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.447 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.8 m -137.99 126.81 32.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.716 0.294 . . . . 0.0 111.06 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -151.64 143.91 24.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.786 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.2 m -115.96 111.09 19.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.707 HG22 HG12 ' A' ' 573' ' ' ILE . 88.5 t -111.04 114.23 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.629 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 61.5 m-85 -84.87 108.99 17.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -100.11 121.13 54.84 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.969 -166.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.51 138.93 8.76 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.789 2.326 . . . . 0.0 112.158 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 66.8 p -83.35 -178.02 6.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.244 0.545 . . . . 0.0 112.087 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 544' ' ' ASN . . . . . 0.438 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -62.57 -37.84 87.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.322 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -34.19 71.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.522 0.677 . . . . 0.0 110.238 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.502 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -70.54 -36.85 73.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.373 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 547' ' ' PHE . . . . . 0.456 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 17.3 m-85 -66.44 -18.01 65.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.222 0.534 . . . . 0.0 109.655 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -92.79 -16.26 25.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.047 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -80.51 -13.92 58.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.005 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.696 HD11 ' HB ' ' A' ' 631' ' ' VAL . 78.8 mt -95.34 143.36 25.98 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.017 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 24.6 Cg_exo -63.05 134.39 45.83 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.766 2.311 . . . . 0.0 111.755 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 552' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 52.7 Cg_exo -54.45 -32.43 73.11 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.039 2.493 . . . . 0.0 112.234 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 44.2 mtm105 -57.87 -30.96 66.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.46 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -86.21 -52.18 5.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.255 0.55 . . . . 0.0 110.539 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 555' ' ' TRP . . . . . 0.516 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -68.84 -38.27 79.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -170.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.0 t -54.6 -24.97 23.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.195 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -82.92 -33.39 26.85 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.412 -0.18 . . . . 0.0 111.0 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.624 ' HB3' ' HG ' ' A' ' 565' ' ' LEU . 14.5 mt -65.26 -50.57 65.26 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 121.002 0.43 . . . . 0.0 110.292 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.462 HD22 HD11 ' A' ' 565' ' ' LEU . 0.6 OUTLIER -69.34 -16.51 63.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.848 0.356 . . . . 0.0 111.424 177.25 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -85.95 -38.34 8.69 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.024 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -124.66 135.28 52.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 111.267 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -73.57 -31.34 63.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.11 -170.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.536 ' H ' ' HD2' ' A' ' 563' ' ' LYS . 9.6 mptt -71.2 -37.05 72.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.85 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.1 -34.52 73.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.676 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.624 ' HG ' ' HB3' ' A' ' 558' ' ' LEU . 0.4 OUTLIER -75.73 -47.27 26.74 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.892 0.377 . . . . 0.0 110.443 177.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 566' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -59.67 -33.99 72.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.426 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -56.3 -52.79 63.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.946 0.403 . . . . 0.0 111.033 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 632' ' ' LEU . 73.9 mt -71.46 -46.67 62.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.429 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' A' ' 527' ' ' LEU . 0.1 OUTLIER -51.96 -34.23 41.3 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.404 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 47.2 mttp -69.47 -26.05 64.38 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.578 ' O ' HD21 ' A' ' 597' ' ' LEU . 52.4 t80 -80.31 -17.04 53.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.959 0.409 . . . . 0.0 110.708 -176.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 572' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 16.4 m-70 -79.89 -6.18 56.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.257 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.707 HG12 HG22 ' A' ' 539' ' ' VAL . 69.1 mt -117.12 117.47 55.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.04 -175.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.1 167.49 34.48 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.64 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.568 ' OD2' ' HB2' ' A' ' 590' ' ' LYS . 8.0 m-20 -54.63 -42.22 70.97 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.06 -176.56 5.71 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.748 -168.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.516 HG12 ' HA2' ' A' ' 623' ' ' GLY . 58.6 mt -82.08 118.23 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.314 -173.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.413 HD11 HG11 ' A' ' 587' ' ' VAL . 4.6 tt -118.49 93.47 4.13 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.9 m -73.5 167.53 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.573 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 580' ' ' SER . . . . . 0.646 ' HA ' HD12 ' A' ' 583' ' ' ILE . 13.1 t -62.37 -24.15 67.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.2 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -71.04 -10.89 69.38 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.036 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -99.9 -17.51 25.3 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.741 HG22 ' HB2' ' A' ' 601' ' ' LEU . 77.4 mt -71.47 94.47 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.362 0.601 . . . . 0.0 110.394 176.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -109.15 -121.47 4.47 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.975 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -58.96 -62.79 1.62 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 110.528 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 7.9 tt -168.48 129.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 587' ' ' VAL . . . . . 0.413 HG11 HD11 ' A' ' 578' ' ' LEU . 47.3 t -129.61 136.05 60.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.95 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 588' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 588' ' ' ARG . 14.7 mtm180 -97.98 120.84 39.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.141 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.76 116.67 32.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.568 ' HB2' ' OD2' ' A' ' 575' ' ' ASP . 23.7 mmmt -63.88 139.23 58.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.723 0.296 . . . . 0.0 110.336 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.581 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 86.5 p -106.14 -173.92 2.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.346 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 76.3 mt -80.79 -39.69 26.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.829 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 593' ' ' GLN . . . . . 0.484 ' OE1' ' HB3' ' A' ' 634' ' ' ALA . 24.4 tt0 -61.84 -29.58 70.27 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.088 0.47 . . . . 0.0 110.833 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 127.03 -18.83 6.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.268 -0.968 . . . . 0.0 114.509 170.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 595' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 596' ' ' LYS . 8.8 t70 -88.52 -158.88 0.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.466 1.133 . . . . 0.0 109.893 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.472 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 10.8 pttm -124.75 135.98 53.46 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.862 0.363 . . . . 0.0 111.07 -169.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 571' ' ' TYR . 94.6 mt -83.85 115.34 22.21 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 172.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -91.32 84.84 5.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.69 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 608' ' ' VAL . 2.4 p -110.08 132.05 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.248 0.547 . . . . 0.0 111.69 -175.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.439 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 5.8 p -144.33 168.76 19.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.148 -176.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.741 ' HB2' HG22 ' A' ' 583' ' ' ILE . 1.8 tt -117.84 112.49 20.45 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -141.14 135.89 31.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.138 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 64.9 t30 61.41 36.29 17.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.279 0.561 . . . . 0.0 110.281 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 67.2 t30 73.24 -2.17 2.82 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.773 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 9.6 p -122.81 147.37 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.852 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.476 HG13 HG21 ' A' ' 583' ' ' ILE . 57.6 t -77.68 132.12 33.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.219 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 5.8 p -123.84 112.29 17.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.06 0.457 . . . . 0.0 111.21 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.622 HG23 ' HB ' ' A' ' 599' ' ' VAL . 10.7 p -114.89 135.29 55.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.485 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.551 ' OD1' HG22 ' A' ' 608' ' ' VAL . 0.5 OUTLIER 57.75 26.36 12.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -177.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 62.8 mttm 76.09 1.4 3.44 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.205 1.002 . . . . 0.0 111.915 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 29.7 mm-40 -101.37 137.35 19.63 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.276 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 11.6 Cg_exo -72.45 126.58 11.7 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.021 2.48 . . . . 0.0 112.294 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.07 141.95 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.996 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -75.65 -60.3 2.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.857 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -141.68 113.48 6.54 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.615 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.432 ' HG3' HG21 ' A' ' 606' ' ' VAL . 65.0 Cg_endo -81.51 169.88 15.03 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.833 2.355 . . . . 0.0 113.053 174.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 2.5 t70 72.95 28.28 1.99 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.479 165.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 52.3 mt -80.9 89.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 619' ' ' MET . . . . . 0.516 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 53.2 mtp -78.97 137.07 37.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.635 0.731 . . . . 0.0 112.74 -171.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -106.26 -177.74 3.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.017 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.489 HG22 ' HA ' ' A' ' 504' ' ' THR . 15.0 t -74.74 -16.54 60.73 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.332 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.788 HD21 HG22 ' A' ' 505' ' ' VAL . 30.7 p-10 -119.37 10.51 11.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 623' ' ' GLY . . . . . 0.516 ' HA2' HG12 ' A' ' 577' ' ' ILE . . . 161.79 -147.05 12.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.415 -1.374 . . . . 0.0 113.52 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 624' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.4 p -139.97 145.06 26.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.86 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 76.8 t -118.74 143.61 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.657 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 626' ' ' HIS . . . . . 0.629 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 34.9 m-70 -130.16 127.19 39.23 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.732 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 98.2 t -79.94 119.3 29.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.7 148.21 17.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.028 0.442 . . . . 0.0 110.581 172.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 33.0 p -95.74 10.5 36.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.65 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -136.03 155.63 49.94 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.696 ' HB ' HD11 ' A' ' 550' ' ' LEU . 52.0 t -96.83 157.29 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.458 HD13 ' ND2' ' A' ' 609' ' ' ASN . 46.4 mt -114.68 112.74 23.34 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.856 0.36 . . . . 0.0 110.277 -170.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -115.73 105.57 12.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.22 0.533 . . . . 0.0 110.746 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 634' ' ' ALA . . . . . 0.484 ' HB3' ' OE1' ' A' ' 593' ' ' GLN . . . . . . . . 0 C--N 1.315 -0.906 0 CA-C-O 118.277 -0.868 . . . . 0.0 109.326 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.441 -1.0 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.4 ' HA ' HG22 ' A' ' 621' ' ' THR . 67.1 p -91.94 -172.12 3.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.712 0.291 . . . . 0.0 110.366 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.858 HG23 ' HB3' ' A' ' 531' ' ' LEU . 4.4 m -49.42 -29.89 4.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.897 170.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.5 ' HG2' ' CB ' ' A' ' 531' ' ' LEU . 85.3 mmm -67.64 -50.43 57.97 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.352 -0.217 . . . . 0.0 110.93 172.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . 0.449 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 1.0 OUTLIER -72.09 -29.77 64.45 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.136 -174.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 1.016 HG11 HG21 ' A' ' 625' ' ' VAL . 8.7 p -58.06 -35.02 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.504 0.669 . . . . 0.0 110.693 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.897 HD23 HG13 ' A' ' 508' ' ' VAL . 7.2 mt -81.65 -33.99 31.03 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.593 177.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -66.03 -25.02 66.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.856 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -102.24 1.88 50.66 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.76 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -111.5 141.83 44.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.522 0.661 . . . . 0.0 111.358 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.453 ' HA ' ' OG ' ' A' ' 516' ' ' SER . 17.2 m120 -75.32 -23.99 57.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.035 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -87.07 -15.37 38.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.075 0.464 . . . . 0.0 110.418 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.883 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 25.5 m-85 -109.51 8.1 25.04 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.898 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 513' ' ' ASN . 67.8 m -57.24 -45.92 83.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -174.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.3 ttp -76.04 -24.02 55.16 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.218 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.532 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 46.8 tp -60.45 -45.22 94.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.984 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 515' ' ' PHE . 5.8 t -53.45 -46.61 59.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.553 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.2 72.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.685 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -71.81 -48.37 46.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.008 0.432 . . . . 0.0 109.931 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.811 HG12 HD21 ' A' ' 569' ' ' LEU . 43.3 mt -56.61 -39.0 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.612 0.72 . . . . 0.0 109.985 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -59.22 -53.25 60.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.909 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.0 m -59.23 -27.33 65.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.859 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -79.12 -28.25 42.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 65.02 32.58 84.67 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.675 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . 0.696 HD21 HD23 ' A' ' 569' ' ' LEU . 3.6 pp -102.65 24.58 10.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.356 0.578 . . . . 0.0 110.486 177.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 56.7 m -46.47 -53.12 11.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.295 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.41 -28.23 58.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -174.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 53.5 m -59.98 -52.47 65.25 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.715 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.858 ' HB3' HG23 ' A' ' 505' ' ' VAL . 27.2 mt -96.21 -8.43 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -175.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -92.88 -9.47 40.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.68 0.752 . . . . 0.0 110.409 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 533' ' ' ARG . 7.9 tpp180 -94.15 157.7 15.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.318 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -77.39 149.76 35.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.02 0.438 . . . . 0.0 110.785 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 164.66 -146.7 11.61 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.691 ' HB ' HG13 ' A' ' 577' ' ' ILE . 16.9 m -129.41 127.39 64.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -149.81 151.29 33.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 0.0 110.931 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 96.9 m -124.4 101.45 7.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.554 HG22 HG12 ' A' ' 573' ' ' ILE . 87.3 t -98.77 111.48 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.832 -174.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 56.3 m-85 -83.47 106.61 15.36 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -98.6 117.0 65.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.451 -166.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.608 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 72.3 Cg_endo -78.49 135.22 13.03 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.819 2.346 . . . . 0.0 112.121 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.3 p -78.45 -176.0 4.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.243 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . 0.51 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 12.0 m120 -73.68 -34.52 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.323 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 548' ' ' ARG . 1.5 pm0 -70.17 -18.99 63.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.099 0.476 . . . . 0.0 110.342 175.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.12 64.37 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.212 0.53 . . . . 0.0 110.789 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . 0.51 ' CD2' ' HA ' ' A' ' 544' ' ' ASN . 19.2 m-85 -66.49 -12.78 59.17 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.195 172.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . 0.509 ' HA ' ' HE ' ' A' ' 548' ' ' ARG . 3.3 mmp_? -92.57 -13.63 29.44 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.323 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -92.36 4.61 53.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.917 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.466 HD12 ' NE1' ' A' ' 555' ' ' TRP . 66.5 mt -113.05 142.71 27.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 0.0 111.588 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 31.3 Cg_exo -59.08 128.07 26.45 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.358 2.039 . . . . 0.0 111.179 174.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 50.1 Cg_exo -54.08 -29.07 53.63 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.955 2.437 . . . . 0.0 113.389 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -59.13 -53.82 54.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.524 0.202 . . . . 0.0 111.47 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.5 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 32.3 mm-40 -63.89 -37.33 86.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.313 0.577 . . . . 0.0 110.633 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' TRP . . . . . 0.466 ' NE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -73.72 -40.22 63.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.817 -177.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 70.8 m -59.38 -22.96 62.15 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.65 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 554' ' ' GLU . 73.5 mtp180 -73.34 -45.14 56.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.298 173.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.626 ' HB3' ' HA ' ' A' ' 565' ' ' LEU . 13.1 mt -67.71 -53.42 27.67 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.559 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -15.58 63.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.802 0.334 . . . . 0.0 111.623 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -88.4 -29.44 19.37 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.44 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . 0.654 ' OD2' ' HG3' ' A' ' 563' ' ' LYS . 24.5 t70 -131.05 124.69 31.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.793 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -62.43 -47.06 85.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -171.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.654 ' HG3' ' OD2' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -72.31 -24.82 61.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.973 -177.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.568 ' HG3' HD23 ' A' ' 558' ' ' LEU . 5.2 tp10 -68.52 -42.71 78.11 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.626 ' HA ' ' HB3' ' A' ' 558' ' ' LEU . 3.4 tt -65.75 -50.97 62.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . 0.46 ' HB1' ' HE2' ' A' ' 570' ' ' LYS . . . -54.87 -32.16 60.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.693 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -52.77 -53.64 45.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.455 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 59.2 mt -82.57 -39.79 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.811 HD21 HG12 ' A' ' 522' ' ' ILE . 22.4 tp -55.75 -36.48 67.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.612 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 68.6 mttm -68.24 -22.64 64.76 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.805 0.336 . . . . 0.0 111.872 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.628 ' O ' HD21 ' A' ' 597' ' ' LEU . 32.5 t80 -80.15 -17.28 52.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.892 0.377 . . . . 0.0 110.842 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . 0.642 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 4.0 m80 -77.87 -8.89 58.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.263 0.554 . . . . 0.0 110.872 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 539' ' ' VAL . 36.2 mt -110.8 116.67 53.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.929 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -78.71 161.77 48.32 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.23 175.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.49 ' OD1' ' HB2' ' A' ' 590' ' ' LYS . 5.2 p-10 -81.57 -10.13 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -172.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -156.69 178.02 10.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 176.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.691 HG13 ' HB ' ' A' ' 536' ' ' VAL . 36.7 mt -89.87 114.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.113 0.482 . . . . 0.0 112.208 -168.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 5.6 tt -112.96 96.16 5.79 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.5 m -80.61 169.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.795 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 617' ' ' ASP . 35.5 p -47.46 -43.28 24.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.376 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -70.42 -6.87 59.4 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.988 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.76 -7.63 47.43 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.226 -0.511 . . . . 0.0 111.927 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.775 HG22 ' HB2' ' A' ' 601' ' ' LEU . 58.2 mt -76.76 104.97 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.982 0.42 . . . . 0.0 110.16 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -103.64 -152.11 22.81 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.003 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -50.91 -56.75 10.83 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.011 0.434 . . . . 0.0 110.534 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 598' ' ' GLU . 6.3 tt -160.32 109.27 1.71 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.212 173.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 97.6 t -116.5 124.89 73.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.923 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . 0.418 ' HD2' ' HD2' ' A' ' 596' ' ' LYS . 85.2 mtm180 -98.01 126.88 43.63 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.855 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 21.9 tp -115.94 142.46 46.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.492 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.498 ' O ' ' HA2' ' A' ' 574' ' ' GLY . 37.2 mtmm -71.84 163.13 28.38 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.782 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.586 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.9 p -128.44 -176.83 3.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.005 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 63.1 mt -82.11 -41.86 19.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.38 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.521 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 31.9 tt0 -59.25 -29.83 67.84 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.579 0.704 . . . . 0.0 110.255 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.79 -11.06 7.46 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.642 169.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . 0.566 ' OD2' ' HG2' ' A' ' 596' ' ' LYS . 3.7 t70 -94.02 -156.38 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.493 0.646 . . . . 0.0 109.985 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.566 ' HG2' ' OD2' ' A' ' 595' ' ' ASP . 19.9 pttm -117.94 142.02 47.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.863 0.363 . . . . 0.0 111.215 -172.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.628 HD21 ' O ' ' A' ' 571' ' ' TYR . 67.1 mt -92.13 116.83 29.28 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 34.5 tt0 -91.26 85.83 5.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.348 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . 0.535 HG12 HG23 ' A' ' 583' ' ' ILE . 35.0 t -93.21 128.87 44.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.796 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 2.7 p -140.25 148.91 42.17 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.586 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.775 ' HB2' HG22 ' A' ' 583' ' ' ILE . 59.3 tp -119.25 112.8 19.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -131.13 110.42 11.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.967 0.413 . . . . 0.0 110.837 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 59.55 53.0 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.423 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 69.81 -5.56 1.21 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.875 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.59 120.73 46.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.88 0.372 . . . . 0.0 110.438 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.434 HG21 ' HG3' ' A' ' 616' ' ' PRO . 43.1 t -85.77 140.81 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.856 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 40.6 m -132.16 142.56 49.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.603 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.6 p -134.69 123.81 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 120.882 0.373 . . . . 0.0 110.046 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.713 ' ND2' HD13 ' A' ' 632' ' ' LEU . 31.5 m-20 61.15 32.1 19.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.559 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 53.2 mttp 76.56 -0.12 3.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.806 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.492 ' HB3' ' OD1' ' A' ' 630' ' ' ASN . 5.3 mm-40 -99.61 130.13 27.4 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.501 ' HD2' HD21 ' A' ' 630' ' ' ASN . 16.5 Cg_exo -68.81 134.46 30.11 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.988 2.458 . . . . 0.0 113.049 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 49.0 t -86.37 143.17 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.703 177.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.11 12.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.655 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 616' ' ' PRO . 32.0 tt0 -152.87 104.65 2.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.162 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . 0.434 ' HG3' HG21 ' A' ' 606' ' ' VAL . 75.0 Cg_endo -74.39 157.41 45.36 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.569 2.179 . . . . 0.0 113.114 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.53 ' HB2' ' HB3' ' A' ' 580' ' ' SER . 1.3 t70 76.7 59.81 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.734 166.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 22.3 mt -108.81 97.12 5.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 165.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 57.4 mtp -79.93 142.64 34.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.621 0.724 . . . . 0.0 112.846 -167.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.72 -175.43 2.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.251 171.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 504' ' ' THR . 12.6 t -82.42 -17.16 46.35 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.316 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.743 HD21 HG22 ' A' ' 505' ' ' VAL . 32.1 p-10 -119.22 14.52 13.03 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 162.76 -160.29 32.69 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.139 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.73 148.96 32.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.746 0.308 . . . . 0.0 110.179 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . 1.016 HG21 HG11 ' A' ' 508' ' ' VAL . 87.5 t -118.28 145.21 24.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.481 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 74.4 m-70 -132.08 126.43 33.76 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.883 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 82.6 t -79.15 119.08 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.2 145.76 21.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.917 0.389 . . . . 0.0 110.241 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 22.9 p -97.73 9.77 41.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . 0.501 HD21 ' HD2' ' A' ' 612' ' ' PRO . 2.6 p30 -140.25 147.89 40.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.666 176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.439 ' HB ' HD11 ' A' ' 550' ' ' LEU . 43.9 t -82.23 160.62 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.713 HD13 ' ND2' ' A' ' 609' ' ' ASN . 42.4 mt . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -167.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.688 0 CA-C-O 121.744 0.635 . . . . 0.0 113.398 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 508' ' ' VAL . 72.4 p -86.01 -171.2 3.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.299 -0.951 . . . . 0.0 110.14 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.7 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 36.4 t -43.9 -45.0 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 123.537 0.523 . . . . 0.0 111.185 173.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.513 ' HB2' ' HB2' ' A' ' 531' ' ' LEU . 10.2 tpt -63.78 -42.3 97.78 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.953 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 510' ' ' LYS . 25.3 t70 -67.78 -37.77 82.49 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.818 0.342 . . . . 0.0 110.631 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.518 HG21 ' HB2' ' A' ' 620' ' ' ALA . 82.8 t -50.61 -40.7 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.796 174.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 5.9 mt -82.37 -35.17 28.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.405 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 507' ' ' ASP . 17.3 mmmt -60.41 -40.71 91.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.823 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -90.87 -12.74 60.13 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.815 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -102.86 141.29 35.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.296 0.57 . . . . 0.0 111.092 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -75.94 -25.86 56.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.573 -174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -83.09 -15.98 48.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.1 0.476 . . . . 0.0 110.246 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.805 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 24.6 m-85 -109.34 17.78 21.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.379 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 12.0 p -57.54 -61.38 2.54 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . 0.492 ' HE1' ' HH2' ' A' ' 555' ' ' TRP . 2.4 ttp -70.57 -20.79 62.76 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.009 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.552 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 49.5 tp -57.42 -45.25 84.81 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.654 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 523' ' ' GLN . 9.1 t -51.39 -47.82 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.905 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.28 -39.32 89.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.905 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.46 -42.09 96.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.028 0.442 . . . . 0.0 110.404 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.685 HG12 HD11 ' A' ' 569' ' ' LEU . 49.8 mt -69.74 -29.1 39.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.557 0.694 . . . . 0.0 109.992 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.0 OUTLIER -65.48 -53.54 41.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.877 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.3 m -65.75 -16.19 63.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.986 0.422 . . . . 0.0 110.904 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -80.5 -17.34 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.267 173.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 74.93 17.94 80.19 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.381 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . 0.743 HD12 HD12 ' A' ' 569' ' ' LEU . 82.1 mt -97.31 17.15 18.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.556 -0.379 . . . . 0.0 111.556 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 46.6 m -55.99 -48.75 75.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . 0.676 ' HA ' ' HB2' ' A' ' 532' ' ' ASN . 31.8 tt0 -62.73 -25.04 67.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.621 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 40.6 m -61.23 -50.48 72.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.608 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.676 ' HG ' ' CG1' ' A' ' 505' ' ' VAL . 0.3 OUTLIER -84.82 -21.65 29.79 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.429 176.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . 0.676 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 0.9 OUTLIER -70.03 -22.2 63.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.671 0.272 . . . . 0.0 110.837 175.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -84.97 126.25 33.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . 0.459 ' OE2' ' HA ' ' A' ' 622' ' ' ASN . 13.9 tp10 -70.79 145.99 50.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.663 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 166.42 -132.1 2.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.827 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.5 m -137.36 127.47 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.656 0.265 . . . . 0.0 110.555 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -149.81 154.63 38.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.967 0.413 . . . . 0.0 110.626 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.7 m -129.02 105.01 7.91 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.758 HG22 HG12 ' A' ' 573' ' ' ILE . 93.5 t -107.26 113.89 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.065 -174.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 60.5 m-85 -83.1 111.25 18.72 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 171.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -104.65 119.71 52.73 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.964 -165.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 541' ' ' ALA . 5.7 Cg_exo -77.89 141.6 19.22 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.335 2.69 . . . . 0.0 112.018 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 81.2 p -83.38 -179.15 7.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.111 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -58.45 -40.47 82.69 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.21 0.529 . . . . 0.0 110.281 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 545' ' ' GLU . 1.5 mp0 -62.78 -23.4 67.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.163 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -78.08 -31.35 50.12 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.275 0.559 . . . . 0.0 111.878 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . 0.497 ' CD1' ' HZ2' ' A' ' 555' ' ' TRP . 41.7 m-85 -67.06 -12.56 60.26 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.238 175.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -91.52 -8.79 46.56 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.73 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -91.16 -8.51 48.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.391 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.62 HD12 ' HE1' ' A' ' 555' ' ' TRP . 40.8 mt -100.3 142.42 24.58 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.411 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.92 142.24 92.4 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.709 2.273 . . . . 0.0 111.665 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.14 -40.38 77.18 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.22 2.613 . . . . 0.0 113.123 -175.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -59.61 -51.21 70.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.521 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.527 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 6.9 mp0 -60.43 -41.33 93.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.459 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' TRP . . . . . 0.62 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -69.17 -45.4 70.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.912 -177.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 35.2 p -58.58 -21.93 54.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.263 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -75.98 -49.86 16.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.87 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.615 ' HB3' ' HA ' ' A' ' 565' ' ' LEU . 12.9 mt -61.18 -63.68 1.21 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.728 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.838 HD13 HD11 ' A' ' 565' ' ' LEU . 3.5 mm? -58.53 -12.02 3.57 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.297 0.639 . . . . 0.0 112.542 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -74.68 -35.46 51.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.876 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . 0.527 ' OD2' ' HG3' ' A' ' 563' ' ' LYS . 16.9 t70 -144.67 153.03 41.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.218 0.509 . . . . 0.0 111.127 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -62.49 -47.28 84.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.048 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.527 ' HG3' ' OD2' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -71.31 -17.75 62.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.941 -177.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.444 ' N ' ' HD3' ' A' ' 563' ' ' LYS . 5.6 mm-40 -81.12 -42.41 20.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.676 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.838 HD11 HD13 ' A' ' 559' ' ' LEU . 0.6 OUTLIER -69.89 -48.27 59.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.329 0.585 . . . . 0.0 109.655 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . 0.52 ' HB1' ' HE3' ' A' ' 570' ' ' LYS . . . -62.56 -27.54 69.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.834 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -52.49 -53.9 39.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.852 0.358 . . . . 0.0 110.686 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 66.1 mt -83.43 -39.06 14.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.366 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.743 HD12 HD12 ' A' ' 527' ' ' LEU . 0.8 OUTLIER -54.99 -32.74 61.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.124 -178.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 97.2 mttt -74.91 -13.75 60.57 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.561 ' O ' HD21 ' A' ' 597' ' ' LEU . 44.7 t80 -86.71 -19.11 29.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.048 0.452 . . . . 0.0 110.885 -177.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 15.3 m80 -77.78 -12.62 59.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.137 0.494 . . . . 0.0 110.566 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.758 HG12 HG22 ' A' ' 539' ' ' VAL . 68.3 mt -105.51 120.5 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.292 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.95 155.86 24.92 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.17 -4.86 57.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.29 168.54 23.76 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.506 0.193 . . . . 0.0 110.509 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.577 HG13 ' HB ' ' A' ' 536' ' ' VAL . 33.1 mt -89.0 117.5 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.602 -170.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 53.3 tp -117.66 97.9 6.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 24.4 m -79.24 170.64 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.096 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.613 ' HA ' HD12 ' A' ' 583' ' ' ILE . 17.9 m -55.96 -30.18 61.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.768 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.5 -13.43 65.46 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.135 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.86 -26.82 7.77 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.769 HG22 ' HB2' ' A' ' 601' ' ' LEU . 74.9 mt -60.9 103.89 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.069 0.461 . . . . 0.0 110.035 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -115.49 -137.03 6.13 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.12 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -59.67 -60.52 3.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 0.0 110.509 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 7.9 tt -157.9 112.75 2.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 67.2 t -121.65 133.53 67.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.128 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . 0.907 ' HD3' ' H ' ' A' ' 588' ' ' ARG . 0.0 OUTLIER -99.33 126.82 45.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.849 -179.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.47 125.51 49.09 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -75.02 143.24 43.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.221 0.534 . . . . 0.0 110.603 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.602 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 84.8 p -107.9 -178.62 3.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.735 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 573' ' ' ILE . 7.0 mp -73.99 -36.14 64.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.38 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -65.97 -30.56 71.15 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 121.559 0.695 . . . . 0.0 110.138 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 126.24 -21.9 6.03 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.08 -0.964 . . . . 0.0 114.006 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 5.5 t70 -81.85 -165.52 1.0 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.042 0.921 . . . . 0.0 110.585 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.43 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 0.2 OUTLIER -123.45 135.51 54.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 0.0 111.442 -170.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.561 HD21 ' O ' ' A' ' 571' ' ' TYR . 84.2 mt -84.74 122.09 28.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.482 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 37.3 mt-10 -92.05 90.27 7.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.44 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . 0.492 HG12 HG23 ' A' ' 583' ' ' ILE . 40.4 t -93.32 133.42 34.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.01 -176.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 32.2 t -143.92 136.82 27.35 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.769 ' HB2' HG22 ' A' ' 583' ' ' ILE . 63.7 tp -113.22 112.98 24.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -133.49 112.52 11.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 604' ' ' ASN . 15.3 t-20 60.03 47.14 10.04 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.13 0.491 . . . . 0.0 109.785 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 603' ' ' ASN . 10.2 t30 74.11 -14.95 0.64 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.723 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 55.9 t -84.18 115.81 26.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 122.175 -0.328 . . . . 0.0 110.665 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.55 HG22 HD13 ' A' ' 601' ' ' LEU . 43.8 t -84.51 136.09 23.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.599 176.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 44.9 m -126.0 147.98 49.4 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 176.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.514 HG11 ' CD1' ' A' ' 540' ' ' PHE . 7.0 p -141.12 119.57 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 1.075 HD22 HD13 ' A' ' 632' ' ' LEU . 29.5 m-20 62.12 31.43 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 24.4 tptp 86.92 -24.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.215 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.509 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 14.4 mm-40 -83.24 132.02 51.53 Favored Pre-proline 0 C--N 1.317 -0.834 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.646 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 13.8 Cg_exo -71.28 135.25 26.48 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.117 2.544 . . . . 0.0 112.856 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.592 HG11 ' HB3' ' A' ' 626' ' ' HIS . 24.7 t -88.74 136.25 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.206 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -88.8 -48.52 7.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.667 -177.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -132.72 89.7 34.6 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.01 159.28 53.79 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.662 2.241 . . . . 0.0 113.431 171.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 75.76 39.02 0.34 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.438 165.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 41.5 mt -87.38 85.76 2.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 166.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 55.7 mtp -80.71 129.57 34.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.645 0.736 . . . . 0.0 112.715 -170.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 508' ' ' VAL . . . -99.65 -171.42 2.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.148 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.405 ' OG1' HG22 ' A' ' 504' ' ' THR . 62.4 p -73.67 -38.46 64.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.498 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.459 ' HA ' ' OE2' ' A' ' 534' ' ' GLU . 30.0 p-10 -99.19 6.06 46.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.47 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 164.27 -152.64 22.53 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.189 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 8.8 p -134.77 144.48 34.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.809 0.338 . . . . 0.0 110.697 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.89 140.55 37.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.709 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . 0.592 ' HB3' HG11 ' A' ' 613' ' ' VAL . 52.3 m-70 -126.9 126.44 43.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.389 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.805 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 69.3 t -76.95 118.74 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 542' ' ' PRO . 0.5 OUTLIER -117.15 149.03 19.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.114 171.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 36.8 p -99.19 15.52 25.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.643 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -138.66 156.03 47.78 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.409 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 632' ' ' LEU . 36.1 t -98.37 160.73 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 174.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 1.075 HD13 HD22 ' A' ' 609' ' ' ASN . 16.2 mt . . . . . 0 C--N 1.319 -0.755 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.633 -167.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.444 -0.779 0 CA-C-O 121.747 0.637 . . . . 0.0 112.931 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 508' ' ' VAL . 51.9 p -91.0 -170.33 2.64 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.862 -0.669 . . . . 0.0 109.687 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.797 HG11 HG21 ' A' ' 539' ' ' VAL . 99.4 t -47.18 -43.42 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 0.0 110.627 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.416 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 36.0 tpp -62.7 -41.07 98.95 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.883 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . 0.833 ' HA ' ' HD3' ' A' ' 510' ' ' LYS . 7.7 t70 -68.17 -32.13 72.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.643 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 504' ' ' THR . 99.6 t -51.3 -60.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.432 173.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.704 HD13 ' O ' ' A' ' 505' ' ' VAL . 5.1 mp -57.36 -37.64 72.92 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.055 0.942 . . . . 0.0 112.18 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.833 ' HD3' ' HA ' ' A' ' 507' ' ' ASP . 40.1 mtpt -54.53 -39.82 68.03 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -94.18 -17.05 41.56 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.143 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -85.37 132.78 34.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.084 0.469 . . . . 0.0 111.092 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -76.49 -25.51 54.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.727 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -80.94 -21.77 40.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.791 0.329 . . . . 0.0 110.351 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.574 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 20.7 m-85 -109.6 13.44 23.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.417 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 74.6 m -57.69 -49.82 75.23 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.5 ttp -74.93 -20.77 59.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.51 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.691 HD13 ' HZ ' ' A' ' 547' ' ' PHE . 59.7 tp -59.48 -44.03 93.14 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.735 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 509' ' ' LEU . 9.4 t -51.66 -51.91 24.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.377 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.61 97.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.971 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.5 83.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.382 0.61 . . . . 0.0 110.406 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.782 HG12 HD21 ' A' ' 569' ' ' LEU . 97.5 mt -62.86 -37.68 79.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.619 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -63.32 -49.15 75.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.746 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 8.5 t -60.57 -32.82 71.89 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.059 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -71.08 -22.26 62.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.031 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 75.98 19.33 78.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.257 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . 0.731 HD21 HD23 ' A' ' 569' ' ' LEU . 3.6 pp -106.79 22.25 16.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.478 0.639 . . . . 0.0 110.646 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 42.0 m -54.6 -43.22 71.97 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.864 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 533' ' ' ARG . 7.9 pt-20 -57.22 -33.15 67.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.422 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.0 m -63.47 -52.57 60.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 110.401 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.418 HD21 HD12 ' A' ' 573' ' ' ILE . 59.8 mt -74.09 -22.75 59.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.542 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.85 9.54 32.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 529' ' ' GLU . 71.4 ttt180 -101.87 143.32 31.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.831 0.348 . . . . 0.0 110.313 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.66 146.69 54.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.544 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 150.83 -139.96 7.59 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.629 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.483 ' HB ' HG13 ' A' ' 577' ' ' ILE . 8.3 m -135.84 127.47 44.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -149.33 146.82 27.72 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 97.5 m -119.11 102.45 8.74 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 170.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.797 HG21 HG11 ' A' ' 505' ' ' VAL . 93.3 t -99.32 113.47 34.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 -173.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 632' ' ' LEU . 52.5 m-85 -86.14 103.87 15.19 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 171.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -96.88 115.24 65.64 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.373 -167.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.605 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 70.1 Cg_endo -81.32 135.04 9.3 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.461 2.107 . . . . 0.0 111.821 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.519 ' HB ' ' OE2' ' A' ' 545' ' ' GLU . 47.8 p -70.03 173.69 6.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.441 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . 0.545 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -67.82 -33.04 74.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.944 0.402 . . . . 0.0 110.902 -178.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.519 ' OE2' ' HB ' ' A' ' 543' ' ' THR . 1.7 pm0 -70.17 -19.75 63.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.858 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -76.34 -33.24 58.98 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.004 0.431 . . . . 0.0 111.3 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . 0.691 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 14.8 m-85 -64.79 -14.85 60.54 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . 0.438 ' HD2' ' HA ' ' A' ' 548' ' ' ARG . 12.9 tpt180 -92.95 -14.75 27.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.84 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -80.67 -19.39 45.35 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.278 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.583 HD11 ' HB ' ' A' ' 631' ' ' VAL . 78.9 mt -97.95 137.2 20.89 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.888 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 34.8 Cg_exo -61.64 136.82 65.02 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.583 2.189 . . . . 0.0 112.051 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.64 -37.5 53.45 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.965 2.443 . . . . 0.0 112.437 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -54.31 -34.17 60.39 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.096 0.474 . . . . 0.0 111.245 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.93 -44.39 12.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.731 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' TRP . . . . . 0.463 ' HE3' HD12 ' A' ' 559' ' ' LEU . 0.0 OUTLIER -81.46 -37.94 27.2 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 29.3 t -54.66 -34.91 62.92 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -66.57 -42.88 86.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.506 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.702 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 46.3 mt -59.06 -54.36 47.98 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.858 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.842 ' HG ' HD21 ' A' ' 565' ' ' LEU . 1.0 OUTLIER -70.7 -3.13 16.97 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -76.96 -29.57 56.97 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.681 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . 0.635 ' OD1' ' HG3' ' A' ' 563' ' ' LYS . 11.1 t70 -142.73 150.95 40.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.556 -176.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.05 81.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.635 ' HG3' ' OD1' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -80.52 -18.45 48.47 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.735 -178.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.53 ' HG2' ' HB3' ' A' ' 561' ' ' ASP . 15.5 mm-40 -72.38 -42.89 64.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.842 HD21 ' HG ' ' A' ' 559' ' ' LEU . 16.8 mt -61.93 -57.16 12.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.09 174.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -54.66 -27.27 38.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.991 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -53.41 -61.78 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.168 0.293 . . . . 0.0 111.491 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 68.7 mt -84.85 -37.65 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.873 0.368 . . . . 0.0 110.207 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.782 HD21 HG12 ' A' ' 522' ' ' ILE . 29.3 tp -55.0 -37.43 66.58 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.822 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 7.8 mtpm? -78.87 -12.91 60.05 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.627 ' HB2' ' CB ' ' A' ' 593' ' ' GLN . 62.0 t80 -84.4 -11.99 55.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.414 0.626 . . . . 0.0 109.666 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . 0.699 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 1.2 m80 -79.49 -16.7 55.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.871 171.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.587 ' HB ' ' HG ' ' A' ' 592' ' ' LEU . 10.7 mm -98.31 115.53 38.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.598 -176.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -80.45 153.83 35.73 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.043 172.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.79 -11.82 59.92 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -171.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.6 177.68 10.1 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.483 HG13 ' HB ' ' A' ' 536' ' ' VAL . 41.7 mt -87.28 120.07 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.572 -172.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' ' 589' ' ' LEU . 4.2 tt -121.36 99.32 6.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.0 167.91 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.918 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.687 ' HB2' ' HB2' ' A' ' 617' ' ' ASP . 36.6 t -56.98 -34.89 68.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.464 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.36 -9.57 61.33 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.345 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -106.03 -9.43 32.19 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.596 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 580' ' ' SER . 76.0 mt -61.97 -44.39 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . 59.14 -99.0 0.12 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.753 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -121.03 -53.18 2.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.937 0.399 . . . . 0.0 110.197 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 599' ' ' VAL . 5.3 tt -162.35 107.75 1.21 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 75.1 t -126.73 129.3 71.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . 0.626 ' HD3' ' HD2' ' A' ' 596' ' ' LYS . 4.0 ptp85 -97.09 128.16 43.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.727 0.775 . . . . 0.0 111.753 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.54 ' HB2' HD12 ' A' ' 578' ' ' LEU . 21.4 tp -120.4 131.92 55.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.843 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 596' ' ' LYS . 81.1 tttt -76.51 151.97 36.22 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.169 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.591 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 85.7 p -110.9 -173.69 2.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.51 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 59.6 mt -80.43 -36.12 34.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.132 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.627 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.3 tt0 -58.46 -30.78 67.21 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.365 0.602 . . . . 0.0 110.502 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.7 6.14 6.16 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.079 -1.058 . . . . 0.0 114.89 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -123.52 -170.54 2.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 118.033 0.917 . . . . 0.0 109.793 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.626 ' HD2' ' HD3' ' A' ' 588' ' ' ARG . 23.4 pttm -103.82 142.04 35.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.124 0.487 . . . . 0.0 111.175 -172.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.585 HD22 HD21 ' A' ' 609' ' ' ASN . 41.8 mt -89.95 117.03 28.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.629 175.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -82.35 94.24 7.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 583' ' ' ILE . 45.6 t -100.56 124.25 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.782 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.645 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 32.9 t -122.77 161.52 23.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.67 -176.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 606' ' ' VAL . 60.0 tp -142.53 113.22 7.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . 0.587 ' O ' HG12 ' A' ' 605' ' ' VAL . 87.8 tttt -135.13 99.79 4.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.806 0.336 . . . . 0.0 110.443 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.56 67.0 1.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.655 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 69.31 10.38 7.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 171.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 602' ' ' LYS . 11.6 p -122.15 126.84 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.175 0.512 . . . . 0.0 110.962 171.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.774 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 40.0 t -93.83 138.15 21.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.537 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . 0.645 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 19.3 m -124.26 104.47 8.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.424 HG11 ' CD1' ' A' ' 540' ' ' PHE . 6.9 p -110.4 117.1 54.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.867 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.699 HD22 ' HB3' ' A' ' 632' ' ' LEU . 9.0 m-20 60.72 33.55 20.16 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.812 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm 83.18 -13.1 0.82 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.013 1.325 . . . . 0.0 111.861 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.501 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 19.9 mm-40 -91.7 132.47 33.06 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.96 0.409 . . . . 0.0 110.604 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 606' ' ' VAL . 2.7 Cg_exo -75.5 125.95 9.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.909 2.406 . . . . 0.0 112.38 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.774 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 22.9 t -83.7 133.1 29.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -75.76 -60.28 2.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.972 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 616' ' ' PRO . 38.7 mt-10 -138.89 101.18 7.88 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 615' ' ' GLU . 80.5 Cg_endo -73.1 168.74 23.96 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.877 2.385 . . . . 0.0 114.137 176.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.687 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 1.4 t70 76.11 42.79 0.18 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.158 165.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 36.7 mt -94.62 92.65 3.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 167.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . 0.503 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 59.5 mtp -80.09 136.16 36.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.243 0.544 . . . . 0.0 112.268 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -99.49 -172.76 2.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.501 172.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 13.2 p -76.76 -26.73 54.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.965 0.412 . . . . 0.0 111.316 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.493 ' OD1' HG23 ' A' ' 505' ' ' VAL . 27.0 p-10 -116.8 15.7 15.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.894 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . 0.429 ' HA2' HG12 ' A' ' 577' ' ' ILE . . . 164.3 -157.53 29.88 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.921 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 13.0 p -133.43 144.73 35.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.826 0.346 . . . . 0.0 110.652 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 79.6 t -114.72 142.27 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.226 0.536 . . . . 0.0 110.48 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . 0.463 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 68.0 m-70 -126.59 121.9 33.53 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.262 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.574 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 85.4 t -76.16 117.98 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 111.501 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.433 HD12 ' O ' ' A' ' 630' ' ' ASN . 1.5 pt -119.02 142.53 33.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.291 173.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 39.9 p -96.29 7.41 46.53 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.708 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . 0.433 ' O ' HD12 ' A' ' 628' ' ' ILE . 6.0 m-20 -128.79 144.05 51.07 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.249 176.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.583 ' HB ' HD11 ' A' ' 550' ' ' LEU . 47.0 t -83.43 157.31 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.699 ' HB3' HD22 ' A' ' 609' ' ' ASN . 86.9 mt . . . . . 0 C--N 1.32 -0.689 0 CA-C-O 121.323 0.582 . . . . 0.0 111.397 -166.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.681 0 N-CA-C 112.105 -0.398 . . . . 0.0 112.105 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 508' ' ' VAL . 58.3 p -94.46 -170.31 2.23 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.694 ' O ' HD13 ' A' ' 509' ' ' LEU . 73.0 t -46.06 -42.83 4.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.603 170.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.7 tpt -59.73 -40.61 88.63 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.659 0.266 . . . . 0.0 111.066 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . 0.528 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 2.2 t70 -68.81 -34.55 75.72 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.207 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 505' ' ' VAL . 99.1 t -51.79 -56.89 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.001 0.429 . . . . 0.0 110.85 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.694 HD13 ' O ' ' A' ' 505' ' ' VAL . 5.4 mp -57.31 -42.33 81.62 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.461 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 510' ' ' LYS . 1.5 tmmt? -67.32 -25.76 66.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -99.49 13.01 61.51 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.872 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -122.63 139.13 54.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.922 0.391 . . . . 0.0 110.895 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -75.46 -16.47 60.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.489 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -91.29 -24.83 19.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.824 0.345 . . . . 0.0 110.901 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.923 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 17.2 m-85 -107.01 8.36 30.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.656 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 13.3 p -54.05 -54.22 42.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -67.87 -29.89 69.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.214 0.53 . . . . 0.0 109.866 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.473 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 41.8 tp -57.42 -45.83 84.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.404 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 515' ' ' PHE . 10.0 t -52.75 -52.02 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.394 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.54 77.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.181 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -72.67 -49.57 30.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.51 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.529 HG12 HD13 ' A' ' 569' ' ' LEU . 77.1 mt -57.94 -35.1 50.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.502 0.668 . . . . 0.0 109.681 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.0 OUTLIER -56.63 -57.5 12.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.21 173.279 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.2 m -57.4 -26.55 61.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.793 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -77.95 -15.85 58.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.369 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 79.51 8.29 87.86 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.341 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 566' ' ' ALA . 71.2 mt -83.26 9.19 11.3 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.795 0.331 . . . . 0.0 111.06 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 46.4 m -52.99 -43.66 66.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -51.54 -45.89 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.388 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 16.2 m -63.91 -41.87 97.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.337 . . . . 0.0 111.735 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 80.5 mt -91.24 -14.1 31.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.841 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . 0.439 HD22 ' N ' ' A' ' 532' ' ' ASN . 0.9 OUTLIER -87.56 -7.4 57.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.023 0.439 . . . . 0.0 110.341 172.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -92.79 147.47 22.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.468 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.11 151.94 43.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.71 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 153.0 -161.18 29.48 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.892 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.684 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.7 m -120.76 127.71 75.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.808 0.337 . . . . 0.0 110.23 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -141.84 155.53 45.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.083 0.468 . . . . 0.0 111.046 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.1 m -124.42 100.83 6.86 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 167.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.609 HG22 HG12 ' A' ' 573' ' ' ILE . 59.7 t -104.54 113.78 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -173.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 60.3 m-85 -86.26 113.84 22.59 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -103.58 116.57 61.73 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -169.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 541' ' ' ALA . 8.2 Cg_exo -72.97 139.42 29.99 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.251 2.634 . . . . 0.0 112.007 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 628' ' ' ILE . 67.6 p -83.05 -176.42 6.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.138 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.22 -30.95 69.73 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.112 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -64.53 -29.81 70.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -67.79 -35.28 78.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.378 0.609 . . . . 0.0 111.339 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . 0.448 ' O ' HD22 ' A' ' 550' ' ' LEU . 6.2 m-85 -73.25 -13.28 61.11 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.131 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -94.57 -38.53 10.83 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.148 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -90.96 7.24 41.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.393 0.616 . . . . 0.0 111.508 -172.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.799 HD12 ' CD1' ' A' ' 555' ' ' TRP . 0.5 OUTLIER -74.97 163.52 67.65 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.235 -178.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.626 ' HB2' ' OE1' ' A' ' 554' ' ' GLU . 3.3 Cg_exo -81.09 126.36 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.307 2.005 . . . . 0.0 109.916 166.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.7 -43.24 60.97 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.518 2.812 . . . . 0.0 114.263 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 553' ' ' ARG . 24.9 mmt180 -71.93 -23.44 61.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 111.486 -172.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.63 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 0.9 OUTLIER -60.88 -53.48 56.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.45 0.643 . . . . 0.0 110.492 175.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' TRP . . . . . 0.799 ' CD1' HD12 ' A' ' 550' ' ' LEU . 4.7 m95 -80.3 -30.34 38.25 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.784 -172.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . 0.44 ' OG ' ' HA ' ' A' ' 553' ' ' ARG . 25.3 p -58.68 -25.45 62.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.337 0.589 . . . . 0.0 109.577 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . 0.774 ' HG3' ' HG2' ' A' ' 564' ' ' GLU . 26.5 tpt180 -84.72 -46.98 10.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.743 173.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 554' ' ' GLU . 74.9 mt -63.19 -60.18 3.76 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.6 HD22 HD11 ' A' ' 565' ' ' LEU . 0.1 OUTLIER -64.57 -12.35 44.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.891 0.376 . . . . 0.0 110.984 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -70.82 -35.84 65.98 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.848 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -145.78 147.3 31.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.319 0.56 . . . . 0.0 110.891 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -67.96 -47.29 69.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.367 -170.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.565 ' HD2' ' H ' ' A' ' 563' ' ' LYS . 0.0 OUTLIER -69.7 -22.85 63.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.061 -177.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.774 ' HG2' ' HG3' ' A' ' 557' ' ' ARG . 7.4 tp10 -77.75 -42.41 34.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.691 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.6 HD11 HD22 ' A' ' 559' ' ' LEU . 0.3 OUTLIER -60.96 -49.43 77.5 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.495 0.664 . . . . 0.0 109.359 175.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . 0.485 ' HA ' HD11 ' A' ' 527' ' ' LEU . . . -55.83 -32.81 63.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.537 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 570' ' ' LYS . 25.6 t-20 -57.63 -46.97 83.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.458 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 558' ' ' LEU . 24.4 mt -83.98 -41.62 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.991 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.529 HD13 HG12 ' A' ' 522' ' ' ILE . 36.0 mt -57.87 -27.34 63.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 592' ' ' LEU . 22.3 ptmt -76.79 -12.66 60.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.014 0.435 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.6 ' O ' HD21 ' A' ' 597' ' ' LEU . 41.1 t80 -83.53 -18.72 37.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.228 0.537 . . . . 0.0 109.79 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . 0.718 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 20.8 m80 -76.16 -10.12 59.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.178 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.609 HG12 HG22 ' A' ' 539' ' ' VAL . 80.1 mt -115.78 119.63 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.056 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.708 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -83.83 161.96 38.75 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.902 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -90.15 3.19 54.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . 0.416 ' HA ' HG23 ' A' ' 536' ' ' VAL . 11.4 pt-20 -160.68 170.45 20.76 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.436 172.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.684 HG13 ' HB ' ' A' ' 536' ' ' VAL . 64.3 mt -87.9 126.2 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.207 -168.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' A' ' 589' ' ' LEU . 2.4 tt -121.51 93.51 4.03 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 20.7 m -77.65 166.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 111.81 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.627 ' HA ' HD12 ' A' ' 583' ' ' ILE . 20.9 t -62.24 -28.19 69.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.306 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.66 68.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.082 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.23 -22.54 11.58 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.035 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.866 HG22 ' HB2' ' A' ' 601' ' ' LEU . 74.0 mt -59.99 109.8 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.103 0.478 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -114.22 -154.24 11.02 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.576 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -50.92 -48.56 60.64 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.981 0.39 . . . . 0.0 110.79 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 4.1 tt -164.36 116.62 1.32 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . 0.443 HG13 HD11 ' A' ' 578' ' ' LEU . 7.3 p -133.67 123.96 46.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . 0.567 ' HD3' ' H ' ' A' ' 588' ' ' ARG . 0.1 OUTLIER -97.23 129.66 44.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.544 0.687 . . . . 0.0 110.873 -174.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.698 ' HB2' HD12 ' A' ' 578' ' ' LEU . 1.5 tm? -110.94 120.04 41.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.242 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -67.24 146.93 53.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.111 0.481 . . . . 0.0 111.286 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.708 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.1 p -106.69 -174.78 2.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.835 -176.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 570' ' ' LYS . 72.9 mt -82.03 -41.44 20.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.06 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.518 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.7 tt0 -59.05 -29.76 67.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.126 0.489 . . . . 0.0 111.024 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 126.74 -14.16 6.76 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.573 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -89.9 -164.38 1.15 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.754 0.777 . . . . 0.0 109.601 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -120.79 137.16 54.67 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.904 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.6 HD21 ' O ' ' A' ' 571' ' ' TYR . 90.6 mt -84.57 116.16 23.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.724 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 90.2 mt-10 -85.28 89.69 7.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.293 -175.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . 0.493 HG12 HG23 ' A' ' 583' ' ' ILE . 47.8 t -91.04 122.23 42.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.74 0.305 . . . . 0.0 111.272 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.647 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 35.9 t -128.53 154.53 46.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.866 ' HB2' HG22 ' A' ' 583' ' ' ILE . 41.0 tp -126.07 129.07 48.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . 0.458 ' HB2' ' HE2' ' A' ' 602' ' ' LYS . 19.1 ttmm -146.78 102.63 3.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.734 0.302 . . . . 0.0 110.199 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . 0.441 ' C ' ' H ' ' A' ' 605' ' ' VAL . 18.7 t-20 58.72 56.88 3.95 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.389 -176.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 68.28 -14.89 0.23 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.983 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . 0.441 ' H ' ' C ' ' A' ' 603' ' ' ASN . 58.7 t -82.42 110.42 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 55.9 t -79.38 136.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.837 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . 0.647 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 36.8 m -124.23 109.42 13.38 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.948 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 11.4 p -112.95 129.14 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.424 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.661 ' ND2' HD13 ' A' ' 632' ' ' LEU . 44.0 m-20 57.86 29.43 17.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm 74.04 22.48 2.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.453 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 0.2 OUTLIER -125.95 149.08 65.05 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 5.9 Cg_exo -78.81 126.27 7.17 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.085 2.524 . . . . 0.0 112.666 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 61.2 t -77.76 136.0 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.524 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -84.74 -42.17 15.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.957 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.58 95.11 3.78 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.665 0.269 . . . . 0.0 110.731 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.99 167.15 27.68 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.437 2.091 . . . . 0.0 113.873 172.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 3.3 t70 75.15 28.95 0.98 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.721 165.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.51 86.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 63.1 mtp -78.38 148.08 33.83 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.362 0.601 . . . . 0.0 112.285 -171.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -124.17 -171.14 2.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.646 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.6 p -80.68 -19.71 44.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.748 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.495 ' OD1' HG23 ' A' ' 505' ' ' VAL . 24.4 p-10 -117.47 15.98 14.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.838 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.15 -148.34 19.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.886 -1.149 . . . . 0.0 113.085 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.7 p -132.14 147.6 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.575 0.226 . . . . 0.0 110.541 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 78.6 t -118.79 142.29 34.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.078 0.465 . . . . 0.0 110.768 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . 0.607 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 52.2 m-70 -130.42 126.82 37.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.413 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.923 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 96.2 t -74.47 118.29 19.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.91 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 543' ' ' THR . 1.2 pt -110.49 171.86 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.014 0.435 . . . . 0.0 110.714 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 21.6 p -117.42 -5.89 11.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.711 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -131.39 168.2 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.306 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 76.8 t -84.03 148.21 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.718 ' HB2' ' CE1' ' A' ' 572' ' ' HIS . 82.6 mt . . . . . 0 C--N 1.32 -0.697 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.291 -170.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.441 -0.968 0 CA-C-O 121.282 0.379 . . . . 0.0 112.454 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.477 HG22 ' OE2' ' A' ' 534' ' ' GLU . 82.0 p -86.17 -168.94 2.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.647 -0.777 . . . . 0.0 110.988 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.422 ' CG2' HG23 ' A' ' 625' ' ' VAL . 4.7 p -56.94 -27.21 26.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.614 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.557 ' HE2' ' HB2' ' A' ' 531' ' ' LEU . 39.5 tpp -71.05 -44.5 65.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.842 174.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . 0.669 ' HA ' ' HB3' ' A' ' 510' ' ' LYS . 5.9 t70 -68.68 -27.31 65.86 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.031 0.443 . . . . 0.0 110.198 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 504' ' ' THR . 91.4 t -50.02 -41.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.674 171.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 509' ' ' LEU . 0.6 OUTLIER -82.03 -36.36 27.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.887 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.679 ' HA ' HG21 ' A' ' 519' ' ' VAL . 28.7 tttm -62.5 -31.45 72.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.802 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -93.78 6.57 73.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.007 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -114.66 137.64 51.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.816 0.341 . . . . 0.0 111.007 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -75.8 -24.08 55.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.589 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -77.56 -28.89 51.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.367 0.603 . . . . 0.0 109.7 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.796 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 26.9 m-85 -105.28 14.78 28.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.877 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 34.8 p -56.45 -53.16 60.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.865 -176.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -68.42 -30.53 69.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.07 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.612 HD13 ' HZ ' ' A' ' 547' ' ' PHE . 54.7 tp -55.4 -47.5 75.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.76 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' A' ' 510' ' ' LYS . 4.0 t -52.27 -47.2 45.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.716 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.82 74.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.041 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.6 -50.2 39.66 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.283 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.58 HG12 HD13 ' A' ' 569' ' ' LEU . 42.9 mt -60.59 -31.38 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.529 0.681 . . . . 0.0 109.658 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.5 OUTLIER -59.63 -59.33 5.61 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.203 173.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.0 m -58.08 -26.83 63.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.897 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -75.09 -17.29 60.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.184 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 70.96 50.32 24.0 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.612 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 566' ' ' ALA . 76.9 mt -128.41 15.47 6.6 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 88.1 m -61.82 -51.57 67.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . 0.665 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 0.0 OUTLIER -60.24 -29.08 68.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.486 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 36.7 m -62.42 -47.95 81.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.962 0.41 . . . . 0.0 110.491 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.557 ' HB2' ' HE2' ' A' ' 506' ' ' MET . 67.2 mt -91.09 -5.03 55.74 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.693 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . 0.584 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 0.9 OUTLIER -83.95 -5.89 59.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.042 172.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . 0.665 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 80.5 mtp180 -85.65 135.41 33.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.792 0.33 . . . . 0.0 110.661 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . 0.477 ' OE2' HG22 ' A' ' 504' ' ' THR . 13.3 mm-40 -78.76 137.04 37.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.951 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 164.47 -117.29 0.75 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.053 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 1.089 HG23 HG13 ' A' ' 577' ' ' ILE . 0.7 OUTLIER -145.99 125.56 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.58 0.229 . . . . 0.0 110.709 -178.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -155.03 137.22 14.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.68 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 98.1 m -107.35 102.32 11.62 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.715 HG22 HG12 ' A' ' 573' ' ' ILE . 61.3 t -99.84 114.89 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.095 0.474 . . . . 0.0 111.211 -175.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 48.6 m-85 -85.77 108.39 18.06 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -100.56 119.39 58.85 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.057 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.56 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 85.5 Cg_endo -82.76 140.14 10.22 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.53 2.153 . . . . 0.0 112.437 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 75.4 p -78.7 -175.93 4.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.532 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -68.94 -35.23 76.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.378 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 545' ' ' GLU . 1.7 mp0 -61.62 -29.96 70.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.064 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -70.07 -34.48 73.25 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.392 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . 0.612 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 21.9 m-85 -70.87 -15.9 62.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.605 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -91.46 -10.91 39.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.063 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -88.09 -2.06 58.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.362 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.77 HD12 ' HE1' ' A' ' 555' ' ' TRP . 66.5 mt -109.68 144.07 29.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.189 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 26.3 Cg_exo -62.74 126.5 18.34 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.506 2.137 . . . . 0.0 111.126 173.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.27 -24.61 60.54 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.891 2.394 . . . . 0.0 113.499 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -68.27 -40.84 81.73 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.788 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -37.84 79.68 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.677 0.751 . . . . 0.0 109.574 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' TRP . . . . . 0.77 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -70.35 -38.24 74.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.832 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.4 t -55.16 -28.25 51.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.574 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . 0.907 ' HG2' ' HG2' ' A' ' 564' ' ' GLU . 14.6 ttp85 -75.72 -32.11 59.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.817 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.496 ' HB3' ' HG ' ' A' ' 565' ' ' LEU . 9.1 mt -78.4 -53.74 6.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.056 0.455 . . . . 0.0 110.333 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 565' ' ' LEU . 1.1 mm? -70.64 -14.31 62.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.261 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -90.6 -49.01 3.3 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -105.15 114.32 28.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.103 0.477 . . . . 0.0 110.063 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.19 -33.09 73.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.214 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -62.31 -37.36 85.28 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.907 ' HG2' ' HG2' ' A' ' 557' ' ' ARG . 7.8 tp10 -69.48 -44.79 70.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.945 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -62.28 -42.02 98.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.014 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . 0.524 ' HA ' HD11 ' A' ' 527' ' ' LEU . . . -57.94 -38.13 75.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.363 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 564' ' ' GLU . 92.7 m-20 -57.06 -56.83 16.64 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.9 0.381 . . . . 0.0 111.077 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 50.3 mt -67.53 -50.21 63.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.486 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.58 HD13 HG12 ' A' ' 522' ' ' ILE . 83.2 mt -59.73 -23.22 63.01 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 34.7 mttp -70.89 -18.09 62.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.781 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.626 ' O ' HD21 ' A' ' 597' ' ' LEU . 35.3 t80 -92.74 -1.83 56.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.398 0.618 . . . . 0.0 110.167 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . 0.594 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 5.7 m80 -89.58 -15.13 33.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.208 174.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.715 HG12 HG22 ' A' ' 539' ' ' VAL . 76.3 mt -111.02 121.0 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.873 -175.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -88.23 153.85 24.77 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.295 176.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.9 -21.32 64.24 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . 0.626 ' HA ' ' CG2' ' A' ' 536' ' ' VAL . 15.7 pt-20 -145.4 153.3 41.06 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 122.224 -0.298 . . . . 0.0 110.676 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 1.089 HG13 HG23 ' A' ' 536' ' ' VAL . 75.2 mt -70.24 114.62 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.814 -176.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.726 HD12 ' HB2' ' A' ' 589' ' ' LEU . 1.6 tt -111.4 98.96 7.85 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 583' ' ' ILE . 28.5 m -76.59 163.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.534 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.731 ' HA ' HD12 ' A' ' 583' ' ' ILE . 28.4 m -56.75 -31.13 64.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.378 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.19 -15.54 67.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.861 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.1 -10.97 40.92 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.219 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 580' ' ' SER . 71.0 mt -78.18 -3.86 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 122.876 0.47 . . . . 0.0 111.262 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -50.7 129.12 29.86 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.804 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 71.49 -85.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.796 0.838 . . . . 0.0 110.868 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.474 HD21 ' HG3' ' A' ' 598' ' ' GLU . 4.7 tt -167.55 117.56 0.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 89.6 t -132.94 130.72 58.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.941 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . 0.525 ' HB3' ' OE1' ' A' ' 598' ' ' GLU . 0.7 OUTLIER -96.96 128.77 44.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.577 0.703 . . . . 0.0 111.28 -178.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.726 ' HB2' HD12 ' A' ' 578' ' ' LEU . 31.1 tp -116.84 126.73 53.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.369 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -65.9 134.35 52.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.777 0.323 . . . . 0.0 110.373 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.644 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 86.7 p -99.24 -171.63 2.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.554 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 570' ' ' LYS . 79.3 mt -81.64 -39.05 25.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -62.54 -30.36 71.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.559 0.695 . . . . 0.0 110.263 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.44 -17.46 6.96 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.503 170.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . 0.497 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.3 t70 -84.12 -176.77 6.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.461 0.631 . . . . 0.0 109.705 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.21 139.56 39.69 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.871 0.367 . . . . 0.0 110.693 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.626 HD21 ' O ' ' A' ' 571' ' ' TYR . 94.9 mt -81.97 115.52 21.17 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.525 ' OE1' ' HB3' ' A' ' 588' ' ' ARG . 2.3 tp10 -94.07 87.28 5.26 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . 0.639 HG22 HG23 ' A' ' 608' ' ' VAL . 2.0 t -99.12 128.16 51.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.007 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' A' ' 606' ' ' VAL . 33.1 t -131.29 108.5 9.71 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.365 -174.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 606' ' ' VAL . 56.8 tp -108.16 116.09 31.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.825 0.345 . . . . 0.0 110.442 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -151.37 133.63 15.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.678 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 58.58 40.56 23.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.598 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 604' ' ' ASN . 7.1 m120 66.15 11.87 8.14 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.597 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.84 107.47 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.022 0.439 . . . . 0.0 110.223 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 613' ' ' VAL . 1.4 p -98.14 137.84 24.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.668 176.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 50.3 m -132.19 120.57 22.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 599' ' ' VAL . 7.6 p -110.27 123.65 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.067 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.706 ' ND2' HD13 ' A' ' 632' ' ' LEU . 24.0 m-20 61.38 33.88 18.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.468 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 48.5 mtpt 83.31 -14.19 0.73 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.32 1.012 . . . . 0.0 112.03 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 34.0 mm-40 -96.72 122.59 56.57 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.811 0.339 . . . . 0.0 110.547 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 23.7 Cg_exo -63.83 133.71 40.26 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.851 2.367 . . . . 0.0 112.499 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.915 ' HB ' HG13 ' A' ' 606' ' ' VAL . 44.4 t -88.8 137.46 21.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -87.09 -60.61 1.93 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.397 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . 0.451 ' H ' ' HB ' ' A' ' 627' ' ' VAL . 16.5 mp0 -128.23 92.44 41.49 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.618 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.28 167.72 26.59 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.606 2.204 . . . . 0.0 113.219 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 74.88 38.28 0.46 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.463 0.705 . . . . 0.0 112.827 166.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 34.0 mt -98.11 89.9 2.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 171.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . 0.602 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 53.0 mtp -82.44 160.46 22.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.542 0.686 . . . . 0.0 112.499 -169.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . 0.415 ' HB2' HG21 ' A' ' 508' ' ' VAL . . . -130.95 -171.17 2.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.446 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 26.0 p -72.93 -37.11 67.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.181 0.515 . . . . 0.0 110.811 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.46 ' HB3' ' OE2' ' A' ' 534' ' ' GLU . 33.4 p-10 -109.95 13.41 23.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.172 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 165.3 -138.1 5.05 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.193 -1.479 . . . . 0.0 113.927 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 10.1 p -160.13 148.74 6.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.727 -171.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . 0.422 HG23 ' CG2' ' A' ' 505' ' ' VAL . 47.8 t -119.49 139.99 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.296 0.57 . . . . 0.0 110.968 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . 0.548 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 60.9 m-70 -127.52 117.85 22.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.796 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 58.1 t -72.34 119.0 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -173.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 542' ' ' PRO . 0.6 OUTLIER -114.31 150.0 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.074 0.464 . . . . 0.0 110.733 173.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 18.1 p -96.82 6.84 47.9 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.924 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -138.67 155.21 48.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.953 0.406 . . . . 0.0 111.489 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 60.4 t -86.99 157.21 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.706 HD13 ' ND2' ' A' ' 609' ' ' ASN . 38.2 mt . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 120.724 0.297 . . . . 0.0 110.899 -167.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.619 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 508' ' ' VAL . 68.7 p -124.91 -170.48 2.17 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.691 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 54.8 t -42.54 -42.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.638 0.586 . . . . 0.0 110.727 168.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -48.9 79.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.261 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -71.54 -28.32 63.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.816 0.341 . . . . 0.0 110.456 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 504' ' ' THR . 71.5 t -53.98 -42.7 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.588 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 4.8 mt -82.18 -33.18 29.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.162 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.514 ' HA ' HG21 ' A' ' 519' ' ' VAL . 1.9 tmmm? -59.9 -40.02 87.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.991 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -89.13 -2.81 76.96 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.785 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.35 144.98 30.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.645 0.723 . . . . 0.0 110.811 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -75.25 -35.0 61.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.578 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -78.43 -13.37 59.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.881 0.372 . . . . 0.0 110.445 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.621 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 24.1 m-85 -113.41 9.63 18.19 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.003 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 64.5 m -58.54 -44.53 89.65 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -173.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.0 ptm -83.24 -20.15 35.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.701 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.57 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 46.9 tp -57.95 -41.67 83.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.38 0.609 . . . . 0.0 109.462 172.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 510' ' ' LYS . 18.6 t -52.04 -52.97 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.666 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -60.32 -32.84 71.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.6 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.11 -49.87 46.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.951 0.405 . . . . 0.0 110.508 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 527' ' ' LEU . 58.6 mt -59.42 -34.2 53.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.486 0.66 . . . . 0.0 109.953 175.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -66.56 -49.51 66.16 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.924 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.3 m -57.12 -34.27 68.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.378 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.945 ' HB2' HD22 ' A' ' 565' ' ' LEU . . . -78.18 -17.97 56.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.142 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 74.58 18.62 79.99 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.005 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . 0.464 ' HB2' HG23 ' A' ' 522' ' ' ILE . 93.3 mt -84.6 5.83 26.31 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.547 -0.384 . . . . 0.0 111.466 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 19.0 m -56.76 -44.13 81.48 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.097 0.475 . . . . 0.0 109.954 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -53.99 -35.23 61.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.029 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 8.3 m -69.49 -36.76 76.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 111.447 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 97.2 mt -96.3 -27.41 14.99 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -173.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -84.58 23.27 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -118.46 152.42 35.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.815 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -69.77 115.68 9.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -178.13 -163.78 30.23 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.68 ' HB ' HG13 ' A' ' 577' ' ' ILE . 20.8 m -119.52 127.93 75.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . 0.512 ' O ' ' HA3' ' A' ' 623' ' ' GLY . 96.5 m-85 -148.54 140.6 23.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.795 0.331 . . . . 0.0 110.683 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 93.5 m -113.74 101.58 9.43 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 170.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.575 HG21 HG11 ' A' ' 505' ' ' VAL . 56.6 t -101.41 119.78 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.419 -174.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.631 ' CD2' HG11 ' A' ' 608' ' ' VAL . 51.5 m-85 -86.43 111.98 21.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -106.99 112.88 63.07 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.705 -167.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.767 ' HA ' HG13 ' A' ' 628' ' ' ILE . 3.3 Cg_exo -79.7 143.21 16.59 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.243 2.628 . . . . 0.0 112.709 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 68.9 p -85.73 -177.44 6.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.585 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -67.86 -25.57 65.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.767 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -71.13 -22.03 62.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.548 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -83.67 -34.62 24.95 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.059 0.457 . . . . 0.0 111.467 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . 0.504 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 5.0 m-85 -68.55 -13.98 62.7 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -93.57 -17.11 23.7 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.615 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -82.8 -13.03 56.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.019 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.577 HD12 ' HE1' ' A' ' 555' ' ' TRP . 46.4 mt -101.63 133.64 20.68 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.8 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.8 135.28 67.09 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.384 2.056 . . . . 0.0 110.925 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.54 -33.56 23.91 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.199 2.599 . . . . 0.0 113.579 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 553' ' ' ARG . 11.4 ptt180 -60.24 -36.24 77.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.656 0.265 . . . . 0.0 111.388 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 557' ' ' ARG . 0.4 OUTLIER -72.72 -40.84 65.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.92 0.39 . . . . 0.0 110.777 -175.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' TRP . . . . . 0.577 ' HE1' HD12 ' A' ' 550' ' ' LEU . 1.1 m95 -80.69 -29.04 36.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.227 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 37.5 t -57.03 -29.65 63.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.332 168.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 554' ' ' GLU . 50.0 mtt180 -75.52 -40.04 57.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.206 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.516 ' HG ' ' HA ' ' A' ' 555' ' ' TRP . 5.3 mt -75.77 -54.66 6.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.882 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.429 ' HA ' HD22 ' A' ' 559' ' ' LEU . 0.2 OUTLIER -64.36 -14.21 55.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.666 0.269 . . . . 0.0 111.583 178.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -98.65 -21.53 16.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.46 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 25.9 t70 -135.75 118.77 16.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.081 0.467 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.78 68.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.792 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.47 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 5.1 tmtm? -59.63 -43.32 93.88 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.096 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 567' ' ' ASN . 8.2 tp10 -75.76 -34.81 60.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.554 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.945 HD22 ' HB2' ' A' ' 525' ' ' ALA . 5.6 tt -68.57 -45.27 72.5 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.11 0.481 . . . . 0.0 109.759 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -64.2 -30.36 71.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.518 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . 0.789 ' HA ' ' NE2' ' A' ' 593' ' ' GLN . 39.0 t30 -55.93 -45.03 78.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.439 0.638 . . . . 0.0 110.506 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 60.6 mt -85.85 -62.53 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.442 -178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.45 HD11 HG12 ' A' ' 522' ' ' ILE . 3.2 tt -55.12 -35.76 65.0 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.548 ' HG2' ' HB2' ' A' ' 592' ' ' LEU . 19.7 ttpp -72.25 -12.34 61.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.62 ' O ' HD21 ' A' ' 597' ' ' LEU . 41.7 t80 -89.28 -18.71 26.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.589 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . 0.475 ' NE2' HG23 ' A' ' 631' ' ' VAL . 2.0 m-70 -73.3 -14.12 61.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.309 0.575 . . . . 0.0 109.91 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.538 HG12 HG22 ' A' ' 539' ' ' VAL . 61.2 mt -101.81 121.78 53.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.839 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.67 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -84.74 164.18 39.1 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.873 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.03 -33.35 75.6 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.171 0.588 . . . . 0.0 112.072 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . 0.469 ' HA ' HG23 ' A' ' 536' ' ' VAL . 13.6 pt-20 -146.37 -178.29 6.08 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.191 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.731 HG23 HG22 ' A' ' 624' ' ' VAL . 14.9 mt -82.28 110.56 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 123.395 0.434 . . . . 0.0 111.114 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 578' ' ' LEU . 1.2 tm? -117.67 94.54 4.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 27.5 m -81.96 172.18 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.473 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.562 ' HA ' HD12 ' A' ' 583' ' ' ILE . 15.8 m -63.03 -20.4 65.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.472 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.01 -13.14 63.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.437 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -103.55 -20.07 11.4 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 580' ' ' SER . 76.5 mt -74.85 90.12 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.202 0.525 . . . . 0.0 110.396 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -102.83 -123.98 5.37 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.876 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -66.5 -57.94 6.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.073 0.463 . . . . 0.0 110.23 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 55.0 tp -156.86 114.42 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.644 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 10.1 p -132.18 132.29 60.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 120.945 0.402 . . . . 0.0 110.126 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . 0.71 ' HG2' ' HA ' ' A' ' 598' ' ' GLU . 40.0 mtp180 -112.5 127.09 55.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.33 0.586 . . . . 0.0 110.899 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.61 126.83 55.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.912 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 3.7 tmmt? -62.95 140.77 58.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.67 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.8 p -103.6 -174.52 2.56 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.744 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.548 ' HB2' ' HG2' ' A' ' 570' ' ' LYS . 78.9 mt -81.56 -42.26 20.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.89 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.789 ' NE2' ' HA ' ' A' ' 567' ' ' ASN . 6.4 tp-100 -61.64 -29.26 69.95 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 127.18 11.7 3.37 Favored Glycine 0 C--N 1.321 -0.267 0 C-N-CA 120.028 -1.082 . . . . 0.0 114.521 166.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -117.43 -156.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -135.46 130.81 35.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.214 0.53 . . . . 0.0 111.922 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 588' ' ' ARG . 92.7 mt -68.6 122.33 18.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.851 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.71 ' HA ' ' HG2' ' A' ' 588' ' ' ARG . 30.0 tt0 -86.35 94.46 9.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . 0.451 HG12 HG23 ' A' ' 583' ' ' ILE . 36.1 t -105.52 133.82 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.802 -175.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 606' ' ' VAL . 7.7 p -140.5 161.84 36.76 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.748 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.473 ' HB2' HG22 ' A' ' 583' ' ' ILE . 67.6 tp -127.46 113.26 15.94 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -136.84 126.21 24.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.443 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 54.59 44.05 29.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.344 0.593 . . . . 0.0 110.546 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 65.3 t30 70.44 -0.39 2.9 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.355 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.76 119.68 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.489 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.788 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 25.9 t -77.59 148.48 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 611' ' ' GLU . 49.1 m -140.21 112.32 7.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.065 0.46 . . . . 0.0 111.968 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.631 HG11 ' CD2' ' A' ' 540' ' ' PHE . 7.5 p -117.17 135.71 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.156 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 1.061 ' HB2' HD23 ' A' ' 632' ' ' LEU . 77.1 m-20 53.58 33.18 15.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.177 0.513 . . . . 0.0 110.397 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt 77.22 9.09 2.71 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.373 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 608' ' ' VAL . 0.3 OUTLIER -113.97 149.65 42.24 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 1.4 Cg_endo -85.98 124.84 2.61 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.986 2.457 . . . . 0.0 113.161 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.788 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 49.9 t -76.19 143.94 12.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.383 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . 0.567 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -89.98 -43.98 10.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.415 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 21.9 tt0 -151.06 92.07 3.86 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 120.971 0.415 . . . . 0.0 111.787 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . 0.524 ' HG3' HG21 ' A' ' 606' ' ' VAL . 83.1 Cg_endo -76.28 169.45 21.97 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.914 2.409 . . . . 0.0 114.124 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 74.47 27.92 1.35 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.693 -1.139 . . . . 0.0 113.15 166.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 627' ' ' VAL . 45.0 mt -87.33 91.84 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 170.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . 0.717 ' HG2' HG13 ' A' ' 624' ' ' VAL . 51.7 mtp -80.18 128.97 34.14 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.585 0.707 . . . . 0.0 112.176 -170.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -100.73 166.92 10.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.341 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -15.13 53.98 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.512 ' OD1' HG23 ' A' ' 505' ' ' VAL . 25.2 p-10 -116.62 15.51 15.51 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 537' ' ' TYR . . . 147.03 -133.51 4.81 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 119.765 -1.207 . . . . 0.0 113.455 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . 0.731 HG22 HG23 ' A' ' 577' ' ' ILE . 0.0 OUTLIER -129.32 152.7 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.109 0.481 . . . . 0.0 111.597 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . 0.513 HG22 HG13 ' A' ' 505' ' ' VAL . 43.7 t -122.65 131.14 73.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.586 170.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . 0.506 ' HB2' ' CD2' ' A' ' 540' ' ' PHE . 77.6 m-70 -120.14 110.56 16.77 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.18 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.621 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 98.9 t -66.93 118.39 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.691 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.767 HG13 ' HA ' ' A' ' 542' ' ' PRO . 5.1 pt -115.77 143.97 24.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.616 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . 0.567 HG23 ' HB2' ' A' ' 614' ' ' ALA . 24.5 p -94.73 1.4 55.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.797 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . 0.462 ' ND2' ' HD2' ' A' ' 612' ' ' PRO . 6.5 m-80 -135.92 135.9 40.02 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.898 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.475 HG23 ' NE2' ' A' ' 572' ' ' HIS . 0.2 OUTLIER -90.3 147.18 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 172.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 1.061 HD23 ' HB2' ' A' ' 609' ' ' ASN . 1.5 mp . . . . . 0 N--CA 1.437 -1.079 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.12 -158.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.443 -0.86 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.439 ' HA ' HG22 ' A' ' 621' ' ' THR . 76.4 p -88.2 -171.67 3.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.838 175.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.579 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 93.5 t -45.16 -46.15 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 123.35 0.406 . . . . 0.0 111.33 174.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.74 ' SD ' ' HB2' ' A' ' 531' ' ' LEU . 0.0 OUTLIER -60.64 -38.11 83.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.886 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . 0.538 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 16.9 t70 -68.19 -38.52 82.09 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 505' ' ' VAL . 96.0 t -53.1 -40.42 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.421 176.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 8.1 mt -77.7 -20.38 53.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.099 -174.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -83.32 -26.24 30.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.162 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -89.38 -0.7 79.44 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.105 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -122.26 141.18 51.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.996 0.398 . . . . 0.0 111.441 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -75.5 -22.59 57.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.102 -177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -73.52 -20.24 60.71 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 110.374 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.726 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 15.9 m-85 -114.74 19.2 16.14 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.788 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 32.9 t -59.05 -57.31 13.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.75 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -64.5 -30.09 71.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.933 0.397 . . . . 0.0 110.237 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.563 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 57.8 tp -53.85 -45.43 70.92 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.873 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 515' ' ' PHE . 14.8 t -50.94 -51.32 21.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.856 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.42 82.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.143 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -65.53 -51.18 61.8 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.42 . . . . 0.0 109.871 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.542 HG21 ' HE3' ' A' ' 506' ' ' MET . 96.6 mt -56.76 -33.63 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.698 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -38.82 92.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.427 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 22.3 m -66.43 -22.22 66.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.035 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -89.51 -30.0 18.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.613 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.41 67.4 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 114.489 0.556 . . . . 0.0 114.489 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 2.0 pp -82.48 24.68 0.68 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.973 0.887 . . . . 0.0 112.531 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.471 HG23 ' HG2' ' A' ' 506' ' ' MET . 58.5 m -57.98 -42.06 84.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.414 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.44 -30.7 65.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.974 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 85.1 m -58.9 -48.61 80.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.802 0.334 . . . . 0.0 111.273 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.74 ' HB2' ' SD ' ' A' ' 506' ' ' MET . 82.9 mt -96.95 -1.22 46.15 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.214 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 528' ' ' THR . 2.1 t-20 -81.29 -19.01 43.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.964 0.412 . . . . 0.0 110.976 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . 0.453 ' HG2' ' H ' ' A' ' 534' ' ' GLU . 33.0 ttt180 -104.06 168.33 9.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.868 0.366 . . . . 0.0 111.238 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . 0.453 ' H ' ' HG2' ' A' ' 533' ' ' ARG . 10.7 tp10 -58.02 147.73 28.43 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.407 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 154.85 -178.3 31.64 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.707 ' HB ' HG13 ' A' ' 577' ' ' ILE . 14.9 m -116.85 126.45 74.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -149.7 142.81 24.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.067 0.461 . . . . 0.0 110.884 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 97.9 m -112.23 110.41 20.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.655 HG22 HG12 ' A' ' 573' ' ' ILE . 65.0 t -109.29 114.94 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 120.879 0.371 . . . . 0.0 111.031 -175.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.63 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 80.4 m-85 -86.33 109.79 19.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -101.7 118.74 58.98 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.528 -166.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.666 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 72.3 Cg_endo -77.51 140.06 18.76 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.63 2.22 . . . . 0.0 111.778 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 69.5 p -78.8 -177.81 5.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.146 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . 0.545 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -73.58 -26.67 60.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.148 0.499 . . . . 0.0 110.152 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 548' ' ' ARG . 1.7 mp0 -68.36 -23.84 64.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.145 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -74.97 -31.37 61.44 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.883 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . 0.545 ' CD2' ' HA ' ' A' ' 544' ' ' ASN . 22.9 m-85 -65.64 -14.53 61.38 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . 0.641 ' HA ' ' HE ' ' A' ' 548' ' ' ARG . 3.3 mmp_? -93.93 -1.44 54.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.487 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -98.67 -11.38 22.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.769 HD12 ' HE1' ' A' ' 555' ' ' TRP . 32.5 mt -98.92 136.81 20.5 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.322 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 4.7 Cg_exo -74.8 140.25 25.83 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.884 2.389 . . . . 0.0 111.379 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 52.7 Cg_exo -57.57 -16.8 25.52 Favored 'Trans proline' 0 C--O 1.224 -0.187 0 C-N-CA 123.043 2.495 . . . . 0.0 112.397 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -53.33 -46.76 69.6 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.768 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 27.4 mm-40 -87.07 -40.5 14.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.239 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' TRP . . . . . 0.769 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.1 OUTLIER -62.26 -38.13 88.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.738 -173.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 24.4 t -52.24 -33.02 39.59 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.579 0.55 . . . . 0.0 111.195 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 -83.95 -37.0 22.85 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 120.531 0.205 . . . . 0.0 110.611 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.862 ' HB3' HD13 ' A' ' 565' ' ' LEU . 41.4 mt -64.78 -49.36 71.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.762 0.315 . . . . 0.0 111.336 -175.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.45 1.98 14.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.872 0.367 . . . . 0.0 111.316 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -108.47 -48.09 0.88 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.879 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -104.11 126.79 51.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.966 0.413 . . . . 0.0 109.906 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.64 66.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.268 -170.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 566' ' ' ALA . 0.0 OUTLIER -79.68 -20.88 45.54 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.295 -177.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.13 -38.82 69.19 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.022 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.862 HD13 ' HB3' ' A' ' 558' ' ' LEU . 18.1 tp -71.41 -41.43 69.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 563' ' ' LYS . . . -59.54 -40.55 87.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.15 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -55.08 -44.53 74.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 632' ' ' LEU . 63.3 mt -72.29 -45.45 61.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.493 HD13 HG12 ' A' ' 522' ' ' ILE . 89.5 mt -64.65 -25.55 68.0 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 97.3 mttt -74.13 -13.72 60.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.69 0.281 . . . . 0.0 111.44 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.557 ' O ' HD21 ' A' ' 597' ' ' LEU . 57.6 t80 -91.51 -18.46 24.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.089 0.471 . . . . 0.0 110.03 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . 0.666 ' HD2' ' HD3' ' A' ' 542' ' ' PRO . 12.0 m80 -74.84 -13.08 60.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.655 HG12 HG22 ' A' ' 539' ' ' VAL . 55.5 mt -109.3 137.91 39.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.857 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -106.67 164.45 13.39 Favored Glycine 0 CA--C 1.516 0.156 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 172.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.61 -10.23 59.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.246 0.523 . . . . 0.0 112.407 -171.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . 0.418 ' HG2' HD21 ' A' ' 589' ' ' LEU . 11.3 pt-20 -144.46 169.86 17.15 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 122.502 -0.123 . . . . 0.0 110.811 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.707 HG13 ' HB ' ' A' ' 536' ' ' VAL . 8.3 mt -88.03 122.99 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.635 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 56.0 tp -126.92 93.7 3.83 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.645 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.17 179.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.036 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 10.9 m -62.25 -23.42 66.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.902 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.58 -17.47 72.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.566 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.26 -34.14 4.91 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.927 HG22 ' HB2' ' A' ' 601' ' ' LEU . 77.7 mt -62.52 99.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 122.968 0.507 . . . . 0.0 110.031 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . -121.05 -73.16 0.32 Allowed Glycine 0 C--O 1.226 -0.367 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.87 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -98.82 -82.25 0.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.839 0.352 . . . . 0.0 110.332 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 5.2 tt -155.18 117.42 4.19 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.49 133.68 67.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.492 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -105.38 110.0 22.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.82 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.418 HD21 ' HG2' ' A' ' 576' ' ' GLU . 0.9 OUTLIER -106.72 127.66 53.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -175.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -71.87 147.28 47.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.873 0.368 . . . . 0.0 110.091 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.479 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 85.8 p -108.98 -178.1 3.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.971 0.415 . . . . 0.0 110.443 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.632 HD23 ' HB ' ' A' ' 573' ' ' ILE . 1.6 mm? -73.62 -37.82 65.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.837 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -64.18 -31.46 72.67 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.459 0.647 . . . . 0.0 110.085 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.29 -17.82 6.98 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.889 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 4.3 t70 -85.6 -165.84 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.975 0.888 . . . . 0.0 110.563 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -115.74 134.18 55.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.19 0.519 . . . . 0.0 111.746 -171.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.557 HD21 ' O ' ' A' ' 571' ' ' TYR . 87.1 mt -90.93 115.34 27.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 39.6 mt-10 -92.9 101.02 13.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.244 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 607' ' ' SER . 39.7 t -108.29 130.87 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 123.353 0.408 . . . . 0.0 111.345 -175.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.558 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 22.7 t -134.0 157.93 44.82 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.35 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.927 ' HB2' HG22 ' A' ' 583' ' ' ILE . 55.7 tp -128.92 118.78 23.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 172.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 602' ' ' LYS . 22.7 tptp -152.28 129.9 11.52 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.17 176.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 58.86 33.29 22.96 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.417 0.448 . . . . 0.0 110.57 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 75.58 -2.55 2.77 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.384 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.61 113.94 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.104 0.478 . . . . 0.0 110.864 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.453 HG13 HG21 ' A' ' 583' ' ' ILE . 61.5 t -77.47 134.12 29.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.446 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 15.9 m -120.52 105.91 11.29 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.599 HG22 ' OD1' ' A' ' 609' ' ' ASN . 12.6 p -111.03 139.79 33.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.599 ' OD1' HG22 ' A' ' 608' ' ' VAL . 3.1 m120 58.36 25.61 13.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . 0.536 ' NZ ' ' HB2' ' A' ' 610' ' ' LYS . 3.7 ttmp? 69.58 22.59 6.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.946 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -130.96 147.5 66.54 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 121.079 0.466 . . . . 0.0 109.952 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -60.76 128.8 26.78 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.55 2.833 . . . . 0.0 113.85 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.558 HG22 HG12 ' A' ' 608' ' ' VAL . 47.8 t -81.47 143.19 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 172.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -79.25 -61.38 2.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.38 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 616' ' ' PRO . 3.1 mt-10 -139.41 100.87 7.55 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 615' ' ' GLU . 74.1 Cg_endo -72.27 162.51 41.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.846 2.364 . . . . 0.0 114.15 174.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 74.89 45.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.533 164.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 34.9 mt -96.03 87.2 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 165.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . 0.525 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 49.9 mtp -76.5 146.19 38.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.519 0.675 . . . . 0.0 112.575 -171.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.48 -171.51 1.85 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.549 -1.205 . . . . 0.0 107.928 172.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 504' ' ' THR . 12.6 t -82.69 -15.71 50.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.863 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.473 ' OD1' HG23 ' A' ' 505' ' ' VAL . 27.9 p-10 -118.72 19.3 13.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.944 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.57 -148.38 19.35 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.69 -1.243 . . . . 0.0 112.993 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 15.0 p -139.31 146.35 25.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.916 0.389 . . . . 0.0 111.093 -175.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 69.9 t -115.34 139.96 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.65 176.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . 0.63 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 67.0 m-70 -125.59 126.99 45.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.251 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.726 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 91.6 t -77.19 119.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -174.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.2 153.0 16.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.038 0.447 . . . . 0.0 110.447 172.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 20.8 p -100.68 3.86 42.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -130.2 152.47 49.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.853 0.359 . . . . 0.0 110.137 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.47 ' HB ' HD11 ' A' ' 550' ' ' LEU . 43.6 t -87.82 151.77 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 172.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.578 HD13 ' ND2' ' A' ' 609' ' ' ASN . 36.8 mt . . . . . 0 C--N 1.318 -0.761 0 CA-C-O 120.906 0.384 . . . . 0.0 110.741 -168.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 CA-C-O 121.303 0.391 . . . . 0.0 112.9 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.506 ' HA ' HG22 ' A' ' 621' ' ' THR . 68.6 p -92.74 -170.02 2.34 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.282 -0.459 . . . . 0.0 110.497 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.604 ' O ' HD13 ' A' ' 509' ' ' LEU . 94.6 t -43.87 -41.26 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.084 169.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 39.7 tpp -60.02 -46.06 90.76 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.148 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.16 -42.32 99.15 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.949 0.404 . . . . 0.0 110.412 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 620' ' ' ALA . 91.2 t -52.82 -46.98 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.266 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.604 HD13 ' O ' ' A' ' 505' ' ' VAL . 3.2 mp -75.67 -37.28 59.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.065 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.578 ' HA ' HG21 ' A' ' 519' ' ' VAL . 64.2 tttp -71.75 -29.9 65.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.957 0.408 . . . . 0.0 111.023 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -84.86 -10.25 79.29 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.726 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . 0.74 ' OD1' ' HG2' ' A' ' 514' ' ' ARG . 34.1 t0 -98.95 134.36 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.241 0.543 . . . . 0.0 110.782 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.41 -35.05 79.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.284 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . 0.74 ' HG2' ' OD1' ' A' ' 512' ' ' ASP . 23.7 ptt180 -83.08 -8.92 59.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.249 -173.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.876 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 23.3 m-85 -116.27 13.0 15.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.943 0.401 . . . . 0.0 110.445 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 25.6 p -57.91 -49.57 76.29 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.272 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -69.4 -31.79 70.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.046 0.45 . . . . 0.0 110.113 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.568 HD13 ' HZ ' ' A' ' 547' ' ' PHE . 56.8 tp -54.57 -47.04 73.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.573 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 510' ' ' LYS . 6.5 t -50.57 -48.66 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.043 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 523' ' ' GLN . . . -63.64 -30.95 71.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.021 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.67 51.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.077 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.845 HG12 HD21 ' A' ' 569' ' ' LEU . 35.7 mt -57.1 -38.21 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.484 0.659 . . . . 0.0 109.612 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' A' ' 520' ' ' ALA . 18.5 tp60 -58.52 -58.91 6.47 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.281 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.0 m -58.81 -23.44 60.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.754 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -86.13 -13.69 46.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.179 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 75.14 12.46 83.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.758 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . 0.667 HD12 HD23 ' A' ' 569' ' ' LEU . 78.5 mt -86.27 13.66 7.7 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.541 -0.388 . . . . 0.0 111.516 -176.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 532' ' ' ASN . 36.7 m -55.57 -47.49 76.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . 0.673 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 12.7 pt-20 -69.2 -16.52 63.63 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.336 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 32.4 m -82.16 -44.67 16.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.623 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 531' ' ' LEU . 27.2 mt -82.47 -20.02 37.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.712 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 528' ' ' THR . 16.6 m-20 -91.01 22.89 3.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.003 0.43 . . . . 0.0 111.122 175.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 11.7 mmt180 -103.15 163.86 11.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.551 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.09 153.76 17.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.183 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 137.9 -138.87 9.93 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.887 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.726 ' HB ' HG12 ' A' ' 577' ' ' ILE . 17.8 m -129.08 127.59 66.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -144.81 128.9 17.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.216 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 87.1 m -106.77 100.25 9.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 170.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.619 HG22 HG12 ' A' ' 573' ' ' ILE . 90.4 t -101.9 116.65 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.18 -173.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.575 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 54.2 m-85 -86.41 111.07 20.17 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 172.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -98.4 115.15 65.85 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.698 -168.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.592 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 73.3 Cg_endo -79.0 134.4 11.72 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.652 2.235 . . . . 0.0 111.181 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 71.4 p -75.95 -179.45 4.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.279 0.561 . . . . 0.0 111.595 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -74.0 -16.76 61.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.796 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 548' ' ' ARG . 39.0 tt0 -76.66 -25.85 54.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.792 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.417 ' HB1' ' N ' ' A' ' 631' ' ' VAL . . . -72.18 -42.36 65.96 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.568 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . 0.568 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 9.1 m-85 -67.27 -13.91 62.42 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.647 0.737 . . . . 0.0 109.315 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 545' ' ' GLU . 37.1 ttm180 -90.22 -10.53 44.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.325 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -97.47 -29.04 13.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.107 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.49 HD13 HG13 ' A' ' 631' ' ' VAL . 7.2 mp -78.67 140.58 59.3 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.018 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.416 ' HG2' ' CB ' ' A' ' 554' ' ' GLU . 23.1 Cg_endo -63.3 134.21 44.19 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.655 2.237 . . . . 0.0 112.052 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.66 -41.24 46.01 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.163 2.575 . . . . 0.0 112.534 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 557' ' ' ARG . 40.0 ttm180 -57.32 -47.86 80.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.707 0.289 . . . . 0.0 110.751 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.416 ' CB ' ' HG2' ' A' ' 551' ' ' PRO . 41.3 tt0 -66.88 -46.25 75.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.098 0.475 . . . . 0.0 110.602 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' TRP . . . . . 0.438 ' CZ2' ' CD1' ' A' ' 547' ' ' PHE . 0.0 OUTLIER -72.44 -42.21 65.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.351 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 51.0 p -55.6 -26.15 42.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.564 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 553' ' ' ARG . 1.8 mmp_? -71.72 -35.57 70.24 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.669 HD22 HG13 ' A' ' 568' ' ' ILE . 16.0 mt -68.64 -50.29 52.43 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.25 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.604 HD22 HD22 ' A' ' 565' ' ' LEU . 0.5 OUTLIER -70.25 0.98 5.36 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 178.013 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -78.03 -46.37 9.41 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.082 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 564' ' ' GLU . 32.1 t70 -125.24 142.65 51.37 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -72.46 -39.88 67.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.014 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.551 ' HD2' ' H ' ' A' ' 563' ' ' LYS . 0.0 OUTLIER -66.16 -35.78 81.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.65 -178.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.426 ' HG2' ' OD2' ' A' ' 561' ' ' ASP . 8.1 mm-40 -74.97 -39.99 60.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.728 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.604 HD22 HD22 ' A' ' 559' ' ' LEU . 39.1 tp -65.32 -43.97 89.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.38 74.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.358 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -53.64 -51.6 62.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.173 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.669 HG13 HD22 ' A' ' 558' ' ' LEU . 24.2 mm -67.07 -52.77 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.845 HD21 HG12 ' A' ' 522' ' ' ILE . 26.7 tp -58.75 -24.56 61.86 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.97 -177.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 87.9 mttt -70.37 -18.08 63.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 0.0 111.627 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 37.5 t80 -89.77 10.08 24.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.992 0.901 . . . . 0.0 109.485 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . 0.592 ' HD2' ' HD3' ' A' ' 542' ' ' PRO . 13.4 m80 -103.78 -15.26 15.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.177 173.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.619 HG12 HG22 ' A' ' 539' ' ' VAL . 64.5 mt -109.89 115.89 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.882 -175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.643 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -83.28 150.52 27.39 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.112 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -67.48 -21.7 65.5 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . 0.633 ' HG2' HD21 ' A' ' 589' ' ' LEU . 15.9 pt-20 -129.35 -178.32 4.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.596 -173.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.726 HG12 ' HB ' ' A' ' 536' ' ' VAL . 48.4 mm -96.16 110.38 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.504 174.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.532 HD21 HG13 ' A' ' 587' ' ' VAL . 57.5 tp -113.32 93.18 4.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.489 HG13 HG22 ' A' ' 577' ' ' ILE . 21.3 m -79.15 168.53 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.689 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.611 ' HA ' HD12 ' A' ' 583' ' ' ILE . 3.5 m -53.16 -32.73 49.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.835 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.62 -17.88 71.42 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.175 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -95.76 -15.47 42.77 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.968 HG22 ' HB2' ' A' ' 601' ' ' LEU . 57.6 mt -75.54 119.59 23.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . 0.601 ' HA2' ' HB3' ' A' ' 601' ' ' LEU . . . -168.22 125.35 1.28 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 62.51 -82.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 O-C-N 124.168 0.569 . . . . 0.0 110.562 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 6.4 tt -163.27 117.24 1.61 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . 0.532 HG13 HD21 ' A' ' 578' ' ' LEU . 6.8 p -128.75 139.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -100.74 135.75 41.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.301 0.572 . . . . 0.0 111.585 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.633 HD21 ' HG2' ' A' ' 576' ' ' GLU . 1.0 OUTLIER -126.7 115.55 19.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.36 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -64.47 128.08 34.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 110.811 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.643 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 89.9 p -95.6 -173.53 2.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.537 -177.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 60.2 mt -76.69 -38.96 53.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.415 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.4 tt0 -61.21 -30.55 70.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.456 0.645 . . . . 0.0 110.501 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.95 -19.51 6.5 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.477 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . 0.521 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.7 t70 -84.6 -169.15 2.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.711 0.756 . . . . 0.0 109.951 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.468 ' HG2' ' OD1' ' A' ' 595' ' ' ASP . 14.2 pttm -110.11 136.33 49.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.923 -172.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.637 ' HA ' ' OD1' ' A' ' 609' ' ' ASN . 91.5 mt -84.22 114.97 22.2 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 170.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.588 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 45.8 mt-10 -86.52 84.91 7.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.393 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 607' ' ' SER . 46.2 t -86.46 118.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.688 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.841 ' HB2' ' HB2' ' A' ' 607' ' ' SER . 13.6 m -118.57 157.02 28.13 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.825 -176.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.968 ' HB2' HG22 ' A' ' 583' ' ' ILE . 58.4 tp -141.79 113.5 7.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -156.41 137.88 13.99 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 60.93 27.06 16.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 64.9 t30 63.84 11.68 6.14 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.436 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 60.0 t -95.13 118.45 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.573 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.582 HG13 HG21 ' A' ' 583' ' ' ILE . 48.9 t -82.17 147.9 5.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.848 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . 0.841 ' HB2' ' HB2' ' A' ' 600' ' ' SER . 16.9 m -134.38 158.13 44.64 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.583 0.23 . . . . 0.0 110.868 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.6 p -153.27 121.23 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.648 175.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.818 HD22 HD13 ' A' ' 632' ' ' LEU . 19.6 m-20 61.46 37.61 16.51 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.986 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 80.1 -12.48 1.04 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.481 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 63.1 mm-40 -95.44 143.17 25.65 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.615 0.245 . . . . 0.0 110.79 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 3.1 Cg_exo -78.81 136.62 13.53 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.134 2.556 . . . . 0.0 112.791 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 40.4 t -89.22 134.38 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -89.29 -35.74 15.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.946 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 29.5 tt0 -150.36 89.08 4.56 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.732 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.38 173.19 13.53 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.125 2.55 . . . . 0.0 113.47 171.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 t70 77.78 23.34 0.8 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.059 164.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . 0.4 HD12 HG23 ' A' ' 627' ' ' VAL . 34.2 mt -94.36 90.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 122.05 -0.406 . . . . 0.0 110.135 174.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 60.6 mtp -85.91 149.49 25.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.472 0.654 . . . . 0.0 112.33 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . 0.509 ' HB2' HG21 ' A' ' 508' ' ' VAL . . . -113.22 -171.77 1.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.613 174.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 504' ' ' THR . 13.1 t -81.73 -17.46 47.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.414 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.436 ' OD1' HG23 ' A' ' 505' ' ' VAL . 28.7 p-10 -117.87 2.5 12.18 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 173.14 -154.77 21.27 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.418 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 8.1 p -137.55 145.47 29.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 539' ' ' VAL . 75.6 t -117.4 140.87 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.978 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . 0.575 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 66.4 m-70 -126.74 118.86 25.56 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.039 175.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.876 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 96.8 t -72.51 122.59 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.0 151.13 21.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.206 0.527 . . . . 0.0 110.592 172.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 11.9 p -94.04 3.22 55.63 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.153 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -136.6 146.27 45.87 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.123 0.487 . . . . 0.0 111.204 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.49 HG13 HD13 ' A' ' 550' ' ' LEU . 0.2 OUTLIER -92.68 158.25 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.818 HD13 HD22 ' A' ' 609' ' ' ASN . 16.6 mt . . . . . 0 C--N 1.324 -0.523 0 CA-C-O 120.867 0.365 . . . . 0.0 111.647 -156.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.668 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.439 -1.113 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 508' ' ' VAL . 75.6 p -95.28 -173.96 3.07 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.749 ' O ' HD13 ' A' ' 509' ' ' LEU . 96.4 t -47.42 -41.06 7.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.396 170.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -41.89 97.86 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.697 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . 0.668 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 9.1 m-20 -68.65 -33.42 73.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.52 0.2 . . . . 0.0 111.159 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 504' ' ' THR . 96.0 t -51.66 -60.54 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.089 0.471 . . . . 0.0 110.958 174.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.749 HD13 ' O ' ' A' ' 505' ' ' VAL . 3.4 mp -59.27 -35.45 73.76 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.625 0.77 . . . . 0.0 111.269 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.61 ' HB3' ' HA ' ' A' ' 507' ' ' ASP . 43.5 tttt -63.75 -29.85 71.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.324 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -97.49 -23.3 14.41 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.237 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.75 132.22 35.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.934 0.397 . . . . 0.0 110.489 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . 0.403 ' HA ' HD22 ' A' ' 513' ' ' ASN . 11.6 m120 -76.19 -18.98 58.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -78.92 -29.43 44.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.017 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.771 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 16.5 m-85 -101.71 18.76 19.59 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.008 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 21.0 p -57.94 -57.27 13.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . 0.418 ' HB3' ' HE2' ' A' ' 517' ' ' MET . 7.8 ttp -74.13 -20.69 60.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.926 0.393 . . . . 0.0 110.158 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 50.5 tp -57.94 -41.96 83.92 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.909 176.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 509' ' ' LEU . 15.2 t -53.45 -54.77 16.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.261 177.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.23 -31.52 72.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.087 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.13 -56.18 8.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.794 0.33 . . . . 0.0 110.37 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.473 ' HA ' HD13 ' A' ' 569' ' ' LEU . 61.6 mt -59.33 -32.24 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.231 0.539 . . . . 0.0 110.235 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.6 OUTLIER -55.59 -60.7 3.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.095 173.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.7 m -61.99 -19.11 62.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.351 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -85.44 -10.91 55.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 70.14 37.68 72.49 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.671 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.55 5.6 29.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.524 0.662 . . . . 0.0 111.044 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 27.2 m -53.46 -49.93 66.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.686 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . 0.649 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 28.3 mt-10 -66.03 -19.21 65.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.551 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 35.1 m -74.07 -34.32 63.99 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.083 0.468 . . . . 0.0 109.818 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.518 HD21 HD13 ' A' ' 573' ' ' ILE . 89.6 mt -93.07 -18.14 23.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.647 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . 0.544 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 0.9 OUTLIER -84.55 17.72 2.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 177.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 21.9 mmt180 -111.25 172.25 6.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.305 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.13 146.28 24.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 153.97 -147.13 16.04 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.896 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.602 ' HB ' HG13 ' A' ' 577' ' ' ILE . 11.2 m -131.7 128.29 60.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -148.15 132.21 17.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.968 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . 0.432 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 95.7 m -104.68 105.23 15.23 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 172.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.785 HG22 HG12 ' A' ' 573' ' ' ILE . 62.6 t -104.78 112.57 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 120.888 0.375 . . . . 0.0 111.378 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.606 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 68.4 m-85 -85.95 108.98 18.45 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -104.66 122.41 43.65 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.069 -168.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.76 138.91 19.39 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.936 2.424 . . . . 0.0 112.491 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 67.4 p -82.78 -176.59 6.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.965 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . 0.471 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 10.8 m120 -62.07 -39.65 93.14 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.67 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -66.1 -21.49 66.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -76.88 -36.45 56.72 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.099 177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . 0.502 ' HZ ' ' HB2' ' A' ' 518' ' ' LEU . 9.5 m-85 -65.31 -13.02 57.49 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 170.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -94.91 -36.42 11.62 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.975 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -91.24 11.02 24.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.13 0.491 . . . . 0.0 111.724 -174.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.799 HD12 ' CD1' ' A' ' 555' ' ' TRP . 0.2 OUTLIER -76.8 167.32 37.73 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.643 -178.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.449 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 7.6 Cg_exo -73.91 125.93 10.27 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.21 1.94 . . . . 0.0 109.952 166.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.97 -54.52 5.31 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.909 2.406 . . . . 0.0 114.138 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -70.81 -18.77 62.72 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.65 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 5.9 tp10 -60.6 -54.87 40.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.609 0.718 . . . . 0.0 109.902 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' TRP . . . . . 0.799 ' CD1' HD12 ' A' ' 550' ' ' LEU . 6.7 m95 -77.79 -24.78 48.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.889 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 52.5 m -51.28 -35.04 35.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.43 0.633 . . . . 0.0 109.616 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -84.69 -50.9 7.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.154 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.698 HD23 ' HG3' ' A' ' 564' ' ' GLU . 40.6 mt -57.61 -55.31 36.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.983 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.42 HD22 HD22 ' A' ' 565' ' ' LEU . 0.1 OUTLIER -70.44 -1.34 10.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -98.27 -31.47 6.5 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.651 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 563' ' ' LYS . 12.9 t70 -130.5 137.84 49.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.633 0.254 . . . . 0.0 110.42 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.7 63.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.681 ' H ' ' HD3' ' A' ' 563' ' ' LYS . 0.1 OUTLIER -73.82 -18.6 60.93 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.717 -178.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.698 ' HG3' HD23 ' A' ' 558' ' ' LEU . 3.7 tp10 -69.63 -46.45 66.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 558' ' ' LEU . 20.0 tp -68.04 -45.57 73.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.087 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -60.76 -23.57 65.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.403 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . 0.834 ' HA ' ' NE2' ' A' ' 593' ' ' GLN . 52.7 t30 -55.87 -50.84 69.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.578 0.704 . . . . 0.0 110.811 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.614 HD12 HD11 ' A' ' 558' ' ' LEU . 46.2 mt -84.53 -39.58 14.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.875 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 522' ' ' ILE . 75.0 mt -61.1 -28.25 68.96 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -77.59 -10.15 59.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.907 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.58 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 50.5 t80 -100.3 -19.16 16.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.085 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -66.34 -24.94 66.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.381 0.61 . . . . 0.0 110.526 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.785 HG12 HG22 ' A' ' 539' ' ' VAL . 83.7 mt -105.43 141.16 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.486 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -102.81 165.92 16.54 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.29 -30.29 67.26 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . 0.5 ' O ' HD11 ' A' ' 589' ' ' LEU . 14.4 pt-20 -148.04 178.4 8.56 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 122.274 -0.266 . . . . 0.0 110.529 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.602 HG13 ' HB ' ' A' ' 536' ' ' VAL . 57.5 mt -81.16 122.23 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.143 0.497 . . . . 0.0 111.961 -171.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.586 HD21 HG13 ' A' ' 587' ' ' VAL . 55.0 tp -122.31 93.26 3.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.424 174.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.4 HG13 HG22 ' A' ' 577' ' ' ILE . 26.7 m -83.81 169.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.469 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.413 ' HA ' HD12 ' A' ' 583' ' ' ILE . 26.1 m -60.41 -15.65 28.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.887 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.76 -16.37 70.02 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 172.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.69 -28.11 6.81 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.846 HG22 ' HB2' ' A' ' 601' ' ' LEU . 53.4 mt -72.14 89.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.226 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . -113.8 -58.59 0.39 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.327 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -113.46 -71.6 0.74 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 175.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 599' ' ' VAL . 6.2 tt -157.83 129.58 6.88 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . 0.586 HG13 HD21 ' A' ' 578' ' ' LEU . 6.8 p -143.86 139.64 25.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.22 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . 0.538 ' HB3' ' HG2' ' A' ' 598' ' ' GLU . 6.3 ptp180 -107.9 140.22 41.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.342 0.591 . . . . 0.0 111.491 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.5 HD11 ' O ' ' A' ' 576' ' ' GLU . 0.5 OUTLIER -124.45 121.63 35.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.298 -179.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.417 ' HE2' ' HA2' ' A' ' 594' ' ' GLY . 24.2 tptm -63.62 140.94 58.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.69 0.281 . . . . 0.0 110.26 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.534 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 60.2 p -102.11 -177.83 3.52 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.72 ' H ' HD22 ' A' ' 592' ' ' LEU . 0.9 OUTLIER -76.68 -44.88 31.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 110.474 178.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.834 ' NE2' ' HA ' ' A' ' 567' ' ' ASN . 6.5 tp-100 -63.4 -30.8 71.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.491 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . 0.417 ' HA2' ' HE2' ' A' ' 590' ' ' LYS . . . 124.62 16.02 3.15 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 119.731 -1.224 . . . . 0.0 114.438 168.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . 0.58 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 10.4 t70 -110.66 -164.87 0.95 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.878 0.839 . . . . 0.0 108.789 174.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.419 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 18.3 pttp -127.24 120.0 27.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.092 0.472 . . . . 0.0 111.35 -172.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.577 HD21 ' O ' ' A' ' 571' ' ' TYR . 98.3 mt -79.2 115.37 18.82 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.538 ' HG2' ' HB3' ' A' ' 588' ' ' ARG . 33.7 mt-10 -108.75 112.36 24.6 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.29 0.567 . . . . 0.0 110.782 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 586' ' ' LEU . 21.3 t -107.59 133.6 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.532 -171.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.757 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 37.9 t -126.02 160.81 29.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.846 ' HB2' HG22 ' A' ' 583' ' ' ILE . 48.8 tp -132.73 127.1 33.97 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . 0.489 ' HG2' ' OD1' ' A' ' 603' ' ' ASN . 60.6 tttp -156.42 129.1 7.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 602' ' ' LYS . 18.6 m120 61.15 28.03 17.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.03 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 56.9 t30 68.64 18.49 8.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.708 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.69 126.53 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.741 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 59.7 t -88.24 137.46 21.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.318 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . 0.757 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 6.9 m -125.19 103.54 8.02 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.503 HG11 ' CD1' ' A' ' 540' ' ' PHE . 7.4 p -109.28 117.96 55.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.53 ' ND2' HD13 ' A' ' 632' ' ' LEU . 12.9 m-20 63.16 29.75 16.06 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 60.0 tttp 77.02 -2.39 2.67 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.311 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.516 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 70.0 mm-40 -92.42 129.57 40.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.397 . . . . 0.0 110.879 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 13.0 Cg_exo -70.51 126.58 12.96 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.295 2.663 . . . . 0.0 112.518 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 32.8 t -86.72 136.62 22.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.887 176.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -83.04 -57.0 3.47 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.128 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -133.66 100.74 13.37 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.451 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.29 164.26 33.15 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.824 2.349 . . . . 0.0 112.628 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 71.64 31.46 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 50.6 mt -85.66 90.21 2.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 168.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 66.6 mtp -79.7 148.39 31.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -169.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -118.45 -175.58 2.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.621 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.3 t -83.64 -9.45 58.88 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.528 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.5 ' OD1' HG23 ' A' ' 505' ' ' VAL . 28.7 p-10 -117.68 7.72 12.62 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.499 0.19 . . . . 0.0 111.481 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 159.25 -143.59 9.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.003 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.1 p -139.34 147.64 24.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.595 0.236 . . . . 0.0 110.589 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.5 141.76 34.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.322 0.582 . . . . 0.0 111.217 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . 0.606 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 46.7 m-70 -126.75 125.28 41.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.771 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 85.5 t -78.18 118.59 25.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.49 155.59 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 120.943 0.401 . . . . 0.0 110.716 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 19.9 p -102.65 4.06 37.84 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.444 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -137.4 163.3 31.38 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.982 0.42 . . . . 0.0 111.254 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.74 142.98 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.779 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.53 HD13 ' ND2' ' A' ' 609' ' ' ASN . 69.9 mt . . . . . 0 N--CA 1.432 -1.371 0 CA-C-O 120.635 0.255 . . . . 0.0 110.473 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 121.251 0.362 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.489 ' HA ' HG22 ' A' ' 621' ' ' THR . 79.0 p -85.98 -172.48 4.11 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.887 HG21 HD22 ' A' ' 531' ' ' LEU . 7.4 m -46.79 -37.97 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.222 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -45.13 90.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.274 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . 0.552 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 6.1 t70 -68.76 -33.35 73.75 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 504' ' ' THR . 94.3 t -52.65 -40.07 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.22 0.533 . . . . 0.0 110.538 174.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 5.6 mt -82.27 -34.51 28.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.405 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.594 ' HA ' HG21 ' A' ' 519' ' ' VAL . 58.1 tttp -66.51 -34.61 78.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.062 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -88.15 -5.4 76.6 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.645 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -106.75 142.04 37.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.29 0.545 . . . . 0.0 111.387 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -68.37 -32.8 73.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.786 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . 0.568 ' HD2' ' H ' ' A' ' 514' ' ' ARG . 3.1 mpt_? -83.02 -19.27 37.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -173.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.732 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 19.9 m-85 -107.75 5.55 26.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.172 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 68.5 m -59.98 -38.1 81.57 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.754 0.312 . . . . 0.0 111.579 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -82.56 -26.01 32.79 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 45.6 tp -58.02 -43.68 86.87 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.913 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 510' ' ' LYS . 7.2 t -50.69 -51.04 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.931 176.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -64.74 -32.8 74.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.926 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.89 -50.19 44.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.158 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.584 HG12 HD11 ' A' ' 569' ' ' LEU . 68.4 mt -57.94 -34.45 48.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.31 0.576 . . . . 0.0 109.789 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.55 -57.72 11.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.452 173.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.2 m -58.63 -26.56 63.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.995 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -74.63 -23.94 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.869 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 68.25 19.62 72.45 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.104 -0.57 . . . . 0.0 114.153 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 569' ' ' LEU . 3.8 pp -104.36 22.44 14.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.579 0.69 . . . . 0.0 111.135 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 88.8 m -53.81 -41.97 67.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.951 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . 0.617 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 1.0 OUTLIER -60.23 -16.38 33.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.226 -178.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 26.2 m -76.18 -51.0 13.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.906 0.384 . . . . 0.0 109.991 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.887 HD22 HG21 ' A' ' 505' ' ' VAL . 61.2 mt -81.39 -13.69 58.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.679 -177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -72.89 -20.01 61.17 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.822 0.344 . . . . 0.0 111.416 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . 0.617 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 59.8 mtt180 -74.09 139.67 44.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.1 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -84.06 131.74 34.78 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 167.54 -120.64 0.92 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.447 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.8 m -137.99 126.81 32.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.716 0.294 . . . . 0.0 111.06 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -151.64 143.91 24.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.786 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.2 m -115.96 111.09 19.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.707 HG22 HG12 ' A' ' 573' ' ' ILE . 88.5 t -111.04 114.23 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.629 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 61.5 m-85 -84.87 108.99 17.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -100.11 121.13 54.84 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.969 -166.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.468 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 93.5 Cg_endo -83.51 138.93 8.76 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.789 2.326 . . . . 0.0 112.158 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 66.8 p -83.35 -178.02 6.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.244 0.545 . . . . 0.0 112.087 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . 0.438 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -62.57 -37.84 87.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.322 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -34.19 71.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.522 0.677 . . . . 0.0 110.238 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.502 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -70.54 -36.85 73.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.373 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . 0.456 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 17.3 m-85 -66.44 -18.01 65.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.222 0.534 . . . . 0.0 109.655 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -92.79 -16.26 25.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.047 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -80.51 -13.92 58.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.005 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.696 HD11 ' HB ' ' A' ' 631' ' ' VAL . 78.8 mt -95.34 143.36 25.98 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.017 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 24.6 Cg_exo -63.05 134.39 45.83 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.766 2.311 . . . . 0.0 111.755 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 52.7 Cg_exo -54.45 -32.43 73.11 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.039 2.493 . . . . 0.0 112.234 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 44.2 mtm105 -57.87 -30.96 66.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.46 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -86.21 -52.18 5.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.255 0.55 . . . . 0.0 110.539 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' TRP . . . . . 0.516 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -68.84 -38.27 79.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -170.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.0 t -54.6 -24.97 23.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.195 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -82.92 -33.39 26.85 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.412 -0.18 . . . . 0.0 111.0 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.624 ' HB3' ' HG ' ' A' ' 565' ' ' LEU . 14.5 mt -65.26 -50.57 65.26 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 121.002 0.43 . . . . 0.0 110.292 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.462 HD22 HD11 ' A' ' 565' ' ' LEU . 0.6 OUTLIER -69.34 -16.51 63.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.848 0.356 . . . . 0.0 111.424 177.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -85.95 -38.34 8.69 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.024 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -124.66 135.28 52.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 111.267 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -73.57 -31.34 63.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.11 -170.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.536 ' HD2' ' H ' ' A' ' 563' ' ' LYS . 9.6 mptt -71.2 -37.05 72.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.85 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.1 -34.52 73.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.676 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.624 ' HG ' ' HB3' ' A' ' 558' ' ' LEU . 0.4 OUTLIER -75.73 -47.27 26.74 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.892 0.377 . . . . 0.0 110.443 177.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -59.67 -33.99 72.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.426 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -56.3 -52.79 63.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.946 0.403 . . . . 0.0 111.033 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 632' ' ' LEU . 73.9 mt -71.46 -46.67 62.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.429 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' A' ' 527' ' ' LEU . 0.1 OUTLIER -51.96 -34.23 41.3 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.404 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 47.2 mttp -69.47 -26.05 64.38 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.578 ' O ' HD21 ' A' ' 597' ' ' LEU . 52.4 t80 -80.31 -17.04 53.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.959 0.409 . . . . 0.0 110.708 -176.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . 0.596 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 16.7 m80 -79.89 -6.18 56.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.257 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.707 HG12 HG22 ' A' ' 539' ' ' VAL . 69.1 mt -117.12 117.47 55.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.04 -175.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.1 167.49 34.48 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.64 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.568 ' OD2' ' HB2' ' A' ' 590' ' ' LYS . 8.0 m-20 -54.63 -42.22 70.97 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.06 -176.56 5.71 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.748 -168.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.516 HG12 ' HA2' ' A' ' 623' ' ' GLY . 58.6 mt -82.08 118.23 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.314 -173.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.413 HD11 HG11 ' A' ' 587' ' ' VAL . 4.6 tt -118.49 93.47 4.13 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.9 m -73.5 167.53 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.573 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.646 ' HA ' HD12 ' A' ' 583' ' ' ILE . 13.1 t -62.37 -24.15 67.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.2 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -71.04 -10.89 69.38 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.036 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -99.9 -17.51 25.3 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.741 HG22 ' HB2' ' A' ' 601' ' ' LEU . 77.4 mt -71.47 94.47 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.362 0.601 . . . . 0.0 110.394 176.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -109.15 -121.47 4.47 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.975 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -58.96 -62.79 1.62 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 110.528 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 7.9 tt -168.48 129.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . 0.413 HG11 HD11 ' A' ' 578' ' ' LEU . 47.3 t -129.61 136.05 60.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.95 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 588' ' ' ARG . 14.7 mtm180 -97.98 120.84 39.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.141 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.76 116.67 32.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.568 ' HB2' ' OD2' ' A' ' 575' ' ' ASP . 23.7 mmmt -63.88 139.23 58.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.723 0.296 . . . . 0.0 110.336 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.581 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 86.5 p -106.14 -173.92 2.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.346 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 76.3 mt -80.79 -39.69 26.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.829 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.443 ' HB3' ' HB2' ' A' ' 571' ' ' TYR . 24.4 tt0 -61.84 -29.58 70.27 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.088 0.47 . . . . 0.0 110.833 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 127.03 -18.83 6.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.268 -0.968 . . . . 0.0 114.509 170.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 596' ' ' LYS . 8.8 t70 -88.52 -158.88 0.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.466 1.133 . . . . 0.0 109.893 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.472 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 10.8 pttm -124.75 135.98 53.46 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.862 0.363 . . . . 0.0 111.07 -169.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 571' ' ' TYR . 94.6 mt -83.85 115.34 22.21 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 172.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -91.32 84.84 5.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.69 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 608' ' ' VAL . 2.4 p -110.08 132.05 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.248 0.547 . . . . 0.0 111.69 -175.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.439 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 5.8 p -144.33 168.76 19.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.148 -176.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.741 ' HB2' HG22 ' A' ' 583' ' ' ILE . 1.8 tt -117.84 112.49 20.45 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -141.14 135.89 31.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.138 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 64.9 t30 61.41 36.29 17.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.279 0.561 . . . . 0.0 110.281 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 67.2 t30 73.24 -2.17 2.82 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.773 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 9.6 p -122.81 147.37 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.852 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.476 HG13 HG21 ' A' ' 583' ' ' ILE . 57.6 t -77.68 132.12 33.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.219 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 5.8 p -123.84 112.29 17.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.06 0.457 . . . . 0.0 111.21 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.622 HG23 ' HB ' ' A' ' 599' ' ' VAL . 10.7 p -114.89 135.29 55.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.485 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.551 ' OD1' HG22 ' A' ' 608' ' ' VAL . 0.5 OUTLIER 57.75 26.36 12.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -177.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 62.8 mttm 76.09 1.4 3.44 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.205 1.002 . . . . 0.0 111.915 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 29.7 mm-40 -101.37 137.35 19.63 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.276 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 11.6 Cg_exo -72.45 126.58 11.7 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.021 2.48 . . . . 0.0 112.294 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.07 141.95 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.996 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -75.65 -60.3 2.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.857 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -141.68 113.48 6.54 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.615 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . 0.432 ' HG3' HG21 ' A' ' 606' ' ' VAL . 65.0 Cg_endo -81.51 169.88 15.03 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.833 2.355 . . . . 0.0 113.053 174.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 2.5 t70 72.95 28.28 1.99 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.479 165.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 52.3 mt -80.9 89.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . 0.516 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 53.2 mtp -78.97 137.07 37.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.635 0.731 . . . . 0.0 112.74 -171.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -106.26 -177.74 3.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.017 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.489 HG22 ' HA ' ' A' ' 504' ' ' THR . 15.0 t -74.74 -16.54 60.73 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.332 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.788 HD21 HG22 ' A' ' 505' ' ' VAL . 30.7 p-10 -119.37 10.51 11.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . 0.516 ' HA2' HG12 ' A' ' 577' ' ' ILE . . . 161.79 -147.05 12.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.415 -1.374 . . . . 0.0 113.52 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.4 p -139.97 145.06 26.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.86 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 76.8 t -118.74 143.61 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.657 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . 0.629 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 34.9 m-70 -130.16 127.19 39.23 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.732 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 98.2 t -79.94 119.3 29.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.7 148.21 17.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.028 0.442 . . . . 0.0 110.581 172.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 33.0 p -95.74 10.5 36.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.65 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -136.03 155.63 49.94 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.696 ' HB ' HD11 ' A' ' 550' ' ' LEU . 52.0 t -96.83 157.29 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.596 ' HB2' ' CE1' ' A' ' 572' ' ' HIS . 46.4 mt . . . . . 0 C--N 1.315 -0.896 0 CA-C-O 120.856 0.36 . . . . 0.0 110.277 -170.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.691 0.282 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 507' ' ' ASP . . . 103.32 13.24 29.09 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.527 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 27.2 ttt -78.92 96.38 5.69 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.107 0.48 . . . . 0.0 110.125 178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . 174.99 -146.7 8.56 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.736 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.4 ' HA ' HG22 ' A' ' 621' ' ' THR . 67.1 p -91.94 -172.12 3.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.712 0.291 . . . . 0.0 110.366 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.858 HG23 ' HB3' ' A' ' 531' ' ' LEU . 4.4 m -49.42 -29.89 4.29 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.897 170.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.5 ' HG2' ' CB ' ' A' ' 531' ' ' LEU . 85.3 mmm -67.64 -50.43 57.97 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.352 -0.217 . . . . 0.0 110.93 172.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . 0.449 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 1.0 OUTLIER -72.09 -29.77 64.45 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.136 -174.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 1.016 HG11 HG21 ' A' ' 625' ' ' VAL . 8.7 p -58.06 -35.02 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.504 0.669 . . . . 0.0 110.693 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.897 HD23 HG13 ' A' ' 508' ' ' VAL . 7.2 mt -81.65 -33.99 31.03 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.593 177.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -66.03 -25.02 66.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.856 -177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -102.24 1.88 50.66 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.76 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -111.5 141.83 44.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.522 0.661 . . . . 0.0 111.358 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.453 ' HA ' ' OG ' ' A' ' 516' ' ' SER . 17.2 m120 -75.32 -23.99 57.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.035 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -87.07 -15.37 38.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.075 0.464 . . . . 0.0 110.418 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.883 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 25.5 m-85 -109.51 8.1 25.04 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.898 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 513' ' ' ASN . 67.8 m -57.24 -45.92 83.47 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -174.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.3 ttp -76.04 -24.02 55.16 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.218 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.532 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 46.8 tp -60.45 -45.22 94.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.984 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 515' ' ' PHE . 5.8 t -53.45 -46.61 59.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.553 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.2 72.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.685 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -71.81 -48.37 46.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.008 0.432 . . . . 0.0 109.931 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.811 HG12 HD21 ' A' ' 569' ' ' LEU . 43.3 mt -56.61 -39.0 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.612 0.72 . . . . 0.0 109.985 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 17.1 tp60 -59.22 -53.25 60.36 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.909 176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.0 m -59.23 -27.33 65.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.859 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -79.12 -28.25 42.92 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.128 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 65.02 32.58 84.67 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.675 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . 0.696 HD21 HD23 ' A' ' 569' ' ' LEU . 3.6 pp -102.65 24.58 10.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.356 0.578 . . . . 0.0 110.486 177.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 56.7 m -46.47 -53.12 11.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.295 -179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -56.41 -28.23 58.79 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -174.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 53.5 m -59.98 -52.47 65.25 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.715 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.858 ' HB3' HG23 ' A' ' 505' ' ' VAL . 27.2 mt -96.21 -8.43 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -175.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -92.88 -9.47 40.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.68 0.752 . . . . 0.0 110.409 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 533' ' ' ARG . 7.9 tpp180 -94.15 157.7 15.95 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.318 177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -77.39 149.76 35.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.02 0.438 . . . . 0.0 110.785 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 164.66 -146.7 11.61 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.691 ' HB ' HG13 ' A' ' 577' ' ' ILE . 16.9 m -129.41 127.39 64.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 176.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -149.81 151.29 33.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 0.0 110.931 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 96.9 m -124.4 101.45 7.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.554 HG22 HG12 ' A' ' 573' ' ' ILE . 87.3 t -98.77 111.48 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.832 -174.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 56.3 m-85 -83.47 106.61 15.36 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -98.6 117.0 65.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.451 -166.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.608 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 72.3 Cg_endo -78.49 135.22 13.03 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.819 2.346 . . . . 0.0 112.121 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.3 p -78.45 -176.0 4.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.243 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . 0.51 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 12.0 m120 -73.68 -34.52 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.323 -173.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 548' ' ' ARG . 1.5 pm0 -70.17 -18.99 63.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.099 0.476 . . . . 0.0 110.342 175.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -73.64 -33.12 64.37 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.212 0.53 . . . . 0.0 110.789 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . 0.51 ' CD2' ' HA ' ' A' ' 544' ' ' ASN . 19.2 m-85 -66.49 -12.78 59.17 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.195 172.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . 0.509 ' HA ' ' HE ' ' A' ' 548' ' ' ARG . 3.3 mmp_? -92.57 -13.63 29.44 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.323 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -92.36 4.61 53.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.917 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.466 HD12 ' NE1' ' A' ' 555' ' ' TRP . 66.5 mt -113.05 142.71 27.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.828 0.347 . . . . 0.0 111.588 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 31.3 Cg_exo -59.08 128.07 26.45 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.358 2.039 . . . . 0.0 111.179 174.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 50.1 Cg_exo -54.08 -29.07 53.63 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.955 2.437 . . . . 0.0 113.389 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -59.13 -53.82 54.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.524 0.202 . . . . 0.0 111.47 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.5 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 32.3 mm-40 -63.89 -37.33 86.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.313 0.577 . . . . 0.0 110.633 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' TRP . . . . . 0.466 ' NE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -73.72 -40.22 63.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.817 -177.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 70.8 m -59.38 -22.96 62.15 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.65 174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 554' ' ' GLU . 73.5 mtp180 -73.34 -45.14 56.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.298 173.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.626 ' HB3' ' HA ' ' A' ' 565' ' ' LEU . 13.1 mt -67.71 -53.42 27.67 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.559 -176.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.18 -15.58 63.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.802 0.334 . . . . 0.0 111.623 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -88.4 -29.44 19.37 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.44 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . 0.654 ' OD2' ' HG3' ' A' ' 563' ' ' LYS . 24.5 t70 -131.05 124.69 31.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.793 -177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -62.43 -47.06 85.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -171.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.654 ' HG3' ' OD2' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -72.31 -24.82 61.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.973 -177.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.568 ' HG3' HD23 ' A' ' 558' ' ' LEU . 5.2 tp10 -68.52 -42.71 78.11 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.626 ' HA ' ' HB3' ' A' ' 558' ' ' LEU . 3.4 tt -65.75 -50.97 62.85 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . 0.46 ' HB1' ' HE2' ' A' ' 570' ' ' LYS . . . -54.87 -32.16 60.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.693 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -52.77 -53.64 45.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.455 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 59.2 mt -82.57 -39.79 16.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.811 HD21 HG12 ' A' ' 522' ' ' ILE . 22.4 tp -55.75 -36.48 67.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.612 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 68.6 mttm -68.24 -22.64 64.76 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.805 0.336 . . . . 0.0 111.872 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.628 ' O ' HD21 ' A' ' 597' ' ' LEU . 32.5 t80 -80.15 -17.28 52.9 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.892 0.377 . . . . 0.0 110.842 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . 0.642 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 4.0 m80 -77.87 -8.89 58.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.263 0.554 . . . . 0.0 110.872 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 539' ' ' VAL . 36.2 mt -110.8 116.67 53.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.929 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -78.71 161.77 48.32 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.23 175.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.49 ' OD1' ' HB2' ' A' ' 590' ' ' LYS . 5.2 p-10 -81.57 -10.13 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -172.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -156.69 178.02 10.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 176.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.691 HG13 ' HB ' ' A' ' 536' ' ' VAL . 36.7 mt -89.87 114.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-O 121.113 0.482 . . . . 0.0 112.208 -168.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 5.6 tt -112.96 96.16 5.79 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 16.5 m -80.61 169.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.795 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 617' ' ' ASP . 35.5 p -47.46 -43.28 24.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.376 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -70.42 -6.87 59.4 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.988 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.76 -7.63 47.43 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.226 -0.511 . . . . 0.0 111.927 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.775 HG22 ' HB2' ' A' ' 601' ' ' LEU . 58.2 mt -76.76 104.97 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.982 0.42 . . . . 0.0 110.16 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -103.64 -152.11 22.81 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.003 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -50.91 -56.75 10.83 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.011 0.434 . . . . 0.0 110.534 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 598' ' ' GLU . 6.3 tt -160.32 109.27 1.71 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.212 173.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 97.6 t -116.5 124.89 73.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.923 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . 0.418 ' HD2' ' HD2' ' A' ' 596' ' ' LYS . 85.2 mtm180 -98.01 126.88 43.63 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.855 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 21.9 tp -115.94 142.46 46.75 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.492 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.498 ' O ' ' HA2' ' A' ' 574' ' ' GLY . 37.2 mtmm -71.84 163.13 28.38 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.782 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.586 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.9 p -128.44 -176.83 3.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.005 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 63.1 mt -82.11 -41.86 19.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.38 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.521 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 31.9 tt0 -59.25 -29.83 67.84 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.579 0.704 . . . . 0.0 110.255 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.79 -11.06 7.46 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.642 169.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . 0.566 ' OD2' ' HG2' ' A' ' 596' ' ' LYS . 3.7 t70 -94.02 -156.38 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.493 0.646 . . . . 0.0 109.985 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.566 ' HG2' ' OD2' ' A' ' 595' ' ' ASP . 19.9 pttm -117.94 142.02 47.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.863 0.363 . . . . 0.0 111.215 -172.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.628 HD21 ' O ' ' A' ' 571' ' ' TYR . 67.1 mt -92.13 116.83 29.28 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 34.5 tt0 -91.26 85.83 5.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.348 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.535 HG12 HG23 ' A' ' 583' ' ' ILE . 35.0 t -93.21 128.87 44.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.796 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 2.7 p -140.25 148.91 42.17 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.586 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.775 ' HB2' HG22 ' A' ' 583' ' ' ILE . 59.3 tp -119.25 112.8 19.92 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -131.13 110.42 11.16 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.967 0.413 . . . . 0.0 110.837 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 59.55 53.0 5.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.423 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 69.81 -5.56 1.21 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.875 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.59 120.73 46.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.88 0.372 . . . . 0.0 110.438 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.434 HG21 ' HG3' ' A' ' 616' ' ' PRO . 43.1 t -85.77 140.81 15.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.856 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 40.6 m -132.16 142.56 49.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.603 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.6 p -134.69 123.81 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 120.882 0.373 . . . . 0.0 110.046 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.713 ' ND2' HD13 ' A' ' 632' ' ' LEU . 31.5 m-20 61.15 32.1 19.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.559 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 53.2 mttp 76.56 -0.12 3.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.806 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.492 ' HB3' ' OD1' ' A' ' 630' ' ' ASN . 5.3 mm-40 -99.61 130.13 27.4 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.501 ' HD2' HD21 ' A' ' 630' ' ' ASN . 16.5 Cg_exo -68.81 134.46 30.11 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.988 2.458 . . . . 0.0 113.049 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 49.0 t -86.37 143.17 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.703 177.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -89.28 -41.11 12.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.655 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 616' ' ' PRO . 32.0 tt0 -152.87 104.65 2.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.162 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.434 ' HG3' HG21 ' A' ' 606' ' ' VAL . 75.0 Cg_endo -74.39 157.41 45.36 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.569 2.179 . . . . 0.0 113.114 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.53 ' HB2' ' HB3' ' A' ' 580' ' ' SER . 1.3 t70 76.7 59.81 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.734 166.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 22.3 mt -108.81 97.12 5.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 165.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 57.4 mtp -79.93 142.64 34.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.621 0.724 . . . . 0.0 112.846 -167.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.72 -175.43 2.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.251 171.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 504' ' ' THR . 12.6 t -82.42 -17.16 46.35 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.062 -0.655 . . . . 0.0 111.316 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.743 HD21 HG22 ' A' ' 505' ' ' VAL . 32.1 p-10 -119.22 14.52 13.03 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 162.76 -160.29 32.69 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.139 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.73 148.96 32.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.746 0.308 . . . . 0.0 110.179 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . 1.016 HG21 HG11 ' A' ' 508' ' ' VAL . 87.5 t -118.28 145.21 24.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.481 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 74.4 m-70 -132.08 126.43 33.76 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.883 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 82.6 t -79.15 119.08 27.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.2 145.76 21.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.917 0.389 . . . . 0.0 110.241 171.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 22.9 p -97.73 9.77 41.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . 0.501 HD21 ' HD2' ' A' ' 612' ' ' PRO . 2.6 p30 -140.25 147.89 40.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.666 176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.439 ' HB ' HD11 ' A' ' 550' ' ' LEU . 43.9 t -82.23 160.62 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.713 HD13 ' ND2' ' A' ' 609' ' ' ASN . 42.4 mt -116.01 132.45 56.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -167.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.85 152.39 41.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.873 0.368 . . . . 0.0 110.147 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.669 -0.682 . . . . 0.0 110.34 -177.584 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.769 0.319 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -85.34 -137.75 4.24 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.855 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 26.6 mmt -117.73 128.96 55.4 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -98.24 -146.25 20.28 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-O 121.744 0.635 . . . . 0.0 113.398 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 508' ' ' VAL . 72.4 p -86.01 -171.2 3.46 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.299 -0.951 . . . . 0.0 110.14 178.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.7 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 36.4 t -43.9 -45.0 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 123.537 0.523 . . . . 0.0 111.185 173.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.513 ' HB2' ' HB2' ' A' ' 531' ' ' LEU . 10.2 tpt -63.78 -42.3 97.78 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.953 -177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 510' ' ' LYS . 25.3 t70 -67.78 -37.77 82.49 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.818 0.342 . . . . 0.0 110.631 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.518 HG21 ' HB2' ' A' ' 620' ' ' ALA . 82.8 t -50.61 -40.7 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.796 174.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 5.9 mt -82.37 -35.17 28.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.405 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' A' ' 507' ' ' ASP . 17.3 mmmt -60.41 -40.71 91.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.823 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -90.87 -12.74 60.13 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.815 -173.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -102.86 141.29 35.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.296 0.57 . . . . 0.0 111.092 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -75.94 -25.86 56.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.573 -174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -83.09 -15.98 48.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.1 0.476 . . . . 0.0 110.246 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.805 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 24.6 m-85 -109.34 17.78 21.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.379 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 12.0 p -57.54 -61.38 2.54 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . 0.492 ' HE1' ' HH2' ' A' ' 555' ' ' TRP . 2.4 ttp -70.57 -20.79 62.76 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.009 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.552 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 49.5 tp -57.42 -45.25 84.81 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.654 176.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 523' ' ' GLN . 9.1 t -51.39 -47.82 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.905 176.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.28 -39.32 89.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.905 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.46 -42.09 96.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.028 0.442 . . . . 0.0 110.404 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.685 HG12 HD11 ' A' ' 569' ' ' LEU . 49.8 mt -69.74 -29.1 39.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.557 0.694 . . . . 0.0 109.992 176.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.0 OUTLIER -65.48 -53.54 41.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.877 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.3 m -65.75 -16.19 63.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.986 0.422 . . . . 0.0 110.904 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -80.5 -17.34 51.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.267 173.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 74.93 17.94 80.19 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.381 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . 0.743 HD12 HD12 ' A' ' 569' ' ' LEU . 82.1 mt -97.31 17.15 18.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 122.556 -0.379 . . . . 0.0 111.556 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 46.6 m -55.99 -48.75 75.29 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . 0.676 ' HA ' ' HB2' ' A' ' 532' ' ' ASN . 31.8 tt0 -62.73 -25.04 67.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.621 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 40.6 m -61.23 -50.48 72.92 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.608 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.676 ' HG ' ' CG1' ' A' ' 505' ' ' VAL . 0.3 OUTLIER -84.82 -21.65 29.79 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 120.186 -0.606 . . . . 0.0 111.429 176.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . 0.676 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 0.9 OUTLIER -70.03 -22.2 63.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.671 0.272 . . . . 0.0 110.837 175.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -84.97 126.25 33.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . 0.459 ' OE2' ' HA ' ' A' ' 622' ' ' ASN . 13.9 tp10 -70.79 145.99 50.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.663 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 166.42 -132.1 2.54 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.113 -0.565 . . . . 0.0 111.827 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.577 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.5 m -137.36 127.47 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.656 0.265 . . . . 0.0 110.555 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -149.81 154.63 38.74 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.967 0.413 . . . . 0.0 110.626 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.7 m -129.02 105.01 7.91 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 169.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.758 HG22 HG12 ' A' ' 573' ' ' ILE . 93.5 t -107.26 113.89 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.065 -174.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 60.5 m-85 -83.1 111.25 18.72 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 171.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -104.65 119.71 52.73 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.964 -165.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 541' ' ' ALA . 5.7 Cg_exo -77.89 141.6 19.22 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.335 2.69 . . . . 0.0 112.018 177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 81.2 p -83.38 -179.15 7.3 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.111 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -58.45 -40.47 82.69 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.21 0.529 . . . . 0.0 110.281 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 545' ' ' GLU . 1.5 mp0 -62.78 -23.4 67.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.163 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -78.08 -31.35 50.12 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.275 0.559 . . . . 0.0 111.878 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . 0.497 ' CD1' ' HZ2' ' A' ' 555' ' ' TRP . 41.7 m-85 -67.06 -12.56 60.26 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.238 175.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -91.52 -8.79 46.56 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.73 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -91.16 -8.51 48.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.391 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.62 HD12 ' HE1' ' A' ' 555' ' ' TRP . 40.8 mt -100.3 142.42 24.58 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.411 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.92 142.24 92.4 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.709 2.273 . . . . 0.0 111.665 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -58.14 -40.38 77.18 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.22 2.613 . . . . 0.0 113.123 -175.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -59.61 -51.21 70.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.521 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.527 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 6.9 mp0 -60.43 -41.33 93.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.459 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' TRP . . . . . 0.62 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -69.17 -45.4 70.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.912 -177.025 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 35.2 p -58.58 -21.93 54.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.263 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -75.98 -49.86 16.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.87 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.615 ' HB3' ' HA ' ' A' ' 565' ' ' LEU . 12.9 mt -61.18 -63.68 1.21 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.728 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.838 HD13 HD11 ' A' ' 565' ' ' LEU . 3.5 mm? -58.53 -12.02 3.57 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.297 0.639 . . . . 0.0 112.542 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -74.68 -35.46 51.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.876 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . 0.527 ' OD2' ' HG3' ' A' ' 563' ' ' LYS . 16.9 t70 -144.67 153.03 41.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.218 0.509 . . . . 0.0 111.127 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -62.49 -47.28 84.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.048 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.527 ' HG3' ' OD2' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -71.31 -17.75 62.44 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.941 -177.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.444 ' N ' ' HD3' ' A' ' 563' ' ' LYS . 5.6 mm-40 -81.12 -42.41 20.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.676 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.838 HD11 HD13 ' A' ' 559' ' ' LEU . 0.6 OUTLIER -69.89 -48.27 59.32 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.329 0.585 . . . . 0.0 109.655 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . 0.52 ' HB1' ' HE3' ' A' ' 570' ' ' LYS . . . -62.56 -27.54 69.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.834 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -52.49 -53.9 39.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.852 0.358 . . . . 0.0 110.686 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 66.1 mt -83.43 -39.06 14.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.366 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.743 HD12 HD12 ' A' ' 527' ' ' LEU . 0.8 OUTLIER -54.99 -32.74 61.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.124 -178.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 97.2 mttt -74.91 -13.75 60.57 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.561 ' O ' HD21 ' A' ' 597' ' ' LEU . 44.7 t80 -86.71 -19.11 29.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.048 0.452 . . . . 0.0 110.885 -177.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . 0.54 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 15.3 m80 -77.78 -12.62 59.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.137 0.494 . . . . 0.0 110.566 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.758 HG12 HG22 ' A' ' 539' ' ' VAL . 68.3 mt -105.51 120.5 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.292 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.95 155.86 24.92 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 173.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.17 -4.86 57.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.29 168.54 23.76 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.506 0.193 . . . . 0.0 110.509 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.577 HG13 ' HB ' ' A' ' 536' ' ' VAL . 33.1 mt -89.0 117.5 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.602 -170.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 53.3 tp -117.66 97.9 6.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 24.4 m -79.24 170.64 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.096 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.613 ' HA ' HD12 ' A' ' 583' ' ' ILE . 17.9 m -55.96 -30.18 61.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.768 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.5 -13.43 65.46 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.135 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.86 -26.82 7.77 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.769 HG22 ' HB2' ' A' ' 601' ' ' LEU . 74.9 mt -60.9 103.89 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.069 0.461 . . . . 0.0 110.035 176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -115.49 -137.03 6.13 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.12 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -59.67 -60.52 3.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.975 0.417 . . . . 0.0 110.509 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 7.9 tt -157.9 112.75 2.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 67.2 t -121.65 133.53 67.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.128 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . 0.907 ' HD3' ' H ' ' A' ' 588' ' ' ARG . 0.0 OUTLIER -99.33 126.82 45.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.849 -179.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.47 125.51 49.09 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 49.5 mmtt -75.02 143.24 43.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.221 0.534 . . . . 0.0 110.603 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.602 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 84.8 p -107.9 -178.62 3.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.735 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 573' ' ' ILE . 7.0 mp -73.99 -36.14 64.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.38 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -65.97 -30.56 71.15 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 121.559 0.695 . . . . 0.0 110.138 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 126.24 -21.9 6.03 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.08 -0.964 . . . . 0.0 114.006 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 5.5 t70 -81.85 -165.52 1.0 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.042 0.921 . . . . 0.0 110.585 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.43 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 0.2 OUTLIER -123.45 135.51 54.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 0.0 111.442 -170.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.561 HD21 ' O ' ' A' ' 571' ' ' TYR . 84.2 mt -84.74 122.09 28.61 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.482 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 37.3 mt-10 -92.05 90.27 7.31 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.44 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.492 HG12 HG23 ' A' ' 583' ' ' ILE . 40.4 t -93.32 133.42 34.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.01 -176.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 32.2 t -143.92 136.82 27.35 Favored 'General case' 0 C--O 1.224 -0.259 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.769 ' HB2' HG22 ' A' ' 583' ' ' ILE . 63.7 tp -113.22 112.98 24.69 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -133.49 112.52 11.6 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 604' ' ' ASN . 15.3 t-20 60.03 47.14 10.04 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.13 0.491 . . . . 0.0 109.785 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 603' ' ' ASN . 10.2 t30 74.11 -14.95 0.64 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.723 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 55.9 t -84.18 115.81 26.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 122.175 -0.328 . . . . 0.0 110.665 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.55 HG22 HD13 ' A' ' 601' ' ' LEU . 43.8 t -84.51 136.09 23.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.599 176.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 44.9 m -126.0 147.98 49.4 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 176.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.514 HG11 ' CD1' ' A' ' 540' ' ' PHE . 7.0 p -141.12 119.57 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 1.075 HD22 HD13 ' A' ' 632' ' ' LEU . 29.5 m-20 62.12 31.43 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 24.4 tptp 86.92 -24.76 0.11 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.215 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.509 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 14.4 mm-40 -83.24 132.02 51.53 Favored Pre-proline 0 C--N 1.317 -0.834 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.646 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 13.8 Cg_exo -71.28 135.25 26.48 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.117 2.544 . . . . 0.0 112.856 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.592 HG11 ' HB3' ' A' ' 626' ' ' HIS . 24.7 t -88.74 136.25 23.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.206 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -88.8 -48.52 7.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.667 -177.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -132.72 89.7 34.6 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.01 159.28 53.79 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.662 2.241 . . . . 0.0 113.431 171.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 75.76 39.02 0.34 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.186 -0.915 . . . . 0.0 113.438 165.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 41.5 mt -87.38 85.76 2.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 166.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 55.7 mtp -80.71 129.57 34.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.645 0.736 . . . . 0.0 112.715 -170.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 508' ' ' VAL . . . -99.65 -171.42 2.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.148 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.405 ' OG1' HG22 ' A' ' 504' ' ' THR . 62.4 p -73.67 -38.46 64.93 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.498 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.459 ' HA ' ' OE2' ' A' ' 534' ' ' GLU . 30.0 p-10 -99.19 6.06 46.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.47 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 164.27 -152.64 22.53 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 119.819 -1.182 . . . . 0.0 113.189 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 8.8 p -134.77 144.48 34.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.809 0.338 . . . . 0.0 110.697 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.89 140.55 37.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.709 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . 0.592 ' HB3' HG11 ' A' ' 613' ' ' VAL . 52.3 m-70 -126.9 126.44 43.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.389 178.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.805 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 69.3 t -76.95 118.74 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 542' ' ' PRO . 0.5 OUTLIER -117.15 149.03 19.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.114 171.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 36.8 p -99.19 15.52 25.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.643 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -138.66 156.03 47.78 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.409 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 632' ' ' LEU . 36.1 t -98.37 160.73 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 174.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 1.075 HD13 HD22 ' A' ' 609' ' ' ASN . 16.2 mt -129.16 111.39 12.88 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.633 -167.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -97.53 134.22 41.05 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.135 0.493 . . . . 0.0 110.818 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 117.731 -1.128 . . . . 0.0 108.802 177.259 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 120.747 0.308 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 139.43 -139.07 9.73 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.006 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 69.41 103.1 0.06 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.484 0.659 . . . . 0.0 110.426 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.469 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -89.21 -141.74 8.47 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.931 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 508' ' ' VAL . 51.9 p -91.0 -170.33 2.64 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.862 -0.669 . . . . 0.0 109.687 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.797 HG11 HG21 ' A' ' 539' ' ' VAL . 99.4 t -47.18 -43.42 7.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 0.0 110.627 172.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.416 ' O ' ' HG3' ' A' ' 510' ' ' LYS . 36.0 tpp -62.7 -41.07 98.95 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.883 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . 0.833 ' HA ' ' HD3' ' A' ' 510' ' ' LYS . 7.7 t70 -68.17 -32.13 72.16 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.643 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 504' ' ' THR . 99.6 t -51.3 -60.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.432 173.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.704 HD13 ' O ' ' A' ' 505' ' ' VAL . 5.1 mp -57.36 -37.64 72.92 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 124.055 0.942 . . . . 0.0 112.18 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.833 ' HD3' ' HA ' ' A' ' 507' ' ' ASP . 40.1 mtpt -54.53 -39.82 68.03 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -94.18 -17.05 41.56 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.143 -175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -85.37 132.78 34.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.084 0.469 . . . . 0.0 111.092 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -76.49 -25.51 54.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.727 -176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -80.94 -21.77 40.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.791 0.329 . . . . 0.0 110.351 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.574 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 20.7 m-85 -109.6 13.44 23.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.417 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 74.6 m -57.69 -49.82 75.23 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.5 ttp -74.93 -20.77 59.55 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.51 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.691 HD13 ' HZ ' ' A' ' 547' ' ' PHE . 59.7 tp -59.48 -44.03 93.14 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.735 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 509' ' ' LEU . 9.4 t -51.66 -51.91 24.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.377 176.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.61 97.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.971 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -62.59 -47.5 83.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.382 0.61 . . . . 0.0 110.406 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.782 HG12 HD21 ' A' ' 569' ' ' LEU . 97.5 mt -62.86 -37.68 79.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.619 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -63.32 -49.15 75.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.746 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 8.5 t -60.57 -32.82 71.89 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.059 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -71.08 -22.26 62.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.031 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 75.98 19.33 78.83 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.257 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . 0.731 HD21 HD23 ' A' ' 569' ' ' LEU . 3.6 pp -106.79 22.25 16.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.478 0.639 . . . . 0.0 110.646 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 42.0 m -54.6 -43.22 71.97 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.864 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 533' ' ' ARG . 7.9 pt-20 -57.22 -33.15 67.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.422 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.0 m -63.47 -52.57 60.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 110.401 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.418 HD21 HD12 ' A' ' 573' ' ' ILE . 59.8 mt -74.09 -22.75 59.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.542 -178.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.85 9.54 32.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 176.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 529' ' ' GLU . 71.4 ttt180 -101.87 143.32 31.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.831 0.348 . . . . 0.0 110.313 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -66.66 146.69 54.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.544 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 150.83 -139.96 7.59 Favored Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.629 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.483 ' HB ' HG13 ' A' ' 577' ' ' ILE . 8.3 m -135.84 127.47 44.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -149.33 146.82 27.72 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 97.5 m -119.11 102.45 8.74 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 170.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.797 HG21 HG11 ' A' ' 505' ' ' VAL . 93.3 t -99.32 113.47 34.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 -173.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 632' ' ' LEU . 52.5 m-85 -86.14 103.87 15.19 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 171.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -96.88 115.24 65.64 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.373 -167.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.605 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 70.1 Cg_endo -81.32 135.04 9.3 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.461 2.107 . . . . 0.0 111.821 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.519 ' HB ' ' OE2' ' A' ' 545' ' ' GLU . 47.8 p -70.03 173.69 6.22 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.441 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . 0.545 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -67.82 -33.04 74.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.944 0.402 . . . . 0.0 110.902 -178.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.519 ' OE2' ' HB ' ' A' ' 543' ' ' THR . 1.7 pm0 -70.17 -19.75 63.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.858 175.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -76.34 -33.24 58.98 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.004 0.431 . . . . 0.0 111.3 177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . 0.691 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 14.8 m-85 -64.79 -14.85 60.54 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 171.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . 0.438 ' HD2' ' HA ' ' A' ' 548' ' ' ARG . 12.9 tpt180 -92.95 -14.75 27.1 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.84 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -80.67 -19.39 45.35 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.278 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.583 HD11 ' HB ' ' A' ' 631' ' ' VAL . 78.9 mt -97.95 137.2 20.89 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.888 176.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 34.8 Cg_exo -61.64 136.82 65.02 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.583 2.189 . . . . 0.0 112.051 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.64 -37.5 53.45 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.965 2.443 . . . . 0.0 112.437 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -54.31 -34.17 60.39 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.096 0.474 . . . . 0.0 111.245 177.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.93 -44.39 12.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.731 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' TRP . . . . . 0.463 ' HE3' HD12 ' A' ' 559' ' ' LEU . 0.0 OUTLIER -81.46 -37.94 27.2 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 29.3 t -54.66 -34.91 62.92 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.618 177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -66.57 -42.88 86.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.506 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.702 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 46.3 mt -59.06 -54.36 47.98 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.858 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.842 ' HG ' HD21 ' A' ' 565' ' ' LEU . 1.0 OUTLIER -70.7 -3.13 16.97 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -76.96 -29.57 56.97 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.681 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . 0.635 ' OD1' ' HG3' ' A' ' 563' ' ' LYS . 11.1 t70 -142.73 150.95 40.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.879 0.371 . . . . 0.0 110.556 -176.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.05 81.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.635 ' HG3' ' OD1' ' A' ' 561' ' ' ASP . 0.0 OUTLIER -80.52 -18.45 48.47 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.735 -178.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.53 ' HG2' ' HB3' ' A' ' 561' ' ' ASP . 15.5 mm-40 -72.38 -42.89 64.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 171.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.842 HD21 ' HG ' ' A' ' 559' ' ' LEU . 16.8 mt -61.93 -57.16 12.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.09 174.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -54.66 -27.27 38.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.991 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -53.41 -61.78 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.168 0.293 . . . . 0.0 111.491 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 68.7 mt -84.85 -37.65 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.873 0.368 . . . . 0.0 110.207 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.782 HD21 HG12 ' A' ' 522' ' ' ILE . 29.3 tp -55.0 -37.43 66.58 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.822 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 7.8 mtpm? -78.87 -12.91 60.05 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.627 ' HB2' ' CB ' ' A' ' 593' ' ' GLN . 62.0 t80 -84.4 -11.99 55.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.414 0.626 . . . . 0.0 109.666 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . 0.699 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 1.2 m80 -79.49 -16.7 55.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.871 171.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.587 ' HB ' ' HG ' ' A' ' 592' ' ' LEU . 10.7 mm -98.31 115.53 38.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.598 -176.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -80.45 153.83 35.73 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.043 172.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.79 -11.82 59.92 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -171.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.6 177.68 10.1 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.483 HG13 ' HB ' ' A' ' 536' ' ' VAL . 41.7 mt -87.28 120.07 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.572 -172.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' ' 589' ' ' LEU . 4.2 tt -121.36 99.32 6.41 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 173.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.0 167.91 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.918 -173.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.687 ' HB2' ' HB2' ' A' ' 617' ' ' ASP . 36.6 t -56.98 -34.89 68.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.464 -178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.36 -9.57 61.33 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.345 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -106.03 -9.43 32.19 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.596 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 580' ' ' SER . 76.0 mt -61.97 -44.39 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . 59.14 -99.0 0.12 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.753 172.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -121.03 -53.18 2.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.937 0.399 . . . . 0.0 110.197 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 599' ' ' VAL . 5.3 tt -162.35 107.75 1.21 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 75.1 t -126.73 129.3 71.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . 0.626 ' HD3' ' HD2' ' A' ' 596' ' ' LYS . 4.0 ptp85 -97.09 128.16 43.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.727 0.775 . . . . 0.0 111.753 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.54 ' HB2' HD12 ' A' ' 578' ' ' LEU . 21.4 tp -120.4 131.92 55.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.843 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 596' ' ' LYS . 81.1 tttt -76.51 151.97 36.22 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.169 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.591 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 85.7 p -110.9 -173.69 2.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.51 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 59.6 mt -80.43 -36.12 34.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.132 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.627 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.3 tt0 -58.46 -30.78 67.21 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.365 0.602 . . . . 0.0 110.502 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.7 6.14 6.16 Favored Glycine 0 C--N 1.317 -0.513 0 C-N-CA 120.079 -1.058 . . . . 0.0 114.89 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -123.52 -170.54 2.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 118.033 0.917 . . . . 0.0 109.793 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.626 ' HD2' ' HD3' ' A' ' 588' ' ' ARG . 23.4 pttm -103.82 142.04 35.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.124 0.487 . . . . 0.0 111.175 -172.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.585 HD22 HD21 ' A' ' 609' ' ' ASN . 41.8 mt -89.95 117.03 28.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.629 175.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -82.35 94.24 7.33 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 583' ' ' ILE . 45.6 t -100.56 124.25 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.782 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.645 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 32.9 t -122.77 161.52 23.81 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.929 -0.309 . . . . 0.0 110.67 -176.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 606' ' ' VAL . 60.0 tp -142.53 113.22 7.39 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.587 ' O ' HG12 ' A' ' 605' ' ' VAL . 87.8 tttt -135.13 99.79 4.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.806 0.336 . . . . 0.0 110.443 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.56 67.0 1.07 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.655 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 69.31 10.38 7.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 171.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 602' ' ' LYS . 11.6 p -122.15 126.84 74.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.175 0.512 . . . . 0.0 110.962 171.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.774 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 40.0 t -93.83 138.15 21.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.537 178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . 0.645 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 19.3 m -124.26 104.47 8.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.424 HG11 ' CD1' ' A' ' 540' ' ' PHE . 6.9 p -110.4 117.1 54.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.867 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.699 HD22 ' HB3' ' A' ' 632' ' ' LEU . 9.0 m-20 60.72 33.55 20.16 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.812 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm 83.18 -13.1 0.82 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.013 1.325 . . . . 0.0 111.861 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.501 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 19.9 mm-40 -91.7 132.47 33.06 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.96 0.409 . . . . 0.0 110.604 -174.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 606' ' ' VAL . 2.7 Cg_exo -75.5 125.95 9.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.909 2.406 . . . . 0.0 112.38 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.774 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 22.9 t -83.7 133.1 29.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -75.76 -60.28 2.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.972 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 616' ' ' PRO . 38.7 mt-10 -138.89 101.18 7.88 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.606 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 615' ' ' GLU . 80.5 Cg_endo -73.1 168.74 23.96 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.877 2.385 . . . . 0.0 114.137 176.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.687 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 1.4 t70 76.11 42.79 0.18 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.765 -1.107 . . . . 0.0 113.158 165.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 36.7 mt -94.62 92.65 3.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 167.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . 0.503 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 59.5 mtp -80.09 136.16 36.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.243 0.544 . . . . 0.0 112.268 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -99.49 -172.76 2.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.501 172.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 13.2 p -76.76 -26.73 54.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.965 0.412 . . . . 0.0 111.316 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.493 ' OD1' HG23 ' A' ' 505' ' ' VAL . 27.0 p-10 -116.8 15.7 15.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.894 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . 0.429 ' HA2' HG12 ' A' ' 577' ' ' ILE . . . 164.3 -157.53 29.88 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.921 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 13.0 p -133.43 144.73 35.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.826 0.346 . . . . 0.0 110.652 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 79.6 t -114.72 142.27 28.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.226 0.536 . . . . 0.0 110.48 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . 0.463 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 68.0 m-70 -126.59 121.9 33.53 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.262 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.574 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 85.4 t -76.16 117.98 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 111.501 -176.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.433 HD12 ' O ' ' A' ' 630' ' ' ASN . 1.5 pt -119.02 142.53 33.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.291 173.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 39.9 p -96.29 7.41 46.53 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.708 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . 0.433 ' O ' HD12 ' A' ' 628' ' ' ILE . 6.0 m-20 -128.79 144.05 51.07 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.249 176.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.583 ' HB ' HD11 ' A' ' 550' ' ' LEU . 47.0 t -83.43 157.31 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.699 ' HB3' HD22 ' A' ' 609' ' ' ASN . 86.9 mt -91.57 116.72 29.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.323 0.582 . . . . 0.0 111.397 -166.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -142.73 118.28 10.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.034 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.421 -176.159 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -71.22 111.31 3.62 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.678 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 14.8 tpt -122.3 141.07 51.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.715 0.293 . . . . 0.0 110.215 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -139.25 -151.91 5.79 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.105 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 508' ' ' VAL . 58.3 p -94.46 -170.31 2.23 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 175.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.694 ' O ' HD13 ' A' ' 509' ' ' LEU . 73.0 t -46.06 -42.83 4.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.603 170.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.7 tpt -59.73 -40.61 88.63 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.659 0.266 . . . . 0.0 111.066 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . 0.528 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 2.2 t70 -68.81 -34.55 75.72 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.207 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 505' ' ' VAL . 99.1 t -51.79 -56.89 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.001 0.429 . . . . 0.0 110.85 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.694 HD13 ' O ' ' A' ' 505' ' ' VAL . 5.4 mp -57.31 -42.33 81.62 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.461 177.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 510' ' ' LYS . 1.5 tmmt? -67.32 -25.76 66.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 -177.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -99.49 13.01 61.51 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.872 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -122.63 139.13 54.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.922 0.391 . . . . 0.0 110.895 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -75.46 -16.47 60.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.489 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -91.29 -24.83 19.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.824 0.345 . . . . 0.0 110.901 -177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.923 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 17.2 m-85 -107.01 8.36 30.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.656 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 13.3 p -54.05 -54.22 42.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -67.87 -29.89 69.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.214 0.53 . . . . 0.0 109.866 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.473 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 41.8 tp -57.42 -45.83 84.19 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.404 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 515' ' ' PHE . 10.0 t -52.75 -52.02 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.394 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.05 -34.54 77.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.181 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -72.67 -49.57 30.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.51 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.529 HG12 HD13 ' A' ' 569' ' ' LEU . 77.1 mt -57.94 -35.1 50.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.502 0.668 . . . . 0.0 109.681 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.0 OUTLIER -56.63 -57.5 12.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.21 173.279 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 16.2 m -57.4 -26.55 61.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.793 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -77.95 -15.85 58.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.369 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 79.51 8.29 87.86 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.341 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 566' ' ' ALA . 71.2 mt -83.26 9.19 11.3 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.795 0.331 . . . . 0.0 111.06 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 46.4 m -52.99 -43.66 66.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -51.54 -45.89 63.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.388 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 16.2 m -63.91 -41.87 97.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.809 0.337 . . . . 0.0 111.735 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 80.5 mt -91.24 -14.1 31.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.841 -175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . 0.439 HD22 ' N ' ' A' ' 532' ' ' ASN . 0.9 OUTLIER -87.56 -7.4 57.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.023 0.439 . . . . 0.0 110.341 172.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -92.79 147.47 22.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.468 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.11 151.94 43.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.71 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 153.0 -161.18 29.48 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.892 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.684 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.7 m -120.76 127.71 75.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.808 0.337 . . . . 0.0 110.23 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -141.84 155.53 45.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.083 0.468 . . . . 0.0 111.046 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.1 m -124.42 100.83 6.86 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 167.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.609 HG22 HG12 ' A' ' 573' ' ' ILE . 59.7 t -104.54 113.78 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -173.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 60.3 m-85 -86.26 113.84 22.59 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -103.58 116.57 61.73 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -169.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 541' ' ' ALA . 8.2 Cg_exo -72.97 139.42 29.99 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.251 2.634 . . . . 0.0 112.007 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 628' ' ' ILE . 67.6 p -83.05 -176.42 6.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.138 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.22 -30.95 69.73 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.112 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -64.53 -29.81 70.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -67.79 -35.28 78.37 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.378 0.609 . . . . 0.0 111.339 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . 0.448 ' O ' HD22 ' A' ' 550' ' ' LEU . 6.2 m-85 -73.25 -13.28 61.11 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.131 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -94.57 -38.53 10.83 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.148 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -90.96 7.24 41.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.393 0.616 . . . . 0.0 111.508 -172.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.799 HD12 ' CD1' ' A' ' 555' ' ' TRP . 0.5 OUTLIER -74.97 163.52 67.65 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.235 -178.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.626 ' HB2' ' OE1' ' A' ' 554' ' ' GLU . 3.3 Cg_exo -81.09 126.36 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.307 2.005 . . . . 0.0 109.916 166.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.7 -43.24 60.97 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.518 2.812 . . . . 0.0 114.263 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 553' ' ' ARG . 24.9 mmt180 -71.93 -23.44 61.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 111.486 -172.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.63 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 0.9 OUTLIER -60.88 -53.48 56.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.45 0.643 . . . . 0.0 110.492 175.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' TRP . . . . . 0.799 ' CD1' HD12 ' A' ' 550' ' ' LEU . 4.7 m95 -80.3 -30.34 38.25 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.784 -172.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . 0.44 ' OG ' ' HA ' ' A' ' 553' ' ' ARG . 25.3 p -58.68 -25.45 62.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.337 0.589 . . . . 0.0 109.577 173.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . 0.774 ' HG3' ' HG2' ' A' ' 564' ' ' GLU . 26.5 tpt180 -84.72 -46.98 10.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.743 173.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 554' ' ' GLU . 74.9 mt -63.19 -60.18 3.76 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.6 HD22 HD11 ' A' ' 565' ' ' LEU . 0.1 OUTLIER -64.57 -12.35 44.14 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.891 0.376 . . . . 0.0 110.984 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -70.82 -35.84 65.98 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.848 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -145.78 147.3 31.73 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.319 0.56 . . . . 0.0 110.891 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -67.96 -47.29 69.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.367 -170.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.565 ' HD2' ' H ' ' A' ' 563' ' ' LYS . 0.0 OUTLIER -69.7 -22.85 63.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.061 -177.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.774 ' HG2' ' HG3' ' A' ' 557' ' ' ARG . 7.4 tp10 -77.75 -42.41 34.26 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.691 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.6 HD11 HD22 ' A' ' 559' ' ' LEU . 0.3 OUTLIER -60.96 -49.43 77.5 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 121.495 0.664 . . . . 0.0 109.359 175.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . 0.485 ' HA ' HD11 ' A' ' 527' ' ' LEU . . . -55.83 -32.81 63.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.537 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 570' ' ' LYS . 25.6 t-20 -57.63 -46.97 83.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.458 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.569 HD12 HD11 ' A' ' 558' ' ' LEU . 24.4 mt -83.98 -41.62 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.991 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.529 HD13 HG12 ' A' ' 522' ' ' ILE . 36.0 mt -57.87 -27.34 63.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 592' ' ' LEU . 22.3 ptmt -76.79 -12.66 60.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.014 0.435 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.6 ' O ' HD21 ' A' ' 597' ' ' LEU . 41.1 t80 -83.53 -18.72 37.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.228 0.537 . . . . 0.0 109.79 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . 0.718 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 20.8 m80 -76.16 -10.12 59.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.178 175.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.609 HG12 HG22 ' A' ' 539' ' ' VAL . 80.1 mt -115.78 119.63 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.056 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.708 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -83.83 161.96 38.75 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.902 174.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -90.15 3.19 54.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . 0.416 ' HA ' HG23 ' A' ' 536' ' ' VAL . 11.4 pt-20 -160.68 170.45 20.76 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.436 172.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.684 HG13 ' HB ' ' A' ' 536' ' ' VAL . 64.3 mt -87.9 126.2 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.207 -168.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' A' ' 589' ' ' LEU . 2.4 tt -121.51 93.51 4.03 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 173.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 20.7 m -77.65 166.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.937 0.399 . . . . 0.0 111.81 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.627 ' HA ' HD12 ' A' ' 583' ' ' ILE . 20.9 t -62.24 -28.19 69.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.306 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.07 -14.66 68.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.082 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.23 -22.54 11.58 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.035 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.866 HG22 ' HB2' ' A' ' 601' ' ' LEU . 74.0 mt -59.99 109.8 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.103 0.478 . . . . 0.0 110.881 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -114.22 -154.24 11.02 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.576 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -50.92 -48.56 60.64 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.981 0.39 . . . . 0.0 110.79 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 4.1 tt -164.36 116.62 1.32 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . 0.443 HG13 HD11 ' A' ' 578' ' ' LEU . 7.3 p -133.67 123.96 46.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . 0.567 ' HD3' ' H ' ' A' ' 588' ' ' ARG . 0.1 OUTLIER -97.23 129.66 44.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.544 0.687 . . . . 0.0 110.873 -174.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.698 ' HB2' HD12 ' A' ' 578' ' ' LEU . 1.5 tm? -110.94 120.04 41.07 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.242 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -67.24 146.93 53.67 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.111 0.481 . . . . 0.0 111.286 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.708 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.1 p -106.69 -174.78 2.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.835 -176.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 570' ' ' LYS . 72.9 mt -82.03 -41.44 20.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.06 175.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.518 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.7 tt0 -59.05 -29.76 67.55 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.126 0.489 . . . . 0.0 111.024 -178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 126.74 -14.16 6.76 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.573 171.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -89.9 -164.38 1.15 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.754 0.777 . . . . 0.0 109.601 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.9 pttp -120.79 137.16 54.67 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.904 -175.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.6 HD21 ' O ' ' A' ' 571' ' ' TYR . 90.6 mt -84.57 116.16 23.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.724 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 90.2 mt-10 -85.28 89.69 7.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.293 -175.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.493 HG12 HG23 ' A' ' 583' ' ' ILE . 47.8 t -91.04 122.23 42.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.74 0.305 . . . . 0.0 111.272 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.647 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 35.9 t -128.53 154.53 46.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.866 ' HB2' HG22 ' A' ' 583' ' ' ILE . 41.0 tp -126.07 129.07 48.4 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.458 ' HB2' ' HE2' ' A' ' 602' ' ' LYS . 19.1 ttmm -146.78 102.63 3.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.734 0.302 . . . . 0.0 110.199 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . 0.441 ' C ' ' H ' ' A' ' 605' ' ' VAL . 18.7 t-20 58.72 56.88 3.95 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.389 -176.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 68.28 -14.89 0.23 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.983 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . 0.441 ' H ' ' C ' ' A' ' 603' ' ' ASN . 58.7 t -82.42 110.42 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 55.9 t -79.38 136.67 23.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.837 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . 0.647 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 36.8 m -124.23 109.42 13.38 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.948 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 11.4 p -112.95 129.14 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.424 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.661 ' ND2' HD13 ' A' ' 632' ' ' LEU . 44.0 m-20 57.86 29.43 17.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm 74.04 22.48 2.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.453 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 0.2 OUTLIER -125.95 149.08 65.05 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 170.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 5.9 Cg_exo -78.81 126.27 7.17 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.085 2.524 . . . . 0.0 112.666 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.596 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 61.2 t -77.76 136.0 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.524 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -84.74 -42.17 15.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.957 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.58 95.11 3.78 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.665 0.269 . . . . 0.0 110.731 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.99 167.15 27.68 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.437 2.091 . . . . 0.0 113.873 172.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 3.3 t70 75.15 28.95 0.98 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.721 165.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.51 86.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 63.1 mtp -78.38 148.08 33.83 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.362 0.601 . . . . 0.0 112.285 -171.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -124.17 -171.14 2.27 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.646 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.6 p -80.68 -19.71 44.57 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.748 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.495 ' OD1' HG23 ' A' ' 505' ' ' VAL . 24.4 p-10 -117.47 15.98 14.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.838 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.15 -148.34 19.33 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.886 -1.149 . . . . 0.0 113.085 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.7 p -132.14 147.6 32.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.575 0.226 . . . . 0.0 110.541 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 78.6 t -118.79 142.29 34.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 121.078 0.465 . . . . 0.0 110.768 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . 0.607 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 52.2 m-70 -130.42 126.82 37.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.413 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.923 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 96.2 t -74.47 118.29 19.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.91 -176.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 543' ' ' THR . 1.2 pt -110.49 171.86 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.014 0.435 . . . . 0.0 110.714 173.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 21.6 p -117.42 -5.89 11.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.711 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -131.39 168.2 17.98 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.306 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 76.8 t -84.03 148.21 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.718 ' HB2' ' CE1' ' A' ' 572' ' ' HIS . 82.6 mt -110.36 139.23 45.77 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.291 -170.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -153.28 156.16 37.9 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.941 179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.812 0.339 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -116.78 100.45 0.9 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.174 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 78.4 mtp -134.68 -78.02 0.45 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.968 0.413 . . . . 0.0 110.2 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -178.77 -157.65 19.75 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.454 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.477 HG22 ' OE2' ' A' ' 534' ' ' GLU . 82.0 p -86.17 -168.94 2.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.647 -0.777 . . . . 0.0 110.988 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.422 ' CG2' HG23 ' A' ' 625' ' ' VAL . 4.7 p -56.94 -27.21 26.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.614 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.557 ' HE2' ' HB2' ' A' ' 531' ' ' LEU . 39.5 tpp -71.05 -44.5 65.66 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.842 174.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . 0.669 ' HA ' ' HB3' ' A' ' 510' ' ' LYS . 5.9 t70 -68.68 -27.31 65.86 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.031 0.443 . . . . 0.0 110.198 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 504' ' ' THR . 91.4 t -50.02 -41.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.674 171.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 509' ' ' LEU . 0.6 OUTLIER -82.03 -36.36 27.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.887 -179.286 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.679 ' HA ' HG21 ' A' ' 519' ' ' VAL . 28.7 tttm -62.5 -31.45 72.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.802 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -93.78 6.57 73.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.007 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -114.66 137.64 51.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.816 0.341 . . . . 0.0 111.007 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -75.8 -24.08 55.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.589 -177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -77.56 -28.89 51.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.367 0.603 . . . . 0.0 109.7 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.796 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 26.9 m-85 -105.28 14.78 28.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.877 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 34.8 p -56.45 -53.16 60.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.865 -176.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -68.42 -30.53 69.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.07 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.612 HD13 ' HZ ' ' A' ' 547' ' ' PHE . 54.7 tp -55.4 -47.5 75.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.76 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' A' ' 510' ' ' LYS . 4.0 t -52.27 -47.2 45.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.716 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -67.29 -32.82 74.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.041 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.6 -50.2 39.66 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.283 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.58 HG12 HD13 ' A' ' 569' ' ' LEU . 42.9 mt -60.59 -31.38 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.529 0.681 . . . . 0.0 109.658 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.5 OUTLIER -59.63 -59.33 5.61 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.203 173.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 19.0 m -58.08 -26.83 63.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.897 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.589 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -75.09 -17.29 60.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.184 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 70.96 50.32 24.0 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.612 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 566' ' ' ALA . 76.9 mt -128.41 15.47 6.6 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 88.1 m -61.82 -51.57 67.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . 0.665 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 0.0 OUTLIER -60.24 -29.08 68.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.486 -178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 36.7 m -62.42 -47.95 81.85 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.962 0.41 . . . . 0.0 110.491 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.557 ' HB2' ' HE2' ' A' ' 506' ' ' MET . 67.2 mt -91.09 -5.03 55.74 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.693 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . 0.584 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 0.9 OUTLIER -83.95 -5.89 59.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.042 172.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . 0.665 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 80.5 mtp180 -85.65 135.41 33.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.792 0.33 . . . . 0.0 110.661 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . 0.477 ' OE2' HG22 ' A' ' 504' ' ' THR . 13.3 mm-40 -78.76 137.04 37.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.951 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 164.47 -117.29 0.75 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.053 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 1.089 HG23 HG13 ' A' ' 577' ' ' ILE . 0.7 OUTLIER -145.99 125.56 5.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.58 0.229 . . . . 0.0 110.709 -178.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -155.03 137.22 14.79 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.68 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . 0.565 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 98.1 m -107.35 102.32 11.62 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 170.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.715 HG22 HG12 ' A' ' 573' ' ' ILE . 61.3 t -99.84 114.89 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.095 0.474 . . . . 0.0 111.211 -175.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 48.6 m-85 -85.77 108.39 18.06 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -100.56 119.39 58.85 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.057 -167.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.56 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 85.5 Cg_endo -82.76 140.14 10.22 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.53 2.153 . . . . 0.0 112.437 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 75.4 p -78.7 -175.93 4.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.532 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -68.94 -35.23 76.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.378 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 545' ' ' GLU . 1.7 mp0 -61.62 -29.96 70.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.064 177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -70.07 -34.48 73.25 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.392 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . 0.612 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 21.9 m-85 -70.87 -15.9 62.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.605 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -91.46 -10.91 39.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.063 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -88.09 -2.06 58.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.362 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.77 HD12 ' HE1' ' A' ' 555' ' ' TRP . 66.5 mt -109.68 144.07 29.15 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.189 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 26.3 Cg_exo -62.74 126.5 18.34 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.506 2.137 . . . . 0.0 111.126 173.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.27 -24.61 60.54 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.891 2.394 . . . . 0.0 113.499 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -68.27 -40.84 81.73 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.788 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -37.84 79.68 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.677 0.751 . . . . 0.0 109.574 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' TRP . . . . . 0.77 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -70.35 -38.24 74.78 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.832 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 23.4 t -55.16 -28.25 51.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.574 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . 0.907 ' HG2' ' HG2' ' A' ' 564' ' ' GLU . 14.6 ttp85 -75.72 -32.11 59.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.817 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.496 ' HB3' ' HG ' ' A' ' 565' ' ' LEU . 9.1 mt -78.4 -53.74 6.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.056 0.455 . . . . 0.0 110.333 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.469 HD22 HD11 ' A' ' 565' ' ' LEU . 1.1 mm? -70.64 -14.31 62.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.261 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -90.6 -49.01 3.3 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -105.15 114.32 28.44 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.103 0.477 . . . . 0.0 110.063 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.19 -33.09 73.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.214 -173.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -62.31 -37.36 85.28 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.907 ' HG2' ' HG2' ' A' ' 557' ' ' ARG . 7.8 tp10 -69.48 -44.79 70.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.945 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -62.28 -42.02 98.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.014 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . 0.524 ' HA ' HD11 ' A' ' 527' ' ' LEU . . . -57.94 -38.13 75.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.363 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 564' ' ' GLU . 92.7 m-20 -57.06 -56.83 16.64 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.9 0.381 . . . . 0.0 111.077 178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 50.3 mt -67.53 -50.21 63.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.486 -175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.58 HD13 HG12 ' A' ' 522' ' ' ILE . 83.2 mt -59.73 -23.22 63.01 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 34.7 mttp -70.89 -18.09 62.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.871 -0.331 . . . . 0.0 111.781 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.626 ' O ' HD21 ' A' ' 597' ' ' LEU . 35.3 t80 -92.74 -1.83 56.5 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.398 0.618 . . . . 0.0 110.167 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . 0.594 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 5.7 m80 -89.58 -15.13 33.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.208 174.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.715 HG12 HG22 ' A' ' 539' ' ' VAL . 76.3 mt -111.02 121.0 62.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.873 -175.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -88.23 153.85 24.77 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.295 176.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -68.9 -21.32 64.24 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . 0.626 ' HA ' ' CG2' ' A' ' 536' ' ' VAL . 15.7 pt-20 -145.4 153.3 41.06 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 122.224 -0.298 . . . . 0.0 110.676 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 1.089 HG13 HG23 ' A' ' 536' ' ' VAL . 75.2 mt -70.24 114.62 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.814 -176.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.726 HD12 ' HB2' ' A' ' 589' ' ' LEU . 1.6 tt -111.4 98.96 7.85 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 583' ' ' ILE . 28.5 m -76.59 163.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.534 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.731 ' HA ' HD12 ' A' ' 583' ' ' ILE . 28.4 m -56.75 -31.13 64.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.378 -176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.19 -15.54 67.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.861 178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.1 -10.97 40.92 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.219 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 580' ' ' SER . 71.0 mt -78.18 -3.86 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 122.876 0.47 . . . . 0.0 111.262 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -50.7 129.12 29.86 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.804 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 71.49 -85.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.796 0.838 . . . . 0.0 110.868 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.474 HD21 ' HG3' ' A' ' 598' ' ' GLU . 4.7 tt -167.55 117.56 0.83 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 89.6 t -132.94 130.72 58.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.941 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . 0.525 ' HB3' ' OE1' ' A' ' 598' ' ' GLU . 0.7 OUTLIER -96.96 128.77 44.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.577 0.703 . . . . 0.0 111.28 -178.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.726 ' HB2' HD12 ' A' ' 578' ' ' LEU . 31.1 tp -116.84 126.73 53.47 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.369 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -65.9 134.35 52.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.777 0.323 . . . . 0.0 110.373 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.644 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 86.7 p -99.24 -171.63 2.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.554 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 570' ' ' LYS . 79.3 mt -81.64 -39.05 25.0 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.67 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -62.54 -30.36 71.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.559 0.695 . . . . 0.0 110.263 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.44 -17.46 6.96 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.503 170.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . 0.497 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.3 t70 -84.12 -176.77 6.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.461 0.631 . . . . 0.0 109.705 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.21 139.56 39.69 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.871 0.367 . . . . 0.0 110.693 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.626 HD21 ' O ' ' A' ' 571' ' ' TYR . 94.9 mt -81.97 115.52 21.17 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 171.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.525 ' OE1' ' HB3' ' A' ' 588' ' ' ARG . 2.3 tp10 -94.07 87.28 5.26 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.639 HG22 HG23 ' A' ' 608' ' ' VAL . 2.0 t -99.12 128.16 51.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.007 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' A' ' 606' ' ' VAL . 33.1 t -131.29 108.5 9.71 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.365 -174.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 606' ' ' VAL . 56.8 tp -108.16 116.09 31.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.825 0.345 . . . . 0.0 110.442 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -151.37 133.63 15.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.678 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 58.58 40.56 23.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.598 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 604' ' ' ASN . 7.1 m120 66.15 11.87 8.14 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.597 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 47.9 t -113.84 107.47 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.022 0.439 . . . . 0.0 110.223 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.915 HG13 ' HB ' ' A' ' 613' ' ' VAL . 1.4 p -98.14 137.84 24.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.668 176.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 50.3 m -132.19 120.57 22.42 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.639 HG23 HG22 ' A' ' 599' ' ' VAL . 7.6 p -110.27 123.65 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.067 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.706 ' ND2' HD13 ' A' ' 632' ' ' LEU . 24.0 m-20 61.38 33.88 18.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.468 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 48.5 mtpt 83.31 -14.19 0.73 Allowed 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.32 1.012 . . . . 0.0 112.03 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 34.0 mm-40 -96.72 122.59 56.57 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.811 0.339 . . . . 0.0 110.547 -174.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 23.7 Cg_exo -63.83 133.71 40.26 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.851 2.367 . . . . 0.0 112.499 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.915 ' HB ' HG13 ' A' ' 606' ' ' VAL . 44.4 t -88.8 137.46 21.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -87.09 -60.61 1.93 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.397 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . 0.451 ' H ' ' HB ' ' A' ' 627' ' ' VAL . 16.5 mp0 -128.23 92.44 41.49 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.618 177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.28 167.72 26.59 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.606 2.204 . . . . 0.0 113.219 172.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 74.88 38.28 0.46 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.463 0.705 . . . . 0.0 112.827 166.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 34.0 mt -98.11 89.9 2.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 171.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . 0.602 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 53.0 mtp -82.44 160.46 22.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.542 0.686 . . . . 0.0 112.499 -169.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . 0.415 ' HB2' HG21 ' A' ' 508' ' ' VAL . . . -130.95 -171.17 2.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.446 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 26.0 p -72.93 -37.11 67.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.181 0.515 . . . . 0.0 110.811 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.46 ' HB3' ' OE2' ' A' ' 534' ' ' GLU . 33.4 p-10 -109.95 13.41 23.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.172 -174.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 165.3 -138.1 5.05 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.193 -1.479 . . . . 0.0 113.927 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 10.1 p -160.13 148.74 6.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.727 -171.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . 0.422 HG23 ' CG2' ' A' ' 505' ' ' VAL . 47.8 t -119.49 139.99 44.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.296 0.57 . . . . 0.0 110.968 178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . 0.548 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 60.9 m-70 -127.52 117.85 22.86 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.796 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 58.1 t -72.34 119.0 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -173.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 542' ' ' PRO . 0.6 OUTLIER -114.31 150.0 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 121.074 0.464 . . . . 0.0 110.733 173.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 18.1 p -96.82 6.84 47.9 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.924 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -138.67 155.21 48.47 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.953 0.406 . . . . 0.0 111.489 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 60.4 t -86.99 157.21 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.706 HD13 ' ND2' ' A' ' 609' ' ' ASN . 38.2 mt -115.65 146.94 41.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.724 0.297 . . . . 0.0 110.899 -167.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -157.72 132.52 8.59 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' ALA . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 571' ' ' TYR . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.712 -0.661 . . . . 0.0 111.105 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -54.99 104.76 0.29 Allowed Glycine 0 C--N 1.33 0.218 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.579 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 26.6 ttt -153.2 145.93 24.32 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 73.19 -132.63 17.04 Favored Glycine 0 CA--C 1.504 -0.619 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.673 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 508' ' ' VAL . 68.7 p -124.91 -170.48 2.17 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 169.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.691 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 54.8 t -42.54 -42.74 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 123.638 0.586 . . . . 0.0 110.727 168.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -48.9 79.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.261 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -71.54 -28.32 63.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.816 0.341 . . . . 0.0 110.456 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 504' ' ' THR . 71.5 t -53.98 -42.7 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.588 171.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 4.8 mt -82.18 -33.18 29.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.162 -178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.514 ' HA ' HG21 ' A' ' 519' ' ' VAL . 1.9 tmmm? -59.9 -40.02 87.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.991 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -89.13 -2.81 76.96 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.785 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -102.35 144.98 30.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.645 0.723 . . . . 0.0 110.811 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -75.25 -35.0 61.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.578 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -78.43 -13.37 59.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.881 0.372 . . . . 0.0 110.445 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.621 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 24.1 m-85 -113.41 9.63 18.19 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.003 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 64.5 m -58.54 -44.53 89.65 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -173.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.0 ptm -83.24 -20.15 35.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.701 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.57 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 46.9 tp -57.95 -41.67 83.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.38 0.609 . . . . 0.0 109.462 172.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 510' ' ' LYS . 18.6 t -52.04 -52.97 20.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.666 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -60.32 -32.84 71.61 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.6 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -70.11 -49.87 46.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.951 0.405 . . . . 0.0 110.508 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 527' ' ' LEU . 58.6 mt -59.42 -34.2 53.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.486 0.66 . . . . 0.0 109.953 175.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -66.56 -49.51 66.16 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.924 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.3 m -57.12 -34.27 68.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.378 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.945 ' HB2' HD22 ' A' ' 565' ' ' LEU . . . -78.18 -17.97 56.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.142 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 74.58 18.62 79.99 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.005 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . 0.464 ' HB2' HG23 ' A' ' 522' ' ' ILE . 93.3 mt -84.6 5.83 26.31 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.547 -0.384 . . . . 0.0 111.466 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 19.0 m -56.76 -44.13 81.48 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.097 0.475 . . . . 0.0 109.954 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -53.99 -35.23 61.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.029 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 8.3 m -69.49 -36.76 76.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.931 0.396 . . . . 0.0 111.447 -175.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 97.2 mt -96.3 -27.41 14.99 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -173.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -84.58 23.27 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -118.46 152.42 35.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.815 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -69.77 115.68 9.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -178.13 -163.78 30.23 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.68 ' HB ' HG13 ' A' ' 577' ' ' ILE . 20.8 m -119.52 127.93 75.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . 0.512 ' O ' ' HA3' ' A' ' 623' ' ' GLY . 96.5 m-85 -148.54 140.6 23.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.795 0.331 . . . . 0.0 110.683 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 93.5 m -113.74 101.58 9.43 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 170.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.575 HG21 HG11 ' A' ' 505' ' ' VAL . 56.6 t -101.41 119.78 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.419 -174.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.631 ' CD2' HG11 ' A' ' 608' ' ' VAL . 51.5 m-85 -86.43 111.98 21.05 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 170.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -106.99 112.88 63.07 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.705 -167.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.767 ' HA ' HG13 ' A' ' 628' ' ' ILE . 3.3 Cg_exo -79.7 143.21 16.59 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.243 2.628 . . . . 0.0 112.709 -175.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 68.9 p -85.73 -177.44 6.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.585 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -67.86 -25.57 65.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.767 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -71.13 -22.03 62.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.548 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -83.67 -34.62 24.95 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.059 0.457 . . . . 0.0 111.467 -177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . 0.504 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 5.0 m-85 -68.55 -13.98 62.7 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 172.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -93.57 -17.11 23.7 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.615 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -82.8 -13.03 56.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.019 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.577 HD12 ' HE1' ' A' ' 555' ' ' TRP . 46.4 mt -101.63 133.64 20.68 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.8 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.8 135.28 67.09 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.384 2.056 . . . . 0.0 110.925 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -48.54 -33.56 23.91 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.199 2.599 . . . . 0.0 113.579 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 553' ' ' ARG . 11.4 ptt180 -60.24 -36.24 77.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.656 0.265 . . . . 0.0 111.388 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 557' ' ' ARG . 0.4 OUTLIER -72.72 -40.84 65.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.92 0.39 . . . . 0.0 110.777 -175.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' TRP . . . . . 0.577 ' HE1' HD12 ' A' ' 550' ' ' LEU . 1.1 m95 -80.69 -29.04 36.56 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.227 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 37.5 t -57.03 -29.65 63.54 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.332 168.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 554' ' ' GLU . 50.0 mtt180 -75.52 -40.04 57.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.206 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.516 ' HG ' ' HA ' ' A' ' 555' ' ' TRP . 5.3 mt -75.77 -54.66 6.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.882 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.429 ' HA ' HD22 ' A' ' 559' ' ' LEU . 0.2 OUTLIER -64.36 -14.21 55.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.666 0.269 . . . . 0.0 111.583 178.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -98.65 -21.53 16.35 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.46 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 25.9 t70 -135.75 118.77 16.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.081 0.467 . . . . 0.0 110.89 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.78 68.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.792 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.47 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 5.1 tmtm? -59.63 -43.32 93.88 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.096 176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 567' ' ' ASN . 8.2 tp10 -75.76 -34.81 60.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.554 -176.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.945 HD22 ' HB2' ' A' ' 525' ' ' ALA . 5.6 tt -68.57 -45.27 72.5 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.11 0.481 . . . . 0.0 109.759 177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -64.2 -30.36 71.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.518 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . 0.789 ' HA ' ' NE2' ' A' ' 593' ' ' GLN . 39.0 t30 -55.93 -45.03 78.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.439 0.638 . . . . 0.0 110.506 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 60.6 mt -85.85 -62.53 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.442 -178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.45 HD11 HG12 ' A' ' 522' ' ' ILE . 3.2 tt -55.12 -35.76 65.0 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.548 ' HG2' ' HB2' ' A' ' 592' ' ' LEU . 19.7 ttpp -72.25 -12.34 61.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.62 ' O ' HD21 ' A' ' 597' ' ' LEU . 41.7 t80 -89.28 -18.71 26.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.589 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . 0.475 ' NE2' HG23 ' A' ' 631' ' ' VAL . 2.0 m-70 -73.3 -14.12 61.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.309 0.575 . . . . 0.0 109.91 177.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.538 HG12 HG22 ' A' ' 539' ' ' VAL . 61.2 mt -101.81 121.78 53.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.839 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.67 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -84.74 164.18 39.1 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.873 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -66.03 -33.35 75.6 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.171 0.588 . . . . 0.0 112.072 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . 0.469 ' HA ' HG23 ' A' ' 536' ' ' VAL . 13.6 pt-20 -146.37 -178.29 6.08 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.191 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.731 HG23 HG22 ' A' ' 624' ' ' VAL . 14.9 mt -82.28 110.56 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 O-C-N 123.395 0.434 . . . . 0.0 111.114 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 578' ' ' LEU . 1.2 tm? -117.67 94.54 4.57 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 27.5 m -81.96 172.18 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.473 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.562 ' HA ' HD12 ' A' ' 583' ' ' ILE . 15.8 m -63.03 -20.4 65.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.472 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.01 -13.14 63.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.437 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -103.55 -20.07 11.4 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 580' ' ' SER . 76.5 mt -74.85 90.12 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.202 0.525 . . . . 0.0 110.396 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -102.83 -123.98 5.37 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.876 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -66.5 -57.94 6.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.073 0.463 . . . . 0.0 110.23 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 55.0 tp -156.86 114.42 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.644 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 10.1 p -132.18 132.29 60.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 120.945 0.402 . . . . 0.0 110.126 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . 0.71 ' HG2' ' HA ' ' A' ' 598' ' ' GLU . 40.0 mtp180 -112.5 127.09 55.96 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.33 0.586 . . . . 0.0 110.899 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.61 126.83 55.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.912 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 3.7 tmmt? -62.95 140.77 58.88 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.67 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 82.8 p -103.6 -174.52 2.56 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.744 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.548 ' HB2' ' HG2' ' A' ' 570' ' ' LYS . 78.9 mt -81.56 -42.26 20.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.89 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.789 ' NE2' ' HA ' ' A' ' 567' ' ' ASN . 6.4 tp-100 -61.64 -29.26 69.95 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.914 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 127.18 11.7 3.37 Favored Glycine 0 C--N 1.321 -0.267 0 C-N-CA 120.028 -1.082 . . . . 0.0 114.521 166.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -117.43 -156.51 0.63 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -135.46 130.81 35.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.214 0.53 . . . . 0.0 111.922 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 588' ' ' ARG . 92.7 mt -68.6 122.33 18.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.851 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.71 ' HA ' ' HG2' ' A' ' 588' ' ' ARG . 30.0 tt0 -86.35 94.46 9.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.451 HG12 HG23 ' A' ' 583' ' ' ILE . 36.1 t -105.52 133.82 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.802 -175.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 606' ' ' VAL . 7.7 p -140.5 161.84 36.76 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.748 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.473 ' HB2' HG22 ' A' ' 583' ' ' ILE . 67.6 tp -127.46 113.26 15.94 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -136.84 126.21 24.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.443 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 54.59 44.05 29.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.344 0.593 . . . . 0.0 110.546 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 65.3 t30 70.44 -0.39 2.9 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.355 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.76 119.68 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.898 0.38 . . . . 0.0 110.489 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.788 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 25.9 t -77.59 148.48 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 611' ' ' GLU . 49.1 m -140.21 112.32 7.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.065 0.46 . . . . 0.0 111.968 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.631 HG11 ' CD2' ' A' ' 540' ' ' PHE . 7.5 p -117.17 135.71 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.156 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 1.061 ' HB2' HD23 ' A' ' 632' ' ' LEU . 77.1 m-20 53.58 33.18 15.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.177 0.513 . . . . 0.0 110.397 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt 77.22 9.09 2.71 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.373 176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 608' ' ' VAL . 0.3 OUTLIER -113.97 149.65 42.24 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 1.4 Cg_endo -85.98 124.84 2.61 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.986 2.457 . . . . 0.0 113.161 178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.788 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 49.9 t -76.19 143.94 12.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.383 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . 0.567 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -89.98 -43.98 10.18 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.415 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 21.9 tt0 -151.06 92.07 3.86 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-O 120.971 0.415 . . . . 0.0 111.787 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.524 ' HG3' HG21 ' A' ' 606' ' ' VAL . 83.1 Cg_endo -76.28 169.45 21.97 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.914 2.409 . . . . 0.0 114.124 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 74.47 27.92 1.35 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.693 -1.139 . . . . 0.0 113.15 166.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . 0.497 HD12 HG23 ' A' ' 627' ' ' VAL . 45.0 mt -87.33 91.84 3.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 170.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . 0.717 ' HG2' HG13 ' A' ' 624' ' ' VAL . 51.7 mtp -80.18 128.97 34.14 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.585 0.707 . . . . 0.0 112.176 -170.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -100.73 166.92 10.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.341 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -15.13 53.98 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.512 ' OD1' HG23 ' A' ' 505' ' ' VAL . 25.2 p-10 -116.62 15.51 15.51 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 537' ' ' TYR . . . 147.03 -133.51 4.81 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 119.765 -1.207 . . . . 0.0 113.455 177.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . 0.731 HG22 HG23 ' A' ' 577' ' ' ILE . 0.0 OUTLIER -129.32 152.7 37.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.109 0.481 . . . . 0.0 111.597 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . 0.513 HG22 HG13 ' A' ' 505' ' ' VAL . 43.7 t -122.65 131.14 73.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.586 170.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . 0.506 ' HB2' ' CD2' ' A' ' 540' ' ' PHE . 77.6 m-70 -120.14 110.56 16.77 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.18 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.621 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 98.9 t -66.93 118.39 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.691 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.767 HG13 ' HA ' ' A' ' 542' ' ' PRO . 5.1 pt -115.77 143.97 24.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.616 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . 0.567 HG23 ' HB2' ' A' ' 614' ' ' ALA . 24.5 p -94.73 1.4 55.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.797 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . 0.462 ' ND2' ' HD2' ' A' ' 612' ' ' PRO . 6.5 m-80 -135.92 135.9 40.02 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.898 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.475 HG23 ' NE2' ' A' ' 572' ' ' HIS . 0.2 OUTLIER -90.3 147.18 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 172.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 1.061 HD23 ' HB2' ' A' ' 609' ' ' ASN . 1.5 mp -109.89 157.65 19.0 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.12 -158.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -160.79 156.86 25.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.576 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.838 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.558 -178.834 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -102.97 46.72 1.18 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.69 -176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 61.0 ttp -80.87 -26.83 36.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.363 0.601 . . . . 0.0 109.572 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -148.67 -155.26 6.61 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.928 178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.439 ' HA ' HG22 ' A' ' 621' ' ' THR . 76.4 p -88.2 -171.67 3.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.19 -0.505 . . . . 0.0 109.838 175.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.579 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 93.5 t -45.16 -46.15 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 123.35 0.406 . . . . 0.0 111.33 174.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.74 ' SD ' ' HB2' ' A' ' 531' ' ' LEU . 0.0 OUTLIER -60.64 -38.11 83.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.886 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . 0.538 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 16.9 t70 -68.19 -38.52 82.09 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 176.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 505' ' ' VAL . 96.0 t -53.1 -40.42 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.421 176.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 8.1 mt -77.7 -20.38 53.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.099 -174.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -83.32 -26.24 30.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.162 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -89.38 -0.7 79.44 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.105 -174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -122.26 141.18 51.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.996 0.398 . . . . 0.0 111.441 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -75.5 -22.59 57.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.102 -177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -73.52 -20.24 60.71 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 110.374 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.726 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 15.9 m-85 -114.74 19.2 16.14 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.788 -176.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 32.9 t -59.05 -57.31 13.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.75 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -64.5 -30.09 71.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.933 0.397 . . . . 0.0 110.237 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.563 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 57.8 tp -53.85 -45.43 70.92 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.873 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 515' ' ' PHE . 14.8 t -50.94 -51.32 21.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.856 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.42 82.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.143 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -65.53 -51.18 61.8 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.42 . . . . 0.0 109.871 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.542 HG21 ' HE3' ' A' ' 506' ' ' MET . 96.6 mt -56.76 -33.63 41.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.698 174.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -38.82 92.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.427 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 22.3 m -66.43 -22.22 66.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.035 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -89.51 -30.0 18.55 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.613 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 77.7 -1.41 67.4 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 114.489 0.556 . . . . 0.0 114.489 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 2.0 pp -82.48 24.68 0.68 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.973 0.887 . . . . 0.0 112.531 -175.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.471 HG23 ' HG2' ' A' ' 506' ' ' MET . 58.5 m -57.98 -42.06 84.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.414 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.44 -30.7 65.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.974 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 85.1 m -58.9 -48.61 80.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.802 0.334 . . . . 0.0 111.273 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.74 ' HB2' ' SD ' ' A' ' 506' ' ' MET . 82.9 mt -96.95 -1.22 46.15 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.214 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 528' ' ' THR . 2.1 t-20 -81.29 -19.01 43.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.964 0.412 . . . . 0.0 110.976 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . 0.453 ' HG2' ' H ' ' A' ' 534' ' ' GLU . 33.0 ttt180 -104.06 168.33 9.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.868 0.366 . . . . 0.0 111.238 -175.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . 0.453 ' H ' ' HG2' ' A' ' 533' ' ' ARG . 10.7 tp10 -58.02 147.73 28.43 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.407 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 154.85 -178.3 31.64 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.707 ' HB ' HG13 ' A' ' 577' ' ' ILE . 14.9 m -116.85 126.45 74.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -149.7 142.81 24.99 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.067 0.461 . . . . 0.0 110.884 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 97.9 m -112.23 110.41 20.65 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 170.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.655 HG22 HG12 ' A' ' 573' ' ' ILE . 65.0 t -109.29 114.94 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 CA-C-O 120.879 0.371 . . . . 0.0 111.031 -175.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.63 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 80.4 m-85 -86.33 109.79 19.22 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 172.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -101.7 118.74 58.98 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.528 -166.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.666 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 72.3 Cg_endo -77.51 140.06 18.76 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.63 2.22 . . . . 0.0 111.778 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 69.5 p -78.8 -177.81 5.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.146 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . 0.545 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -73.58 -26.67 60.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.148 0.499 . . . . 0.0 110.152 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 548' ' ' ARG . 1.7 mp0 -68.36 -23.84 64.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.145 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -74.97 -31.37 61.44 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.883 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . 0.545 ' CD2' ' HA ' ' A' ' 544' ' ' ASN . 22.9 m-85 -65.64 -14.53 61.38 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . 0.641 ' HA ' ' HE ' ' A' ' 548' ' ' ARG . 3.3 mmp_? -93.93 -1.44 54.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.487 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -98.67 -11.38 22.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.631 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.769 HD12 ' HE1' ' A' ' 555' ' ' TRP . 32.5 mt -98.92 136.81 20.5 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.322 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 4.7 Cg_exo -74.8 140.25 25.83 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.884 2.389 . . . . 0.0 111.379 176.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 52.7 Cg_exo -57.57 -16.8 25.52 Favored 'Trans proline' 0 C--O 1.224 -0.187 0 C-N-CA 123.043 2.495 . . . . 0.0 112.397 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -53.33 -46.76 69.6 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.768 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 27.4 mm-40 -87.07 -40.5 14.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.239 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' TRP . . . . . 0.769 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.1 OUTLIER -62.26 -38.13 88.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.738 -173.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 24.4 t -52.24 -33.02 39.59 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.579 0.55 . . . . 0.0 111.195 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 60.8 mtm-85 -83.95 -37.0 22.85 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 120.531 0.205 . . . . 0.0 110.611 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.862 ' HB3' HD13 ' A' ' 565' ' ' LEU . 41.4 mt -64.78 -49.36 71.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.762 0.315 . . . . 0.0 111.336 -175.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.45 1.98 14.94 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 120.872 0.367 . . . . 0.0 111.316 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -108.47 -48.09 0.88 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.879 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -104.11 126.79 51.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.966 0.413 . . . . 0.0 109.906 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -73.13 -37.64 66.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.268 -170.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 566' ' ' ALA . 0.0 OUTLIER -79.68 -20.88 45.54 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.295 -177.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.13 -38.82 69.19 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.022 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.862 HD13 ' HB3' ' A' ' 558' ' ' LEU . 18.1 tp -71.41 -41.43 69.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 173.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 563' ' ' LYS . . . -59.54 -40.55 87.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.15 178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -55.08 -44.53 74.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 632' ' ' LEU . 63.3 mt -72.29 -45.45 61.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.493 HD13 HG12 ' A' ' 522' ' ' ILE . 89.5 mt -64.65 -25.55 68.0 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -178.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 592' ' ' LEU . 97.3 mttt -74.13 -13.72 60.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.69 0.281 . . . . 0.0 111.44 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.557 ' O ' HD21 ' A' ' 597' ' ' LEU . 57.6 t80 -91.51 -18.46 24.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.089 0.471 . . . . 0.0 110.03 178.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . 0.666 ' HD2' ' HD3' ' A' ' 542' ' ' PRO . 12.0 m80 -74.84 -13.08 60.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.655 HG12 HG22 ' A' ' 539' ' ' VAL . 55.5 mt -109.3 137.91 39.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.857 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -106.67 164.45 13.39 Favored Glycine 0 CA--C 1.516 0.156 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 172.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.61 -10.23 59.76 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.246 0.523 . . . . 0.0 112.407 -171.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . 0.418 ' HG2' HD21 ' A' ' 589' ' ' LEU . 11.3 pt-20 -144.46 169.86 17.15 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 122.502 -0.123 . . . . 0.0 110.811 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.707 HG13 ' HB ' ' A' ' 536' ' ' VAL . 8.3 mt -88.03 122.99 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.635 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 56.0 tp -126.92 93.7 3.83 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.645 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.9 m -86.17 179.52 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.036 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 10.9 m -62.25 -23.42 66.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.902 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -69.58 -17.47 72.86 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.566 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -100.26 -34.14 4.91 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.927 HG22 ' HB2' ' A' ' 601' ' ' LEU . 77.7 mt -62.52 99.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 122.968 0.507 . . . . 0.0 110.031 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . -121.05 -73.16 0.32 Allowed Glycine 0 C--O 1.226 -0.367 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.87 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -98.82 -82.25 0.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.839 0.352 . . . . 0.0 110.332 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 5.2 tt -155.18 117.42 4.19 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.49 133.68 67.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.492 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -105.38 110.0 22.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.82 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.418 HD21 ' HG2' ' A' ' 576' ' ' GLU . 0.9 OUTLIER -106.72 127.66 53.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -175.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -71.87 147.28 47.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.873 0.368 . . . . 0.0 110.091 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.479 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 85.8 p -108.98 -178.1 3.49 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.971 0.415 . . . . 0.0 110.443 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.632 HD23 ' HB ' ' A' ' 573' ' ' ILE . 1.6 mm? -73.62 -37.82 65.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.837 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -64.18 -31.46 72.67 Favored 'General case' 0 N--CA 1.46 0.072 0 CA-C-O 121.459 0.647 . . . . 0.0 110.085 178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.29 -17.82 6.98 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.478 -0.868 . . . . 0.0 113.889 172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 4.3 t70 -85.6 -165.84 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.975 0.888 . . . . 0.0 110.563 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -115.74 134.18 55.28 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.19 0.519 . . . . 0.0 111.746 -171.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.557 HD21 ' O ' ' A' ' 571' ' ' TYR . 87.1 mt -90.93 115.34 27.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 170.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 39.6 mt-10 -92.9 101.02 13.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.244 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 607' ' ' SER . 39.7 t -108.29 130.87 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 123.353 0.408 . . . . 0.0 111.345 -175.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.558 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 22.7 t -134.0 157.93 44.82 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.35 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.927 ' HB2' HG22 ' A' ' 583' ' ' ILE . 55.7 tp -128.92 118.78 23.22 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 172.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 602' ' ' LYS . 22.7 tptp -152.28 129.9 11.52 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.784 -0.367 . . . . 0.0 110.17 176.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 58.86 33.29 22.96 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.417 0.448 . . . . 0.0 110.57 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 75.58 -2.55 2.77 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.384 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.61 113.94 29.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.104 0.478 . . . . 0.0 110.864 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.453 HG13 HG21 ' A' ' 583' ' ' ILE . 61.5 t -77.47 134.12 29.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.446 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 15.9 m -120.52 105.91 11.29 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.599 HG22 ' OD1' ' A' ' 609' ' ' ASN . 12.6 p -111.03 139.79 33.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.599 ' OD1' HG22 ' A' ' 608' ' ' VAL . 3.1 m120 58.36 25.61 13.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.536 ' NZ ' ' HB2' ' A' ' 610' ' ' LYS . 3.7 ttmp? 69.58 22.59 6.22 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.946 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -130.96 147.5 66.54 Favored Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-O 121.079 0.466 . . . . 0.0 109.952 175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -60.76 128.8 26.78 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.55 2.833 . . . . 0.0 113.85 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.558 HG22 HG12 ' A' ' 608' ' ' VAL . 47.8 t -81.47 143.19 12.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 172.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -79.25 -61.38 2.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.38 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 616' ' ' PRO . 3.1 mt-10 -139.41 100.87 7.55 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 615' ' ' GLU . 74.1 Cg_endo -72.27 162.51 41.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.846 2.364 . . . . 0.0 114.15 174.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 74.89 45.5 0.15 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.533 164.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 34.9 mt -96.03 87.2 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 165.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . 0.525 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 49.9 mtp -76.5 146.19 38.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.519 0.675 . . . . 0.0 112.575 -171.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.48 -171.51 1.85 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.549 -1.205 . . . . 0.0 107.928 172.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 504' ' ' THR . 12.6 t -82.69 -15.71 50.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.863 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.473 ' OD1' HG23 ' A' ' 505' ' ' VAL . 27.9 p-10 -118.72 19.3 13.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.944 -178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.57 -148.38 19.35 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.69 -1.243 . . . . 0.0 112.993 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 15.0 p -139.31 146.35 25.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.916 0.389 . . . . 0.0 111.093 -175.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 69.9 t -115.34 139.96 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.65 176.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . 0.63 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 67.0 m-70 -125.59 126.99 45.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.251 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.726 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 91.6 t -77.19 119.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -174.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.2 153.0 16.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.038 0.447 . . . . 0.0 110.447 172.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 20.8 p -100.68 3.86 42.73 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.28 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -130.2 152.47 49.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.853 0.359 . . . . 0.0 110.137 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.47 ' HB ' HD11 ' A' ' 550' ' ' LEU . 43.6 t -87.82 151.77 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 172.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.578 HD13 ' ND2' ' A' ' 609' ' ' ASN . 36.8 mt -106.77 112.45 25.43 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.906 0.384 . . . . 0.0 110.741 -168.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -102.39 123.29 45.92 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.834 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 CA-C-O 118.079 -0.963 . . . . 0.0 109.712 177.92 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 120.579 0.228 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 94.11 71.22 1.13 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.962 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 20.3 ptp -177.26 30.35 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.108 0.48 . . . . 0.0 110.081 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -106.4 -148.22 15.55 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.9 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.506 ' HA ' HG22 ' A' ' 621' ' ' THR . 68.6 p -92.74 -170.02 2.34 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.282 -0.459 . . . . 0.0 110.497 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.604 ' O ' HD13 ' A' ' 509' ' ' LEU . 94.6 t -43.87 -41.26 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.084 169.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 39.7 tpp -60.02 -46.06 90.76 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.148 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.16 -42.32 99.15 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.949 0.404 . . . . 0.0 110.412 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.509 HG21 ' HB2' ' A' ' 620' ' ' ALA . 91.2 t -52.82 -46.98 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.266 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.604 HD13 ' O ' ' A' ' 505' ' ' VAL . 3.2 mp -75.67 -37.28 59.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.065 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.578 ' HA ' HG21 ' A' ' 519' ' ' VAL . 64.2 tttp -71.75 -29.9 65.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.957 0.408 . . . . 0.0 111.023 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -84.86 -10.25 79.29 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.726 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . 0.74 ' OD1' ' HG2' ' A' ' 514' ' ' ARG . 34.1 t0 -98.95 134.36 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.241 0.543 . . . . 0.0 110.782 -176.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -66.41 -35.05 79.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.284 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . 0.74 ' HG2' ' OD1' ' A' ' 512' ' ' ASP . 23.7 ptt180 -83.08 -8.92 59.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.249 -173.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.876 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 23.3 m-85 -116.27 13.0 15.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 120.943 0.401 . . . . 0.0 110.445 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 25.6 p -57.91 -49.57 76.29 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.272 -175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -69.4 -31.79 70.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.046 0.45 . . . . 0.0 110.113 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.568 HD13 ' HZ ' ' A' ' 547' ' ' PHE . 56.8 tp -54.57 -47.04 73.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.573 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.578 HG21 ' HA ' ' A' ' 510' ' ' LYS . 6.5 t -50.57 -48.66 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.043 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 523' ' ' GLN . . . -63.64 -30.95 71.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.021 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -72.97 -46.67 51.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.077 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.845 HG12 HD21 ' A' ' 569' ' ' LEU . 35.7 mt -57.1 -38.21 59.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.484 0.659 . . . . 0.0 109.612 175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' A' ' 520' ' ' ALA . 18.5 tp60 -58.52 -58.91 6.47 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.281 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.0 m -58.81 -23.44 60.46 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.754 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -86.13 -13.69 46.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.179 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 75.14 12.46 83.44 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.758 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . 0.667 HD12 HD23 ' A' ' 569' ' ' LEU . 78.5 mt -86.27 13.66 7.7 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.541 -0.388 . . . . 0.0 111.516 -176.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' A' ' 532' ' ' ASN . 36.7 m -55.57 -47.49 76.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 110.637 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . 0.673 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 12.7 pt-20 -69.2 -16.52 63.63 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.336 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 32.4 m -82.16 -44.67 16.14 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.873 0.368 . . . . 0.0 110.623 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 531' ' ' LEU . 27.2 mt -82.47 -20.02 37.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.712 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 528' ' ' THR . 16.6 m-20 -91.01 22.89 3.44 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.003 0.43 . . . . 0.0 111.122 175.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . 0.673 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 11.7 mmt180 -103.15 163.86 11.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.551 176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.09 153.76 17.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.183 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 137.9 -138.87 9.93 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.887 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.726 ' HB ' HG12 ' A' ' 577' ' ' ILE . 17.8 m -129.08 127.59 66.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -144.81 128.9 17.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.216 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 87.1 m -106.77 100.25 9.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 170.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.619 HG22 HG12 ' A' ' 573' ' ' ILE . 90.4 t -101.9 116.65 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.18 -173.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.575 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 54.2 m-85 -86.41 111.07 20.17 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 172.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -98.4 115.15 65.85 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.698 -168.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.592 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 73.3 Cg_endo -79.0 134.4 11.72 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.652 2.235 . . . . 0.0 111.181 177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 71.4 p -75.95 -179.45 4.88 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.279 0.561 . . . . 0.0 111.595 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -74.0 -16.76 61.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.796 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 548' ' ' ARG . 39.0 tt0 -76.66 -25.85 54.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.792 175.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.417 ' HB1' ' N ' ' A' ' 631' ' ' VAL . . . -72.18 -42.36 65.96 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.568 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . 0.568 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 9.1 m-85 -67.27 -13.91 62.42 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.647 0.737 . . . . 0.0 109.315 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 545' ' ' GLU . 37.1 ttm180 -90.22 -10.53 44.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.325 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -97.47 -29.04 13.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.107 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.49 HD13 HG13 ' A' ' 631' ' ' VAL . 7.2 mp -78.67 140.58 59.3 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.018 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.416 ' HG2' ' CB ' ' A' ' 554' ' ' GLU . 23.1 Cg_endo -63.3 134.21 44.19 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.655 2.237 . . . . 0.0 112.052 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.66 -41.24 46.01 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.163 2.575 . . . . 0.0 112.534 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 557' ' ' ARG . 40.0 ttm180 -57.32 -47.86 80.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.707 0.289 . . . . 0.0 110.751 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.416 ' CB ' ' HG2' ' A' ' 551' ' ' PRO . 41.3 tt0 -66.88 -46.25 75.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.098 0.475 . . . . 0.0 110.602 -177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' TRP . . . . . 0.438 ' CZ2' ' CD1' ' A' ' 547' ' ' PHE . 0.0 OUTLIER -72.44 -42.21 65.28 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.351 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 51.0 p -55.6 -26.15 42.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.564 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 553' ' ' ARG . 1.8 mmp_? -71.72 -35.57 70.24 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.669 HD22 HG13 ' A' ' 568' ' ' ILE . 16.0 mt -68.64 -50.29 52.43 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.25 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.604 HD22 HD22 ' A' ' 565' ' ' LEU . 0.5 OUTLIER -70.25 0.98 5.36 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 178.013 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -78.03 -46.37 9.41 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.082 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 564' ' ' GLU . 32.1 t70 -125.24 142.65 51.37 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -72.46 -39.88 67.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.014 -173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.551 ' HD2' ' H ' ' A' ' 563' ' ' LYS . 0.0 OUTLIER -66.16 -35.78 81.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.65 -178.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.426 ' HG2' ' OD2' ' A' ' 561' ' ' ASP . 8.1 mm-40 -74.97 -39.99 60.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.728 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.604 HD22 HD22 ' A' ' 559' ' ' LEU . 39.1 tp -65.32 -43.97 89.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.38 74.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.358 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -53.64 -51.6 62.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.173 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.669 HG13 HD22 ' A' ' 558' ' ' LEU . 24.2 mm -67.07 -52.77 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.845 HD21 HG12 ' A' ' 522' ' ' ILE . 26.7 tp -58.75 -24.56 61.86 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.97 -177.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 592' ' ' LEU . 87.9 mttt -70.37 -18.08 63.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 0.0 111.627 178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 37.5 t80 -89.77 10.08 24.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.992 0.901 . . . . 0.0 109.485 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . 0.592 ' HD2' ' HD3' ' A' ' 542' ' ' PRO . 13.4 m80 -103.78 -15.26 15.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.177 173.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.619 HG12 HG22 ' A' ' 539' ' ' VAL . 64.5 mt -109.89 115.89 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.882 -175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.643 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -83.28 150.52 27.39 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.112 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -67.48 -21.7 65.5 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . 0.633 ' HG2' HD21 ' A' ' 589' ' ' LEU . 15.9 pt-20 -129.35 -178.32 4.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.596 -173.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.726 HG12 ' HB ' ' A' ' 536' ' ' VAL . 48.4 mm -96.16 110.38 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.504 174.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.532 HD21 HG13 ' A' ' 587' ' ' VAL . 57.5 tp -113.32 93.18 4.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.489 HG13 HG22 ' A' ' 577' ' ' ILE . 21.3 m -79.15 168.53 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.689 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.611 ' HA ' HD12 ' A' ' 583' ' ' ILE . 3.5 m -53.16 -32.73 49.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.835 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.62 -17.88 71.42 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.175 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -95.76 -15.47 42.77 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.968 HG22 ' HB2' ' A' ' 601' ' ' LEU . 57.6 mt -75.54 119.59 23.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . 0.601 ' HA2' ' HB3' ' A' ' 601' ' ' LEU . . . -168.22 125.35 1.28 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 62.51 -82.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 O-C-N 124.168 0.569 . . . . 0.0 110.562 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . . . . . . . . . 6.4 tt -163.27 117.24 1.61 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . 0.532 HG13 HD21 ' A' ' 578' ' ' LEU . 6.8 p -128.75 139.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -100.74 135.75 41.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.301 0.572 . . . . 0.0 111.585 -174.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.633 HD21 ' HG2' ' A' ' 576' ' ' GLU . 1.0 OUTLIER -126.7 115.55 19.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.36 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -64.47 128.08 34.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 110.811 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.643 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 89.9 p -95.6 -173.53 2.91 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.537 -177.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 60.2 mt -76.69 -38.96 53.54 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.415 ' CB ' ' HB2' ' A' ' 571' ' ' TYR . 33.4 tt0 -61.21 -30.55 70.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.456 0.645 . . . . 0.0 110.501 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 125.95 -19.51 6.5 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.215 -0.902 . . . . 0.0 113.477 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . 0.521 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.7 t70 -84.6 -169.15 2.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 117.711 0.756 . . . . 0.0 109.951 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.468 ' HG2' ' OD1' ' A' ' 595' ' ' ASP . 14.2 pttm -110.11 136.33 49.52 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.923 -172.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.637 ' HA ' ' OD1' ' A' ' 609' ' ' ASN . 91.5 mt -84.22 114.97 22.2 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 170.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.588 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 45.8 mt-10 -86.52 84.91 7.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.393 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 607' ' ' SER . 46.2 t -86.46 118.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.688 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.841 ' HB2' ' HB2' ' A' ' 607' ' ' SER . 13.6 m -118.57 157.02 28.13 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.825 -176.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.968 ' HB2' HG22 ' A' ' 583' ' ' ILE . 58.4 tp -141.79 113.5 7.83 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -156.41 137.88 13.99 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 60.93 27.06 16.94 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 64.9 t30 63.84 11.68 6.14 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.436 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 60.0 t -95.13 118.45 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.573 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.582 HG13 HG21 ' A' ' 583' ' ' ILE . 48.9 t -82.17 147.9 5.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.848 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . 0.841 ' HB2' ' HB2' ' A' ' 600' ' ' SER . 16.9 m -134.38 158.13 44.64 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 120.583 0.23 . . . . 0.0 110.868 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.6 p -153.27 121.23 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.648 175.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.818 HD22 HD13 ' A' ' 632' ' ' LEU . 19.6 m-20 61.46 37.61 16.51 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.986 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 80.1 -12.48 1.04 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.481 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 63.1 mm-40 -95.44 143.17 25.65 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.615 0.245 . . . . 0.0 110.79 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 3.1 Cg_exo -78.81 136.62 13.53 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.134 2.556 . . . . 0.0 112.791 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 40.4 t -89.22 134.38 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -89.29 -35.74 15.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.946 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 29.5 tt0 -150.36 89.08 4.56 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.732 -175.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.38 173.19 13.53 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.125 2.55 . . . . 0.0 113.47 171.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.0 t70 77.78 23.34 0.8 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.059 164.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . 0.4 HD12 HG23 ' A' ' 627' ' ' VAL . 34.2 mt -94.36 90.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 O-C-N 122.05 -0.406 . . . . 0.0 110.135 174.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 60.6 mtp -85.91 149.49 25.18 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.472 0.654 . . . . 0.0 112.33 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . 0.509 ' HB2' HG21 ' A' ' 508' ' ' VAL . . . -113.22 -171.77 1.94 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.613 174.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 504' ' ' THR . 13.1 t -81.73 -17.46 47.73 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.414 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.436 ' OD1' HG23 ' A' ' 505' ' ' VAL . 28.7 p-10 -117.87 2.5 12.18 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . 0.502 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 173.14 -154.77 21.27 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.418 -178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 8.1 p -137.55 145.47 29.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 539' ' ' VAL . 75.6 t -117.4 140.87 38.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.978 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . 0.575 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 66.4 m-70 -126.74 118.86 25.56 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.039 175.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.876 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 96.8 t -72.51 122.59 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -174.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -119.0 151.13 21.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.206 0.527 . . . . 0.0 110.592 172.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 11.9 p -94.04 3.22 55.63 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.153 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 -136.6 146.27 45.87 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.123 0.487 . . . . 0.0 111.204 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.49 HG13 HD13 ' A' ' 550' ' ' LEU . 0.2 OUTLIER -92.68 158.25 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.818 HD13 HD22 ' A' ' 609' ' ' ASN . 16.6 mt -117.97 147.97 42.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.867 0.365 . . . . 0.0 111.647 -156.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -144.13 122.1 12.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.113 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.06 176.717 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 503' ' ' GLY . . . -76.31 -23.65 70.42 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.946 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 5.4 tpt 75.72 -30.09 0.19 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.069 0.948 . . . . 0.0 110.859 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.668 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -173.39 -155.17 11.32 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 175.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 508' ' ' VAL . 75.6 p -95.28 -173.96 3.07 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.749 ' O ' HD13 ' A' ' 509' ' ' LEU . 96.4 t -47.42 -41.06 7.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.396 170.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -41.89 97.86 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.697 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . 0.668 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 9.1 m-20 -68.65 -33.42 73.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.52 0.2 . . . . 0.0 111.159 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 504' ' ' THR . 96.0 t -51.66 -60.54 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.089 0.471 . . . . 0.0 110.958 174.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.749 HD13 ' O ' ' A' ' 505' ' ' VAL . 3.4 mp -59.27 -35.45 73.76 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.625 0.77 . . . . 0.0 111.269 177.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.61 ' HB3' ' HA ' ' A' ' 507' ' ' ASP . 43.5 tttt -63.75 -29.85 71.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.324 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -97.49 -23.3 14.41 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.237 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -90.75 132.22 35.96 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.934 0.397 . . . . 0.0 110.489 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . 0.403 ' HA ' HD22 ' A' ' 513' ' ' ASN . 11.6 m120 -76.19 -18.98 58.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -175.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -78.92 -29.43 44.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.017 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.771 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 16.5 m-85 -101.71 18.76 19.59 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.008 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 21.0 p -57.94 -57.27 13.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . 0.418 ' HB3' ' HE2' ' A' ' 517' ' ' MET . 7.8 ttp -74.13 -20.69 60.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.926 0.393 . . . . 0.0 110.158 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.52 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 50.5 tp -57.94 -41.96 83.92 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.909 176.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 509' ' ' LEU . 15.2 t -53.45 -54.77 16.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.261 177.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.23 -31.52 72.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.087 -177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.13 -56.18 8.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.794 0.33 . . . . 0.0 110.37 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.473 ' HA ' HD13 ' A' ' 569' ' ' LEU . 61.6 mt -59.33 -32.24 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.231 0.539 . . . . 0.0 110.235 178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 0.6 OUTLIER -55.59 -60.7 3.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.095 173.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.7 m -61.99 -19.11 62.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.351 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -85.44 -10.91 55.54 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.897 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 70.14 37.68 72.49 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.671 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.55 5.6 29.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.524 0.662 . . . . 0.0 111.044 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 27.2 m -53.46 -49.93 66.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.686 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . 0.649 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 28.3 mt-10 -66.03 -19.21 65.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.551 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 35.1 m -74.07 -34.32 63.99 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.083 0.468 . . . . 0.0 109.818 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.518 HD21 HD13 ' A' ' 573' ' ' ILE . 89.6 mt -93.07 -18.14 23.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.647 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . 0.544 ' HB2' ' HA ' ' A' ' 529' ' ' GLU . 0.9 OUTLIER -84.55 17.72 2.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 177.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . 0.649 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 21.9 mmt180 -111.25 172.25 6.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.305 176.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -94.13 146.28 24.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 153.97 -147.13 16.04 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.896 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.602 ' HB ' HG13 ' A' ' 577' ' ' ILE . 11.2 m -131.7 128.29 60.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -148.15 132.21 17.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.968 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . 0.432 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 95.7 m -104.68 105.23 15.23 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 172.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.785 HG22 HG12 ' A' ' 573' ' ' ILE . 62.6 t -104.78 112.57 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 120.888 0.375 . . . . 0.0 111.378 -174.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.606 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 68.4 m-85 -85.95 108.98 18.45 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 172.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -104.66 122.41 43.65 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.069 -168.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.76 138.91 19.39 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.936 2.424 . . . . 0.0 112.491 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 67.4 p -82.78 -176.59 6.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.965 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . 0.471 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 10.8 m120 -62.07 -39.65 93.14 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.67 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -66.1 -21.49 66.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -76.88 -36.45 56.72 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.099 177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . 0.502 ' HZ ' ' HB2' ' A' ' 518' ' ' LEU . 9.5 m-85 -65.31 -13.02 57.49 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 170.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -94.91 -36.42 11.62 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.975 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -91.24 11.02 24.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.13 0.491 . . . . 0.0 111.724 -174.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.799 HD12 ' CD1' ' A' ' 555' ' ' TRP . 0.2 OUTLIER -76.8 167.32 37.73 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.643 -178.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.449 ' HB2' ' HB2' ' A' ' 554' ' ' GLU . 7.6 Cg_exo -73.91 125.93 10.27 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.21 1.94 . . . . 0.0 109.952 166.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.97 -54.52 5.31 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.909 2.406 . . . . 0.0 114.138 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -70.81 -18.77 62.72 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -174.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.65 ' O ' ' HG ' ' A' ' 558' ' ' LEU . 5.9 tp10 -60.6 -54.87 40.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.609 0.718 . . . . 0.0 109.902 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' TRP . . . . . 0.799 ' CD1' HD12 ' A' ' 550' ' ' LEU . 6.7 m95 -77.79 -24.78 48.77 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.889 -177.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 52.5 m -51.28 -35.04 35.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.43 0.633 . . . . 0.0 109.616 169.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -84.69 -50.9 7.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.154 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.698 HD23 ' HG3' ' A' ' 564' ' ' GLU . 40.6 mt -57.61 -55.31 36.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.983 -172.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.42 HD22 HD22 ' A' ' 565' ' ' LEU . 0.1 OUTLIER -70.44 -1.34 10.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -98.27 -31.47 6.5 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.651 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 563' ' ' LYS . 12.9 t70 -130.5 137.84 49.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.633 0.254 . . . . 0.0 110.42 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.7 63.52 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.681 ' H ' ' HD3' ' A' ' 563' ' ' LYS . 0.1 OUTLIER -73.82 -18.6 60.93 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.717 -178.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.698 ' HG3' HD23 ' A' ' 558' ' ' LEU . 3.7 tp10 -69.63 -46.45 66.17 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 171.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.582 ' HB2' ' O ' ' A' ' 558' ' ' LEU . 20.0 tp -68.04 -45.57 73.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.087 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -60.76 -23.57 65.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.403 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . 0.834 ' HA ' ' NE2' ' A' ' 593' ' ' GLN . 52.7 t30 -55.87 -50.84 69.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.578 0.704 . . . . 0.0 110.811 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.614 HD12 HD11 ' A' ' 558' ' ' LEU . 46.2 mt -84.53 -39.58 14.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.875 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 522' ' ' ILE . 75.0 mt -61.1 -28.25 68.96 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -77.59 -10.15 59.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.907 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.58 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 50.5 t80 -100.3 -19.16 16.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.085 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -66.34 -24.94 66.6 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.381 0.61 . . . . 0.0 110.526 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.785 HG12 HG22 ' A' ' 539' ' ' VAL . 83.7 mt -105.43 141.16 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.486 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -102.81 165.92 16.54 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -70.29 -30.29 67.26 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -171.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . 0.5 ' O ' HD11 ' A' ' 589' ' ' LEU . 14.4 pt-20 -148.04 178.4 8.56 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 122.274 -0.266 . . . . 0.0 110.529 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.602 HG13 ' HB ' ' A' ' 536' ' ' VAL . 57.5 mt -81.16 122.23 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 121.143 0.497 . . . . 0.0 111.961 -171.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.586 HD21 HG13 ' A' ' 587' ' ' VAL . 55.0 tp -122.31 93.26 3.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.424 174.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.4 HG13 HG22 ' A' ' 577' ' ' ILE . 26.7 m -83.81 169.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.469 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.413 ' HA ' HD12 ' A' ' 583' ' ' ILE . 26.1 m -60.41 -15.65 28.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.887 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -68.76 -16.37 70.02 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 172.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -101.69 -28.11 6.81 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.846 HG22 ' HB2' ' A' ' 601' ' ' LEU . 53.4 mt -72.14 89.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.793 0.33 . . . . 0.0 110.226 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 601' ' ' LEU . . . -113.8 -58.59 0.39 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.327 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -113.46 -71.6 0.74 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 175.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 599' ' ' VAL . 6.2 tt -157.83 129.58 6.88 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . 0.586 HG13 HD21 ' A' ' 578' ' ' LEU . 6.8 p -143.86 139.64 25.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.22 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . 0.538 ' HB3' ' HG2' ' A' ' 598' ' ' GLU . 6.3 ptp180 -107.9 140.22 41.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.342 0.591 . . . . 0.0 111.491 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.5 HD11 ' O ' ' A' ' 576' ' ' GLU . 0.5 OUTLIER -124.45 121.63 35.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.298 -179.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.417 ' HE2' ' HA2' ' A' ' 594' ' ' GLY . 24.2 tptm -63.62 140.94 58.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.69 0.281 . . . . 0.0 110.26 177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.534 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 60.2 p -102.11 -177.83 3.52 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.72 ' H ' HD22 ' A' ' 592' ' ' LEU . 0.9 OUTLIER -76.68 -44.88 31.88 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.127 0.489 . . . . 0.0 110.474 178.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.834 ' NE2' ' HA ' ' A' ' 567' ' ' ASN . 6.5 tp-100 -63.4 -30.8 71.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.491 -176.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . 0.417 ' HA2' ' HE2' ' A' ' 590' ' ' LYS . . . 124.62 16.02 3.15 Favored Glycine 0 C--N 1.318 -0.447 0 C-N-CA 119.731 -1.224 . . . . 0.0 114.438 168.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . 0.58 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 10.4 t70 -110.66 -164.87 0.95 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.878 0.839 . . . . 0.0 108.789 174.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.419 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 18.3 pttp -127.24 120.0 27.67 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.092 0.472 . . . . 0.0 111.35 -172.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.577 HD21 ' O ' ' A' ' 571' ' ' TYR . 98.3 mt -79.2 115.37 18.82 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.538 ' HG2' ' HB3' ' A' ' 588' ' ' ARG . 33.7 mt-10 -108.75 112.36 24.6 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.29 0.567 . . . . 0.0 110.782 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 586' ' ' LEU . 21.3 t -107.59 133.6 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.532 -171.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.757 ' HB3' ' HB2' ' A' ' 607' ' ' SER . 37.9 t -126.02 160.81 29.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.846 ' HB2' HG22 ' A' ' 583' ' ' ILE . 48.8 tp -132.73 127.1 33.97 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.489 ' HG2' ' OD1' ' A' ' 603' ' ' ASN . 60.6 tttp -156.42 129.1 7.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . 0.489 ' OD1' ' HG2' ' A' ' 602' ' ' LYS . 18.6 m120 61.15 28.03 17.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.03 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 56.9 t30 68.64 18.49 8.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.708 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.69 126.53 60.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.741 174.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 59.7 t -88.24 137.46 21.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.318 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . 0.757 ' HB2' ' HB3' ' A' ' 600' ' ' SER . 6.9 m -125.19 103.54 8.02 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.503 HG11 ' CD1' ' A' ' 540' ' ' PHE . 7.4 p -109.28 117.96 55.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.53 ' ND2' HD13 ' A' ' 632' ' ' LEU . 12.9 m-20 63.16 29.75 16.06 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 60.0 tttp 77.02 -2.39 2.67 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.311 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.516 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 70.0 mm-40 -92.42 129.57 40.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.397 . . . . 0.0 110.879 178.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 13.0 Cg_exo -70.51 126.58 12.96 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.295 2.663 . . . . 0.0 112.518 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.744 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 32.8 t -86.72 136.62 22.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.887 176.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -83.04 -57.0 3.47 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.128 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -133.66 100.74 13.37 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.451 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.29 164.26 33.15 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.824 2.349 . . . . 0.0 112.628 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 71.64 31.46 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 169.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 50.6 mt -85.66 90.21 2.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 168.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . 0.524 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 66.6 mtp -79.7 148.39 31.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -169.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -118.45 -175.58 2.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.702 -1.135 . . . . 0.0 108.621 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.3 t -83.64 -9.45 58.88 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.528 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.5 ' OD1' HG23 ' A' ' 505' ' ' VAL . 28.7 p-10 -117.68 7.72 12.62 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.499 0.19 . . . . 0.0 111.481 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 159.25 -143.59 9.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.004 -1.093 . . . . 0.0 113.003 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.1 p -139.34 147.64 24.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.595 0.236 . . . . 0.0 110.589 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.5 141.76 34.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.322 0.582 . . . . 0.0 111.217 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . 0.606 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 46.7 m-70 -126.75 125.28 41.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.771 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 85.5 t -78.18 118.59 25.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -175.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.49 155.59 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 120.943 0.401 . . . . 0.0 110.716 172.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 19.9 p -102.65 4.06 37.84 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.444 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -137.4 163.3 31.38 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.982 0.42 . . . . 0.0 111.254 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.74 142.98 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.779 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.53 HD13 ' ND2' ' A' ' 609' ' ' ASN . 69.9 mt -95.34 167.7 11.17 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 120.635 0.255 . . . . 0.0 110.473 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -161.58 138.64 8.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.886 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.215 179.574 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 120.602 0.239 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -74.65 80.46 0.91 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.335 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 19.3 ptm -86.32 89.92 8.01 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.499 0.666 . . . . 0.0 110.203 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 507' ' ' ASP . . . -103.39 -160.32 25.12 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.513 -178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.489 ' HA ' HG22 ' A' ' 621' ' ' THR . 79.0 p -85.98 -172.48 4.11 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.887 HG21 HD22 ' A' ' 531' ' ' LEU . 7.4 m -46.79 -37.97 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.222 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.96 -45.13 90.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.274 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . 0.552 ' CB ' ' HA3' ' A' ' 503' ' ' GLY . 6.1 t70 -68.76 -33.35 73.75 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 504' ' ' THR . 94.3 t -52.65 -40.07 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.22 0.533 . . . . 0.0 110.538 174.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 5.6 mt -82.27 -34.51 28.7 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.405 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.594 ' HA ' HG21 ' A' ' 519' ' ' VAL . 58.1 tttp -66.51 -34.61 78.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.062 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -88.15 -5.4 76.6 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.645 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -106.75 142.04 37.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.29 0.545 . . . . 0.0 111.387 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -68.37 -32.8 73.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.786 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . 0.568 ' HD2' ' H ' ' A' ' 514' ' ' ARG . 3.1 mpt_? -83.02 -19.27 37.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -173.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.732 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 19.9 m-85 -107.75 5.55 26.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.172 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 68.5 m -59.98 -38.1 81.57 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.754 0.312 . . . . 0.0 111.579 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.6 tmm? -82.56 -26.01 32.79 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 515' ' ' PHE . 45.6 tp -58.02 -43.68 86.87 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.913 175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 510' ' ' LYS . 7.2 t -50.69 -51.04 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.931 176.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -64.74 -32.8 74.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.926 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.89 -50.19 44.82 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.158 176.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.584 HG12 HD11 ' A' ' 569' ' ' LEU . 68.4 mt -57.94 -34.45 48.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.31 0.576 . . . . 0.0 109.789 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.55 -57.72 11.16 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.452 173.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 49.2 m -58.63 -26.56 63.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.995 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -74.63 -23.94 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.869 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 68.25 19.62 72.45 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.104 -0.57 . . . . 0.0 114.153 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 569' ' ' LEU . 3.8 pp -104.36 22.44 14.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.579 0.69 . . . . 0.0 111.135 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 88.8 m -53.81 -41.97 67.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.951 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . 0.617 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 1.0 OUTLIER -60.23 -16.38 33.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.226 -178.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 26.2 m -76.18 -51.0 13.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.906 0.384 . . . . 0.0 109.991 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.887 HD22 HG21 ' A' ' 505' ' ' VAL . 61.2 mt -81.39 -13.69 58.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.679 -177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -72.89 -20.01 61.17 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.822 0.344 . . . . 0.0 111.416 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . 0.617 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 59.8 mtt180 -74.09 139.67 44.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.1 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -84.06 131.74 34.78 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 167.54 -120.64 0.92 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.447 ' HB ' HG13 ' A' ' 577' ' ' ILE . 15.8 m -137.99 126.81 32.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.716 0.294 . . . . 0.0 111.06 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -151.64 143.91 24.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.786 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 99.2 m -115.96 111.09 19.88 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.707 HG22 HG12 ' A' ' 573' ' ' ILE . 88.5 t -111.04 114.23 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.946 -176.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.629 ' CD1' ' HB2' ' A' ' 626' ' ' HIS . 61.5 m-85 -84.87 108.99 17.8 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -100.11 121.13 54.84 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.969 -166.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.468 ' HD3' ' HD2' ' A' ' 572' ' ' HIS . 93.5 Cg_endo -83.51 138.93 8.76 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.789 2.326 . . . . 0.0 112.158 178.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 66.8 p -83.35 -178.02 6.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.244 0.545 . . . . 0.0 112.087 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . 0.438 ' HA ' ' CD2' ' A' ' 547' ' ' PHE . 0.9 OUTLIER -62.57 -37.84 87.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.322 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -34.19 71.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.522 0.677 . . . . 0.0 110.238 178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.502 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -70.54 -36.85 73.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.373 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . 0.456 ' HZ ' HD13 ' A' ' 518' ' ' LEU . 17.3 m-85 -66.44 -18.01 65.12 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.222 0.534 . . . . 0.0 109.655 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 21.2 ttp85 -92.79 -16.26 25.57 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.047 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -80.51 -13.92 58.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.005 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.696 HD11 ' HB ' ' A' ' 631' ' ' VAL . 78.8 mt -95.34 143.36 25.98 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.017 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 24.6 Cg_exo -63.05 134.39 45.83 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.766 2.311 . . . . 0.0 111.755 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 52.7 Cg_exo -54.45 -32.43 73.11 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.039 2.493 . . . . 0.0 112.234 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 44.2 mtm105 -57.87 -30.96 66.24 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.46 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -86.21 -52.18 5.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.255 0.55 . . . . 0.0 110.539 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' TRP . . . . . 0.516 ' HE1' HD12 ' A' ' 550' ' ' LEU . 0.0 OUTLIER -68.84 -38.27 79.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -170.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.0 t -54.6 -24.97 23.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.195 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 49.9 mtm-85 -82.92 -33.39 26.85 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.412 -0.18 . . . . 0.0 111.0 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.624 ' HB3' ' HG ' ' A' ' 565' ' ' LEU . 14.5 mt -65.26 -50.57 65.26 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-O 121.002 0.43 . . . . 0.0 110.292 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.462 HD22 HD11 ' A' ' 565' ' ' LEU . 0.6 OUTLIER -69.34 -16.51 63.55 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.848 0.356 . . . . 0.0 111.424 177.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -85.95 -38.34 8.69 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.024 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -124.66 135.28 52.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.158 0.504 . . . . 0.0 111.267 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -73.57 -31.34 63.57 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.11 -170.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.536 ' HD2' ' H ' ' A' ' 563' ' ' LYS . 9.6 mptt -71.2 -37.05 72.12 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.85 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.1 -34.52 73.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.676 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.624 ' HG ' ' HB3' ' A' ' 558' ' ' LEU . 0.4 OUTLIER -75.73 -47.27 26.74 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.892 0.377 . . . . 0.0 110.443 177.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -59.67 -33.99 72.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.426 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -56.3 -52.79 63.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.946 0.403 . . . . 0.0 111.033 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 632' ' ' LEU . 73.9 mt -71.46 -46.67 62.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.429 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' A' ' 527' ' ' LEU . 0.1 OUTLIER -51.96 -34.23 41.3 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.404 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 47.2 mttp -69.47 -26.05 64.38 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.578 ' O ' HD21 ' A' ' 597' ' ' LEU . 52.4 t80 -80.31 -17.04 53.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.959 0.409 . . . . 0.0 110.708 -176.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . 0.596 ' CE1' ' HB2' ' A' ' 632' ' ' LEU . 16.7 m80 -79.89 -6.18 56.95 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.257 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.707 HG12 HG22 ' A' ' 539' ' ' VAL . 69.1 mt -117.12 117.47 55.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.04 -175.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.1 167.49 34.48 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.64 177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.568 ' OD2' ' HB2' ' A' ' 590' ' ' LYS . 8.0 m-20 -54.63 -42.22 70.97 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.06 -176.56 5.71 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.748 -168.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.516 HG12 ' HA2' ' A' ' 623' ' ' GLY . 58.6 mt -82.08 118.23 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.314 -173.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.413 HD11 HG11 ' A' ' 587' ' ' VAL . 4.6 tt -118.49 93.47 4.13 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 172.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 17.9 m -73.5 167.53 2.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.573 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.646 ' HA ' HD12 ' A' ' 583' ' ' ILE . 13.1 t -62.37 -24.15 67.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.2 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -71.04 -10.89 69.38 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.036 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -99.9 -17.51 25.3 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.741 HG22 ' HB2' ' A' ' 601' ' ' LEU . 77.4 mt -71.47 94.47 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.362 0.601 . . . . 0.0 110.394 176.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -109.15 -121.47 4.47 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.975 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -58.96 -62.79 1.62 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.846 0.355 . . . . 0.0 110.528 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.439 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 7.9 tt -168.48 129.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . 0.413 HG11 HD11 ' A' ' 578' ' ' LEU . 47.3 t -129.61 136.05 60.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.95 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 588' ' ' ARG . 14.7 mtm180 -97.98 120.84 39.09 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.141 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.76 116.67 32.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.568 ' HB2' ' OD2' ' A' ' 575' ' ' ASP . 23.7 mmmt -63.88 139.23 58.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.723 0.296 . . . . 0.0 110.336 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.581 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 86.5 p -106.14 -173.92 2.41 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.346 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 570' ' ' LYS . 76.3 mt -80.79 -39.69 26.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.829 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.484 ' OE1' ' HB3' ' A' ' 634' ' ' ALA . 24.4 tt0 -61.84 -29.58 70.27 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.088 0.47 . . . . 0.0 110.833 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 127.03 -18.83 6.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.268 -0.968 . . . . 0.0 114.509 170.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 596' ' ' LYS . 8.8 t70 -88.52 -158.88 0.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.466 1.133 . . . . 0.0 109.893 177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.472 ' H ' ' CG ' ' A' ' 595' ' ' ASP . 10.8 pttm -124.75 135.98 53.46 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.862 0.363 . . . . 0.0 111.07 -169.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.578 HD21 ' O ' ' A' ' 571' ' ' TYR . 94.6 mt -83.85 115.34 22.21 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 172.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -91.32 84.84 5.66 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.69 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 608' ' ' VAL . 2.4 p -110.08 132.05 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.248 0.547 . . . . 0.0 111.69 -175.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.439 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 5.8 p -144.33 168.76 19.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.148 -176.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.741 ' HB2' HG22 ' A' ' 583' ' ' ILE . 1.8 tt -117.84 112.49 20.45 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 172.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -141.14 135.89 31.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.138 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 64.9 t30 61.41 36.29 17.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.279 0.561 . . . . 0.0 110.281 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 67.2 t30 73.24 -2.17 2.82 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.773 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 9.6 p -122.81 147.37 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.852 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.476 HG13 HG21 ' A' ' 583' ' ' ILE . 57.6 t -77.68 132.12 33.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.219 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 5.8 p -123.84 112.29 17.1 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.06 0.457 . . . . 0.0 111.21 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.622 HG23 ' HB ' ' A' ' 599' ' ' VAL . 10.7 p -114.89 135.29 55.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.485 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.551 ' OD1' HG22 ' A' ' 608' ' ' VAL . 0.5 OUTLIER 57.75 26.36 12.99 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -177.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 62.8 mttm 76.09 1.4 3.44 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.205 1.002 . . . . 0.0 111.915 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 29.7 mm-40 -101.37 137.35 19.63 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.276 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 11.6 Cg_exo -72.45 126.58 11.7 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 123.021 2.48 . . . . 0.0 112.294 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.07 141.95 14.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.996 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -75.65 -60.3 2.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.857 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -141.68 113.48 6.54 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.615 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.432 ' HG3' HG21 ' A' ' 606' ' ' VAL . 65.0 Cg_endo -81.51 169.88 15.03 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.833 2.355 . . . . 0.0 113.053 174.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 580' ' ' SER . 2.5 t70 72.95 28.28 1.99 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.479 165.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . . . . . . . . . 52.3 mt -80.9 89.54 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 172.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . 0.516 ' HA ' ' HA ' ' A' ' 624' ' ' VAL . 53.2 mtp -78.97 137.07 37.43 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.635 0.731 . . . . 0.0 112.74 -171.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -106.26 -177.74 3.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.017 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.489 HG22 ' HA ' ' A' ' 504' ' ' THR . 15.0 t -74.74 -16.54 60.73 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.332 -178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.788 HD21 HG22 ' A' ' 505' ' ' VAL . 30.7 p-10 -119.37 10.51 11.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . 0.516 ' HA2' HG12 ' A' ' 577' ' ' ILE . . . 161.79 -147.05 12.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.415 -1.374 . . . . 0.0 113.52 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 619' ' ' MET . 14.4 p -139.97 145.06 26.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.064 0.459 . . . . 0.0 110.86 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . . . . . . . . . 76.8 t -118.74 143.61 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.657 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . 0.629 ' HB2' ' CD1' ' A' ' 540' ' ' PHE . 34.9 m-70 -130.16 127.19 39.23 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.732 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 98.2 t -79.94 119.3 29.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -174.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.7 148.21 17.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.028 0.442 . . . . 0.0 110.581 172.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 33.0 p -95.74 10.5 36.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.65 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -136.03 155.63 49.94 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.696 ' HB ' HD11 ' A' ' 550' ' ' LEU . 52.0 t -96.83 157.29 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.596 ' HB2' ' CE1' ' A' ' 572' ' ' HIS . 46.4 mt -114.68 112.74 23.34 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.856 0.36 . . . . 0.0 110.277 -170.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -115.73 105.57 12.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.22 0.533 . . . . 0.0 110.746 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' ALA . . . . . 0.484 ' HB3' ' OE1' ' A' ' 593' ' ' GLN . . . . . . . . 0 C--N 1.315 -0.906 0 CA-C-O 118.277 -0.868 . . . . 0.0 109.326 177.03 . . . . . . . . 1 1 . 1 stop_ save_